{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json \n",
    "import os \n",
    "import pandas as pd \n",
    "import numpy as np \n",
    "import random\n",
    "from collections import defaultdict \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def _get_size(cancer, mode):\n",
    "    if (cancer == \"breast\" or cancer == \"ovarian\") and mode == \"train\":\n",
    "        return 100\n",
    "    elif cancer == \"melanoma\" and mode == \"train\":\n",
    "        return 10 \n",
    "    elif (cancer == \"breast\" or cancer == \"ovarian\") and mode == \"dev\":\n",
    "        return 20 \n",
    "    elif cancer == \"melanoma\" and mode == \"dev\":\n",
    "        return 2 "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### convert non-empty json for rel type \n",
    "multi seq classification"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "20\n",
      "237 [169  40 232 209  16 133 196   5 215 232 141 201 214 143 122 194   2 234\n",
      " 104 149]\n",
      "20\n",
      "681 [597 453  11 496 632 212 489 455 533 302 529 362 431 491 326 140 327 212\n",
      "  14 508]\n",
      "2\n",
      "558 [112 137]\n"
     ]
    }
   ],
   "source": [
    "# sample\n",
    "\n",
    "mode = \"dev\"\n",
    "\n",
    "\n",
    "final_lst = []\n",
    "for cancer in [\"breast\", \"ovarian\", \"melanoma\"]:\n",
    "    file = f\"/users/the/NER_MTB/timeset/my_code_result/notebooks1/{cancer}_{mode}_non_empty_rel.json\"\n",
    "    with open(file, \"r\") as infile: \n",
    "        dct = json.load(infile)\n",
    "\n",
    "    non_none_rel = [] # exclude the one dones't have relatioship\n",
    "    for pair in dct: \n",
    "        if pair[\"rel_type\"]is None or pair[\"rel_type\"] == \"none\": \n",
    "            continue \n",
    "        non_none_rel.append(pair)\n",
    "\n",
    "    with open(f'./{cancer}_{mode}_non_none_rel.json', 'w') as f:\n",
    "        json.dump(non_none_rel, f, indent=4) \n",
    "    len(non_none_rel)\n",
    "\n",
    "    size = _get_size(cancer, mode)\n",
    "    print(size)\n",
    "    random_lst = np.random.randint(0, len(dct), size)\n",
    "    print(len(dct), random_lst)\n",
    "\n",
    "    for ind, pair in enumerate(non_none_rel):\n",
    "        if ind in random_lst:\n",
    "            chose_pair = defaultdict()\n",
    "            chose_pair[\"filename\"] = pair[\"filename\"]\n",
    "            chose_pair[\"context\"] = pair[\"context\"]\n",
    "            chose_pair[\"arg1\"] = {\"mention\": pair[\"arg1\"][\"mention\"],\n",
    "                                  \"start\": pair[\"arg1\"][\"start\"],\n",
    "                                   \"end\": pair[\"arg1\"][\"end\"]}\n",
    "            chose_pair[\"arg2\"] = {\"mention\": pair[\"arg2\"][\"mention\"],\n",
    "                            \"start\": pair[\"arg2\"][\"start\"],\n",
    "                            \"end\": pair[\"arg2\"][\"end\"]}\n",
    "            chose_pair[\"relation\"] = pair[\"rel_type\"]\n",
    "            final_lst.append(chose_pair)\n",
    "        else: \n",
    "            continue\n",
    "\n",
    "with open(f'/users/the/NER_MTB/timeset/my_code_result/input_data/rel_label_task/tddiscourse/{mode}.json', 'w') as f:\n",
    "        json.dump(final_lst, f, indent=4) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'filename': 'patient30_report006_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TAMOXIFEN', 'nth_sent': 3, 'start': 20, 'end': 29}, 'arg2': {'mention': 'THIS YEAR', 'nth_sent': 3, 'start': 30, 'end': 39}, 'context': 'SHE HAS BEEN TAKING TAMOXIFEN THIS YEAR.  '}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 4, 'start': 68, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #3/4 adjuvant Adriamycin and Cytoxan with Neulasta support.'}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 4, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #3/4 adjuvant Adriamycin and Cytoxan with Neulasta support.'}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 10, 'start': 68, 'end': 73}, 'arg2': {'mention': 'weekly', 'nth_sent': 10, 'start': 61, 'end': 67}, 'context': 'Cycle #3/4 adjuvant Adriamycin and Cytoxan to be followed by weekly Taxol PREVIOUS THERAPY: See table below.'}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 16, 'start': 65, 'end': 76}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 16, 'start': 104, 'end': 112}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments Doxorubicin/Cyclophosphamide Person55  4/4/2013                                                                                                                                                                Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 16, 'start': 77, 'end': 93}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 16, 'start': 104, 'end': 112}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments Doxorubicin/Cyclophosphamide Person55  4/4/2013                                                                                                                                                                Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 102, 'start': 68, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 102, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #3/4 adjuvant Adriamycin and Cytoxan.   '}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 102, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 102, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #3/4 adjuvant Adriamycin and Cytoxan.   '}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 103, 'start': 8, 'end': 18}, 'arg2': {'mention': 'today', 'nth_sent': 103, 'start': 31, 'end': 36}, 'context': 'Cycle 3 Adriamycin and Cytoxan today with Neulasta tomorrow  Continue to hold Decadron secondary to migraine headache  Discontinue Compazine.'}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 103, 'start': 23, 'end': 30}, 'arg2': {'mention': 'today', 'nth_sent': 103, 'start': 31, 'end': 36}, 'context': 'Cycle 3 Adriamycin and Cytoxan today with Neulasta tomorrow  Continue to hold Decadron secondary to migraine headache  Discontinue Compazine.'}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 72, 'end': 77}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 21, 'end': 26}, 'context': 'The patient presents today to complete her adjuvant chemotherapy weekly Taxol, #12 of 12.'}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 72, 'end': 77}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 65, 'end': 71}, 'context': 'The patient presents today to complete her adjuvant chemotherapy weekly Taxol, #12 of 12.'}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 10, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 10, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 10, 'start': 66, 'end': 77}, 'arg2': {'mention': '6/6/2013', 'nth_sent': 10, 'start': 114, 'end': 122}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 10, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 10, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 10, 'start': 78, 'end': 94}, 'arg2': {'mention': '6/6/2013', 'nth_sent': 10, 'start': 114, 'end': 122}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 10, 'start': 135, 'end': 145}, 'arg2': {'mention': '7/2/2013', 'nth_sent': 10, 'start': 156, 'end': 164}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 48, 'end': 53}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy using Taxol, cycle 12 of 12.'}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 88, 'start': 126, 'end': 131}, 'arg2': {'mention': 'currently', 'nth_sent': 88, 'start': 90, 'end': 99}, 'context': 'The patient has undergone a segmental mastectomy, chemotherapy Adriamycin/Cytoxan, and is currently completing her #12 weekly Taxol.  '}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 88, 'start': 126, 'end': 131}, 'arg2': {'mention': 'weekly', 'nth_sent': 88, 'start': 119, 'end': 125}, 'context': 'The patient has undergone a segmental mastectomy, chemotherapy Adriamycin/Cytoxan, and is currently completing her #12 weekly Taxol.  '}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 3, 'start': 66, 'end': 76}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 81, 'end': 88}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 11, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 11, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 12, 'start': 48, 'end': 58}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy using Adriamycin and Cytoxan, cycle 4 of 4.'}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 12, 'start': 63, 'end': 70}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy using Adriamycin and Cytoxan, cycle 4 of 4.'}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 93, 'start': 51, 'end': 56}, 'arg2': {'mention': 'weekly', 'nth_sent': 93, 'start': 44, 'end': 50}, 'context': 'The patient will return in 3 weeks to begin weekly Taxol.'}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 5, 'start': 68, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 adjuvant Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 adjuvant Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 95, 'end': 107}, 'arg2': {'mention': 'the day of', 'nth_sent': 6, 'start': 84, 'end': 94}, 'context': \"At today's visit, she reports that she had a migraine headache for 4 days, starting the day of chemotherapy.\"}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 21, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 21, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013                                                                                                                                                                Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 21, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 21, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013                                                                                                                                                                Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 101, 'start': 68, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 101, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 adjuvant Adriamycin and Cytoxan.   '}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 101, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 101, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 adjuvant Adriamycin and Cytoxan.   '}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 104, 'start': 50, 'end': 60}, 'arg2': {'mention': '1week', 'nth_sent': 104, 'start': 20, 'end': 25}, 'context': 'Return to clinic in 1week for cycle #2/4 adjuvant Adriamycin and Cytoxan .  '}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan ', 'nth_sent': 104, 'start': 65, 'end': 72}, 'arg2': {'mention': '1week', 'nth_sent': 104, 'start': 20, 'end': 25}, 'context': 'Return to clinic in 1week for cycle #2/4 adjuvant Adriamycin and Cytoxan .  '}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 76, 'end': 81}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #4 weekly Taxol.'}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 76, 'end': 81}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 69, 'end': 75}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #4 weekly Taxol.'}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 10, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 10, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 10, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 10, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 11, 'start': 55, 'end': 60}, 'arg2': {'mention': 'currently', 'nth_sent': 11, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy using weekly Taxol, #4 of 12.'}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 11, 'start': 55, 'end': 60}, 'arg2': {'mention': 'weekly', 'nth_sent': 11, 'start': 48, 'end': 54}, 'context': 'She is currently on adjuvant chemotherapy using weekly Taxol, #4 of 12.'}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 94, 'start': 91, 'end': 103}, 'arg2': {'mention': 'currently', 'nth_sent': 94, 'start': 62, 'end': 71}, 'context': 'The patient has undergone a left segmental mastectomy, and is currently receiving adjuvant chemotherapy in light of her triple negative status.'}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 95, 'start': 46, 'end': 51}, 'arg2': {'mention': 'weekly', 'nth_sent': 95, 'start': 39, 'end': 45}, 'context': 'She is here prior to cycle #4 of 12 of weekly Taxol.  '}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 98, 'start': 89, 'end': 94}, 'arg2': {'mention': 'weekly', 'nth_sent': 98, 'start': 66, 'end': 72}, 'context': 'The patient will return in 4 weeks to be seen, prior to cycle #8, weekly to continue her Taxol.  '}\n",
      "{'filename': 'patient47_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 5, 'start': 109, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 115, 'end': 120}, 'context': 'I have personally performed the medical decision making and would like to add: Patient47 is finishing up her Taxol today.'}\n",
      "{'filename': 'patient47_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 5, 'start': 100, 'end': 105}, 'arg2': {'mention': 'weekly', 'nth_sent': 5, 'start': 93, 'end': 99}, 'context': 'Medical Oncology:  Adjuvant Chemo with Dr. Person2, 4 of 4 cycles of Adriamycin/Cytoxan + 12 weekly Taxol.'}\n",
      "{'filename': 'patient47_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 6, 'start': 17, 'end': 22}, 'arg2': {'mention': 'Sept. 17th', 'nth_sent': 6, 'start': 41, 'end': 51}, 'context': 'Her last dose of Taxol will be tomorrow, Sept. 17th.  '}\n",
      "{'filename': 'patient47_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 35, 'end': 40}, 'arg2': {'mention': 'At this point', 'nth_sent': 2, 'start': 0, 'end': 13}, 'context': 'At this point she will be going on Taxol.'}\n",
      "{'filename': 'patient47_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 44, 'start': 50, 'end': 62}, 'arg2': {'mention': 'at this point in time', 'nth_sent': 44, 'start': 63, 'end': 84}, 'context': \"Hypertension NOS   Breast cancer-still undergoing chemotherapy at this point in time  Osteoporosis we'll give her a drug holiday from bisphosphonates given the fact she's been on drugs for about 10 years.\"}\n",
      "{'filename': 'patient47_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 108, 'start': 247, 'end': 252}, 'arg2': {'mention': '12 weeks', 'nth_sent': 108, 'start': 235, 'end': 243}, 'context': 'Patient47 is a 57-year-old postmenopausal female with left T2, N0, M0 IDC diagnosed January 18, 2013, triple negative    Recommendations were given for adjuvant chemotherapy with Adriamycin and Cytoxan Q. 21 days 4 cycles, followed by 12 weeks of Taxol  She will require adjuvant radiation therapy.'}\n",
      "{'filename': 'patient47_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 2, 'start': 57, 'end': 67}, 'arg2': {'mention': 'April 4, 2013', 'nth_sent': 2, 'start': 83, 'end': 96}, 'context': 'The patient received her first dose of chemotherapy with Adriamycin and Cytoxan on April 4, 2013.'}\n",
      "{'filename': 'patient47_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 2, 'start': 72, 'end': 79}, 'arg2': {'mention': 'April 4, 2013', 'nth_sent': 2, 'start': 83, 'end': 96}, 'context': 'The patient received her first dose of chemotherapy with Adriamycin and Cytoxan on April 4, 2013.'}\n",
      "{'filename': 'patient47_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 64, 'start': 115, 'end': 127}, 'arg2': {'mention': 'next week', 'nth_sent': 64, 'start': 128, 'end': 137}, 'context': 'The patient is also advised to her oncologist about this occurrence since she is scheduled for repeat second cycle chemotherapy next week.'}\n",
      "{'filename': 'patient47_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 9, 'start': 92, 'end': 97}, 'arg2': {'mention': '12 weeks', 'nth_sent': 9, 'start': 80, 'end': 88}, 'context': 'Given her high risk, node (-) phenotype, I recommend 4 cycles of AC followed by 12 weeks of taxol.'}\n",
      "{'filename': 'patient47_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'A.C', 'nth_sent': 67, 'start': 236, 'end': 239}, 'arg2': {'mention': 'today', 'nth_sent': 67, 'start': 249, 'end': 254}, 'context': 'Right Breast: Without palpable masses, skin lesions, or subcutaneous nodules  ASSESSMENT AND PLAN:  Patient47 is a 57 year old postmenopausal female with a history of left T2, N0, M0 IDC diagnosed January 2013, ER/PR HER-2 negative  1. A.C. #1 of 4 today 2.'}\n",
      "{'filename': 'patient47_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 78, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 79, 'start': 106, 'end': 114}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person126  4/4/2013                                                                                                                                                                                                                                              Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                             Comments:  '}\n",
      "{'filename': 'patient47_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 78, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 79, 'start': 106, 'end': 114}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person126  4/4/2013                                                                                                                                                                                                                                              Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                             Comments:  '}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 79, 'end': 84}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #8/12 weekly Taxol.  '}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 79, 'end': 84}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 72, 'end': 78}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #8/12 weekly Taxol.  '}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 8, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 8, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013                                                                                                                                                                                                                                      Comments:  Radiation Oncology Therapies:'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 8, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 8, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013                                                                                                                                                                                                                                      Comments:  Radiation Oncology Therapies:'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 8, 'start': 66, 'end': 77}, 'arg2': {'mention': '6/6/2013', 'nth_sent': 8, 'start': 114, 'end': 122}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013                                                                                                                                                                                                                                      Comments:  Radiation Oncology Therapies:'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 8, 'start': 78, 'end': 94}, 'arg2': {'mention': '6/6/2013', 'nth_sent': 8, 'start': 114, 'end': 122}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013                                                                                                                                                                                                                                      Comments:  Radiation Oncology Therapies:'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 8, 'start': 135, 'end': 145}, 'arg2': {'mention': '7/2/2013', 'nth_sent': 8, 'start': 156, 'end': 164}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013                                                                                                                                                                                                                                      Comments:  Radiation Oncology Therapies:'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 10, 'start': 55, 'end': 60}, 'arg2': {'mention': 'currently', 'nth_sent': 10, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy using weekly Taxol, #8 of 12.'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 10, 'start': 55, 'end': 60}, 'arg2': {'mention': 'weekly', 'nth_sent': 10, 'start': 48, 'end': 54}, 'context': 'She is currently on adjuvant chemotherapy using weekly Taxol, #8 of 12.'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 75, 'start': 91, 'end': 103}, 'arg2': {'mention': 'currently', 'nth_sent': 75, 'start': 62, 'end': 71}, 'context': 'The patient has undergone a left segmental mastectomy, and is currently receiving adjuvant chemotherapy in light of her triple negative status.'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 76, 'start': 46, 'end': 51}, 'arg2': {'mention': 'weekly', 'nth_sent': 76, 'start': 39, 'end': 45}, 'context': 'She is here prior to cycle #8 of 12 of weekly Taxol, which she is tolerating well.  '}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 76, 'end': 81}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #1 weekly Taxol.'}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 76, 'end': 81}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 69, 'end': 75}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #1 weekly Taxol.'}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 66, 'end': 77}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 11, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 78, 'end': 94}, 'arg2': {'mention': '4/4/2013', 'nth_sent': 11, 'start': 105, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 55, 'end': 60}, 'arg2': {'mention': 'weekly', 'nth_sent': 12, 'start': 48, 'end': 54}, 'context': 'She is currently on adjuvant chemotherapy using weekly Taxol, #1 of 12.'}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 91, 'start': 91, 'end': 103}, 'arg2': {'mention': 'currently', 'nth_sent': 91, 'start': 62, 'end': 71}, 'context': 'The patient has undergone a left segmental mastectomy, and is currently receiving adjuvant chemotherapy.'}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 92, 'start': 46, 'end': 51}, 'arg2': {'mention': 'weekly', 'nth_sent': 92, 'start': 39, 'end': 45}, 'context': 'She is here prior to cycle #1 of 12 of weekly Taxol.  '}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 95, 'start': 70, 'end': 75}, 'arg2': {'mention': 'weekly', 'nth_sent': 95, 'start': 47, 'end': 53}, 'context': 'The patient will return in 3 weeks to be seen, weekly to continue her Taxol.  '}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 55, 'end': 60}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy using weekly Taxol, #1 of 12.'}\n",
      "{'filename': 'patient10_report064_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 79, 'start': 36, 'end': 44}, 'arg2': {'mention': '2 weeks ago', 'nth_sent': 79, 'start': 45, 'end': 56}, 'context': 'Patient10 just recently started her Arimidex 2 weeks ago.'}\n",
      "{'filename': 'patient10_report064_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 14, 'start': 66, 'end': 75}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 14, 'start': 104, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 3/12/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                             '}\n",
      "{'filename': 'patient10_report064_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 14, 'start': 76, 'end': 92}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 14, 'start': 104, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 3/12/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                             '}\n",
      "{'filename': 'patient10_report064_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 15, 'start': 62, 'end': 70}, 'arg2': {'mention': 'currently', 'nth_sent': 15, 'start': 7, 'end': 16}, 'context': 'She is currently starting on adjuvant endocrine therapy using Arimidex.'}\n",
      "{'filename': 'patient10_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 9, 'start': 27, 'end': 32}, 'arg2': {'mention': '4/2/13', 'nth_sent': 9, 'start': 36, 'end': 42}, 'context': 'She most recently received chemo on 4/2/13 and Neutlasta 4/3/13.'}\n",
      "{'filename': 'patient10_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 9, 'start': 21, 'end': 26}, 'arg2': {'mention': '4 weeks ago', 'nth_sent': 9, 'start': 45, 'end': 56}, 'context': 'She reports her last chemo was approximately 4 weeks ago.'}\n",
      "{'filename': 'patient10_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 116, 'end': 128}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 101, 'end': 106}, 'context': 'I have personally performed the medical decision making and would like to add: Ms. Patient10 is here today to start chemotherapy.'}\n",
      "{'filename': 'patient10_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 13, 'start': 158, 'end': 166}, 'arg2': {'mention': '4/2', 'nth_sent': 13, 'start': 202, 'end': 205}, 'context': '(AMBIEN 5 MG ORAL TABLET) 2 TABS BY MOUTH AT BEDTIME AS NEEDED FOR FOR SLEEP     Hospital Course  Pt is a 64 y.o woman with stage I breast cancer on adjuvant taxotere and cytoxan, last chemotherapy was 4/2 with neulasta 4/3 who was admitted with c/o epigastric abdominal pain and nausea and vomiting.'}\n",
      "{'filename': 'patient10_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 13, 'start': 171, 'end': 178}, 'arg2': {'mention': '4/2', 'nth_sent': 13, 'start': 202, 'end': 205}, 'context': '(AMBIEN 5 MG ORAL TABLET) 2 TABS BY MOUTH AT BEDTIME AS NEEDED FOR FOR SLEEP     Hospital Course  Pt is a 64 y.o woman with stage I breast cancer on adjuvant taxotere and cytoxan, last chemotherapy was 4/2 with neulasta 4/3 who was admitted with c/o epigastric abdominal pain and nausea and vomiting.'}\n",
      "{'filename': 'patient10_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 2, 'start': 27, 'end': 32}, 'arg2': {'mention': 'April 2,\\n2013', 'nth_sent': 2, 'start': 36, 'end': 49}, 'context': 'She most recently received chemo on April 2, 2013, with last on April 3, 2013.'}\n",
      "{'filename': 'patient10_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 2, 'start': 27, 'end': 32}, 'arg2': {'mention': 'April 3, 2013', 'nth_sent': 2, 'start': 64, 'end': 77}, 'context': 'She most recently received chemo on April 2, 2013, with last on April 3, 2013.'}\n",
      "{'filename': 'patient10_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 5, 'start': 63, 'end': 71}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 21, 'end': 26}, 'context': 'The patient presents today to begin her adjuvant chemotherapy, Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient10_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 76, 'end': 83}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 21, 'end': 26}, 'context': 'The patient presents today to begin her adjuvant chemotherapy, Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient10_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 13, 'start': 271, 'end': 279}, 'arg2': {'mention': 'currently', 'nth_sent': 13, 'start': 221, 'end': 230}, 'context': 'Radiation Oncology Therapies: Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently starting on adjuvant chemotherapy using Taxotere and Cytoxan, cycle 1 of 4.'}\n",
      "{'filename': 'patient10_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 13, 'start': 284, 'end': 291}, 'arg2': {'mention': 'currently', 'nth_sent': 13, 'start': 221, 'end': 230}, 'context': 'Radiation Oncology Therapies: Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently starting on adjuvant chemotherapy using Taxotere and Cytoxan, cycle 1 of 4.'}\n",
      "{'filename': 'patient10_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 6, 'start': 12, 'end': 17}, 'arg2': {'mention': 'April 2nd', 'nth_sent': 6, 'start': 21, 'end': 30}, 'context': 'Patient had chemo on April 2nd with neulasta on April 3rd.'}\n",
      "{'filename': 'patient10_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 18, 'start': 23, 'end': 30}, 'arg2': {'mention': 'April 2nd', 'nth_sent': 18, 'start': 43, 'end': 52}, 'context': 'Receicing taxotere and cytoxan, cycle 2 on April 2nd with neulasta April 3rd.     '}\n",
      "{'filename': 'patient10_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 18, 'start': 10, 'end': 18}, 'arg2': {'mention': 'April 2nd', 'nth_sent': 18, 'start': 43, 'end': 52}, 'context': 'Receicing taxotere and cytoxan, cycle 2 on April 2nd with neulasta April 3rd.     '}\n",
      "{'filename': 'patient10_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 77, 'start': 63, 'end': 70}, 'arg2': {'mention': 'last week', 'nth_sent': 77, 'start': 82, 'end': 91}, 'context': '   64 year old lady with breast cancer s/p cycle 2 of taxotere/cytoxan + neulasta last week, coming in with low grade fevers, nausea, mild abdominal pain, constipation, and possible UTI.   '}\n",
      "{'filename': 'patient10_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 77, 'start': 54, 'end': 62}, 'arg2': {'mention': 'last week', 'nth_sent': 77, 'start': 82, 'end': 91}, 'context': '   64 year old lady with breast cancer s/p cycle 2 of taxotere/cytoxan + neulasta last week, coming in with low grade fevers, nausea, mild abdominal pain, constipation, and possible UTI.   '}\n",
      "{'filename': 'patient10_report055_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 20, 'start': 66, 'end': 75}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 20, 'start': 105, 'end': 114}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person210 4 3/12/2013                                                                                                                                                                                                                                              Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              Labs and radiology reviewed  Allergies  Allergen Reactions   Bee Stings Anaphylaxis   anaphylaxis   Celestone (Betamethasone Sodium Phosphate)   '}\n",
      "{'filename': 'patient10_report055_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 20, 'start': 76, 'end': 92}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 20, 'start': 105, 'end': 114}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person210 4 3/12/2013                                                                                                                                                                                                                                              Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              Labs and radiology reviewed  Allergies  Allergen Reactions   Bee Stings Anaphylaxis   anaphylaxis   Celestone (Betamethasone Sodium Phosphate)   '}\n",
      "{'filename': 'patient10_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 2, 'start': 27, 'end': 32}, 'arg2': {'mention': 'April 2,\\n2013', 'nth_sent': 2, 'start': 36, 'end': 49}, 'context': 'She most recently received chemo on April 2, 2013, with last on April 3, 2013.'}\n",
      "{'filename': 'patient10_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 2, 'start': 27, 'end': 32}, 'arg2': {'mention': 'April 3, 2013', 'nth_sent': 2, 'start': 64, 'end': 77}, 'context': 'She most recently received chemo on April 2, 2013, with last on April 3, 2013.'}\n",
      "{'filename': 'patient10_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 225, 'end': 237}, 'arg2': {'mention': 'April 4, 2013', 'nth_sent': 4, 'start': 258, 'end': 271}, 'context': 'None   Triage Intervention(s):  None   Triage Disposition:  Treatment Room   History of Present Illness  This is a 64-year-old white female with a significant past medical history of breast cancer who is currently undergoing chemotherapy, last treatment was April 4, 2013.'}\n",
      "{'filename': 'patient10_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 92, 'start': 121, 'end': 133}, 'arg2': {'mention': 'currently', 'nth_sent': 92, 'start': 108, 'end': 117}, 'context': 'Medical Decision Making  64-year-old white female who presents to the ER today complaining of fever, who is currently on chemotherapy, with abdominal pain and nausea.'}\n",
      "{'filename': 'patient10_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 5, 'start': 62, 'end': 70}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue adjuvant chemotherapy, Taxotere and Cytoxan #2/4 with Neulasta.'}\n",
      "{'filename': 'patient10_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 75, 'end': 82}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue adjuvant chemotherapy, Taxotere and Cytoxan #2/4 with Neulasta.'}\n",
      "{'filename': 'patient10_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 14, 'start': 66, 'end': 75}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 14, 'start': 104, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 3/12/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient10_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 14, 'start': 76, 'end': 92}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 14, 'start': 104, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 3/12/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              '}\n",
      "{'filename': 'patient10_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 78, 'start': 39, 'end': 47}, 'arg2': {'mention': 'daily', 'nth_sent': 78, 'start': 64, 'end': 69}, 'context': 'The plan for Ms. Patient10 is to begin Arimidex 1 mg 1 by mouth daily.'}\n",
      "{'filename': 'patient10_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 12, 'start': 62, 'end': 70}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 7, 'end': 16}, 'context': 'She is currently starting on adjuvant endocrine therapy using Arimidex.'}\n",
      "{'filename': 'patient10_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 11, 'start': 66, 'end': 75}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 11, 'start': 104, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 3/12/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                             '}\n",
      "{'filename': 'patient10_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 76, 'end': 92}, 'arg2': {'mention': '3/12/2013', 'nth_sent': 11, 'start': 104, 'end': 113}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 3/12/2013 Comments:  Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                             '}\n",
      "{'filename': 'patient10_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 31, 'end': 43}, 'arg2': {'mention': 'this coming week', 'nth_sent': 6, 'start': 55, 'end': 71}, 'context': 'She does have another round of chemotherapy, coming up this coming week.'}\n",
      "{'filename': 'patient10_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 86, 'start': 26, 'end': 31}, 'arg2': {'mention': 'next week', 'nth_sent': 86, 'start': 12, 'end': 21}, 'context': 'Will return next week foe chemo, pending her final decison     '}\n",
      "{'filename': 'patient10_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 107, 'end': 119}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 86, 'end': 95}, 'context': 'None   History of Present Illness  64-year-old white female with known breast cancer, currently undergoing chemotherapy, presents with weakness, and fever.'}\n",
      "{'filename': 'patient10_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 24, 'end': 36}, 'arg2': {'mention': 'one week ago', 'nth_sent': 5, 'start': 43, 'end': 55}, 'context': 'She states she received chemotherapy about one week ago.'}\n",
      "{'filename': 'patient10_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'CHEMO', 'nth_sent': 20, 'start': 164, 'end': 169}, 'arg2': {'mention': 'every 3 weeks', 'nth_sent': 20, 'start': 0, 'end': 13}, 'context': 'every 3 weeks IV [Last Dose: 03/12/13 00:00][Compliance:  Status: Still taking, as prescribed Source: Patient Comment: Pt relates is scheduled every 3 weeks for IV CHEMO for 4 total doses of chemo.'}\n",
      "{'filename': 'patient10_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 20, 'start': 191, 'end': 196}, 'arg2': {'mention': '3-12--13', 'nth_sent': 21, 'start': 30, 'end': 37}, 'context': 'every 3 weeks IV [Last Dose: 03/12/13 00:00][Compliance:  Status: Still taking, as prescribed Source: Patient Comment: Pt relates is scheduled every 3 weeks for IV CHEMO for 4 total doses of chemo. She completed the first one on 3-12--13]  zolpidem (Ambien 5 mg oral tablet) 10 mg AT BEDTIME PRN By Mouth'}\n",
      "{'filename': 'patient10_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 9, 'start': 21, 'end': 26}, 'arg2': {'mention': '4 weeks ago', 'nth_sent': 9, 'start': 45, 'end': 56}, 'context': 'She reports her last chemo was approximately 4 weeks ago.'}\n",
      "{'filename': 'patient10_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 31, 'end': 43}, 'arg2': {'mention': 'this coming week', 'nth_sent': 6, 'start': 55, 'end': 71}, 'context': 'She does have another round of chemotherapy, coming up this coming week.'}\n",
      "{'filename': 'patient10_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 124, 'end': 131}, 'arg2': {'mention': '4/2', 'nth_sent': 3, 'start': 143, 'end': 146}, 'context': 'Office Phone:     History of Present Illness  Ms. Patient10 is a pleasant 64y/o woman currently being treated w/ Taxotere & Cytoxan (last dose 4/2) for Stage I breast ca admitted 4/21 w/ a one day h/o epigastric pain with a bandlike distribution radiating to the back.'}\n",
      "{'filename': 'patient10_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 3, 'start': 113, 'end': 121}, 'arg2': {'mention': '4/2', 'nth_sent': 3, 'start': 143, 'end': 146}, 'context': 'Office Phone:     History of Present Illness  Ms. Patient10 is a pleasant 64y/o woman currently being treated w/ Taxotere & Cytoxan (last dose 4/2) for Stage I breast ca admitted 4/21 w/ a one day h/o epigastric pain with a bandlike distribution radiating to the back.'}\n",
      "{'filename': 'patient10_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 91, 'start': 18, 'end': 23}, 'arg2': {'mention': '3 weeks previously', 'nth_sent': 91, 'start': 24, 'end': 42}, 'context': 'I breast ca (last chemo 3 weeks previously) admitted with what appears to be gallstone pancreatitis.'}\n",
      "{'filename': 'patient11_report001_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 119, 'start': 86, 'end': 96}, 'arg2': {'mention': '12 weeks', 'nth_sent': 119, 'start': 74, 'end': 82}, 'context': 'My recommendation would be 4 cycles of Adriamycin and Cytoxan followed by 12 weeks of paclitaxel.'}\n",
      "{'filename': 'patient11_report001_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 120, 'start': 26, 'end': 36}, 'arg2': {'mention': 'weekly', 'nth_sent': 120, 'start': 19, 'end': 25}, 'context': 'I believe that the weekly paclitaxel will allow us to better titrate her dosing for her blood counts.'}\n",
      "{'filename': 'patient11_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 13, 'start': 12, 'end': 17}, 'arg2': {'mention': '5-6 months', 'nth_sent': 13, 'start': 48, 'end': 58}, 'context': 'Status post Taxol chemotherapy given weekly for 5-6 months, July 2011.'}\n",
      "{'filename': 'patient11_report008_PGN_breast', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 4, 'start': 97, 'end': 102}, 'arg2': {'mention': 'Feb', 'nth_sent': 4, 'start': 122, 'end': 125}, 'context': 'Past medical history is significant for right infiltrating breast cancer, s/p 6 months of weekly taxol chemotherapy (from Feb-July 2011) and a segmental mastectomy on 1/25/11.  '}\n",
      "{'filename': 'patient11_report008_PGN_breast', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 4, 'start': 97, 'end': 102}, 'arg2': {'mention': 'July\\n2011', 'nth_sent': 4, 'start': 126, 'end': 135}, 'context': 'Past medical history is significant for right infiltrating breast cancer, s/p 6 months of weekly taxol chemotherapy (from Feb-July 2011) and a segmental mastectomy on 1/25/11.  '}\n",
      "{'filename': 'patient11_report018_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 108, 'end': 113}, 'arg2': {'mention': 'February', 'nth_sent': 2, 'start': 132, 'end': 140}, 'context': 'She has a past medical history significant for right infiltrating breast CA, status post 6 months of weekly Taxol chemotherapy from February to July 2011, and a segmental mastectomy on 01/25/2011.'}\n",
      "{'filename': 'patient11_report018_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 108, 'end': 113}, 'arg2': {'mention': 'July 2011', 'nth_sent': 2, 'start': 144, 'end': 153}, 'context': 'She has a past medical history significant for right infiltrating breast CA, status post 6 months of weekly Taxol chemotherapy from February to July 2011, and a segmental mastectomy on 01/25/2011.'}\n",
      "{'filename': 'patient40_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 3, 'start': 62, 'end': 72}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to start neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 77, 'end': 84}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to start neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 22, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 22, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013                                                                                                                                                                                                                                              Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 22, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 22, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013                                                                                                                                                                                                                                              Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 48, 'start': 44, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 48, 'start': 33, 'end': 38}, 'context': '1. Patient to start chemotherapy today with AC# 1 of 4. Risks, benefits, indications and side effects were reviewed with patient.'}\n",
      "{'filename': 'patient40_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 3, 'start': 65, 'end': 75}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to continue neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 80, 'end': 87}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to continue neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 76, 'start': 44, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 76, 'start': 33, 'end': 38}, 'context': 'Patient to continue chemotherapy today with AC# 3 of 4.  2. RTC in 3 weeks to continue chemotherapy.  '}\n",
      "{'filename': 'patient40_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 410, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 82, 'start': 134, 'end': 139}, 'arg2': {'mention': 'weekly', 'nth_sent': 82, 'start': 127, 'end': 133}, 'context': 'It is recommended that the patient receive neoadjuvant chemotherapy, Adriamycin and Cytoxan x4 cycles followed by 12 cycles of weekly Taxol.  '}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 73, 'end': 79}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 90, 'end': 95}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 83, 'end': 89}, 'context': 'She completed 4 cycles of Adriamycin and Cytoxan, and is here prior to cycle #8 of weekly Taxol.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 11, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 11, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 11, 'start': 162, 'end': 172}, 'arg2': {'mention': '10/16/2013', 'nth_sent': 11, 'start': 191, 'end': 201}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 242, 'end': 247}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 191, 'end': 200}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 8 of 12.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 242, 'end': 247}, 'arg2': {'mention': 'weekly', 'nth_sent': 12, 'start': 235, 'end': 241}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 8 of 12.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 69, 'start': 65, 'end': 70}, 'arg2': {'mention': 'weekly', 'nth_sent': 69, 'start': 58, 'end': 64}, 'context': 'She is here to continue her neoadjuvant chemotherapy with weekly Taxol, and is here prior to cycle #8.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 70, 'start': 71, 'end': 76}, 'arg2': {'mention': 'weekly', 'nth_sent': 70, 'start': 64, 'end': 70}, 'context': 'The plan for Ms. Patient40 is to proceed with cycle #8 of 12 of weekly Taxol.'}\n",
      "{'filename': 'patient40_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 2, 'start': 19, 'end': 21}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 31, 'end': 36}, 'context': 'Patient to receive AC number 3 today.'}\n",
      "{'filename': 'patient40_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 2, 'start': 9, 'end': 11}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 21, 'end': 26}, 'context': 'Continue AC number 4 today.'}\n",
      "{'filename': 'patient40_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 3, 'start': 30, 'end': 35}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 11, 'end': 17}, 'context': 'Will start weekly neoadjuvant taxol in 3 weeks.     '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 73, 'end': 79}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 90, 'end': 95}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 83, 'end': 89}, 'context': 'She completed 4 cycles of Adriamycin and Cytoxan, and is here prior to cycle #4 of weekly Taxol.'}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 11, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 11, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 11, 'start': 162, 'end': 172}, 'arg2': {'mention': '10/16/2013', 'nth_sent': 11, 'start': 191, 'end': 201}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 242, 'end': 247}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 191, 'end': 200}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 1 of 12.'}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 242, 'end': 247}, 'arg2': {'mention': 'weekly', 'nth_sent': 12, 'start': 235, 'end': 241}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 1 of 12.'}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 70, 'start': 65, 'end': 70}, 'arg2': {'mention': 'weekly', 'nth_sent': 70, 'start': 58, 'end': 64}, 'context': 'She is here to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 71, 'start': 71, 'end': 76}, 'arg2': {'mention': 'weekly', 'nth_sent': 71, 'start': 64, 'end': 70}, 'context': 'The plan for Ms. Patient40 is to proceed with cycle #4 of 12 of weekly Taxol.'}\n",
      "{'filename': 'patient40_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'adriamycin', 'nth_sent': 0, 'start': 28, 'end': 38}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 47, 'end': 52}, 'context': 'Patient receiving cycle 2/4 adriamycin/cytoxan today.'}\n",
      "{'filename': 'patient40_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 0, 'start': 39, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 47, 'end': 52}, 'context': 'Patient receiving cycle 2/4 adriamycin/cytoxan today.'}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 3, 'start': 65, 'end': 75}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to continue neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 80, 'end': 87}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to continue neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 13, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 13, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 13, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 13, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 13, 'start': 84, 'end': 95}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 13, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 13, 'start': 96, 'end': 112}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 13, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 71, 'start': 44, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 71, 'start': 33, 'end': 38}, 'context': 'Patient to continue chemotherapy today with AC# 4 of 4. Will start weekly Taxol in 3 weeks.  '}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 71, 'start': 74, 'end': 79}, 'arg2': {'mention': 'weekly', 'nth_sent': 71, 'start': 67, 'end': 73}, 'context': 'Patient to continue chemotherapy today with AC# 4 of 4. Will start weekly Taxol in 3 weeks.  '}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 3, 'start': 81, 'end': 91}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy, cycle #2 of Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 96, 'end': 103}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy, cycle #2 of Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 10, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 10, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013                                                                                                                                                                                                                                              Comments:'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 10, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 10, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013                                                                                                                                                                                                                                              Comments:'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 11, 'start': 266, 'end': 276}, 'arg2': {'mention': 'currently', 'nth_sent': 11, 'start': 222, 'end': 231}, 'context': 'Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using Adriamycin and, cycle 2 of 4.'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 80, 'start': 61, 'end': 71}, 'arg2': {'mention': 'currently', 'nth_sent': 80, 'start': 15, 'end': 24}, 'context': 'The patient is currently receiving neoadjuvant chemotherapy, Adriamycin and Cytoxan, and is here prior to cycle #2.'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 80, 'start': 76, 'end': 83}, 'arg2': {'mention': 'currently', 'nth_sent': 80, 'start': 15, 'end': 24}, 'context': 'The patient is currently receiving neoadjuvant chemotherapy, Adriamycin and Cytoxan, and is here prior to cycle #2.'}\n",
      "{'filename': 'patient40_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 16, 'end': 21}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 9, 'end': 15}, 'context': 'Continue weekly taxol.     '}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '7/24/2013', 'nth_sent': 11, 'start': 130, 'end': 139}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 11, 'start': 84, 'end': 95}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 11, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 11, 'start': 96, 'end': 112}, 'arg2': {'mention': '9/25/2013', 'nth_sent': 11, 'start': 140, 'end': 149}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 242, 'end': 247}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 191, 'end': 200}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 1 of 12.'}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 12, 'start': 242, 'end': 247}, 'arg2': {'mention': 'weekly', 'nth_sent': 12, 'start': 235, 'end': 241}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 1 of 12.'}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 72, 'start': 65, 'end': 70}, 'arg2': {'mention': 'weekly', 'nth_sent': 72, 'start': 58, 'end': 64}, 'context': 'She is here to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 73, 'start': 71, 'end': 76}, 'arg2': {'mention': 'weekly', 'nth_sent': 73, 'start': 64, 'end': 70}, 'context': 'The plan for Ms. Patient40 is to proceed with cycle #1 of 12 of weekly Taxol.'}\n",
      "{'filename': 'patient40_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 28, 'end': 33}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 21, 'end': 27}, 'context': 'Continue neoadjuvant weekly taxol.     '}\n",
      "{'filename': 'patient40_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 72, 'end': 84}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 39, 'end': 48}, 'context': 'Pt tumor was 4.9cm in dimension and pt currently undergoing neoadjuvant chemotherapy.'}\n",
      "{'filename': 'patient40_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 90, 'end': 95}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 83, 'end': 89}, 'context': 'Has completed 4 cycles of cytoxan/Adriamycin and scheduled to undergo 12 cycles of weekly Taxol prior to undergoing surgery.'}\n",
      "{'filename': 'patient40_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 410, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'A/C', 'nth_sent': 3, 'start': 0, 'end': 3}, 'arg2': {'mention': '7/24', 'nth_sent': 3, 'start': 8, 'end': 12}, 'context': 'A/C # 1 7/24.'}\n",
      "{'filename': 'patient42_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 8, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 14, 'start': 0, 'end': 8}, 'arg2': {'mention': 'daily', 'nth_sent': 14, 'start': 23, 'end': 28}, 'context': 'Arimidex 1 mg by mouth daily, since PREVIOUS THERAPY: See table below.'}\n",
      "{'filename': 'patient42_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 107, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 107, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.  '}\n",
      "{'filename': 'patient42_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 33, 'start': 111, 'end': 122}, 'arg2': {'mention': 'every day', 'nth_sent': 34, 'start': 169, 'end': 178}, 'context': 'Oral Tab Take 1 by mouth three times a day 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Amlodipine (NORVASC) 5 mg Oral Tablet 1 tablet by mouth daily 90 Tab 3   Losartan (COZAAR)'}\n",
      "{'filename': 'patient42_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 33, 'start': 124, 'end': 132}, 'arg2': {'mention': 'every day', 'nth_sent': 34, 'start': 169, 'end': 178}, 'context': 'Oral Tab Take 1 by mouth three times a day 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Amlodipine (NORVASC) 5 mg Oral Tablet 1 tablet by mouth daily 90 Tab 3   Losartan (COZAAR)'}\n",
      "{'filename': 'patient42_report076_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 12, 'start': 211, 'end': 222}, 'arg2': {'mention': 'every day', 'nth_sent': 13, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3  Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report076_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 12, 'start': 224, 'end': 232}, 'arg2': {'mention': 'every day', 'nth_sent': 13, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3  Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 18, 'start': 30, 'end': 41}, 'arg2': {'mention': 'every day', 'nth_sent': 19, 'start': 88, 'end': 97}, 'context': '20 mg Oral capsule One daily  anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day  Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  ASPIRIN LOW STRENGTH'}\n",
      "{'filename': 'patient42_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 18, 'start': 43, 'end': 51}, 'arg2': {'mention': 'every day', 'nth_sent': 19, 'start': 88, 'end': 97}, 'context': '20 mg Oral capsule One daily  anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day  Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  ASPIRIN LOW STRENGTH'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 8, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 11, 'start': 0, 'end': 8}, 'arg2': {'mention': 'daily', 'nth_sent': 11, 'start': 23, 'end': 28}, 'context': 'Arimidex 1 mg by mouth daily, since September 17, 2012 PREVIOUS THERAPY:'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 11, 'start': 0, 'end': 8}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 11, 'start': 36, 'end': 54}, 'context': 'Arimidex 1 mg by mouth daily, since September 17, 2012 PREVIOUS THERAPY:'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 31, 'start': 211, 'end': 222}, 'arg2': {'mention': 'every day', 'nth_sent': 32, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Losartan (COZAAR)'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 31, 'start': 224, 'end': 232}, 'arg2': {'mention': 'every day', 'nth_sent': 32, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Losartan (COZAAR)'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 106, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 106, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 8, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 11, 'start': 0, 'end': 8}, 'arg2': {'mention': 'daily', 'nth_sent': 11, 'start': 23, 'end': 28}, 'context': 'Arimidex 1 mg by mouth daily, since September 17, 2012 PREVIOUS THERAPY:'}\n",
      "{'filename': 'patient42_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 28, 'start': 211, 'end': 222}, 'arg2': {'mention': 'every day', 'nth_sent': 29, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Losartan (COZAAR)'}\n",
      "{'filename': 'patient42_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 28, 'start': 224, 'end': 232}, 'arg2': {'mention': 'every day', 'nth_sent': 29, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Losartan (COZAAR)'}\n",
      "{'filename': 'patient42_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 101, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 101, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report074_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ANASTROZOLE', 'nth_sent': 19, 'start': 23, 'end': 34}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 20, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report074_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 19, 'start': 36, 'end': 44}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 20, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 8, 'start': 124, 'end': 133}, 'arg2': {'mention': 'five years', 'nth_sent': 8, 'start': 108, 'end': 118}, 'context': 'Since her last visit, she did have an Oncotype DX done and her score equaled 31 with a 21% reoccurrence and five years with tamoxifen alone, which places her right in the middle of the intermediate- and high-risk category, where adjuvant chemotherapy would likely be recommended.'}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 93, 'end': 101}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 8, 'start': 108, 'end': 126}, 'context': 'The patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 17, 'start': 0, 'end': 8}, 'arg2': {'mention': 'daily', 'nth_sent': 17, 'start': 23, 'end': 28}, 'context': 'Arimidex 1 mg by mouth daily, since PREVIOUS THERAPY: See table below.'}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 39, 'start': 208, 'end': 219}, 'arg2': {'mention': 'every day', 'nth_sent': 40, 'start': 266, 'end': 275}, 'context': 'mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3   Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 39, 'start': 221, 'end': 229}, 'arg2': {'mention': 'every day', 'nth_sent': 40, 'start': 266, 'end': 275}, 'context': 'mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3   Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 111, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17, 2012', 'nth_sent': 111, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.   '}\n",
      "{'filename': 'patient42_report073_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ANASTROZOLE', 'nth_sent': 12, 'start': 23, 'end': 34}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 13, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report073_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 12, 'start': 36, 'end': 44}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 13, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report073_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 23, 'start': 143, 'end': 151}, 'arg2': {'mention': '01/03/13', 'nth_sent': 22, 'start': 97, 'end': 105}, 'context': '60 MG BY MOUTH ONCE A DAY (No Change)  Medication Information Comment:  Medications Given Today: 01/03/13 08:58 amlodipine 5 mg 01/03/13 08:57 Arimidex 1 mg 01/03/13 07:00 clindamycin 600 mg 01/03/13 08:58 Colace 100 mg 01/03/13 08:58 fluoxetine 20 mg 01/03/13 08:41'}\n",
      "{'filename': 'patient42_report071_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ANASTROZOLE', 'nth_sent': 18, 'start': 23, 'end': 34}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 19, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report071_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 18, 'start': 36, 'end': 44}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 19, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report071_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 30, 'start': 35, 'end': 43}, 'arg2': {'mention': '01/03/13', 'nth_sent': 29, 'start': 18, 'end': 26}, 'context': 'amlodipine 5 mg   01/03/13 08:57   Arimidex 1'}\n",
      "{'filename': 'patient42_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 24, 'start': 211, 'end': 222}, 'arg2': {'mention': 'every day', 'nth_sent': 25, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3   Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 24, 'start': 224, 'end': 232}, 'arg2': {'mention': 'every day', 'nth_sent': 25, 'start': 269, 'end': 278}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3   Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report070_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ANASTROZOLE', 'nth_sent': 17, 'start': 23, 'end': 34}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 18, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report070_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 17, 'start': 36, 'end': 44}, 'arg2': {'mention': 'ONCE A DAY', 'nth_sent': 18, 'start': 0, 'end': 10}, 'context': 'ONCE A DAY (No Change) ANASTROZOLE (ARIMIDEX 1 MG ORAL TABLET) 1 TAB BY MOUTH ONCE A DAY (No Change)'}\n",
      "{'filename': 'patient42_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 18, 'start': 650, 'end': 661}, 'arg2': {'mention': 'every day', 'nth_sent': 20, 'start': 708, 'end': 717}, 'context': 'Allergies  Allergen Reactions   Clonidine   Fatigue oversedation   Coricidin (Chlorpheniramine-Acetaminophen)   Dustmites, Molds, Mildew [Other]   Erythromycin   Erythromycin Stinoprate   Pcn (Penicillin G Benzathine & Proc)   Sulfa(Sulfonamide Antibiotics)    MEDICATIONS Outpatient Prescriptions Marked as Taking for the 12/7/12 encounter (Office Visit) with Person51, PA-C  Medication Sig Dispense Refill   Amlodipine (NORVASC) 5 mg Oral tablet 1 tablet by mouth daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11  Losartan (COZAAR) 100'}\n",
      "{'filename': 'patient42_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 18, 'start': 663, 'end': 671}, 'arg2': {'mention': 'every day', 'nth_sent': 20, 'start': 708, 'end': 717}, 'context': 'Allergies  Allergen Reactions   Clonidine   Fatigue oversedation   Coricidin (Chlorpheniramine-Acetaminophen)   Dustmites, Molds, Mildew [Other]   Erythromycin   Erythromycin Stinoprate   Pcn (Penicillin G Benzathine & Proc)   Sulfa(Sulfonamide Antibiotics)    MEDICATIONS Outpatient Prescriptions Marked as Taking for the 12/7/12 encounter (Office Visit) with Person51, PA-C  Medication Sig Dispense Refill   Amlodipine (NORVASC) 5 mg Oral tablet 1 tablet by mouth daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11  Losartan (COZAAR) 100'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 9, 'end': 21}, 'arg2': {'mention': 'October 22, 2009', 'nth_sent': 5, 'start': 46, 'end': 62}, 'context': 'The last chemotherapy regimen was received on October 22, 2009.'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 47, 'start': 89, 'end': 101}, 'arg2': {'mention': 'current', 'nth_sent': 47, 'start': 81, 'end': 88}, 'context': 'Dr. Person8 will may decisions as to whether or not the patient will continue on current chemotherapy regimen.  '}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 50, 'start': 81, 'end': 93}, 'arg2': {'mention': 'October 22, 2009', 'nth_sent': 50, 'start': 106, 'end': 122}, 'context': \"The patient follows with Dr. [UUU TTT], as previously stated; the patient's last chemotherapy regimen, on October 22, 2009, at which point patient also received Neulasta.\"}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 4, 'start': 120, 'end': 129}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 100, 'end': 109}, 'context': 'The patient was admitted for further workup her past medical history includes breast cancer; she is currently receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 4, 'start': 131, 'end': 139}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 100, 'end': 109}, 'context': 'The patient was admitted for further workup her past medical history includes breast cancer; she is currently receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 144, 'end': 155}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 100, 'end': 109}, 'context': 'The patient was admitted for further workup her past medical history includes breast cancer; she is currently receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 52, 'start': 35, 'end': 44}, 'arg2': {'mention': 'currently', 'nth_sent': 52, 'start': 12, 'end': 21}, 'context': 'The patient currently is receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 52, 'start': 46, 'end': 54}, 'arg2': {'mention': 'currently', 'nth_sent': 52, 'start': 12, 'end': 21}, 'context': 'The patient currently is receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 52, 'start': 59, 'end': 70}, 'arg2': {'mention': 'currently', 'nth_sent': 52, 'start': 12, 'end': 21}, 'context': 'The patient currently is receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient34_report009_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 7, 'start': 53, 'end': 58}, 'arg2': {'mention': '10/22/09', 'nth_sent': 7, 'start': 71, 'end': 79}, 'context': 'Past Medical History: breast CA, currently receiving chemo, last chemo 10/22/09 mitral valve prolapse tonsillectomy  Subjective/Events Overnight: chart and labs reviewed, pt. seen and examined.'}\n",
      "{'filename': 'patient34_report009_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 42, 'start': 5, 'end': 10}, 'arg2': {'mention': '10/22/09', 'nth_sent': 42, 'start': 11, 'end': 19}, 'context': 'Last chemo 10/22/09.  '}\n",
      "{'filename': 'patient27_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 10, 'start': 16, 'end': 25}, 'arg2': {'mention': 'two weeks ago', 'nth_sent': 10, 'start': 46, 'end': 59}, 'context': 'She started her tamoxifen as instructed about two weeks ago.'}\n",
      "{'filename': 'patient27_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 2, 'start': 24, 'end': 33}, 'arg2': {'mention': 'two weeks', 'nth_sent': 2, 'start': 52, 'end': 61}, 'context': 'The patient has been on tamoxifen for approximately two weeks, started January 2012.  '}\n",
      "{'filename': 'patient27_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 63, 'start': 12, 'end': 21}, 'arg2': {'mention': 'five years', 'nth_sent': 64, 'start': 74, 'end': 84}, 'context': 'She started tamoxifen in January 2012. Ideally, she needs to be on it for five years that would take us to January 2017.'}\n",
      "{'filename': 'patient27_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 2, 'start': 24, 'end': 33}, 'arg2': {'mention': 'January 2012', 'nth_sent': 2, 'start': 71, 'end': 83}, 'context': 'The patient has been on tamoxifen for approximately two weeks, started January 2012.  '}\n",
      "{'filename': 'patient27_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 63, 'start': 12, 'end': 21}, 'arg2': {'mention': 'January 2012', 'nth_sent': 63, 'start': 25, 'end': 37}, 'context': 'She started tamoxifen in January 2012.'}\n",
      "{'filename': 'patient27_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Tamoxifen', 'nth_sent': 7, 'start': 17, 'end': 26}, 'arg2': {'mention': 'next week', 'nth_sent': 7, 'start': 27, 'end': 36}, 'context': 'Will be starting Tamoxifen next week (Dr. Person32).'}\n",
      "{'filename': 'patient27_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 4, 'start': 24, 'end': 33}, 'arg2': {'mention': 'daily', 'nth_sent': 4, 'start': 82, 'end': 87}, 'context': 'She has been started on tamoxifen by Dr. Person2 and is presently taking 1 tablet daily.'}\n",
      "{'filename': 'patient27_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 7, 'start': 9, 'end': 18}, 'arg2': {'mention': 'next week', 'nth_sent': 7, 'start': 19, 'end': 28}, 'context': '_ taking tamoxifen next week.'}\n",
      "{'filename': 'patient27_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 4, 'start': 24, 'end': 33}, 'arg2': {'mention': 'daily', 'nth_sent': 4, 'start': 82, 'end': 87}, 'context': 'She has been started on tamoxifen by Dr. Person2 and is presently taking 1 tablet daily.'}\n",
      "{'filename': 'patient27_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 6, 'start': 19, 'end': 28}, 'arg2': {'mention': 'January 2013', 'nth_sent': 6, 'start': 32, 'end': 44}, 'context': 'She was started on tamoxifen in January 2013.'}\n",
      "{'filename': 'patient27_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 7, 'start': 19, 'end': 28}, 'arg2': {'mention': 'January 2018', 'nth_sent': 7, 'start': 68, 'end': 80}, 'context': 'She needs to be on tamoxifen for five years that will take us until January 2018.'}\n",
      "{'filename': 'patient27_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 7, 'start': 19, 'end': 28}, 'arg2': {'mention': 'five years', 'nth_sent': 7, 'start': 33, 'end': 43}, 'context': 'She needs to be on tamoxifen for five years that will take us until January 2018.'}\n",
      "{'filename': 'patient27_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 61, 'start': 12, 'end': 21}, 'arg2': {'mention': 'January 2013', 'nth_sent': 61, 'start': 25, 'end': 37}, 'context': 'She started tamoxifen in January 2013.'}\n",
      "{'filename': 'patient27_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 6, 'start': 23, 'end': 32}, 'arg2': {'mention': 'next week', 'nth_sent': 6, 'start': 33, 'end': 42}, 'context': 'She is to begin taking tamoxifen next week.'}\n",
      "{'filename': 'patient38_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 11, 'start': 47, 'end': 55}, 'arg2': {'mention': 'October 13', 'nth_sent': 11, 'start': 111, 'end': 121}, 'context': 'The plan was to give a total of four cycles of Taxotere and cyclophosphamide and her fourth cycle was given on October 13.'}\n",
      "{'filename': 'patient38_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cyclophosphamide', 'nth_sent': 11, 'start': 60, 'end': 76}, 'arg2': {'mention': 'October 13', 'nth_sent': 11, 'start': 111, 'end': 121}, 'context': 'The plan was to give a total of four cycles of Taxotere and cyclophosphamide and her fourth cycle was given on October 13.'}\n",
      "{'filename': 'patient38_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 83, 'start': 274, 'end': 276}, 'arg2': {'mention': 'October 13', 'nth_sent': 83, 'start': 319, 'end': 329}, 'context': 'In summary, Ms. Patient38 is a 63-year-old Caucasian female who is diagnosed with a stage 1, T1c, N0, M0, ER/PR-positive, HER-2/neu negative, and HER2 FISH-negative infiltrating ductal carcinoma of the left breast diagnosed in April 2010, status post adjuvant chemotherapy, TC times four cycles (last cycle finished on October 13), who presents for neutropenic fever.'}\n",
      "{'filename': 'patient38_report067_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 1, 'start': 72, 'end': 77}, 'arg2': {'mention': 'December', 'nth_sent': 1, 'start': 109, 'end': 117}, 'context': 'Pt has a history of breast cancer, which she had a lumpectomy last May, chemo and radiation that finished in December.'}\n",
      "{'filename': 'patient38_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 113, 'end': 125}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 100, 'end': 109}, 'context': 'HISTORY OF PRESENT ILLNESS: This is a 63-year-old female who has a history of breast cancer that is currently on chemotherapy.'}\n",
      "{'filename': 'patient38_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 25, 'end': 37}, 'arg2': {'mention': 'a week ago', 'nth_sent': 4, 'start': 64, 'end': 74}, 'context': 'She has had 3 courses of chemotherapy, her last one, I believe, a week ago.'}\n",
      "{'filename': 'patient38_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 0, 'start': 113, 'end': 125}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 100, 'end': 109}, 'context': 'HISTORY OF PRESENT ILLNESS:  A 63-year-old African American female with a history of breast cancer, currently on chemotherapy.'}\n",
      "{'filename': 'patient38_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 34, 'end': 46}, 'arg2': {'mention': '10/13/2010', 'nth_sent': 5, 'start': 50, 'end': 60}, 'context': 'She had received her last dose of chemotherapy on 10/13/2010.'}\n",
      "{'filename': 'patient38_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 6, 'start': 27, 'end': 35}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 7, 'end': 16}, 'context': 'She is currently receiving Taxotere and Cytoxan, which this was her fourth cycle.'}\n",
      "{'filename': 'patient38_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 6, 'start': 40, 'end': 47}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 7, 'end': 16}, 'context': 'She is currently receiving Taxotere and Cytoxan, which this was her fourth cycle.'}\n",
      "{'filename': 'patient38_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 71, 'end': 83}, 'arg2': {'mention': 'October', 'nth_sent': 9, 'start': 37, 'end': 44}, 'context': 'She had been last febrile earlier in October after receiving a dose of chemotherapy and going on a cruise with her husband.'}\n",
      "{'filename': 'patient38_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 78, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 65, 'end': 74}, 'context': 'She reported some low-grade fever and chills, and because she is currently on chemotherapy for breast cancer, she was following Oncology instructions to be seen with a fever.'}\n",
      "{'filename': 'patient38_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 48, 'end': 60}, 'arg2': {'mention': 'currently', 'nth_sent': 9, 'start': 7, 'end': 16}, 'context': 'She is currently on or about her third round of chemotherapy with a 4-round regimen planned for treatment of her breast cancer.'}\n",
      "{'filename': 'patient04_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 11, 'start': 42, 'end': 50}, 'arg2': {'mention': 'today', 'nth_sent': 12, 'start': 121, 'end': 126}, 'context': 'CURRENT THERAPY:  Adjuvant treatment with Taxotere 75 mg/sq m, and Cytoxan 600 mg/sq m. She is here to initiate cycle #3 today.  '}\n",
      "{'filename': 'patient04_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 11, 'start': 67, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 12, 'start': 121, 'end': 126}, 'context': 'CURRENT THERAPY:  Adjuvant treatment with Taxotere 75 mg/sq m, and Cytoxan 600 mg/sq m. She is here to initiate cycle #3 today.  '}\n",
      "{'filename': 'patient04_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 47, 'start': 67, 'end': 69}, 'arg2': {'mention': 'today', 'nth_sent': 47, 'start': 122, 'end': 127}, 'context': 'The patient is here to receive adjuvant chemotherapy, 3rd cycle of TC out of 6.  PLAN:  1. Continue with 3rd cycles of TC today.  '}\n",
      "{'filename': 'patient04_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 35, 'start': 8, 'end': 10}, 'arg2': {'mention': 'today', 'nth_sent': 35, 'start': 11, 'end': 16}, 'context': 'Cycle 5 TC today.  '}\n",
      "{'filename': 'patient04_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 30, 'start': 106, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 30, 'start': 71, 'end': 76}, 'context': '2. She is doing reasonably well on adjuvant systemic chemotherapy, and today she will receive cycle #5 of Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient04_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 30, 'start': 119, 'end': 126}, 'arg2': {'mention': 'today', 'nth_sent': 30, 'start': 71, 'end': 76}, 'context': '2. She is doing reasonably well on adjuvant systemic chemotherapy, and today she will receive cycle #5 of Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient04_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 10, 'start': 70, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 11, 'start': 141, 'end': 146}, 'context': 'Therefore, I am treating her with adjuvant systemic chemotherapy with Taxotere and Cytoxan for a total of 6 cycles. She presents for cycle 5 today.   '}\n",
      "{'filename': 'patient04_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 10, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 11, 'start': 141, 'end': 146}, 'context': 'Therefore, I am treating her with adjuvant systemic chemotherapy with Taxotere and Cytoxan for a total of 6 cycles. She presents for cycle 5 today.   '}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 11, 'start': 42, 'end': 50}, 'arg2': {'mention': 'today', 'nth_sent': 12, 'start': 127, 'end': 132}, 'context': 'CURRENT THERAPY:  Adjuvant treatment with Taxotere 75 mg/sq m and Cytoxan 600 mg/sq m. She is here to receive her second cycle today.  '}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 11, 'start': 66, 'end': 73}, 'arg2': {'mention': 'today', 'nth_sent': 12, 'start': 127, 'end': 132}, 'context': 'CURRENT THERAPY:  Adjuvant treatment with Taxotere 75 mg/sq m and Cytoxan 600 mg/sq m. She is here to receive her second cycle today.  '}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 49, 'start': 27, 'end': 29}, 'arg2': {'mention': 'today', 'nth_sent': 49, 'start': 30, 'end': 35}, 'context': 'Continue with 2nd cycle of TC today  2.'}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 10, 'start': 58, 'end': 66}, 'arg2': {'mention': '3 weeks back', 'nth_sent': 10, 'start': 106, 'end': 118}, 'context': '2. The patient was started on adjuvant chemotherapy using Taxotere with Cytoxan, received her first cycle 3 weeks back.   '}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 10, 'start': 72, 'end': 79}, 'arg2': {'mention': '3 weeks back', 'nth_sent': 10, 'start': 106, 'end': 118}, 'context': '2. The patient was started on adjuvant chemotherapy using Taxotere with Cytoxan, received her first cycle 3 weeks back.   '}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 47, 'start': 85, 'end': 87}, 'arg2': {'mention': 'today', 'nth_sent': 47, 'start': 88, 'end': 93}, 'context': 'The patient is here to receive adjuvant chemotherapy in the form of her 2nd cycle of TC today.  '}\n",
      "{'filename': 'patient04_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 15, 'start': 50, 'end': 55}, 'arg2': {'mention': 'today', 'nth_sent': 15, 'start': 31, 'end': 36}, 'context': 'The patient returned to clinic today to start her chemo.'}\n",
      "{'filename': 'patient04_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 60, 'start': 29, 'end': 41}, 'arg2': {'mention': 'today', 'nth_sent': 60, 'start': 42, 'end': 47}, 'context': 'Will start standard adjuvant chemotherapy today.  '}\n",
      "{'filename': 'patient04_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 61, 'start': 47, 'end': 54}, 'arg2': {'mention': 'today', 'nth_sent': 61, 'start': 66, 'end': 71}, 'context': 'PLAN:  1. Adjuvant chemotherapy, Taxotere plus Cytoxan, 1st cycle today.'}\n",
      "{'filename': 'patient04_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 61, 'start': 33, 'end': 41}, 'arg2': {'mention': 'today', 'nth_sent': 61, 'start': 66, 'end': 71}, 'context': 'PLAN:  1. Adjuvant chemotherapy, Taxotere plus Cytoxan, 1st cycle today.'}\n",
      "{'filename': 'patient04_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemo', 'nth_sent': 70, 'start': 0, 'end': 5}, 'arg2': {'mention': 'today', 'nth_sent': 70, 'start': 27, 'end': 32}, 'context': 'Chemo consent was obtained today.     '}\n",
      "{'filename': 'patient04_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 23, 'end': 35}, 'arg2': {'mention': 'July 16th', 'nth_sent': 4, 'start': 59, 'end': 68}, 'context': 'She underwent adjuvant chemotherapy, which she finished on July 16th and is now anticipating left chest wall postmastectomy radiation therapy, which she anticipates completion in the first week of October 2012.'}\n",
      "{'filename': 'patient04_report052_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 3, 'start': 20, 'end': 29}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 7, 'end': 16}, 'context': 'She is currently on tamoxifen.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Tamoxifen', 'nth_sent': 13, 'start': 93, 'end': 102}, 'arg2': {'mention': 'Aug 2012', 'nth_sent': 13, 'start': 128, 'end': 136}, 'context': 'She completed 6 weeks of XRT at Institution by Dr. Person27 in Sept 2012   CURRENT THERAPY:  Tamoxifen 20mg po daily started in Aug 2012.  '}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 16, 'start': 23, 'end': 25}, 'arg2': {'mention': 'July 2012', 'nth_sent': 16, 'start': 29, 'end': 38}, 'context': 'She completed adjuvant TC in July 2012 and then completed XRT to the left chest and axilla in Sept 2012.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 11, 'start': 87, 'end': 94}, 'arg2': {'mention': 'July 2012', 'nth_sent': 11, 'start': 131, 'end': 140}, 'context': 'Therefore, the patient was started on adjuvant systemic chemotherapy with Taxotere and Cytoxan for 6 cycles, this was completed in July 2012.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 11, 'start': 74, 'end': 82}, 'arg2': {'mention': 'July 2012', 'nth_sent': 11, 'start': 131, 'end': 140}, 'context': 'Therefore, the patient was started on adjuvant systemic chemotherapy with Taxotere and Cytoxan for 6 cycles, this was completed in July 2012.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 17, 'start': 16, 'end': 25}, 'arg2': {'mention': 'August 2012', 'nth_sent': 17, 'start': 29, 'end': 40}, 'context': 'She started her tamoxifen in August 2012.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 58, 'start': 12, 'end': 21}, 'arg2': {'mention': 'daily', 'nth_sent': 58, 'start': 30, 'end': 35}, 'context': '1. Continue tamoxifen 20mg po daily 2.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 15, 'start': 86, 'end': 95}, 'arg2': {'mention': 'today', 'nth_sent': 15, 'start': 32, 'end': 37}, 'context': 'Ms. Patient04 returns to clinic today for follow up after completing XRT and starting tamoxifen.'}\n",
      "{'filename': 'patient04_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 11, 'start': 74, 'end': 82}, 'arg2': {'mention': 'July 2012', 'nth_sent': 11, 'start': 131, 'end': 140}, 'context': 'Therefore, the patient was started on adjuvant systemic chemotherapy with Taxotere and Cytoxan for 6 cycles, this was completed in July 2012.'}\n",
      "{'filename': 'patient04_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 11, 'start': 87, 'end': 94}, 'arg2': {'mention': 'July 2012', 'nth_sent': 11, 'start': 131, 'end': 140}, 'context': 'Therefore, the patient was started on adjuvant systemic chemotherapy with Taxotere and Cytoxan for 6 cycles, this was completed in July 2012.'}\n",
      "{'filename': 'patient04_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Tamoxifen', 'nth_sent': 13, 'start': 93, 'end': 102}, 'arg2': {'mention': 'Aug 2012', 'nth_sent': 13, 'start': 128, 'end': 136}, 'context': 'She completed 6 weeks of XRT at Institution by Dr. Person27 in Sept 2012   CURRENT THERAPY:  Tamoxifen 20mg po daily started in Aug 2012.  '}\n",
      "{'filename': 'patient04_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 56, 'start': 12, 'end': 21}, 'arg2': {'mention': 'daily', 'nth_sent': 56, 'start': 30, 'end': 35}, 'context': '1. Continue tamoxifen 20mg po daily 2.'}\n",
      "{'filename': 'patient04_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 12, 'start': 38, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 92, 'end': 97}, 'context': 'CURRENT THERAPY:  Adjuvant chemo with Taxotere and Cytoxan. She is here to initiate cycle 4 today.  '}\n",
      "{'filename': 'patient04_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 12, 'start': 51, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 92, 'end': 97}, 'context': 'CURRENT THERAPY:  Adjuvant chemo with Taxotere and Cytoxan. She is here to initiate cycle 4 today.  '}\n",
      "{'filename': 'patient04_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 53, 'start': 22, 'end': 24}, 'arg2': {'mention': 'today', 'nth_sent': 53, 'start': 25, 'end': 30}, 'context': 'Continue 4th cycle of TC today  2. BRCA1-2 test was negative  3.'}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 49, 'start': 46, 'end': 54}, 'arg2': {'mention': 'today', 'nth_sent': 49, 'start': 19, 'end': 24}, 'context': 'The patient is due today to finish cycle 6 of Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 49, 'start': 59, 'end': 66}, 'arg2': {'mention': 'today', 'nth_sent': 49, 'start': 19, 'end': 24}, 'context': 'The patient is due today to finish cycle 6 of Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 53, 'start': 37, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 53, 'start': 47, 'end': 52}, 'context': 'I also gave the patient a script for tamoxifen today, which she can start over the next week.'}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 12, 'start': 18, 'end': 25}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 94, 'end': 99}, 'context': 'CURRENT THERAPY:  Cytoxan and Taxotere q.3 weeks for 6 cycles. The patient is due for cycle 6 today.  '}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 12, 'start': 30, 'end': 38}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 94, 'end': 99}, 'context': 'CURRENT THERAPY:  Cytoxan and Taxotere q.3 weeks for 6 cycles. The patient is due for cycle 6 today.  '}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 54, 'start': 28, 'end': 37}, 'arg2': {'mention': '5 years', 'nth_sent': 54, 'start': 17, 'end': 24}, 'context': 'She will require 5 years of tamoxifen therapy.'}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 15, 'start': 63, 'end': 70}, 'arg2': {'mention': 'today', 'nth_sent': 15, 'start': 102, 'end': 107}, 'context': 'The patient is currently on adjuvant therapy with Taxotere and Cytoxan, and is due for the last cycle today.'}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 15, 'start': 50, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 15, 'start': 102, 'end': 107}, 'context': 'The patient is currently on adjuvant therapy with Taxotere and Cytoxan, and is due for the last cycle today.'}\n",
      "{'filename': 'patient04_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 12, 'start': 38, 'end': 46}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 92, 'end': 97}, 'context': 'CURRENT THERAPY:  Adjuvant chemo with Taxotere and Cytoxan. She is here to initiate cycle 4 today.  '}\n",
      "{'filename': 'patient04_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 12, 'start': 51, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 92, 'end': 97}, 'context': 'CURRENT THERAPY:  Adjuvant chemo with Taxotere and Cytoxan. She is here to initiate cycle 4 today.  '}\n",
      "{'filename': 'patient04_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 53, 'start': 22, 'end': 24}, 'arg2': {'mention': 'today', 'nth_sent': 53, 'start': 25, 'end': 30}, 'context': 'Continue 4th cycle of TC today  2. BRCA1-2 test was negative  3.'}\n",
      "{'filename': 'patient04_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 15, 'start': 50, 'end': 55}, 'arg2': {'mention': 'today', 'nth_sent': 15, 'start': 31, 'end': 36}, 'context': 'The patient returned to clinic today to start her chemo.'}\n",
      "{'filename': 'patient04_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 60, 'start': 47, 'end': 54}, 'arg2': {'mention': 'today', 'nth_sent': 60, 'start': 66, 'end': 71}, 'context': 'PLAN:  1. Adjuvant chemotherapy, Taxotere plus Cytoxan, 1st cycle today.'}\n",
      "{'filename': 'patient04_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 60, 'start': 33, 'end': 41}, 'arg2': {'mention': 'today', 'nth_sent': 60, 'start': 66, 'end': 71}, 'context': 'PLAN:  1. Adjuvant chemotherapy, Taxotere plus Cytoxan, 1st cycle today.'}\n",
      "{'filename': 'patient04_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemo', 'nth_sent': 69, 'start': 0, 'end': 5}, 'arg2': {'mention': 'today', 'nth_sent': 69, 'start': 27, 'end': 32}, 'context': 'Chemo consent was obtained today.   '}\n",
      "{'filename': 'patient14_report013_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 203, 'end': 215}, 'arg2': {'mention': 'April 10, 2008', 'nth_sent': 8, 'start': 222, 'end': 236}, 'context': 'PAST MEDICAL HISTORY: Significant for breast CA diagnosed 2007, infiltrating ductal CA, right breast CA, ER/PR positive and HER2-Neu negative, status post segmental resection and sentinel mapping, first chemotherapy given April 10, 2008.  '}\n",
      "{'filename': 'patient14_report013_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 15, 'start': 31, 'end': 43}, 'arg2': {'mention': 'April 10, 2008', 'nth_sent': 15, 'start': 47, 'end': 61}, 'context': 'She has most recently received chemotherapy on April 10, 2008.'}\n",
      "{'filename': 'patient14_report013_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 18, 'start': 18, 'end': 30}, 'arg2': {'mention': 'April 10, 2008', 'nth_sent': 18, 'start': 37, 'end': 51}, 'context': 'As above, initial chemotherapy given April 10, 2008.  '}\n",
      "{'filename': 'patient14_report012_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 129, 'end': 141}, 'arg2': {'mention': 'last\\nThursday', 'nth_sent': 8, 'start': 148, 'end': 161}, 'context': 'The patient is a 52-year-old female with a past medical history significant for breast cancer, status post lumpectomy, had first chemotherapy given last Thursday.  '}\n",
      "{'filename': 'patient14_report012_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 14, 'start': 6, 'end': 11}, 'arg2': {'mention': 'April 10, 2008', 'nth_sent': 14, 'start': 18, 'end': 32}, 'context': 'First chemo given April 10, 2008.  '}\n",
      "{'filename': 'patient14_report012_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 20, 'start': 8, 'end': 13}, 'arg2': {'mention': 'April 10', 'nth_sent': 20, 'start': 20, 'end': 28}, 'context': 'Initial chemo given April 10.  '}\n",
      "{'filename': 'patient32_report012_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 410, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 88, 'end': 100}, 'arg2': {'mention': 'about ten days prior', 'nth_sent': 7, 'start': 101, 'end': 121}, 'context': 'This patient is a 54-year-old white female with a history of breast cancer, status post chemotherapy about ten days prior to admission, who presented to the emergency room on 07/07/2001 complaining of significant left leg swelling.'}\n",
      "{'filename': 'patient12_report007_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'adriamycin', 'nth_sent': 90, 'start': 54, 'end': 64}, 'arg2': {'mention': 'every 3 weeks', 'nth_sent': 90, 'start': 98, 'end': 111}, 'context': 'Neoadjuvant chemotherapy with 4 cycles of neoadjuvant adriamycin and cytoxan, given intravenously every 3 weeks for 4 treatments to be followed by neoadjuvant taxol, given intravenously weekly for 12 weeks.  '}\n",
      "{'filename': 'patient12_report007_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 90, 'start': 69, 'end': 76}, 'arg2': {'mention': 'every 3 weeks', 'nth_sent': 90, 'start': 98, 'end': 111}, 'context': 'Neoadjuvant chemotherapy with 4 cycles of neoadjuvant adriamycin and cytoxan, given intravenously every 3 weeks for 4 treatments to be followed by neoadjuvant taxol, given intravenously weekly for 12 weeks.  '}\n",
      "{'filename': 'patient12_report007_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 90, 'start': 159, 'end': 164}, 'arg2': {'mention': '12 weeks', 'nth_sent': 90, 'start': 197, 'end': 205}, 'context': 'Neoadjuvant chemotherapy with 4 cycles of neoadjuvant adriamycin and cytoxan, given intravenously every 3 weeks for 4 treatments to be followed by neoadjuvant taxol, given intravenously weekly for 12 weeks.  '}\n",
      "{'filename': 'patient12_report007_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 90, 'start': 159, 'end': 164}, 'arg2': {'mention': 'weekly', 'nth_sent': 90, 'start': 186, 'end': 192}, 'context': 'Neoadjuvant chemotherapy with 4 cycles of neoadjuvant adriamycin and cytoxan, given intravenously every 3 weeks for 4 treatments to be followed by neoadjuvant taxol, given intravenously weekly for 12 weeks.  '}\n",
      "{'filename': 'patient12_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 62, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for initiation of chemotherapy.'}\n",
      "{'filename': 'patient12_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 50, 'start': 62, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 50, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for initiation of chemotherapy.'}\n",
      "{'filename': 'patient12_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 12, 'start': 84, 'end': 95}, 'arg2': {'mention': '12/12/2013', 'nth_sent': 12, 'start': 124, 'end': 134}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55 1 12/12/2013     Paclitaxel Person55                          RADIOLOGYREVIEWED:'}\n",
      "{'filename': 'patient12_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 12, 'start': 96, 'end': 112}, 'arg2': {'mention': '12/12/2013', 'nth_sent': 12, 'start': 124, 'end': 134}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55 1 12/12/2013     Paclitaxel Person55                          RADIOLOGYREVIEWED:'}\n",
      "{'filename': 'patient26_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 49, 'start': 62, 'end': 67}, 'arg2': {'mention': 'next week', 'nth_sent': 49, 'start': 37, 'end': 46}, 'context': 'She is to follow up with Dr. Person6 next week and resume her chemo.  '}\n",
      "{'filename': 'patient26_report012_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 1, 'start': 24, 'end': 32}, 'arg2': {'mention': '3\\nMONTHS', 'nth_sent': 1, 'start': 37, 'end': 45}, 'context': 'PATIENT HAS BEEN TAKING ARIMIDEX FOR 3 MONTHS.'}\n",
      "{'filename': 'patient41_report023_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 12, 'end': 24}, 'arg2': {'mention': 'last\\nweek', 'nth_sent': 2, 'start': 25, 'end': 34}, 'context': 'Patient had chemotherapy last week.'}\n",
      "{'filename': 'patient41_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 8, 'start': 23, 'end': 31}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 8, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 8, 'start': 33, 'end': 40}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 8, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 52, 'start': 12, 'end': 24}, 'arg2': {'mention': 'last\\n week', 'nth_sent': 52, 'start': 25, 'end': 35}, 'context': 'Patient had chemotherapy last  week.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 6, 'start': 23, 'end': 31}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 6, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 6, 'start': 33, 'end': 40}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 6, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotheray', 'nth_sent': 31, 'start': 7, 'end': 18}, 'arg2': {'mention': 'recent', 'nth_sent': 31, 'start': 0, 'end': 6}, 'context': 'recent chemotheray.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 82, 'start': 77, 'end': 82}, 'arg2': {'mention': 'aug 8ths', 'nth_sent': 82, 'start': 84, 'end': 92}, 'context': 'Plan 44 year old, presented with abd cramping, diarrhea/constipation, recent chemo, aug 8ths.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 99, 'start': 22, 'end': 30}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 99, 'start': 13, 'end': 20}, 'context': 'recent chemo aug 8th, taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 99, 'start': 32, 'end': 39}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 99, 'start': 13, 'end': 20}, 'context': 'recent chemo aug 8th, taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 10, 'start': 291, 'end': 298}, 'arg2': {'mention': 'August 8, 2013', 'nth_sent': 10, 'start': 270, 'end': 284}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.'}\n",
      "{'filename': 'patient41_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 10, 'start': 303, 'end': 312}, 'arg2': {'mention': 'August 8, 2013', 'nth_sent': 10, 'start': 270, 'end': 284}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.'}\n",
      "{'filename': 'patient41_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 35, 'start': 78, 'end': 90}, 'arg2': {'mention': 'recent', 'nth_sent': 35, 'start': 71, 'end': 77}, 'context': 'She was started on Flagyl and Zosyn, concern for neutropenia, colitis, recent chemotherapy possible induced colitis symptoms.'}\n",
      "{'filename': 'patient41_report042_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 11, 'start': 291, 'end': 298}, 'arg2': {'mention': 'August 8, 2013', 'nth_sent': 11, 'start': 270, 'end': 284}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.  '}\n",
      "{'filename': 'patient41_report042_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 11, 'start': 303, 'end': 312}, 'arg2': {'mention': 'August 8, 2013', 'nth_sent': 11, 'start': 270, 'end': 284}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.  '}\n",
      "{'filename': 'patient41_report042_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 35, 'start': 78, 'end': 90}, 'arg2': {'mention': 'recent', 'nth_sent': 35, 'start': 71, 'end': 77}, 'context': 'She was started on Flagyl and Zosyn, concern for neutropenia, colitis, recent chemotherapy possible induced colitis symptoms.  '}\n",
      "{'filename': 'patient41_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 6, 'start': 63, 'end': 72}, 'arg2': {'mention': 'August 8', 'nth_sent': 6, 'start': 3, 'end': 11}, 'context': 'On August 8, she received her first cycle of chemotherapy with docetaxel and cyclophosphamide - did not receive prophylactic antibiotics.'}\n",
      "{'filename': 'patient41_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cyclophosphamide', 'nth_sent': 6, 'start': 77, 'end': 93}, 'arg2': {'mention': 'August 8', 'nth_sent': 6, 'start': 3, 'end': 11}, 'context': 'On August 8, she received her first cycle of chemotherapy with docetaxel and cyclophosphamide - did not receive prophylactic antibiotics.'}\n",
      "{'filename': 'patient41_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 104, 'start': 63, 'end': 75}, 'arg2': {'mention': 'recent', 'nth_sent': 104, 'start': 56, 'end': 62}, 'context': 'The patient is at risk for C. difficile infection given recent chemotherapy and antibiotic use.'}\n",
      "{'filename': 'patient41_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 46, 'start': 112, 'end': 122}, 'arg2': {'mention': 'weekly', 'nth_sent': 46, 'start': 105, 'end': 111}, 'context': 'She was scheduled to undergo chemotherapy Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel.'}\n",
      "{'filename': 'patient41_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 47, 'start': 53, 'end': 61}, 'arg2': {'mention': '8 th of August', 'nth_sent': 47, 'start': 7, 'end': 21}, 'context': 'On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 47, 'start': 63, 'end': 70}, 'arg2': {'mention': '8 th of August', 'nth_sent': 47, 'start': 7, 'end': 21}, 'context': 'On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 3, 'start': 63, 'end': 72}, 'arg2': {'mention': 'August 8', 'nth_sent': 3, 'start': 3, 'end': 11}, 'context': 'On August 8, she received her first cycle of chemotherapy with docetaxel and cyclophosphamide.'}\n",
      "{'filename': 'patient41_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cyclophosphamide', 'nth_sent': 3, 'start': 77, 'end': 93}, 'arg2': {'mention': 'August 8', 'nth_sent': 3, 'start': 3, 'end': 11}, 'context': 'On August 8, she received her first cycle of chemotherapy with docetaxel and cyclophosphamide.'}\n",
      "{'filename': 'patient41_report015_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 24, 'start': 32, 'end': 44}, 'arg2': {'mention': 'next week', 'nth_sent': 24, 'start': 13, 'end': 22}, 'context': 'She will RTC next week to start chemotherapy.     '}\n",
      "{'filename': 'patient41_report039_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 67, 'start': 152, 'end': 159}, 'arg2': {'mention': 'August 8th', 'nth_sent': 67, 'start': 177, 'end': 187}, 'context': 'Ms. Person11 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.  '}\n",
      "{'filename': 'patient41_report039_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 67, 'start': 164, 'end': 173}, 'arg2': {'mention': 'August 8th', 'nth_sent': 67, 'start': 177, 'end': 187}, 'context': 'Ms. Person11 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.  '}\n",
      "{'filename': 'patient41_report039_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 72, 'start': 35, 'end': 47}, 'arg2': {'mention': 'August 8th', 'nth_sent': 72, 'start': 51, 'end': 61}, 'context': 'Neutropenia w/o fever - Induced by chemotherapy on August 8th.'}\n",
      "{'filename': 'patient41_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 67, 'start': 14, 'end': 26}, 'arg2': {'mention': '1-2 weeks', 'nth_sent': 67, 'start': 34, 'end': 43}, 'context': 'We will begin chemotherapy within 1-2 weeks 2.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 5, 'start': 70, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #4/4-6 adjuvant taxotere and cytoxan.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #4/4-6 adjuvant taxotere and cytoxan.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 13, 'start': 397, 'end': 406}, 'arg2': {'mention': '8/8/2013', 'nth_sent': 13, 'start': 435, 'end': 443}, 'context': 'Oncotype Dx:  35      Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                             Medical Oncology Therapies: Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 8/8/2013 10/10/2013 Completed                                                                                                                                                              Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                    RADIOLOGYREVIEWED:   CT scan abdomen/pelvis performed on August 15, 2013 revealed:No CT evidence of colitis.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 13, 'start': 407, 'end': 423}, 'arg2': {'mention': '10/10/2013', 'nth_sent': 13, 'start': 444, 'end': 454}, 'context': 'Oncotype Dx:  35      Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                             Medical Oncology Therapies: Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 8/8/2013 10/10/2013 Completed                                                                                                                                                              Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                    RADIOLOGYREVIEWED:   CT scan abdomen/pelvis performed on August 15, 2013 revealed:No CT evidence of colitis.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 13, 'start': 407, 'end': 423}, 'arg2': {'mention': '8/8/2013', 'nth_sent': 13, 'start': 435, 'end': 443}, 'context': 'Oncotype Dx:  35      Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                             Medical Oncology Therapies: Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 8/8/2013 10/10/2013 Completed                                                                                                                                                              Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                    RADIOLOGYREVIEWED:   CT scan abdomen/pelvis performed on August 15, 2013 revealed:No CT evidence of colitis.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 13, 'start': 397, 'end': 406}, 'arg2': {'mention': '10/10/2013', 'nth_sent': 13, 'start': 444, 'end': 454}, 'context': 'Oncotype Dx:  35      Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                             Medical Oncology Therapies: Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51 4 8/8/2013 10/10/2013 Completed                                                                                                                                                              Radiation Oncology Therapies:  Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                    RADIOLOGYREVIEWED:   CT scan abdomen/pelvis performed on August 15, 2013 revealed:No CT evidence of colitis.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 89, 'start': 70, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 89, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #4/4-6 adjuvant taxotere and cytoxan.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 89, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 89, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #4/4-6 adjuvant taxotere and cytoxan.'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 91, 'start': 22, 'end': 30}, 'arg2': {'mention': 'today', 'nth_sent': 91, 'start': 60, 'end': 65}, 'context': 'Cycle #4/4-6 adjuvant taxotere and cytoxan, last cycle, due today.  '}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 91, 'start': 35, 'end': 42}, 'arg2': {'mention': 'today', 'nth_sent': 91, 'start': 60, 'end': 65}, 'context': 'Cycle #4/4-6 adjuvant taxotere and cytoxan, last cycle, due today.  '}\n",
      "{'filename': 'patient41_report037_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 198, 'end': 205}, 'arg2': {'mention': '8-08-2013', 'nth_sent': 5, 'start': 183, 'end': 192}, 'context': 'This 44 year old, white female, hx of recently diagnosed, May 2013, breast cancer, s/p LEFT partial mastectomy with LEFT sentinel node biopsy 7-03-2013, s/p 1st/4 cycles chemotherapy 8-08-2013 with cytoxan + Docetaxol, (did not receive neupogen) presented 8-15-2013 with alteration in bowels.'}\n",
      "{'filename': 'patient41_report037_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxol', 'nth_sent': 5, 'start': 208, 'end': 217}, 'arg2': {'mention': '8-08-2013', 'nth_sent': 5, 'start': 183, 'end': 192}, 'context': 'This 44 year old, white female, hx of recently diagnosed, May 2013, breast cancer, s/p LEFT partial mastectomy with LEFT sentinel node biopsy 7-03-2013, s/p 1st/4 cycles chemotherapy 8-08-2013 with cytoxan + Docetaxol, (did not receive neupogen) presented 8-15-2013 with alteration in bowels.'}\n",
      "{'filename': 'patient41_report037_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 87, 'start': 77, 'end': 82}, 'arg2': {'mention': 'aug 8ths', 'nth_sent': 87, 'start': 84, 'end': 92}, 'context': 'Plan 44 year old, presented with abd cramping, diarrhea/constipation, recent chemo, aug 8ths.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 9, 'start': 112, 'end': 122}, 'arg2': {'mention': 'weekly', 'nth_sent': 9, 'start': 105, 'end': 111}, 'context': 'She was scheduled to undergo chemotherapy Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 10, 'start': 53, 'end': 61}, 'arg2': {'mention': '8 th of August', 'nth_sent': 10, 'start': 7, 'end': 21}, 'context': 'On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 10, 'start': 63, 'end': 70}, 'arg2': {'mention': '8 th of August', 'nth_sent': 10, 'start': 7, 'end': 21}, 'context': 'On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 95, 'start': 112, 'end': 122}, 'arg2': {'mention': 'weekly', 'nth_sent': 95, 'start': 105, 'end': 111}, 'context': 'She was scheduled to undergo chemotherapy Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 96, 'start': 53, 'end': 61}, 'arg2': {'mention': '8 th of August', 'nth_sent': 96, 'start': 7, 'end': 21}, 'context': 'On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 96, 'start': 63, 'end': 70}, 'arg2': {'mention': '8 th of August', 'nth_sent': 96, 'start': 7, 'end': 21}, 'context': 'On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report006_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 89, 'start': 51, 'end': 60}, 'arg2': {'mention': '5 years', 'nth_sent': 89, 'start': 40, 'end': 47}, 'context': 'I also explained she is a candidate for 5 years of tamoxifen therapy.  '}\n",
      "{'filename': 'patient41_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 72, 'start': 3, 'end': 11}, 'arg2': {'mention': 'today', 'nth_sent': 72, 'start': 39, 'end': 44}, 'context': '1. Taxotere and Cytoxan cycle 2 of 4-6 today with 20% dose reduction on both medications Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 72, 'start': 16, 'end': 23}, 'arg2': {'mention': 'today', 'nth_sent': 72, 'start': 39, 'end': 44}, 'context': '1. Taxotere and Cytoxan cycle 2 of 4-6 today with 20% dose reduction on both medications Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 12, 'end': 24}, 'arg2': {'mention': 'end of last week', 'nth_sent': 9, 'start': 32, 'end': 48}, 'context': 'She got her chemotherapy in the end of last week, did not get any Neupogen or Neulasta.  '}\n",
      "{'filename': 'patient41_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 26, 'start': 11, 'end': 23}, 'arg2': {'mention': 'Recent', 'nth_sent': 26, 'start': 4, 'end': 10}, 'context': '7.  Recent chemotherapy.'}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 3, 'start': 182, 'end': 189}, 'arg2': {'mention': 'August 8th', 'nth_sent': 3, 'start': 207, 'end': 217}, 'context': 'History of Present Illness   Ms. Patient41 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.  '}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 3, 'start': 194, 'end': 203}, 'arg2': {'mention': 'August 8th', 'nth_sent': 3, 'start': 207, 'end': 217}, 'context': 'History of Present Illness   Ms. Patient41 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.  '}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 12, 'start': 32, 'end': 39}, 'arg2': {'mention': 'August 8th', 'nth_sent': 12, 'start': 59, 'end': 69}, 'context': 'She received her first cycle of cytoxan witgh docetaxel on August 8th without neupogen.'}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 12, 'start': 46, 'end': 55}, 'arg2': {'mention': 'August 8th', 'nth_sent': 12, 'start': 59, 'end': 69}, 'context': 'She received her first cycle of cytoxan witgh docetaxel on August 8th without neupogen.'}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 127, 'start': 153, 'end': 160}, 'arg2': {'mention': 'August 8th', 'nth_sent': 127, 'start': 178, 'end': 188}, 'context': 'Ms. Patient41 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.   '}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 127, 'start': 165, 'end': 174}, 'arg2': {'mention': 'August 8th', 'nth_sent': 127, 'start': 178, 'end': 188}, 'context': 'Ms. Patient41 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.   '}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 132, 'start': 26, 'end': 38}, 'arg2': {'mention': 'August 8th', 'nth_sent': 132, 'start': 42, 'end': 52}, 'context': 'Neutropenia  - Induced by chemotherapy on August 8th.'}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 4, 'start': 80, 'end': 88}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy treatment with Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 4, 'start': 93, 'end': 100}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy treatment with Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 12, 'start': 416, 'end': 425}, 'arg2': {'mention': '8/8/2013', 'nth_sent': 12, 'start': 453, 'end': 461}, 'context': 'Oncotype Dx:  35   Comments:  Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                            Comments:  Medical Oncology Therapies:  Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51  8/8/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 12, 'start': 426, 'end': 442}, 'arg2': {'mention': '8/8/2013', 'nth_sent': 12, 'start': 453, 'end': 461}, 'context': 'Oncotype Dx:  35   Comments:  Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                            Comments:  Medical Oncology Therapies:  Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51  8/8/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 77, 'start': 86, 'end': 94}, 'arg2': {'mention': 'At that time', 'nth_sent': 77, 'start': 0, 'end': 12}, 'context': 'At that time, it will be determined whether the patient will receive 4 or 6 cycles of Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 77, 'start': 99, 'end': 106}, 'arg2': {'mention': 'At that time', 'nth_sent': 77, 'start': 0, 'end': 12}, 'context': 'At that time, it will be determined whether the patient will receive 4 or 6 cycles of Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 13, 'start': 232, 'end': 240}, 'arg2': {'mention': 'currently', 'nth_sent': 13, 'start': 191, 'end': 200}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on adjuvant chemotherapy using Taxotere and Cytoxan, cycle 3 of 4.'}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 13, 'start': 245, 'end': 252}, 'arg2': {'mention': 'currently', 'nth_sent': 13, 'start': 191, 'end': 200}, 'context': 'Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on adjuvant chemotherapy using Taxotere and Cytoxan, cycle 3 of 4.'}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 63, 'start': 0, 'end': 8}, 'arg2': {'mention': 'today', 'nth_sent': 63, 'start': 36, 'end': 41}, 'context': 'Taxotere and Cytoxan cycle 1 of 4-6 today.'}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 63, 'start': 13, 'end': 20}, 'arg2': {'mention': 'today', 'nth_sent': 63, 'start': 36, 'end': 41}, 'context': 'Taxotere and Cytoxan cycle 1 of 4-6 today.'}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 76, 'start': 416, 'end': 425}, 'arg2': {'mention': '8/8/2013', 'nth_sent': 76, 'start': 453, 'end': 461}, 'context': 'Oncotype Dx:  35   Comments:  Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                            Comments:  Medical Oncology Therapies:  Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51  8/8/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 76, 'start': 426, 'end': 442}, 'arg2': {'mention': '8/8/2013', 'nth_sent': 76, 'start': 453, 'end': 461}, 'context': 'Oncotype Dx:  35   Comments:  Biopsies / Surgeries:  Procedure Provider Side Date Completed Comments  Stereotactic Core Breast Biopsy  Left 5/22/2013   Segmental Mastectomy with Sentinel Node Biopsy  Left 7/8/2013   Re-excision Segmental Mastectomy  Left 7/18/2013                            Comments:  Medical Oncology Therapies:  Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person51  8/8/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 6, 'start': 47, 'end': 55}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy with Taxotere and Cytoxan 1/4-6.'}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 6, 'start': 60, 'end': 67}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 7, 'end': 16}, 'context': 'She is currently on adjuvant chemotherapy with Taxotere and Cytoxan 1/4-6.'}\n",
      "{'filename': 'patient41_report016_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 67, 'start': 14, 'end': 26}, 'arg2': {'mention': '1-2 weeks', 'nth_sent': 67, 'start': 34, 'end': 43}, 'context': 'We will begin chemotherapy within 1-2 weeks 2.'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 5, 'start': 23, 'end': 31}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 5, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 33, 'end': 40}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 5, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotheray', 'nth_sent': 30, 'start': 7, 'end': 18}, 'arg2': {'mention': 'recent', 'nth_sent': 30, 'start': 0, 'end': 6}, 'context': 'recent chemotheray.'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 105, 'start': 79, 'end': 84}, 'arg2': {'mention': 'aug 8ths', 'nth_sent': 105, 'start': 86, 'end': 94}, 'context': 'Plan   44 year old, presented with abd cramping, diarrhea/constipation, recent chemo, aug 8ths.'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxotere', 'nth_sent': 114, 'start': 22, 'end': 30}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 114, 'start': 13, 'end': 20}, 'context': 'recent chemo aug 8th, taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 114, 'start': 32, 'end': 39}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 114, 'start': 13, 'end': 20}, 'context': 'recent chemo aug 8th, taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report043_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 198, 'end': 205}, 'arg2': {'mention': '8-08-2013', 'nth_sent': 5, 'start': 183, 'end': 192}, 'context': 'This 44 year old, white female, hx of recently diagnosed, May 2013, breast cancer, s/p LEFT partial mastectomy with LEFT sentinel node biopsy 7-03-2013, s/p 1st/4 cycles chemotherapy 8-08-2013 with cytoxan + Docetaxol, (did not receive neupogen) presented 8-15-2013 with alteration in bowels.'}\n",
      "{'filename': 'patient41_report043_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxol', 'nth_sent': 5, 'start': 208, 'end': 217}, 'arg2': {'mention': '8-08-2013', 'nth_sent': 5, 'start': 183, 'end': 192}, 'context': 'This 44 year old, white female, hx of recently diagnosed, May 2013, breast cancer, s/p LEFT partial mastectomy with LEFT sentinel node biopsy 7-03-2013, s/p 1st/4 cycles chemotherapy 8-08-2013 with cytoxan + Docetaxol, (did not receive neupogen) presented 8-15-2013 with alteration in bowels.'}\n",
      "{'filename': 'patient41_report043_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 28, 'start': 7, 'end': 19}, 'arg2': {'mention': 'recent', 'nth_sent': 28, 'start': 0, 'end': 6}, 'context': 'recent chemotherapy, possible induced colitis symptoms.  '}\n",
      "{'filename': 'patient41_report043_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 90, 'start': 77, 'end': 82}, 'arg2': {'mention': 'aug 8ths', 'nth_sent': 90, 'start': 84, 'end': 92}, 'context': 'Plan 44 year old, presented with abd cramping, diarrhea/constipation, recent chemo, aug 8ths.'}\n",
      "{'filename': 'patient41_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 11, 'start': 291, 'end': 298}, 'arg2': {'mention': 'August 8, 2013', 'nth_sent': 11, 'start': 270, 'end': 284}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.'}\n",
      "{'filename': 'patient41_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 11, 'start': 303, 'end': 312}, 'arg2': {'mention': 'August 8, 2013', 'nth_sent': 11, 'start': 270, 'end': 284}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.'}\n",
      "{'filename': 'patient41_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 36, 'start': 78, 'end': 90}, 'arg2': {'mention': 'recent', 'nth_sent': 36, 'start': 71, 'end': 77}, 'context': 'She was started on Flagyl and Zosyn, concern for neutropenia, colitis, recent chemotherapy possible induced colitis symptoms.'}\n",
      "{'filename': 'patient41_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 21, 'start': 122, 'end': 124}, 'arg2': {'mention': 'earlier this month', 'nth_sent': 21, 'start': 138, 'end': 156}, 'context': 'History of present illness:  Pt is a 44 yo F w/recent diagnosis of breast cancer s/p mastectomy followed by initiation of TC chemotherapy earlier this month.'}\n",
      "{'filename': 'patient41_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 53, 'start': 158, 'end': 168}, 'arg2': {'mention': 'weekly', 'nth_sent': 53, 'start': 151, 'end': 157}, 'context': 'Based on these findings, Dr. Person32 recommends adjuvant chemotherapy with a course of Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel.'}\n",
      "{'filename': 'patient41_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 19, 'start': 12, 'end': 24}, 'arg2': {'mention': 'last\\n week', 'nth_sent': 19, 'start': 25, 'end': 35}, 'context': 'Patient had chemotherapy last  week.'}\n",
      "{'filename': 'patient92_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Abraxane', 'nth_sent': 2, 'start': 37, 'end': 45}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 30, 'end': 36}, 'context': 'Therapy completed 9 cycles of weekly Abraxane.  '}\n",
      "{'filename': 'patient92_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Abraxane', 'nth_sent': 8, 'start': 57, 'end': 65}, 'arg2': {'mention': 'weekly', 'nth_sent': 8, 'start': 50, 'end': 56}, 'context': 'She has now completed 9 of a planned 12 cycles of weekly Abraxane.'}\n",
      "{'filename': 'patient43_report007_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aromatase inhibitor', 'nth_sent': 41, 'start': 49, 'end': 68}, 'arg2': {'mention': '5 years', 'nth_sent': 41, 'start': 87, 'end': 94}, 'context': 'I would anticipate that she will benefit from an aromatase inhibitor for a duration of 5 years.  '}\n",
      "{'filename': 'patient43_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Tamoxifen', 'nth_sent': 7, 'start': 18, 'end': 27}, 'arg2': {'mention': 'every other day', 'nth_sent': 7, 'start': 28, 'end': 43}, 'context': 'CURRENT THERAPY:  Tamoxifen every other day with joint pains.  '}\n",
      "{'filename': 'patient43_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 20, 'start': 35, 'end': 43}, 'arg2': {'mention': '5 years', 'nth_sent': 20, 'start': 68, 'end': 75}, 'context': '2. The patient will get started on Arimidex; will continue this for 5 years.'}\n",
      "{'filename': 'patient43_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 3, 'start': 35, 'end': 43}, 'arg2': {'mention': 'daily', 'nth_sent': 4, 'start': 54, 'end': 59}, 'context': 'CURRENT THERAPY:  To be started on Arimidex 1 mg p.o. daily and to continue until April 2017.  '}\n",
      "{'filename': 'patient46_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 3, 'start': 33, 'end': 41}, 'arg2': {'mention': 'five years', 'nth_sent': 3, 'start': 46, 'end': 56}, 'context': 'The patient will continue on her Arimidex for five years.'}\n",
      "{'filename': 'patient46_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ANASTROZOLE', 'nth_sent': 0, 'start': 74, 'end': 85}, 'arg2': {'mention': 'daily', 'nth_sent': 1, 'start': 102, 'end': 107}, 'context': 'Outpatient Prescriptions Prior to Visit  Medication Sig Dispense Refill   ANASTROZOLE (ARIMIDEX ORAL) daily     Calcium (CALCIO DEL MAR) 500'}\n",
      "{'filename': 'patient46_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 0, 'start': 87, 'end': 95}, 'arg2': {'mention': 'daily', 'nth_sent': 1, 'start': 102, 'end': 107}, 'context': 'Outpatient Prescriptions Prior to Visit  Medication Sig Dispense Refill   ANASTROZOLE (ARIMIDEX ORAL) daily     Calcium (CALCIO DEL MAR) 500'}\n",
      "{'filename': 'patient46_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ANASTROZOLE', 'nth_sent': 0, 'start': 74, 'end': 85}, 'arg2': {'mention': 'daily', 'nth_sent': 1, 'start': 102, 'end': 107}, 'context': 'Outpatient Prescriptions Prior to Visit  Medication Sig Dispense Refill   ANASTROZOLE (ARIMIDEX ORAL) daily     Calcium (CALCIO DEL MAR) 500'}\n",
      "{'filename': 'patient46_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 0, 'start': 87, 'end': 95}, 'arg2': {'mention': 'daily', 'nth_sent': 1, 'start': 102, 'end': 107}, 'context': 'Outpatient Prescriptions Prior to Visit  Medication Sig Dispense Refill   ANASTROZOLE (ARIMIDEX ORAL) daily     Calcium (CALCIO DEL MAR) 500'}\n",
      "{'filename': 'patient93_report022_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 414, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 5, 'start': 35, 'end': 44}, 'arg2': {'mention': '09/17/2010', 'nth_sent': 5, 'start': 48, 'end': 58}, 'context': 'She recently had chemotherapy with Herceptin on 09/17/2010.  '}\n",
      "{'filename': 'patient93_report022_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 414, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 35, 'end': 47}, 'arg2': {'mention': '09/23/2010', 'nth_sent': 10, 'start': 51, 'end': 61}, 'context': 'The patient is noted to be due for chemotherapy on 09/23/2010.  '}\n",
      "{'filename': 'patient93_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 88, 'end': 93}, 'arg2': {'mention': '9/10', 'nth_sent': 8, 'start': 100, 'end': 104}, 'context': 'The patient has stage 4 breast carcinoma with lung and mediastinal mets and has been on Taxol since 9/10.'}\n",
      "{'filename': 'patient93_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 153, 'end': 165}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 132, 'end': 141}, 'context': 'History of Present Illness Ms. Person20 is a 56 y/o female with PMH significant for metastatic breast cancer with mets to the lung, currently undergoing chemotherapy, who presents with complaints of fevers, chills and productive cough, found to have pneumonia.'}\n",
      "{'filename': 'patient93_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 15, 'start': 9, 'end': 21}, 'arg2': {'mention': '9/17/2010', 'nth_sent': 15, 'start': 26, 'end': 35}, 'context': 'Her last chemotherapy was 9/17/2010.  '}\n",
      "{'filename': 'patient93_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 21, 'start': 271, 'end': 276}, 'arg2': {'mention': 'Currently', 'nth_sent': 21, 'start': 245, 'end': 254}, 'context': 'Histories Past Medical History -Breast Cancer diagnosed 2006 after finding lump in her breast -Underwent Neoadjuvant chemo and then bilateral mastectomy followed for XRT -Staged IIB with no mets -April 2010 found to have LUL metastatic disease -Currently on 2nd cycle of Taxol  '}\n",
      "{'filename': 'patient93_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 78, 'start': 146, 'end': 158}, 'arg2': {'mention': 'currently', 'nth_sent': 78, 'start': 125, 'end': 134}, 'context': 'Impression and Plan Ms. Person20 is a 56 y/o female with PMH significant for metastatic breast cancer with mets to the lung, currently undergoing chemotherapy, who presents with complaints of fevers, chills and productive cough, found to have pneumonia.  '}\n",
      "{'filename': 'patient93_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 89, 'start': 13, 'end': 25}, 'arg2': {'mention': 'Currently', 'nth_sent': 89, 'start': 0, 'end': 9}, 'context': 'Currently on chemotherapy Plan -Management per oncology  Thank you for this interesting consult D/w Dr. Person28.'}\n",
      "{'filename': 'patient20_report011_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 6, 'start': 13, 'end': 21}, 'arg2': {'mention': 'CURRENTLY', 'nth_sent': 6, 'start': 0, 'end': 9}, 'context': 'CURRENTLY ON ARIMIDEX.'}\n",
      "{'filename': 'patient30_report006_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'TAMOXIFEN', 'nth_sent': 3, 'start': 20, 'end': 29}, 'arg2': {'mention': '3   6   02', 'nth_sent': 4, 'start': 121, 'end': 127}, 'context': 'SHE HAS BEEN TAKING TAMOXIFEN THIS YEAR.   COMPARISON:  Made with the previous left breast mammograms of 12/17/98 and of 3/6/02.  FINDINGS:  There is no new or suspicious dominant mass, cluster of microcalcifications, or area of architectural distortion that suggests the presence of malignancy.  '}\n",
      "{'filename': 'patient47_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 4, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #3/4 adjuvant Adriamycin and Cytoxan with Neulasta support.'}\n",
      "{'filename': 'patient47_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 10, 'start': 135, 'end': 145}, 'arg2': {'mention': '7   2   2013', 'nth_sent': 10, 'start': 156, 'end': 164}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013 Comments:  Radiation Oncology Therapies:  '}\n",
      "{'filename': 'patient47_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 81, 'end': 88}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient47_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 83, 'end': 90}, 'arg2': {'mention': 'day', 'nth_sent': 6, 'start': 40, 'end': 43}, 'context': \"She presents to our outpatient clinic today for cycle #2/4 adjuvant Adriamycin and Cytoxan. At today's visit, she reports that she had a migraine headache for 4 days, starting the day of chemotherapy.\"}\n",
      "{'filename': 'patient47_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 76, 'end': 81}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #4 weekly Taxol.'}\n",
      "{'filename': 'patient47_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 5, 'start': 100, 'end': 105}, 'arg2': {'mention': 'tomorrow', 'nth_sent': 6, 'start': 138, 'end': 146}, 'context': 'Medical Oncology:  Adjuvant Chemo with Dr. Person2, 4 of 4 cycles of Adriamycin/Cytoxan + 12 weekly Taxol. Her last dose of Taxol will be tomorrow, Sept. 17th.  '}\n",
      "{'filename': 'patient47_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 15, 'start': 32, 'end': 44}, 'arg2': {'mention': 'March  ', 'nth_sent': 16, 'start': 164, 'end': 169}, 'context': 'She did have some problems with chemotherapy in terms of neutropenia as well as thrombocytopenia.   She did have a MUGA which showed an ejection fraction of 73% in March.  '}\n",
      "{'filename': 'patient47_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 108, 'start': 247, 'end': 252}, 'arg2': {'mention': 'March 29   2013', 'nth_sent': 109, 'start': 343, 'end': 357}, 'context': 'Patient47 is a 57-year-old postmenopausal female with left T2, N0, M0 IDC diagnosed January 18, 2013, triple negative    Recommendations were given for adjuvant chemotherapy with Adriamycin and Cytoxan Q. 21 days 4 cycles, followed by 12 weeks of Taxol  She will require adjuvant radiation therapy. She has an appointment with Dr. Person70 on March 29, 2013  Recommend genetic counseling for this 57 year-old female with triple negative breast cancer  Baseline MUGA scan  Dictated by Person112, CRNP, for Person124, MD. Person124, MD examined the patient, outlined this plan of treatment.'}\n",
      "{'filename': 'patient47_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 165, 'end': 177}, 'arg2': {'mention': 'recently', 'nth_sent': 1, 'start': 87, 'end': 95}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a very pleasant 57-year-old woman with history of recently diagnosed left breast cancer, status post surgery and first cycle of chemotherapy, presents to clinic with the above symptoms.'}\n",
      "{'filename': 'patient47_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'AC', 'nth_sent': 4, 'start': 48, 'end': 50}, 'arg2': {'mention': '3   29   2013', 'nth_sent': 5, 'start': 227, 'end': 236}, 'context': 'She is currently on adjuvant chemotherapy using AC 1/4 Her last radiology results, included the following:  Baseline MUGA scan LVEF is 72% LABS REVIEWED:  Last CBC and Differential:  Lab Results  Component Value Date  WBC 3.7* 3/29/2013  RBC 4.16 3/29/2013  HGB 13.2 3/29/2013  HCT 41.1 3/29/2013  MCV 98.8* 3/29/2013  MCH 31.7 3/29/2013  MCHCMANUAL 32.1* 3/29/2013  RDW 14.1 3/29/2013  MNPLATVOL 7.9 3/29/2013  PLATELETS 194 3/29/2013  NEUTROPHILS 51 3/29/2013  ABSNEUTROPHILS 1.89* 3/29/2013  LYMPHOCYTES 32 3/29/2013  ABSLYMPH 1.19 3/29/2013  MONOCYTES 14* 3/29/2013  ABSMONO 0.52 3/29/2013  EOSINOPHILS 3 3/29/2013  ABSEOS 0.10 3/29/2013  BASOPHILS 0'}\n",
      "{'filename': 'patient47_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 8, 'start': 135, 'end': 145}, 'arg2': {'mention': '7   2   2013', 'nth_sent': 8, 'start': 156, 'end': 164}, 'context': 'Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55  4/4/2013 6/6/2013 Completed   Paclitaxel Person55  7/2/2013                                                                                                                                                                                                                                      Comments:  Radiation Oncology Therapies:'}\n",
      "{'filename': 'patient47_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 76, 'end': 81}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy, #1 weekly Taxol.'}\n",
      "{'filename': 'patient10_report064_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 78, 'start': 86, 'end': 98}, 'arg2': {'mention': 'Arimidex 2 weeks ago', 'nth_sent': 79, 'start': 158, 'end': 178}, 'context': 'The patient has undergone a left segmental mastectomy, and completed only 2 cycles of chemotherapy because of toxicity.   Patient10 just recently started her Arimidex 2 weeks ago.'}\n",
      "{'filename': 'patient10_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 1, 'start': 353, 'end': 360}, 'arg2': {'mention': 'April 3   2013', 'nth_sent': 2, 'start': 426, 'end': 439}, 'context': 'Patient10 MRN:   ACCOUNT #:   DATE OF BIRTH:  10/26/1948   ATTENDING PHYSICIAN:  Person5 CONSULTING PHYSICIAN:  Location WEINBERG ADMISSION DATE:  04/21/2013 CONSULTATION DATE:  04/22/2013  Patient10 is a 64-year-old with a history of stage 1 intraductal left breast cancer treated in December 2012, with a left segmental mastectomy and on Taxotere and Cytoxan. She most recently received chemo on April 2, 2013, with last on April 3, 2013.'}\n",
      "{'filename': 'patient10_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 76, 'end': 83}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 21, 'end': 26}, 'context': 'The patient presents today to begin her adjuvant chemotherapy, Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient10_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 80, 'start': 142, 'end': 154}, 'arg2': {'mention': 'now', 'nth_sent': 79, 'start': 31, 'end': 34}, 'context': 'Given cipro, will continue for now and follow up on urine culture.    Nausea/vomiting/decreased po intake:  Likely in association with recent chemotherapy aggravated by constipation.'}\n",
      "{'filename': 'patient10_report055_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 12, 'start': 129, 'end': 141}, 'arg2': {'mention': 'the near future', 'nth_sent': 11, 'start': 60, 'end': 75}, 'context': \"She will be receiving a cholecystectomy with Dr. Person2 in the near future. She is decided that she doesn't want any additional chemotherapy.\"}\n",
      "{'filename': 'patient10_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 1, 'start': 353, 'end': 360}, 'arg2': {'mention': 'April 3   2013', 'nth_sent': 2, 'start': 426, 'end': 439}, 'context': 'Patient10 MRN:   ACCOUNT #:   DATE OF BIRTH:  10/26/1948   ATTENDING PHYSICIAN:  Person5 CONSULTING PHYSICIAN:  Location WEINBERG ADMISSION DATE:  04/21/2013 CONSULTATION DATE:  04/22/2013  Patient10 is a 64-year-old with a history of stage 1 intraductal left breast cancer treated in December 2012, with a left segmental mastectomy and on Taxotere and Cytoxan. She most recently received chemo on April 2, 2013, with last on April 3, 2013.'}\n",
      "{'filename': 'patient10_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 225, 'end': 237}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 204, 'end': 213}, 'context': 'None   Triage Intervention(s):  None   Triage Disposition:  Treatment Room   History of Present Illness  This is a 64-year-old white female with a significant past medical history of breast cancer who is currently undergoing chemotherapy, last treatment was April 4, 2013.'}\n",
      "{'filename': 'patient10_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 75, 'end': 82}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue adjuvant chemotherapy, Taxotere and Cytoxan #2/4 with Neulasta.'}\n",
      "{'filename': 'patient10_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 77, 'start': 86, 'end': 98}, 'arg2': {'mention': 'daily', 'nth_sent': 78, 'start': 259, 'end': 264}, 'context': 'The patient has undergone a left segmental mastectomy, and completed only 2 cycles of chemotherapy because of toxicity, radiation therapy, and is here to discuss starting antiestrogen therapy.   The plan for Ms. Patient10 is to begin Arimidex 1 mg 1 by mouth daily.'}\n",
      "{'filename': 'patient10_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 31, 'end': 43}, 'arg2': {'mention': 'day', 'nth_sent': 7, 'start': 117, 'end': 120}, 'context': 'She does have another round of chemotherapy, coming up this coming week. She says she was doing well for a couple of days and over the past day to day and a half she reports upper abdominal pain.'}\n",
      "{'filename': 'patient10_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 107, 'end': 119}, 'arg2': {'mention': 'about one week ago', 'nth_sent': 5, 'start': 193, 'end': 211}, 'context': 'None   History of Present Illness  64-year-old white female with known breast cancer, currently undergoing chemotherapy, presents with weakness, and fever. She states she received chemotherapy about one week ago.'}\n",
      "{'filename': 'patient10_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 31, 'end': 43}, 'arg2': {'mention': 'day', 'nth_sent': 7, 'start': 117, 'end': 120}, 'context': 'She does have another round of chemotherapy, coming up this coming week. She says she was doing well for a couple of days and over the past day to day and a half she reports upper abdominal pain.'}\n",
      "{'filename': 'patient10_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 124, 'end': 131}, 'arg2': {'mention': 'about 12 hours', 'nth_sent': 4, 'start': 296, 'end': 310}, 'context': 'Office Phone:     History of Present Illness  Ms. Patient10 is a pleasant 64y/o woman currently being treated w/ Taxotere & Cytoxan (last dose 4/2) for Stage I breast ca admitted 4/21 w/ a one day h/o epigastric pain with a bandlike distribution radiating to the back. Pain was severe, and after about 12 hours was accompanied with nausea and then subsequent non-bloody, non-bilious emesis.'}\n",
      "{'filename': 'patient11_report001_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 119, 'start': 86, 'end': 96}, 'arg2': {'mention': 'by 12 weeks', 'nth_sent': 119, 'start': 71, 'end': 82}, 'context': 'My recommendation would be 4 cycles of Adriamycin and Cytoxan followed by 12 weeks of paclitaxel.'}\n",
      "{'filename': 'patient11_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 13, 'start': 18, 'end': 30}, 'arg2': {'mention': 'July 2011', 'nth_sent': 13, 'start': 60, 'end': 69}, 'context': 'Status post Taxol chemotherapy given weekly for 5-6 months, July 2011.'}\n",
      "{'filename': 'patient11_report008_PGN_breast', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 103, 'end': 115}, 'arg2': {'mention': '8   31   11', 'nth_sent': 5, 'start': 210, 'end': 217}, 'context': 'Past medical history is significant for right infiltrating breast cancer, s/p 6 months of weekly taxol chemotherapy (from Feb-July 2011) and a segmental mastectomy on 1/25/11.   She presented to Institution on 8/31/11 with redness, warmth, and tenderness of the skin above her port and a low grade fever.  '}\n",
      "{'filename': 'patient11_report018_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 114, 'end': 126}, 'arg2': {'mention': '08   31   2011', 'nth_sent': 3, 'start': 229, 'end': 239}, 'context': 'She has a past medical history significant for right infiltrating breast CA, status post 6 months of weekly Taxol chemotherapy from February to July 2011, and a segmental mastectomy on 01/25/2011. She presented to Institution on 08/31/2011 with redness, warmth, and tenderness of the skin above her port and a low-grade fever.'}\n",
      "{'filename': 'patient40_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 44, 'end': 56}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to start neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 47, 'end': 59}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to continue neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 11, 'start': 162, 'end': 172}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 436, 'end': 445}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide RASTOGI, PRIYA 4 7/24/2013 9/25/2013 Completed   Paclitaxel RASTOGI, PRIYA 12 10/16/2013 Comments:  Radiation Oncology Therapies:   Site Provider Side # of Fractions Date Started Date Completed Reason Discontinued Comments                                                                                              She is currently on neoadjuvant chemotherapy using weekly Taxol, cycle 8 of 12.'}\n",
      "{'filename': 'patient40_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 54, 'end': 66}, 'arg2': {'mention': 'today  ', 'nth_sent': 2, 'start': 31, 'end': 36}, 'context': 'Patient to receive AC number 3 today. Doing well with chemotherapy.     '}\n",
      "{'filename': 'patient40_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 3, 'start': 58, 'end': 63}, 'arg2': {'mention': 'today  ', 'nth_sent': 2, 'start': 21, 'end': 26}, 'context': 'Continue AC number 4 today. Will start weekly neoadjuvant taxol in 3 weeks.     '}\n",
      "{'filename': 'patient40_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 0, 'start': 39, 'end': 46}, 'arg2': {'mention': 'today  ', 'nth_sent': 0, 'start': 47, 'end': 52}, 'context': 'Patient receiving cycle 2/4 adriamycin/cytoxan today.'}\n",
      "{'filename': 'patient40_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 47, 'end': 59}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 17, 'end': 22}, 'context': 'Patient presents today to continue neoadjuvant chemotherapy with Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 3, 'start': 96, 'end': 103}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy, cycle #2 of Adriamycin and Cytoxan.'}\n",
      "{'filename': 'patient40_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 80, 'end': 85}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her neoadjuvant chemotherapy with weekly Taxol.'}\n",
      "{'filename': 'patient40_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 190, 'end': 202}, 'arg2': {'mention': 'recently', 'nth_sent': 0, 'start': 39, 'end': 47}, 'context': 'SUBJECTIVE:  62yo pt with a history of recently diagnosed T2NxMx R invasive ductal ca, ER/PR positive, Her2 negative. Pt tumor was 4.9cm in dimension and pt currently undergoing neoadjuvant chemotherapy.'}\n",
      "{'filename': 'patient40_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 410, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 0, 'start': 34, 'end': 41}, 'arg2': {'mention': '7   10   2013', 'nth_sent': 1, 'start': 76, 'end': 85}, 'context': 'Chemo teaching done on Adriamycin/Cytoxan. For Bone Scan, CT C/A/P, labs on 7/10/2013.'}\n",
      "{'filename': 'patient42_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17   2012', 'nth_sent': 8, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report076_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 12, 'start': 224, 'end': 232}, 'arg2': {'mention': '2 puffs twice a day', 'nth_sent': 13, 'start': 462, 'end': 481}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3  Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 18, 'start': 43, 'end': 51}, 'arg2': {'mention': 'every day', 'nth_sent': 19, 'start': 88, 'end': 97}, 'context': '20 mg Oral capsule One daily  anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day  Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  ASPIRIN LOW STRENGTH'}\n",
      "{'filename': 'patient42_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17   2012', 'nth_sent': 8, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 8, 'start': 89, 'end': 97}, 'arg2': {'mention': 'September 17   2012', 'nth_sent': 8, 'start': 104, 'end': 122}, 'context': 'Patient presents to our outpatient clinic today for continued followup and evaluation on Arimidex since September 17, 2012.'}\n",
      "{'filename': 'patient42_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 9, 'start': 106, 'end': 113}, 'arg2': {'mention': 'today', 'nth_sent': 10, 'start': 172, 'end': 177}, 'context': 'She also talked about this with the oncologist Dr. Person2 and are both in agreement with doing Taxotere, Cytoxan x4 followed by an aromatase inhibitor. The patient states today she is worried about (chemo) brain.'}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'arimidex', 'nth_sent': 112, 'start': 9, 'end': 17}, 'arg2': {'mention': 'August of 2014', 'nth_sent': 113, 'start': 30, 'end': 44}, 'context': 'Continue arimidex.   DEXA due August of 2014.  '}\n",
      "{'filename': 'patient42_report073_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 23, 'start': 143, 'end': 151}, 'arg2': {'mention': 'Today', 'nth_sent': 22, 'start': 90, 'end': 95}, 'context': '60 MG BY MOUTH ONCE A DAY (No Change)  Medication Information Comment:  Medications Given Today: 01/03/13 08:58 amlodipine 5 mg 01/03/13 08:57 Arimidex 1 mg 01/03/13 07:00 clindamycin 600 mg 01/03/13 08:58 Colace 100 mg 01/03/13 08:58 fluoxetine 20 mg 01/03/13 08:41'}\n",
      "{'filename': 'patient42_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 24, 'start': 224, 'end': 232}, 'arg2': {'mention': '2 puffs twice a day', 'nth_sent': 25, 'start': 462, 'end': 481}, 'context': '60 mg Oral tablet Take one daily 90 Tab 3   Calcium-Cholecalciferol, D3, (CALTRATE-600 PLUS VITAMIN D3) 600 mg(1,500mg) -400 unit Oral Tab bid 90 12   Fluoxetine (PROZAC) 20 mg Oral capsule One daily 90 Cap 3   anastrozole (ARIMIDEX) 1 mg Oral tablet Take one by mouth every day 30 Tab 5   Albuterol Sulfate (PROAIR HFA) 90 mcg/actuation Inhl HFA Aerosol Inhaler 2 puffs every 6 hrs as needed 1 Inhaler 11   Fluticasone (FLOVENT HFA) 110 mcg/Actuation Inhl Aero 2 puffs twice a day 3 3   Omega-3 Fatty Acids (FISH OIL) Oral Cap 1 tablet by mouth daily  0   '}\n",
      "{'filename': 'patient42_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Ac', 'nth_sent': 14, 'start': 37, 'end': 39}, 'arg2': {'mention': '11   26   2002', 'nth_sent': 15, 'start': 211, 'end': 221}, 'context': 'Past Medical History  Diagnosis Date Ac infect polyneuritis 1993  Guillan-Barre  Mitral valve disorder   Mitral valve prolapse  Ac infect polyneuritis  Herpes simplex nos   ORAL AND LABIAL  Fx metatarsal-closed 11/26/2002  left foot.  '}\n",
      "{'filename': 'patient34_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 144, 'end': 155}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 100, 'end': 109}, 'context': 'The patient was admitted for further workup her past medical history includes breast cancer; she is currently receiving Herceptin, Taxotere and carboplatin.'}\n",
      "{'filename': 'patient27_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 2, 'start': 24, 'end': 33}, 'arg2': {'mention': 'January 2012', 'nth_sent': 2, 'start': 71, 'end': 83}, 'context': 'The patient has been on tamoxifen for approximately two weeks, started January 2012.  '}\n",
      "{'filename': 'patient27_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'TAMOXIFEN', 'nth_sent': 34, 'start': 106, 'end': 115}, 'arg2': {'mention': 'daily', 'nth_sent': 35, 'start': 161, 'end': 166}, 'context': 'Hives   Prednisone Other See Comments   \"Neck burn\"    Current Outpatient Prescriptions  Medication Sig   TAMOXIFEN CITRATE (TAMOXIFEN ORAL) Take 1 tab by mouth daily   Levothyroxine (SYNTHROID)'}\n",
      "{'filename': 'patient27_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 6, 'start': 19, 'end': 28}, 'arg2': {'mention': 'for five years', 'nth_sent': 7, 'start': 75, 'end': 89}, 'context': 'She was started on tamoxifen in January 2013. She needs to be on tamoxifen for five years that will take us until January 2018.'}\n",
      "{'filename': 'patient38_report067_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 2, 'start': 18, 'end': 26}, 'arg2': {'mention': 'daily', 'nth_sent': 3, 'start': 158, 'end': 163}, 'context': 'She is now taking Arimidex and feeling \"okay\". She states that she is till tried in the am, sleeping longer than she would like, but is able to do her normal daily activities without difficulty.'}\n",
      "{'filename': 'patient38_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 113, 'end': 125}, 'arg2': {'mention': '  a week ago', 'nth_sent': 4, 'start': 191, 'end': 201}, 'context': 'HISTORY OF PRESENT ILLNESS: This is a 63-year-old female who has a history of breast cancer that is currently on chemotherapy. She has had 3 courses of chemotherapy, her last one, I believe, a week ago.'}\n",
      "{'filename': 'patient38_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 0, 'start': 113, 'end': 125}, 'arg2': {'mention': 'April  ', 'nth_sent': 1, 'start': 175, 'end': 180}, 'context': 'HISTORY OF PRESENT ILLNESS:  A 63-year-old African American female with a history of breast cancer, currently on chemotherapy. Had a Pap test performed on the vaginal cuff in April, which showed inconclusive reading.'}\n",
      "{'filename': 'patient38_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 34, 'end': 46}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 69, 'end': 78}, 'context': 'She had received her last dose of chemotherapy on 10/13/2010. She is currently receiving Taxotere and Cytoxan, which this was her fourth cycle.'}\n",
      "{'filename': 'patient38_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 78, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 65, 'end': 74}, 'context': 'She reported some low-grade fever and chills, and because she is currently on chemotherapy for breast cancer, she was following Oncology instructions to be seen with a fever.'}\n",
      "{'filename': 'patient04_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxotere', 'nth_sent': 10, 'start': 70, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 11, 'start': 141, 'end': 146}, 'context': 'Therefore, I am treating her with adjuvant systemic chemotherapy with Taxotere and Cytoxan for a total of 6 cycles. She presents for cycle 5 today.   '}\n",
      "{'filename': 'patient04_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 39, 'end': 51}, 'arg2': {'mention': '3 weeks', 'nth_sent': 10, 'start': 106, 'end': 113}, 'context': '2. The patient was started on adjuvant chemotherapy using Taxotere with Cytoxan, received her first cycle 3 weeks back.   '}\n",
      "{'filename': 'patient04_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Herceptin', 'nth_sent': 11, 'start': 180, 'end': 189}, 'arg2': {'mention': '3   13', 'nth_sent': 10, 'start': 47, 'end': 51}, 'context': 'Positive for lymphovascular space involvement, 3/13 lymph nodes positive for metastases.   3. We discussed with the patient, the clinical trial low HER-2 trial, with TC plus/minus Herceptin in patients with node-positive or node-negative high-grade breast cancer.'}\n",
      "{'filename': 'patient04_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 23, 'end': 35}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 224, 'end': 229}, 'context': 'She underwent adjuvant chemotherapy, which she finished on July 16th and is now anticipating left chest wall postmastectomy radiation therapy, which she anticipates completion in the first week of October 2012. She presents today to discuss her options for breast reconstruction.'}\n",
      "{'filename': 'patient04_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 15, 'start': 86, 'end': 95}, 'arg2': {'mention': 'today', 'nth_sent': 15, 'start': 32, 'end': 37}, 'context': 'Ms. Patient04 returns to clinic today for follow up after completing XRT and starting tamoxifen.'}\n",
      "{'filename': 'patient04_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Tamoxifen', 'nth_sent': 13, 'start': 93, 'end': 102}, 'arg2': {'mention': 'daily', 'nth_sent': 13, 'start': 111, 'end': 116}, 'context': 'She completed 6 weeks of XRT at Institution by Dr. Person27 in Sept 2012   CURRENT THERAPY:  Tamoxifen 20mg po daily started in Aug 2012.  '}\n",
      "{'filename': 'patient04_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 10, 'start': 127, 'end': 134}, 'arg2': {'mention': '3   13', 'nth_sent': 9, 'start': 16, 'end': 20}, 'context': 'The patient had 3/13 lymph nodes positive for metastases.   2. The patient started on adjuvant chemotherapy using Taxotere and Cytoxan, and the plan is to total 6 cycles.  '}\n",
      "{'filename': 'patient04_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 53, 'start': 234, 'end': 243}, 'arg2': {'mention': 'the next month', 'nth_sent': 52, 'start': 87, 'end': 101}, 'context': 'The patient will also plan to see the plastic surgeons for reconstructive surgery over the next month, and she will plan for reconstructive surgery to be done after her adjuvant radiation therapy. I also gave the patient a script for tamoxifen today, which she can start over the next week.'}\n",
      "{'filename': 'patient04_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 10, 'start': 127, 'end': 134}, 'arg2': {'mention': '3   13', 'nth_sent': 9, 'start': 16, 'end': 20}, 'context': 'The patient had 3/13 lymph nodes positive for metastases.   2. The patient started on adjuvant chemotherapy using Taxotere and Cytoxan, and the plan is to total 6 cycles.  '}\n",
      "{'filename': 'patient04_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 59, 'start': 249, 'end': 261}, 'arg2': {'mention': 'recently', 'nth_sent': 58, 'start': 57, 'end': 65}, 'context': 'The patient is a 46-year-old premenopausal woman who was recently diagnosed with stage II, T1c N1 M0 lobular breast cancer, ER/PR positive, HER-2 negative, Ki 67 of 20% to 30%, status post a modified radical mastectomy. Will start standard adjuvant chemotherapy today.  '}\n",
      "{'filename': 'patient14_report013_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 203, 'end': 215}, 'arg2': {'mention': 'April 10   2008', 'nth_sent': 8, 'start': 222, 'end': 236}, 'context': 'PAST MEDICAL HISTORY: Significant for breast CA diagnosed 2007, infiltrating ductal CA, right breast CA, ER/PR positive and HER2-Neu negative, status post segmental resection and sentinel mapping, first chemotherapy given April 10, 2008.  '}\n",
      "{'filename': 'patient14_report012_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 129, 'end': 141}, 'arg2': {'mention': 'Thursday', 'nth_sent': 8, 'start': 153, 'end': 161}, 'context': 'The patient is a 52-year-old female with a past medical history significant for breast cancer, status post lumpectomy, had first chemotherapy given last Thursday.  '}\n",
      "{'filename': 'patient32_report012_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 410, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 88, 'end': 100}, 'arg2': {'mention': 'standing two days prior', 'nth_sent': 8, 'start': 321, 'end': 344}, 'context': 'This patient is a 54-year-old white female with a history of breast cancer, status post chemotherapy about ten days prior to admission, who presented to the emergency room on 07/07/2001 complaining of significant left leg swelling. She noted pain in her left groin four days prior to admission and began to feel dizzy on standing two days prior to admission.  '}\n",
      "{'filename': 'patient12_report007_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 90, 'start': 12, 'end': 24}, 'arg2': {'mention': 'for 12 weeks', 'nth_sent': 90, 'start': 193, 'end': 205}, 'context': 'Neoadjuvant chemotherapy with 4 cycles of neoadjuvant adriamycin and cytoxan, given intravenously every 3 weeks for 4 treatments to be followed by neoadjuvant taxol, given intravenously weekly for 12 weeks.  '}\n",
      "{'filename': 'patient12_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 12, 'start': 139, 'end': 149}, 'arg2': {'mention': 'December 9   2013', 'nth_sent': 13, 'start': 213, 'end': 229}, 'context': 'Drug Name Person9 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person55 1 12/12/2013     Paclitaxel Person55                          RADIOLOGYREVIEWED: MUGA scan December 9, 2013 left ventricular ejection fraction 71%.'}\n",
      "{'filename': 'patient26_report010_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 25, 'start': 139, 'end': 151}, 'arg2': {'mention': 'recently', 'nth_sent': 25, 'start': 91, 'end': 99}, 'context': 'HISTORY OF PRESENT ILLNESS:  Ms. Person11 is a very pleasant 58-year-old white female with recently diagnosed breast cancer and undergoing chemotherapy, who developed a fever and was found to be neutropenic on admission.  '}\n",
      "{'filename': 'patient26_report012_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 1, 'start': 24, 'end': 32}, 'arg2': {'mention': '3 MONTHS  ', 'nth_sent': 1, 'start': 37, 'end': 45}, 'context': 'PATIENT HAS BEEN TAKING ARIMIDEX FOR 3 MONTHS.'}\n",
      "{'filename': 'patient41_report023_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 12, 'end': 24}, 'arg2': {'mention': 'chemotherapy last week', 'nth_sent': 2, 'start': 12, 'end': 34}, 'context': 'Patient had chemotherapy last week.'}\n",
      "{'filename': 'patient41_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxotere', 'nth_sent': 85, 'start': 256, 'end': 264}, 'arg2': {'mention': 'Oral 1   16', 'nth_sent': 84, 'start': 66, 'end': 76}, 'context': 'Medications Given in the ED:  8/15 Meds  3:00 p Iohexol 17,500 mg Oral  1:16 p Sodium Chloride 0.9% 1,000 mL IV; Ondansetron 4 mg IV Push; Famotidine 20 mg IV Push      Medical Decision Making  Discussed with the Oncology nurse and admitting medical team. Taxotere can induce colitis and perforations of bowel.'}\n",
      "{'filename': 'patient41_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 6, 'start': 33, 'end': 40}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 6, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 254, 'end': 266}, 'arg2': {'mention': 'May 2013', 'nth_sent': 10, 'start': 105, 'end': 113}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.'}\n",
      "{'filename': 'patient41_report042_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 11, 'start': 254, 'end': 266}, 'arg2': {'mention': 'May 2013', 'nth_sent': 11, 'start': 105, 'end': 113}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.  '}\n",
      "{'filename': 'patient41_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'AC', 'nth_sent': 62, 'start': 175, 'end': 177}, 'arg2': {'mention': 'Every 4 Hours', 'nth_sent': 62, 'start': 127, 'end': 140}, 'context': '[Compliance:  Status: Still taking, as prescribed Source: Patient]  acetaminophen-hydrocodone (Vicodin 500mg-5mg tab) 1 tab(s) Every 4 Hours PRN By Mouth   famotidine (Pepcid AC) 10 mg 2 TIMES A DAY By Mouth'}\n",
      "{'filename': 'patient41_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 47, 'start': 187, 'end': 194}, 'arg2': {'mention': 'by 12 weeks', 'nth_sent': 46, 'start': 90, 'end': 101}, 'context': 'She was scheduled to undergo chemotherapy Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel. On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 45, 'end': 57}, 'arg2': {'mention': 'August 8', 'nth_sent': 3, 'start': 3, 'end': 11}, 'context': 'On August 8, she received her first cycle of chemotherapy with docetaxel and cyclophosphamide.'}\n",
      "{'filename': 'patient41_report039_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 67, 'start': 134, 'end': 146}, 'arg2': {'mention': 'now', 'nth_sent': 67, 'start': 192, 'end': 195}, 'context': 'Ms. Person11 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.  '}\n",
      "{'filename': 'patient41_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 11, 'start': 371, 'end': 383}, 'arg2': {'mention': 'every 12 hours', 'nth_sent': 12, 'start': 554, 'end': 568}, 'context': 'Allergies  Allergen Reactions   Environmental Allergens Other See Comments   Nasal congestion; sinus headaches; migraines Outpatient Prescriptions Marked as Taking for the 8/1/13 encounter (Office Visit) with Person51, MD  Medication Sig Dispense Refill   dexamethasone (DECADRON) 4 mg Oral tablet Take 2 tabs by mouth twice daily x 5 days starting the day prior to each chemotherapy 40 tablet 2   IBUPROFEN (ADVIL ORAL) prn     LORATADINE/PSEUDOEPHEDRINE (CLARITIN-D 24 HOUR ORAL) daily     ondansetron HCl (ZOFRAN) 8 mg Oral tablet Take 1 tab by mouth every 12 hours x 6 doses starting the evening after each chemotherapy 25 tablet 1   prochlorperazine maleate (COMPAZINE) 10'}\n",
      "{'filename': 'patient41_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 83, 'end': 90}, 'arg2': {'mention': 'today  ', 'nth_sent': 5, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #4/4-6 adjuvant taxotere and cytoxan.'}\n",
      "{'filename': 'patient41_report037_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 198, 'end': 205}, 'arg2': {'mention': 'Thursday', 'nth_sent': 6, 'start': 350, 'end': 358}, 'context': 'This 44 year old, white female, hx of recently diagnosed, May 2013, breast cancer, s/p LEFT partial mastectomy with LEFT sentinel node biopsy 7-03-2013, s/p 1st/4 cycles chemotherapy 8-08-2013 with cytoxan + Docetaxol, (did not receive neupogen) presented 8-15-2013 with alteration in bowels. Felt OK over the weekend, but felt constipation, last BM Thursday.'}\n",
      "{'filename': 'patient41_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 10, 'start': 187, 'end': 194}, 'arg2': {'mention': 'by 12 weeks', 'nth_sent': 9, 'start': 90, 'end': 101}, 'context': 'She was scheduled to undergo chemotherapy Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel. On the 8 th of August she started her first cycle of taxotere, cytoxan.'}\n",
      "{'filename': 'patient41_report006_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 90, 'start': 217, 'end': 229}, 'arg2': {'mention': '5 years', 'nth_sent': 89, 'start': 40, 'end': 47}, 'context': 'I also explained she is a candidate for 5 years of tamoxifen therapy.   In all likelihood, we will plan performance of the Oncotype DX assay on the tumor block to assess her risk of recurrence and benefit of systemic chemotherapy.  '}\n",
      "{'filename': 'patient41_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 71, 'start': 31, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 72, 'start': 84, 'end': 89}, 'context': 'She presents to begin adjuvant chemotherapy. 1. Taxotere and Cytoxan cycle 2 of 4-6 today with 20% dose reduction on both medications Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 12, 'end': 24}, 'arg2': {'mention': 'the end of last week', 'nth_sent': 9, 'start': 28, 'end': 48}, 'context': 'She got her chemotherapy in the end of last week, did not get any Neupogen or Neulasta.  '}\n",
      "{'filename': 'patient41_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 164, 'end': 176}, 'arg2': {'mention': 'now', 'nth_sent': 3, 'start': 222, 'end': 225}, 'context': 'History of Present Illness   Ms. Patient41 is a 44 year-old patient with history breast cancer, migrane, GERD and hemorrhoids who underwent first cycle of adjuvant chemotherapy with cytoxan and docetaxel on August 8th and now presents with severe diarrhea and neutropenia.  '}\n",
      "{'filename': 'patient41_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 4, 'start': 93, 'end': 100}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 21, 'end': 26}, 'context': 'The patient presents today to continue her adjuvant chemotherapy treatment with Taxotere and Cytoxan.'}\n",
      "{'filename': 'patient41_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 4, 'start': 44, 'end': 51}, 'arg2': {'mention': '4   6', 'nth_sent': 4, 'start': 56, 'end': 59}, 'context': 'She presents to begin adjuvant Taxotere and Cytoxan for 4-6 cycles.'}\n",
      "{'filename': 'patient41_report016_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 11, 'start': 371, 'end': 383}, 'arg2': {'mention': 'every 12 hours', 'nth_sent': 12, 'start': 554, 'end': 568}, 'context': 'Allergies  Allergen Reactions   Environmental Allergens Other See Comments   Nasal congestion; sinus headaches; migraines Outpatient Prescriptions Marked as Taking for the 8/1/13 encounter (Office Visit) with Person51, MD  Medication Sig Dispense Refill   dexamethasone (DECADRON) 4 mg Oral tablet Take 2 tabs by mouth twice daily x 5 days starting the day prior to each chemotherapy 40 tablet 2   IBUPROFEN (ADVIL ORAL) prn     LORATADINE/PSEUDOEPHEDRINE (CLARITIN-D 24 HOUR ORAL) daily     ondansetron HCl (ZOFRAN) 8 mg Oral tablet Take 1 tab by mouth every 12 hours x 6 doses starting the evening after each chemotherapy 25 tablet 1   prochlorperazine maleate (COMPAZINE) 10'}\n",
      "{'filename': 'patient41_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cytoxan', 'nth_sent': 5, 'start': 33, 'end': 40}, 'arg2': {'mention': 'aug 8th', 'nth_sent': 5, 'start': 44, 'end': 51}, 'context': 'Started chemo therapy, taxotere, cytoxan on aug 8th.'}\n",
      "{'filename': 'patient41_report043_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 170, 'end': 182}, 'arg2': {'mention': 'Thursday', 'nth_sent': 6, 'start': 350, 'end': 358}, 'context': 'This 44 year old, white female, hx of recently diagnosed, May 2013, breast cancer, s/p LEFT partial mastectomy with LEFT sentinel node biopsy 7-03-2013, s/p 1st/4 cycles chemotherapy 8-08-2013 with cytoxan + Docetaxol, (did not receive neupogen) presented 8-15-2013 with alteration in bowels. Felt OK over the weekend, but felt constipation, last BM Thursday.'}\n",
      "{'filename': 'patient41_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 11, 'start': 254, 'end': 266}, 'arg2': {'mention': 'May 2013', 'nth_sent': 11, 'start': 105, 'end': 113}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a 44-year-old white female with a history of recently diagnosed, in May 2013, breast cancer status post left partial mastectomy with left sentinel node biopsy on July 3, 2013, status post her first out of 4 cycles of chemotherapy on August 8, 2013, with Cytoxan and docetaxel.'}\n",
      "{'filename': 'patient41_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'AC', 'nth_sent': 55, 'start': 175, 'end': 177}, 'arg2': {'mention': 'Every 4 Hours', 'nth_sent': 55, 'start': 127, 'end': 140}, 'context': '[Compliance:  Status: Still taking, as prescribed Source: Patient]  acetaminophen-hydrocodone (Vicodin 500mg-5mg tab) 1 tab(s) Every 4 Hours PRN By Mouth   famotidine (Pepcid AC) 10 mg 2 TIMES A DAY By Mouth'}\n",
      "{'filename': 'patient41_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 53, 'start': 58, 'end': 70}, 'arg2': {'mention': 'by 12 weeks', 'nth_sent': 53, 'start': 136, 'end': 147}, 'context': 'Based on these findings, Dr. Person32 recommends adjuvant chemotherapy with a course of Adriamycin and Cytoxan (A/C) x4 cycles followed by 12 weeks of weekly paclitaxel.'}\n",
      "{'filename': 'patient41_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxotere', 'nth_sent': 52, 'start': 265, 'end': 273}, 'arg2': {'mention': '8   15 Meds 1   16', 'nth_sent': 52, 'start': 112, 'end': 127}, 'context': 'Autom... 8/15 1:10p Urobilinogen .. 0.2 m...  8/15 12:37p Total Protein 6.9       Medications Given in the ED:  8/15 Meds  1:16 p Sodium Chloride 0.9% 1,000 mL IV; Ondansetron 4 mg IV Push; Famotidine 20 mg IV Push     Impression and Plan  Diagnosis:  Neutropenia  Taxotere colitis vs enteritis.  '}\n",
      "{'filename': 'patient92_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 50, 'end': 62}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 98, 'end': 103}, 'context': 'REASON FOR VISIT:  Assess response to neoadjuvant chemotherapy.   Patient92 returns to the office today for ongoing management of biopsy-proven left breast cancer with axillary lymph node metastasis.'}\n",
      "{'filename': 'patient43_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 3, 'start': 35, 'end': 43}, 'arg2': {'mention': 'April 2017', 'nth_sent': 4, 'start': 82, 'end': 92}, 'context': 'CURRENT THERAPY:  To be started on Arimidex 1 mg p.o. daily and to continue until April 2017.  '}\n",
      "{'filename': 'patient46_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Arimidex', 'nth_sent': 3, 'start': 33, 'end': 41}, 'arg2': {'mention': 'for five years', 'nth_sent': 3, 'start': 42, 'end': 56}, 'context': 'The patient will continue on her Arimidex for five years.'}\n",
      "{'filename': 'patient46_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 0, 'start': 87, 'end': 95}, 'arg2': {'mention': 'daily', 'nth_sent': 1, 'start': 102, 'end': 107}, 'context': 'Outpatient Prescriptions Prior to Visit  Medication Sig Dispense Refill   ANASTROZOLE (ARIMIDEX ORAL) daily     Calcium (CALCIO DEL MAR) 500'}\n",
      "{'filename': 'patient46_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'ARIMIDEX', 'nth_sent': 0, 'start': 87, 'end': 95}, 'arg2': {'mention': 'daily', 'nth_sent': 1, 'start': 102, 'end': 107}, 'context': 'Outpatient Prescriptions Prior to Visit  Medication Sig Dispense Refill   ANASTROZOLE (ARIMIDEX ORAL) daily     Calcium (CALCIO DEL MAR) 500'}\n",
      "{'filename': 'patient93_report022_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 414, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 17, 'end': 29}, 'arg2': {'mention': '09   17   2010', 'nth_sent': 5, 'start': 48, 'end': 58}, 'context': 'She recently had chemotherapy with Herceptin on 09/17/2010.  '}\n",
      "{'filename': 'patient93_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 88, 'end': 93}, 'arg2': {'mention': '11   10', 'nth_sent': 9, 'start': 142, 'end': 147}, 'context': 'The patient has stage 4 breast carcinoma with lung and mediastinal mets and has been on Taxol since 9/10. She did have an MRI of the brain in 11/10 shortly after the onset of the dizziness and nausea and this test was unremarkable.   '}\n",
      "{'filename': 'patient93_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 153, 'end': 165}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 132, 'end': 141}, 'context': 'History of Present Illness Ms. Person20 is a 56 y/o female with PMH significant for metastatic breast cancer with mets to the lung, currently undergoing chemotherapy, who presents with complaints of fevers, chills and productive cough, found to have pneumonia.'}\n",
      "{'filename': 'patient03_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 53, 'end': 65}, 'arg2': {'mention': 'approximately four weeks ago', 'nth_sent': 3, 'start': 92, 'end': 120}, 'context': 'She has received six cycles of carboplatin and Taxol chemotherapy at Location and recently, approximately four weeks ago, completed this chemotherapy and was sent to the CT scan again in a local cancer center to have a postchemotherapy CT scan.'}\n",
      "{'filename': 'patient31_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 2, 'start': 5, 'end': 10}, 'arg2': {'mention': 'January 24, 2012', 'nth_sent': 2, 'start': 18, 'end': 34}, 'context': 'Last chemo was on January 24, 2012, who presents to Urgent Care today with a complaint of right ear pain, sore throat, and cough.'}\n",
      "{'filename': 'patient31_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 34, 'end': 39}, 'arg2': {'mention': 'Today', 'nth_sent': 4, 'start': 0, 'end': 5}, 'context': 'Today she presents for cycle 5 of Taxol/Carbo.'}\n",
      "{'filename': 'patient31_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 4, 'start': 40, 'end': 45}, 'arg2': {'mention': 'Today', 'nth_sent': 4, 'start': 0, 'end': 5}, 'context': 'Today she presents for cycle 5 of Taxol/Carbo.'}\n",
      "{'filename': 'patient31_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 25, 'start': 102, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 25, 'start': 167, 'end': 172}, 'context': '300 mg Oral Tablet 1 po bid 180 Tab 3   CALTRATE-600 PLUS TABLET 600-200 PO 1 tablet, PO, q day  0    Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient31_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 28, 'start': 102, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 28, 'start': 167, 'end': 172}, 'context': '300 mg Oral Tablet 1 po bid 180 Tab 3   CALTRATE-600 PLUS TABLET 600-200 PO 1 tablet, PO, q day  0    Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient31_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 4, 'start': 34, 'end': 39}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle 6 of taxol/carbo.'}\n",
      "{'filename': 'patient31_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 4, 'start': 40, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle 6 of taxol/carbo.'}\n",
      "{'filename': 'patient31_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 6, 'start': 32, 'end': 37}, 'arg2': {'mention': 'last month', 'nth_sent': 6, 'start': 38, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)'}\n",
      "{'filename': 'patient31_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 26, 'end': 31}, 'arg2': {'mention': 'last month', 'nth_sent': 6, 'start': 38, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)'}\n",
      "{'filename': 'patient31_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 18, 'start': 108, 'end': 120}, 'arg2': {'mention': 'today', 'nth_sent': 18, 'start': 173, 'end': 178}, 'context': 'mg Oral Tablet 1 tablet, PO, Q day 90 Tab 3   CALTRATE-600 PLUS TABLET 600-200 PO 1 tablet, PO, q day  0    Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient31_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 34, 'end': 39}, 'arg2': {'mention': 'Today', 'nth_sent': 4, 'start': 0, 'end': 5}, 'context': 'Today she presents for cycle 4 of Taxol/Carbo.'}\n",
      "{'filename': 'patient31_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 4, 'start': 40, 'end': 45}, 'arg2': {'mention': 'Today', 'nth_sent': 4, 'start': 0, 'end': 5}, 'context': 'Today she presents for cycle 4 of Taxol/Carbo.'}\n",
      "{'filename': 'patient31_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 29, 'start': 77, 'end': 89}, 'arg2': {'mention': 'today', 'nth_sent': 29, 'start': 142, 'end': 147}, 'context': '5 mg Oral Tablet Take 1 tablet by mouth daily for 2 weeks total 14 Tab 3     Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient31_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 26, 'end': 31}, 'arg2': {'mention': 'last month', 'nth_sent': 6, 'start': 38, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)   '}\n",
      "{'filename': 'patient31_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 6, 'start': 32, 'end': 37}, 'arg2': {'mention': 'last month', 'nth_sent': 6, 'start': 38, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)   '}\n",
      "{'filename': 'patient31_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 14, 'start': 108, 'end': 120}, 'arg2': {'mention': 'today', 'nth_sent': 14, 'start': 173, 'end': 178}, 'context': 'mg Oral Tablet 1 tablet, PO, Q day 90 Tab 3   CALTRATE-600 PLUS TABLET 600-200 PO 1 tablet, PO, q day  0    Chemotherapy labs were reviewed and are acceptable for treatment today.  '}\n",
      "{'filename': 'patient31_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 6, 'start': 32, 'end': 37}, 'arg2': {'mention': 'last month', 'nth_sent': 6, 'start': 38, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)   '}\n",
      "{'filename': 'patient31_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 26, 'end': 31}, 'arg2': {'mention': 'last month', 'nth_sent': 6, 'start': 38, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 2, 'start': 262, 'end': 272}, 'arg2': {'mention': '2/20/12', 'nth_sent': 2, 'start': 296, 'end': 303}, 'context': 'Chief Complaint  Shortness of breath   History of Present Illness  Mrs. Patient16 is a 64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently on third cycle of Paclitaxel/Carboplatin (last dose 2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 273, 'end': 284}, 'arg2': {'mention': '2/20/12', 'nth_sent': 2, 'start': 296, 'end': 303}, 'context': 'Chief Complaint  Shortness of breath   History of Present Illness  Mrs. Patient16 is a 64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently on third cycle of Paclitaxel/Carboplatin (last dose 2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 28, 'start': 536, 'end': 546}, 'arg2': {'mention': '12/15/11', 'nth_sent': 29, 'start': 575, 'end': 583}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 28, 'start': 551, 'end': 562}, 'arg2': {'mention': '12/15/11', 'nth_sent': 29, 'start': 575, 'end': 583}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 28, 'start': 536, 'end': 546}, 'arg2': {'mention': '1/12/12', 'nth_sent': 29, 'start': 596, 'end': 603}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 28, 'start': 551, 'end': 562}, 'arg2': {'mention': '1/12/12', 'nth_sent': 29, 'start': 596, 'end': 603}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 28, 'start': 536, 'end': 546}, 'arg2': {'mention': '2/20/12', 'nth_sent': 29, 'start': 616, 'end': 623}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 28, 'start': 551, 'end': 562}, 'arg2': {'mention': '2/20/12', 'nth_sent': 29, 'start': 616, 'end': 623}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 125, 'start': 195, 'end': 205}, 'arg2': {'mention': '2/20/12', 'nth_sent': 125, 'start': 229, 'end': 236}, 'context': 'Mrs. Patient16 is a 64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently on third cycle of Paclitaxel/Carboplatin (last dose 2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 125, 'start': 206, 'end': 217}, 'arg2': {'mention': '2/20/12', 'nth_sent': 125, 'start': 229, 'end': 236}, 'context': 'Mrs. Patient16 is a 64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently on third cycle of Paclitaxel/Carboplatin (last dose 2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 130, 'start': 952, 'end': 964}, 'arg2': {'mention': 'recent', 'nth_sent': 130, 'start': 945, 'end': 951}, 'context': 'And if does not resolve, start Diltiazem (pt was placed on Diltiazem during last hospitalization)  - defer anticoagulation as pt has high bleeding risk: hx of cirrhosis and p/w intermittent hematuria   #Hyponatremia - likely Hypovolemia from Diuretic use vs. adrenal insufficiency A: - pt appears dry on exam  - serum osmolality of 270  - pt is on diuretics due to hx of cirrhosis with ascites s/p paracentesis - AM cortisol obtained: WNL  P: - will obtain urine lytes and creatinine  - continue NS @ 125 cc/hr  - BMP q 6 hrs, ensure not too rapid correction   #Renal insufficiency - likely from dehydration  A: - Cr: 1.2 (baseline 0.8 to 0.9) P: - NS @ 125 cc/hr  - will obtain urine lytes and creatinine and calculate FeNa  #Anion Gap metabolic acidosis A: - possibly due to infection vs. uremia   - sugars are under good control, pt is unlikely in DKA  P: - will check lactate  - consider aggressive IV hydration    #Neutropenia - likely 2/2 recent chemotherapy  A: - pt is afebrile, WBC count of 0.6, ANC of 0  - Blood cx obtained  - C. diff toxin obtained as pt had recent episode of diarrhea and has hx of C. Diff colitis  - lactate will be obtained  P: - continue to monitor WBC count/vitals/symptoms   #Prophylaxis: SCDs given high risk of bleed and low platelets, PPI   '}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 28, 'start': 551, 'end': 562}, 'arg2': {'mention': '12/15/11', 'nth_sent': 29, 'start': 575, 'end': 583}, 'context': 'Initially, this was felt to be large cell neuroendocrine of lung, however pathology noted pt had an ovarian mass and additional immunostains showed neoplastic cells expressed WT1 and PAX8 which raised the possibility of poorly differentiated large cell carcinoma with neuroendocrine differentiation could be derived from ovary (poorly differentiated serous carcinoma).  - given these results, pt was was seen by a Gynecologic Oncology surgeon who advised against surgery  - pt was seen by Dr. Person9 of medical oncology and started on Paclitaxel and Carboplatin (1st cycle: 12/15/11, 2nd cycle: 1/12/12, 3rd cycle: 2/20/12)   '}\n",
      "{'filename': 'patient16_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 27, 'end': 38}, 'arg2': {'mention': '12/15/2011', 'nth_sent': 3, 'start': 53, 'end': 63}, 'context': 'Her first and only dose of carboplatin/ taxol was on 12/15/2011 by Dr Person5.  '}\n",
      "{'filename': 'patient16_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 3, 'start': 40, 'end': 45}, 'arg2': {'mention': '12/15/2011', 'nth_sent': 3, 'start': 53, 'end': 63}, 'context': 'Her first and only dose of carboplatin/ taxol was on 12/15/2011 by Dr Person5.  '}\n",
      "{'filename': 'patient16_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 36, 'start': 44, 'end': 49}, 'arg2': {'mention': '12/15', 'nth_sent': 36, 'start': 59, 'end': 64}, 'context': '(1) Metastatic ovarian CA - Last chemo with Carbo/Taxol on 12/15 - Continue supportive care - f/u with Dr. Person5 at Person40 once medically stable (2) Ascites - Likely malignant with significant omental disease - Palliative paracentesis scheduled today...send ascitic fluid for cytology (3) Right hydronephrosis - s/p stent 12/22 - Post-procedure hematuria...h/h stable - f/u with Urology     Perform - Completed by Person109 (on 12/27/2011 17:56)  '}\n",
      "{'filename': 'patient16_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 36, 'start': 50, 'end': 55}, 'arg2': {'mention': '12/15', 'nth_sent': 36, 'start': 59, 'end': 64}, 'context': '(1) Metastatic ovarian CA - Last chemo with Carbo/Taxol on 12/15 - Continue supportive care - f/u with Dr. Person5 at Person40 once medically stable (2) Ascites - Likely malignant with significant omental disease - Palliative paracentesis scheduled today...send ascitic fluid for cytology (3) Right hydronephrosis - s/p stent 12/22 - Post-procedure hematuria...h/h stable - f/u with Urology     Perform - Completed by Person109 (on 12/27/2011 17:56)  '}\n",
      "{'filename': 'patient16_report078_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 26, 'start': 34, 'end': 44}, 'arg2': {'mention': 'December 15, 2011', 'nth_sent': 26, 'start': 73, 'end': 90}, 'context': 'She was started on treatment with paclitaxel and carboplatin x1 cycle on December 15, 2011, unfortunately, 2 days later, she developed atrial fibrillation and shortness of breath.'}\n",
      "{'filename': 'patient16_report078_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 26, 'start': 49, 'end': 60}, 'arg2': {'mention': 'December 15, 2011', 'nth_sent': 26, 'start': 73, 'end': 90}, 'context': 'She was started on treatment with paclitaxel and carboplatin x1 cycle on December 15, 2011, unfortunately, 2 days later, she developed atrial fibrillation and shortness of breath.'}\n",
      "{'filename': 'patient16_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ataxol', 'nth_sent': 131, 'start': 17, 'end': 23}, 'arg2': {'mention': 'recently', 'nth_sent': 131, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 131, 'start': 28, 'end': 39}, 'arg2': {'mention': 'recently', 'nth_sent': 131, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 136, 'start': 79, 'end': 84}, 'arg2': {'mention': 'recent', 'nth_sent': 136, 'start': 72, 'end': 78}, 'context': \"12/20 seen by medical oncology, neutropenic, did receive neulasta after recent chemo per patient's oncologist: Dr Person60.\"}\n",
      "{'filename': 'patient16_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Liposomal doxorubicin', 'nth_sent': 6, 'start': 18, 'end': 39}, 'arg2': {'mention': 'July\\n11, 2012', 'nth_sent': 6, 'start': 66, 'end': 79}, 'context': 'CURRENT THERAPY:  Liposomal doxorubicin at 25 mg/sq m x1 cycle on July 11, 2012.  '}\n",
      "{'filename': 'patient16_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Gemcitabine', 'nth_sent': 11, 'start': 3, 'end': 14}, 'arg2': {'mention': 'March 2012', 'nth_sent': 11, 'start': 34, 'end': 44}, 'context': '2. Gemcitabine and cisplatin from March 2012 through June 2012, discontinued secondary to disease progression.  '}\n",
      "{'filename': 'patient16_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 11, 'start': 19, 'end': 28}, 'arg2': {'mention': 'March 2012', 'nth_sent': 11, 'start': 34, 'end': 44}, 'context': '2. Gemcitabine and cisplatin from March 2012 through June 2012, discontinued secondary to disease progression.  '}\n",
      "{'filename': 'patient16_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Gemcitabine', 'nth_sent': 11, 'start': 3, 'end': 14}, 'arg2': {'mention': 'June 2012', 'nth_sent': 11, 'start': 53, 'end': 62}, 'context': '2. Gemcitabine and cisplatin from March 2012 through June 2012, discontinued secondary to disease progression.  '}\n",
      "{'filename': 'patient16_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 11, 'start': 19, 'end': 28}, 'arg2': {'mention': 'June 2012', 'nth_sent': 11, 'start': 53, 'end': 62}, 'context': '2. Gemcitabine and cisplatin from March 2012 through June 2012, discontinued secondary to disease progression.  '}\n",
      "{'filename': 'patient16_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'liposomal doxorubicin', 'nth_sent': 13, 'start': 78, 'end': 99}, 'arg2': {'mention': 'July 11, 2012', 'nth_sent': 13, 'start': 103, 'end': 116}, 'context': 'Since her last office visit, she had port placement and received 1st cycle of liposomal doxorubicin on July 11, 2012.'}\n",
      "{'filename': 'patient16_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ataxol', 'nth_sent': 100, 'start': 17, 'end': 23}, 'arg2': {'mention': 'recently', 'nth_sent': 100, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 100, 'start': 28, 'end': 39}, 'arg2': {'mention': 'recently', 'nth_sent': 100, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 105, 'start': 79, 'end': 84}, 'arg2': {'mention': 'recent', 'nth_sent': 105, 'start': 72, 'end': 78}, 'context': \"12/20 seen by medical oncology, neutropenic, did receive neulasta after recent chemo per patient's oncologist: Dr Person60.\"}\n",
      "{'filename': 'patient16_report089_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 86, 'end': 98}, 'arg2': {'mention': 'February 2, 2012', 'nth_sent': 9, 'start': 53, 'end': 69}, 'context': 'Apparently, the  patient presented to Institution on February 2, 2012, for scheduled  chemotherapy, but her blood sugars were found to be in the 600s, and she was  admitted to the hospital for further monitoring and therapy.   '}\n",
      "{'filename': 'patient16_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ataxol', 'nth_sent': 103, 'start': 17, 'end': 23}, 'arg2': {'mention': 'recently', 'nth_sent': 103, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 103, 'start': 28, 'end': 39}, 'arg2': {'mention': 'recently', 'nth_sent': 103, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 108, 'start': 79, 'end': 84}, 'arg2': {'mention': 'recent', 'nth_sent': 108, 'start': 72, 'end': 78}, 'context': \"12/20 seen by medical oncology, neutropenic, did receive neulasta after recent chemo per patient's oncologist: Dr Person60.\"}\n",
      "{'filename': 'patient16_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 10, 'start': 37, 'end': 42}, 'arg2': {'mention': '12/15/2011', 'nth_sent': 10, 'start': 53, 'end': 63}, 'context': 'She received her first chemotherapy, Carbo/Taxol, on 12/15/2011.'}\n",
      "{'filename': 'patient16_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 10, 'start': 43, 'end': 48}, 'arg2': {'mention': '12/15/2011', 'nth_sent': 10, 'start': 53, 'end': 63}, 'context': 'She received her first chemotherapy, Carbo/Taxol, on 12/15/2011.'}\n",
      "{'filename': 'patient16_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 106, 'start': 30, 'end': 41}, 'arg2': {'mention': '12/15/2001', 'nth_sent': 106, 'start': 55, 'end': 65}, 'context': 'She received her 1st cycle of Carboplatin and Taxol on 12/15/2001 with resultant neutropenia but without fever or signs/symptoms of infection.'}\n",
      "{'filename': 'patient16_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 106, 'start': 46, 'end': 51}, 'arg2': {'mention': '12/15/2001', 'nth_sent': 106, 'start': 55, 'end': 65}, 'context': 'She received her 1st cycle of Carboplatin and Taxol on 12/15/2001 with resultant neutropenia but without fever or signs/symptoms of infection.'}\n",
      "{'filename': 'patient16_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 7, 'start': 194, 'end': 204}, 'arg2': {'mention': '2/20/12', 'nth_sent': 7, 'start': 218, 'end': 225}, 'context': 'Hospital Course   64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently s/p third cycle of Paclitaxel/Carboplatin (2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 7, 'start': 205, 'end': 216}, 'arg2': {'mention': '2/20/12', 'nth_sent': 7, 'start': 218, 'end': 225}, 'context': 'Hospital Course   64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently s/p third cycle of Paclitaxel/Carboplatin (2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carbotaxol', 'nth_sent': 57, 'start': 50, 'end': 60}, 'arg2': {'mention': 'December 15, 2011', 'nth_sent': 57, 'start': 64, 'end': 81}, 'context': 'Onc Hx:  stage IV ovarian cancer:  s/p cycle I of Carbotaxol on December 15, 2011 and receive Neulasta on the same day.  '}\n",
      "{'filename': 'patient16_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cabotaxol', 'nth_sent': 58, 'start': 16, 'end': 25}, 'arg2': {'mention': 'Jan. 12, 2012', 'nth_sent': 58, 'start': 29, 'end': 42}, 'context': 's/p Cycle II of cabotaxol on Jan. 12, 2012  s/p VATS, left wedge resection of upper lobe Nov. 23,2011   breast cancer stage 0:  s/p right segmental mastectomy 1/2011 ER/PR +  PSHx mastectomy  Social Hx lives iwth husband no tobacco, EtoH or illicit drugs  Family Hx  NO h/o cancer or hematologic issues in the family.'}\n",
      "{'filename': 'patient16_report115_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Gemcitabine', 'nth_sent': 7, 'start': 18, 'end': 29}, 'arg2': {'mention': 'March 2012', 'nth_sent': 7, 'start': 57, 'end': 67}, 'context': 'CURRENT THERAPY:  Gemcitabine and cisplatin initiated in March 2012.   '}\n",
      "{'filename': 'patient16_report115_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 7, 'start': 34, 'end': 43}, 'arg2': {'mention': 'March 2012', 'nth_sent': 7, 'start': 57, 'end': 67}, 'context': 'CURRENT THERAPY:  Gemcitabine and cisplatin initiated in March 2012.   '}\n",
      "{'filename': 'patient16_report028_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ataxol', 'nth_sent': 83, 'start': 17, 'end': 23}, 'arg2': {'mention': 'recently', 'nth_sent': 83, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report028_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 83, 'start': 28, 'end': 39}, 'arg2': {'mention': 'recently', 'nth_sent': 83, 'start': 4, 'end': 12}, 'context': 'She recently had ataxol and carboplatin.  '}\n",
      "{'filename': 'patient16_report114_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cistoplatin', 'nth_sent': 13, 'start': 38, 'end': 49}, 'arg2': {'mention': '6/13/12', 'nth_sent': 13, 'start': 29, 'end': 36}, 'context': 'She had a chemo treatment on 6/13/12- cistoplatin; and paclitaxel.'}\n",
      "{'filename': 'patient16_report114_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 13, 'start': 55, 'end': 65}, 'arg2': {'mention': '6/13/12', 'nth_sent': 13, 'start': 29, 'end': 36}, 'context': 'She had a chemo treatment on 6/13/12- cistoplatin; and paclitaxel.'}\n",
      "{'filename': 'patient16_report114_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 100, 'start': 81, 'end': 93}, 'arg2': {'mention': 'recent', 'nth_sent': 100, 'start': 74, 'end': 80}, 'context': \"Course:  Developed afib with rapid ventricular response in the setting of recent chemotherapy, diarrhea/ being NPO- likely dehydration contributing and noted palpitations more frequently in the past several months; Sign PMHX for afib - paroxysmal- intially treated with diltiazem- spontaneously converted not con't due to constipation then on lopressor 12.5mg po bid B/P did not tolerate; At that time palpitations infrequent and associated with dehydration so AV nodal agents not continued; Now with increasing frequency; BY exam dehydrated.  \"}\n",
      "{'filename': 'patient17_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paxil', 'nth_sent': 27, 'start': 28, 'end': 33}, 'arg2': {'mention': 'next 2-3 weeks', 'nth_sent': 27, 'start': 66, 'end': 80}, 'context': 'Dr. Person4 is recommending Paxil and carboplatin to start in the next 2-3 weeks.'}\n",
      "{'filename': 'patient17_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 27, 'start': 38, 'end': 49}, 'arg2': {'mention': 'next 2-3 weeks', 'nth_sent': 27, 'start': 66, 'end': 80}, 'context': 'Dr. Person4 is recommending Paxil and carboplatin to start in the next 2-3 weeks.'}\n",
      "{'filename': 'patient17_report131_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 4, 'start': 30, 'end': 32}, 'arg2': {'mention': '2/21/13', 'nth_sent': 4, 'start': 39, 'end': 46}, 'context': 'She has completed 5 cycles of TC as of 2/21/13 with Moon Twp Cancer center.'}\n",
      "{'filename': 'patient17_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 7, 'start': 18, 'end': 29}, 'arg2': {'mention': 'November 15, 2012', 'nth_sent': 7, 'start': 57, 'end': 74}, 'context': 'CURRENT THERAPY:  Carboplatin and paclitaxel, first dose November 15, 2012.  '}\n",
      "{'filename': 'patient17_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 34, 'end': 44}, 'arg2': {'mention': 'November 15, 2012', 'nth_sent': 7, 'start': 57, 'end': 74}, 'context': 'CURRENT THERAPY:  Carboplatin and paclitaxel, first dose November 15, 2012.  '}\n",
      "{'filename': 'patient17_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 9, 'start': 113, 'end': 124}, 'arg2': {'mention': '3 weeks ago', 'nth_sent': 9, 'start': 38, 'end': 49}, 'context': 'She was last seen in the clinic about 3 weeks ago at which time she received her first dose of chemotherapy with Carboplatin and Taxol.'}\n",
      "{'filename': 'patient17_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 9, 'start': 129, 'end': 134}, 'arg2': {'mention': '3 weeks ago', 'nth_sent': 9, 'start': 38, 'end': 49}, 'context': 'She was last seen in the clinic about 3 weeks ago at which time she received her first dose of chemotherapy with Carboplatin and Taxol.'}\n",
      "{'filename': 'patient17_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 202, 'end': 207}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 146, 'end': 151}, 'context': 'Patient17  PATIENT ID#:  DATE OF BIRTH: 03/06/1932 DATE OF VISIT: 11/12/2012   Office Note  CHIEF COMPLAINT:  Ms. Patient17 returns to the office today for consideration to initiate her chemotherapy of Taxol and carboplatin for an ovarian carcinoma.  '}\n",
      "{'filename': 'patient17_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 212, 'end': 223}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 146, 'end': 151}, 'context': 'Patient17  PATIENT ID#:  DATE OF BIRTH: 03/06/1932 DATE OF VISIT: 11/12/2012   Office Note  CHIEF COMPLAINT:  Ms. Patient17 returns to the office today for consideration to initiate her chemotherapy of Taxol and carboplatin for an ovarian carcinoma.  '}\n",
      "{'filename': 'patient17_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 57, 'start': 110, 'end': 122}, 'arg2': {'mention': 'Thursday', 'nth_sent': 57, 'start': 126, 'end': 134}, 'context': 'Ms. Patient17 would prefer to return home on Wednesday and get somewhat settled in her condo before beginning chemotherapy on Thursday.'}\n",
      "{'filename': 'patient17_report132_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 7, 'start': 18, 'end': 29}, 'arg2': {'mention': 'November 15, 2012', 'nth_sent': 7, 'start': 57, 'end': 74}, 'context': 'CURRENT THERAPY:  Carboplatin and paclitaxel, first dose November 15, 2012.  '}\n",
      "{'filename': 'patient17_report132_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 34, 'end': 44}, 'arg2': {'mention': 'November 15, 2012', 'nth_sent': 7, 'start': 57, 'end': 74}, 'context': 'CURRENT THERAPY:  Carboplatin and paclitaxel, first dose November 15, 2012.  '}\n",
      "{'filename': 'patient17_report132_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 16, 'start': 34, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 16, 'start': 56, 'end': 61}, 'context': 'She has for 6th and final dose of Carboplatin and Taxol today.  '}\n",
      "{'filename': 'patient17_report132_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 16, 'start': 50, 'end': 55}, 'arg2': {'mention': 'today', 'nth_sent': 16, 'start': 56, 'end': 61}, 'context': 'She has for 6th and final dose of Carboplatin and Taxol today.  '}\n",
      "{'filename': 'patient17_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 35, 'end': 47}, 'arg2': {'mention': '12/5/12', 'nth_sent': 10, 'start': 65, 'end': 72}, 'context': 'She denies abdominal pain her last chemotherapy treatment was on 12/5/12'}\n",
      "{'filename': 'patient17_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 52, 'start': 34, 'end': 46}, 'arg2': {'mention': 'December 5', 'nth_sent': 52, 'start': 50, 'end': 60}, 'context': \"It is unlikely that the patient's chemotherapy on December 5 with the causing her nausea and vomiting today on December 18.\"}\n",
      "{'filename': 'patient17_report102_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 20, 'start': 55, 'end': 67}, 'arg2': {'mention': 'next week or so', 'nth_sent': 20, 'start': 75, 'end': 90}, 'context': 'Dr. Person4 called and recommended that she start with chemotherapy in the next week or so.  '}\n",
      "{'filename': 'patient17_report102_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 22, 'start': 64, 'end': 71}, 'arg2': {'mention': 'one year', 'nth_sent': 22, 'start': 76, 'end': 84}, 'context': 'After reversal of her colostomy, we would recommend maintenance Avastin for one year.  '}\n",
      "{'filename': 'patient17_report137_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 29, 'end': 34}, 'arg2': {'mention': 'March 14', 'nth_sent': 7, 'start': 64, 'end': 72}, 'context': 'She has finished 6 cycles of Taxol and carboplatin completed on March 14.   '}\n",
      "{'filename': 'patient17_report137_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 39, 'end': 50}, 'arg2': {'mention': 'March 14', 'nth_sent': 7, 'start': 64, 'end': 72}, 'context': 'She has finished 6 cycles of Taxol and carboplatin completed on March 14.   '}\n",
      "{'filename': 'patient07_report071_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 22, 'start': 24, 'end': 29}, 'arg2': {'mention': 'weekly', 'nth_sent': 22, 'start': 17, 'end': 23}, 'context': 'We will continue weekly Taxol and carbo three weeks on, one week off.'}\n",
      "{'filename': 'patient07_report071_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 22, 'start': 34, 'end': 39}, 'arg2': {'mention': 'weekly', 'nth_sent': 22, 'start': 17, 'end': 23}, 'context': 'We will continue weekly Taxol and carbo three weeks on, one week off.'}\n",
      "{'filename': 'patient07_report075_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 3, 'end': 8}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 25, 'end': 31}, 'context': '1. Taxol and carboplatin weekly, Taxol has a dose of 70 mg/m2 weekly, three weeks on and one week off and carboplatin at an AUC of 2. 2.'}\n",
      "{'filename': 'patient07_report075_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 13, 'end': 24}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 25, 'end': 31}, 'context': '1. Taxol and carboplatin weekly, Taxol has a dose of 70 mg/m2 weekly, three weeks on and one week off and carboplatin at an AUC of 2. 2.'}\n",
      "{'filename': 'patient07_report072_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 37, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 8, 'start': 12, 'end': 17}, 'context': 'She reports today for cycle 5 of her chemotherapy.  '}\n",
      "{'filename': 'patient07_report074_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 3, 'end': 8}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 25, 'end': 31}, 'context': '1. Taxol and carboplatin weekly.'}\n",
      "{'filename': 'patient07_report074_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 13, 'end': 24}, 'arg2': {'mention': 'weekly', 'nth_sent': 4, 'start': 25, 'end': 31}, 'context': '1. Taxol and carboplatin weekly.'}\n",
      "{'filename': 'patient07_report074_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 22, 'start': 36, 'end': 41}, 'arg2': {'mention': 'weekly', 'nth_sent': 22, 'start': 29, 'end': 35}, 'context': 'The patient to continue with weekly Taxol and carboplatin, 3 weeks on and 1 week off with Neupogen shots.'}\n",
      "{'filename': 'patient07_report074_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 22, 'start': 46, 'end': 57}, 'arg2': {'mention': 'weekly', 'nth_sent': 22, 'start': 29, 'end': 35}, 'context': 'The patient to continue with weekly Taxol and carboplatin, 3 weeks on and 1 week off with Neupogen shots.'}\n",
      "{'filename': 'patient42_report008_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 200, 'end': 205}, 'arg2': {'mention': '4/4/2011', 'nth_sent': 0, 'start': 245, 'end': 253}, 'context': 'CLINICAL SUMMARY:  Ms. Patient42 is a 67-year-old female with a history of stage IA malignant Person4 cell tumor of the ovary status post staging surgery on December 10, 2010, followed by 3 cycles of Taxol and carboplatin which was completed on 4/4/2011.'}\n",
      "{'filename': 'patient42_report008_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 210, 'end': 221}, 'arg2': {'mention': '4/4/2011', 'nth_sent': 0, 'start': 245, 'end': 253}, 'context': 'CLINICAL SUMMARY:  Ms. Patient42 is a 67-year-old female with a history of stage IA malignant Person4 cell tumor of the ovary status post staging surgery on December 10, 2010, followed by 3 cycles of Taxol and carboplatin which was completed on 4/4/2011.'}\n",
      "{'filename': 'patient42_report006_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 21, 'end': 33}, 'arg2': {'mention': '04/04/2011', 'nth_sent': 2, 'start': 72, 'end': 82}, 'context': 'Patient is receiving chemotherapy, with the most recent treatment dated 04/04/2011.'}\n",
      "{'filename': 'patient08_report109_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemo', 'nth_sent': 25, 'start': 78, 'end': 83}, 'arg2': {'mention': '05/07/14', 'nth_sent': 25, 'start': 57, 'end': 65}, 'context': 'ANOO TAMBER   Institution Institution , 4Location, PA,   05/07/14 at 9:00 AM: Chemo  CHEMO IN WCC AT Institution  WITHIN 1 WEEK : Person136   100 MEDICAL ARTS BUILDING , Location, PA,   05/21/14 at 8:20 AM: PANITI SUKUMVANICH   Institution OF Institution  , Location, PA,   '}\n",
      "{'filename': 'patient08_report109_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 22, 'start': 23, 'end': 34}, 'arg2': {'mention': '04/24/14', 'nth_sent': 22, 'start': 6, 'end': 14}, 'context': '40 mg 04/24/14 5:09 pm gemcitabine'}\n",
      "{'filename': 'patient08_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 71, 'end': 76}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 18, 'end': 23}, 'context': 'Patient08 came in today as scheduled for day 15 of Cycle #5 dose dense Taxol/Carboplatin.'}\n",
      "{'filename': 'patient08_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 0, 'start': 77, 'end': 88}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 18, 'end': 23}, 'context': 'Patient08 came in today as scheduled for day 15 of Cycle #5 dose dense Taxol/Carboplatin.'}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 121, 'end': 133}, 'arg2': {'mention': 'february, 2014', 'nth_sent': 2, 'start': 137, 'end': 151}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemzar', 'nth_sent': 2, 'start': 187, 'end': 193}, 'arg2': {'mention': '4/23', 'nth_sent': 2, 'start': 213, 'end': 217}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 2, 'start': 194, 'end': 203}, 'arg2': {'mention': '4/23', 'nth_sent': 2, 'start': 213, 'end': 217}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 73, 'start': 101, 'end': 113}, 'arg2': {'mention': 'february, 2014', 'nth_sent': 73, 'start': 117, 'end': 131}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease, s/p IR GJ on 6/11.  '}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemzar', 'nth_sent': 73, 'start': 167, 'end': 173}, 'arg2': {'mention': '4/23', 'nth_sent': 73, 'start': 193, 'end': 197}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease, s/p IR GJ on 6/11.  '}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 73, 'start': 174, 'end': 183}, 'arg2': {'mention': '4/23', 'nth_sent': 73, 'start': 193, 'end': 197}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease, s/p IR GJ on 6/11.  '}\n",
      "{'filename': 'patient08_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 53, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 2 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 63, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 2 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 156, 'end': 161}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 94, 'end': 103}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 166, 'end': 177}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 94, 'end': 103}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 34, 'end': 46}, 'arg2': {'mention': 'at this time', 'nth_sent': 7, 'start': 47, 'end': 59}, 'context': \"The patient's is to continue with chemotherapy at this time.\"}\n",
      "{'filename': 'patient08_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 69, 'end': 74}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 7, 'end': 16}, 'context': 'She is currently undergoing neoadjuvant chemotherapy with dose dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 79, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 7, 'end': 16}, 'context': 'She is currently undergoing neoadjuvant chemotherapy with dose dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 121, 'end': 133}, 'arg2': {'mention': 'february, 2014', 'nth_sent': 2, 'start': 137, 'end': 151}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor..  '}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemzar', 'nth_sent': 2, 'start': 187, 'end': 193}, 'arg2': {'mention': '4/23', 'nth_sent': 2, 'start': 213, 'end': 217}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor..  '}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 2, 'start': 194, 'end': 203}, 'arg2': {'mention': '4/23', 'nth_sent': 2, 'start': 213, 'end': 217}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor..  '}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 61, 'start': 101, 'end': 113}, 'arg2': {'mention': 'february, 2014', 'nth_sent': 61, 'start': 117, 'end': 131}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease.  '}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemzar', 'nth_sent': 61, 'start': 167, 'end': 173}, 'arg2': {'mention': '4/23', 'nth_sent': 61, 'start': 193, 'end': 197}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease.  '}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 61, 'start': 174, 'end': 183}, 'arg2': {'mention': '4/23', 'nth_sent': 61, 'start': 193, 'end': 197}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease.  '}\n",
      "{'filename': 'patient08_report110_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 61, 'start': 34, 'end': 39}, 'arg2': {'mention': '5/7/14', 'nth_sent': 61, 'start': 65, 'end': 71}, 'context': 'Follow Up Instructions: in FU for chemo in WCC at Institution on 5/7/14 at 9:00am FU prior to chemo in gyn/onc clinic at Institution on 5/21/14 at 8:20am FU with Person60, prn as outpatient.'}\n",
      "{'filename': 'patient08_report110_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 61, 'start': 34, 'end': 39}, 'arg2': {'mention': '5/21/14', 'nth_sent': 61, 'start': 136, 'end': 143}, 'context': 'Follow Up Instructions: in FU for chemo in WCC at Institution on 5/7/14 at 9:00am FU prior to chemo in gyn/onc clinic at Institution on 5/21/14 at 8:20am FU with Person60, prn as outpatient.'}\n",
      "{'filename': 'patient08_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 53, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 3 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 63, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 3 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 156, 'end': 161}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 94, 'end': 103}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 166, 'end': 177}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 94, 'end': 103}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 53, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 5 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 63, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 5 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 154, 'end': 159}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 92, 'end': 101}, 'context': 'SUBJECTIVE Patient08 is a 66 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.   '}\n",
      "{'filename': 'patient08_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 164, 'end': 175}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 92, 'end': 101}, 'context': 'SUBJECTIVE Patient08 is a 66 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.   '}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 121, 'end': 133}, 'arg2': {'mention': 'february, 2014', 'nth_sent': 2, 'start': 137, 'end': 151}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemzar', 'nth_sent': 2, 'start': 187, 'end': 193}, 'arg2': {'mention': '4/23', 'nth_sent': 2, 'start': 213, 'end': 217}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 2, 'start': 194, 'end': 203}, 'arg2': {'mention': '4/23', 'nth_sent': 2, 'start': 213, 'end': 217}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 72, 'start': 101, 'end': 113}, 'arg2': {'mention': 'february, 2014', 'nth_sent': 72, 'start': 117, 'end': 131}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease, s/p IR GJ on 6/11.  '}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemzar', 'nth_sent': 72, 'start': 167, 'end': 173}, 'arg2': {'mention': '4/23', 'nth_sent': 72, 'start': 193, 'end': 197}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease, s/p IR GJ on 6/11.  '}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 72, 'start': 174, 'end': 183}, 'arg2': {'mention': '4/23', 'nth_sent': 72, 'start': 193, 'end': 197}, 'context': 'The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction and progression of disease, s/p IR GJ on 6/11.  '}\n",
      "{'filename': 'patient08_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 34, 'end': 46}, 'arg2': {'mention': 'at this time', 'nth_sent': 7, 'start': 47, 'end': 59}, 'context': \"The patient's is to continue with chemotherapy at this time.  \"}\n",
      "{'filename': 'patient08_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 69, 'end': 74}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 7, 'end': 16}, 'context': 'She is currently undergoing neoadjuvant chemotherapy with dose dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 79, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 7, 'end': 16}, 'context': 'She is currently undergoing neoadjuvant chemotherapy with dose dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 53, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 4 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 63, 'end': 74}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 21, 'end': 26}, 'context': 'The patient presents today for cycle 4 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 156, 'end': 161}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 94, 'end': 103}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 166, 'end': 177}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 94, 'end': 103}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report122_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 18, 'start': 77, 'end': 86}, 'arg2': {'mention': 'at the time', 'nth_sent': 18, 'start': 98, 'end': 109}, 'context': 'Of note, this patient has had a prolonged oncologic course and was receiving cisplatin and Gemzar at the time of her admission and had progressed despite this chemotherapy.  '}\n",
      "{'filename': 'patient08_report122_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Gemzar', 'nth_sent': 18, 'start': 91, 'end': 97}, 'arg2': {'mention': 'at the time', 'nth_sent': 18, 'start': 98, 'end': 109}, 'context': 'Of note, this patient has had a prolonged oncologic course and was receiving cisplatin and Gemzar at the time of her admission and had progressed despite this chemotherapy.  '}\n",
      "{'filename': 'patient20_report140_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 59, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 59, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person283 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report140_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 59, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 59, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person283 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 45, 'start': 13, 'end': 24}, 'arg2': {'mention': '7/19', 'nth_sent': 45, 'start': 1, 'end': 5}, 'context': '[7/19 20:33] carboplatin 565mg IV ONCE [7/20 10:15] ketorolac (Toradol) 15mg IVP ONCE Recently Discontinued Medications AMINO ACID/DEXTROSE/LIPID TPN (ADULT) 1,800 mL 1,800mL Cycle over 14 hours IV haloperidol (Haldol) 1mg IVP Q4H hydromorphone 30 mL (Hydromorphone 1 mg/mL'}\n",
      "{'filename': 'patient20_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 56, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 56, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT, will d/w SW re: dispo planning  Professional Services Credentials Title and Author Person66: MD.'}\n",
      "{'filename': 'patient20_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 56, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 56, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT, will d/w SW re: dispo planning  Professional Services Credentials Title and Author Person66: MD.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 10, 'start': 43, 'end': 48}, 'arg2': {'mention': '7/19', 'nth_sent': 10, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 10, 'start': 49, 'end': 54}, 'arg2': {'mention': '7/19', 'nth_sent': 10, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 54, 'start': 43, 'end': 48}, 'arg2': {'mention': '7/19', 'nth_sent': 54, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 54, 'start': 49, 'end': 54}, 'arg2': {'mention': '7/19', 'nth_sent': 54, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 71, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 71, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 71, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 71, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 74, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 74, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT, possible discharge home tomorrow with home health for TPN, wound care  Professional Services Credentials Title and Author Person283 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 74, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 74, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT, possible discharge home tomorrow with home health for TPN, wound care  Professional Services Credentials Title and Author Person283 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report189_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 15, 'start': 11, 'end': 21}, 'arg2': {'mention': '9/24', 'nth_sent': 15, 'start': 30, 'end': 34}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25.  '}\n",
      "{'filename': 'patient20_report189_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 5, 'start': 57, 'end': 67}, 'arg2': {'mention': 'recent', 'nth_sent': 5, 'start': 39, 'end': 45}, 'context': 'Her symtpoms were likely the result of recent chemo with carbotaxol and neulasta tx.'}\n",
      "{'filename': 'patient20_report161_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 31, 'end': 36}, 'arg2': {'mention': 'September 5, 2012', 'nth_sent': 8, 'start': 62, 'end': 79}, 'context': 'She received her last cycle of Taxol carboplatin, her 3rd, on September 5, 2012.   '}\n",
      "{'filename': 'patient20_report161_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 8, 'start': 37, 'end': 48}, 'arg2': {'mention': 'September 5, 2012', 'nth_sent': 8, 'start': 62, 'end': 79}, 'context': 'She received her last cycle of Taxol carboplatin, her 3rd, on September 5, 2012.   '}\n",
      "{'filename': 'patient20_report161_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 32, 'end': 44}, 'arg2': {'mention': 'July 19, 2012', 'nth_sent': 6, 'start': 58, 'end': 71}, 'context': 'She received her first cycle of chemotherapy inpatient on July 19, 2012.'}\n",
      "{'filename': 'patient20_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 93, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 93, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT, will d/w SW re: dispo planning  Professional Services Credentials Title and Author Person66: MD.'}\n",
      "{'filename': 'patient20_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 93, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 93, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT, will d/w SW re: dispo planning  Professional Services Credentials Title and Author Person66: MD.'}\n",
      "{'filename': 'patient20_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 59, 'start': 13, 'end': 24}, 'arg2': {'mention': '7/19', 'nth_sent': 59, 'start': 1, 'end': 5}, 'context': '[7/19 20:33] carboplatin 565mg IV ONCE [7/19 14:55] dexamethasone 20mg IV ONCE'}\n",
      "{'filename': 'patient20_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 66, 'start': 18, 'end': 28}, 'arg2': {'mention': '7/19', 'nth_sent': 66, 'start': 6, 'end': 10}, 'context': 'ONCE [7/19 15:43] paclitaxel 330 mg + FILTER 330mg IV'}\n",
      "{'filename': 'patient20_report239_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 34, 'start': 89, 'end': 94}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 34, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report239_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 34, 'start': 73, 'end': 84}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 34, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report239_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 38, 'start': 47, 'end': 59}, 'arg2': {'mention': 'recent', 'nth_sent': 38, 'start': 40, 'end': 46}, 'context': 'Her symptoms are likely a result of her recent chemotherapy.'}\n",
      "{'filename': 'patient20_report238_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 32, 'start': 73, 'end': 84}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 32, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report238_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 32, 'start': 89, 'end': 94}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 32, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report238_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 36, 'start': 47, 'end': 59}, 'arg2': {'mention': 'recent', 'nth_sent': 36, 'start': 40, 'end': 46}, 'context': 'Her symptoms are likely a result of her recent chemotherapy.'}\n",
      "{'filename': 'patient20_report134_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 75, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 75, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person339 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report134_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 75, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 75, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person339 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report175_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 22, 'start': 11, 'end': 21}, 'arg2': {'mention': '9/24', 'nth_sent': 22, 'start': 30, 'end': 34}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Histories  Past Medical History: 1. Diabetes  2. Hypertension 3. Depression.  '}\n",
      "{'filename': 'patient20_report175_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 22, 'start': 59, 'end': 64}, 'arg2': {'mention': '9/5', 'nth_sent': 22, 'start': 98, 'end': 101}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Histories  Past Medical History: 1. Diabetes  2. Hypertension 3. Depression.  '}\n",
      "{'filename': 'patient20_report175_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 22, 'start': 65, 'end': 76}, 'arg2': {'mention': '9/5', 'nth_sent': 22, 'start': 98, 'end': 101}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Histories  Past Medical History: 1. Diabetes  2. Hypertension 3. Depression.  '}\n",
      "{'filename': 'patient20_report175_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 81, 'start': 99, 'end': 109}, 'arg2': {'mention': 'recently', 'nth_sent': 81, 'start': 77, 'end': 85}, 'context': '68 yo woman with Stage IIIC high grade papillary serous adenocarcinoma, most recently s/p 4 cycles carbotaxol and recent Neulasta with worsening abdominal pain and nausea which may be related to underlying disease progression, symptoms not suggestive of obstruction at this time, ileostomy with good output  Pain: continue dialudid 0.2mg IV prn, encouraged patient to use more often.'}\n",
      "{'filename': 'patient20_report129_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 78, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 78, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person343 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report129_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 78, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 78, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person343 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report136_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 61, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 61, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person338 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report136_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 61, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 61, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person338 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report123_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 41, 'start': 13, 'end': 24}, 'arg2': {'mention': '7/19', 'nth_sent': 41, 'start': 1, 'end': 5}, 'context': '[7/19 20:33] carboplatin 565mg IV ONCE [7/19 14:55] dexamethasone 20mg IV ONCE'}\n",
      "{'filename': 'patient20_report123_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 45, 'start': 13, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 45, 'start': 1, 'end': 5}, 'context': '[7/19 15:43] paclitaxel 330 mg + FILTER 330mg IV'}\n",
      "{'filename': 'patient20_report263_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 0, 'start': 340, 'end': 350}, 'arg2': {'mention': '9/24', 'nth_sent': 0, 'start': 352, 'end': 356}, 'context': 'SUBJECTIVE 68 year old with IIIC papillary serous ovarian CA s/p suboptimal tumor debulking/XL/supra cervical hyst/ rsx/ileocolonic rsx and SSA/loop ileostomy/cystotomy repair and stent placement in June 2012 complicated by ileostomy repair/gtube placement, recent admission for gtube site infection requiring removal, now s/p fourth cycle carbotaxol (9/24), neulasta 9/25.  October 19, 2012, the patient underwent exploratory laparotomy/ileostomy revision/small bowel resection with reanastomosis/colonic anastomosis.  '}\n",
      "{'filename': 'patient20_report263_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 4, 'start': 14, 'end': 16}, 'arg2': {'mention': '1/2013', 'nth_sent': 4, 'start': 17, 'end': 23}, 'context': 'She restarted TC 1/2013.'}\n",
      "{'filename': 'patient20_report263_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 21, 'start': 271, 'end': 283}, 'arg2': {'mention': 'today', 'nth_sent': 21, 'start': 336, 'end': 341}, 'context': 'Normal appearance, no discharge, lesions, cystocele or rectocele,  Cervix: Absent  Uterus: Absent  Adnexae: Absent, no mass  Parametrium: Not Involved    No outpatient prescriptions have been marked as taking for the 2/11/13 encounter (Appointment) with Person2, PA-C.   Chemotherapy labs were reviewed and are acceptable for treatment today.   '}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 11, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 11, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 11, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 11, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 48, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 48, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 48, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 48, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 62, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 62, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 62, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 62, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 64, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 64, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report181_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 28, 'start': 232, 'end': 242}, 'arg2': {'mention': '9/24', 'nth_sent': 28, 'start': 254, 'end': 258}, 'context': '100mL/hr IV  Allergies  NKA  Assessment and Plan 68yo HD3 w/ history of stage IIIC high grade papillary serous adenocarcinoma admitted for deconditioning, symptomatic control of n/v, and fluid resuscitation in the context of recent carbotaxol cycle 4 on 9/24.  '}\n",
      "{'filename': 'patient20_report181_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 2, 'start': 148, 'end': 153}, 'arg2': {'mention': '9/24', 'nth_sent': 2, 'start': 163, 'end': 167}, 'context': 'None Author: Person128  Basic Information 68 yo HD3 w/ high grade serous OvCA p/w N/V/decreased PO in take/abdominal pain in the context of cycle 4 carbo/taxol on 9/24 and s/p debulking/XL/supracervical hys/BSO/omx/rectosigmoid resection/ileocolonic rsxn w/ side to side reanastomosis/creation of loop ileostomy and cystotomy repair with stents in 6/2012 and s/p 7/5 illeostomy repair and venting G-tube complicated by a protracted hospital stay including ICU admission 2/2 intraop blood loss.'}\n",
      "{'filename': 'patient20_report181_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 154, 'end': 159}, 'arg2': {'mention': '9/24', 'nth_sent': 2, 'start': 163, 'end': 167}, 'context': 'None Author: Person128  Basic Information 68 yo HD3 w/ high grade serous OvCA p/w N/V/decreased PO in take/abdominal pain in the context of cycle 4 carbo/taxol on 9/24 and s/p debulking/XL/supracervical hys/BSO/omx/rectosigmoid resection/ileocolonic rsxn w/ side to side reanastomosis/creation of loop ileostomy and cystotomy repair with stents in 6/2012 and s/p 7/5 illeostomy repair and venting G-tube complicated by a protracted hospital stay including ICU admission 2/2 intraop blood loss.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 12, 'start': 43, 'end': 48}, 'arg2': {'mention': '7/19', 'nth_sent': 12, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 12, 'start': 49, 'end': 54}, 'arg2': {'mention': '7/19', 'nth_sent': 12, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 59, 'start': 43, 'end': 48}, 'arg2': {'mention': '7/19', 'nth_sent': 59, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 59, 'start': 49, 'end': 54}, 'arg2': {'mention': '7/19', 'nth_sent': 59, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 76, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 76, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 76, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 76, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 79, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 79, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 79, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 79, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report258_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 26, 'start': 86, 'end': 97}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 26, 'start': 155, 'end': 173}, 'context': 'After she recovered postoperatively, the patient had started on adjuvant therapy with carboplatin and Taxol and had received 4 cycles with the last one on September 24, 2012.'}\n",
      "{'filename': 'patient20_report258_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 26, 'start': 102, 'end': 107}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 26, 'start': 155, 'end': 173}, 'context': 'After she recovered postoperatively, the patient had started on adjuvant therapy with carboplatin and Taxol and had received 4 cycles with the last one on September 24, 2012.'}\n",
      "{'filename': 'patient20_report258_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 65, 'start': 115, 'end': 127}, 'arg2': {'mention': 'November 26, 2012', 'nth_sent': 65, 'start': 40, 'end': 57}, 'context': 'The patient does have an appointment on November 26, 2012, at 8:30 a.m. with Dr. Person29 prior to proceeding with chemotherapy.'}\n",
      "{'filename': 'patient20_report258_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 66, 'start': 219, 'end': 231}, 'arg2': {'mention': 'today', 'nth_sent': 66, 'start': 242, 'end': 247}, 'context': 'As the patient is being discharged on this same date from the hospital, she was premedicated 20 mg of Decadron the evening of November 25, 2012, and again 20 mg this morning prior to discharge from the hospital for her chemotherapy treatment today.  '}\n",
      "{'filename': 'patient20_report249_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 12, 'start': 0, 'end': 5}, 'arg2': {'mention': '9/24/12', 'nth_sent': 12, 'start': 20, 'end': 27}, 'context': 'Carbo/taxol x4 last 9/24/12.  '}\n",
      "{'filename': 'patient20_report249_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 12, 'start': 6, 'end': 11}, 'arg2': {'mention': '9/24/12', 'nth_sent': 12, 'start': 20, 'end': 27}, 'context': 'Carbo/taxol x4 last 9/24/12.  '}\n",
      "{'filename': 'patient20_report160_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 24, 'end': 36}, 'arg2': {'mention': '7/19/12', 'nth_sent': 5, 'start': 51, 'end': 58}, 'context': 'Received first cycle of chemotherapy in patient on 7/19/12.  '}\n",
      "{'filename': 'patient20_report160_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 8, 'start': 32, 'end': 42}, 'arg2': {'mention': 'today', 'nth_sent': 8, 'start': 9, 'end': 14}, 'context': 'Presents today for cycle # 3 of Paclitaxel and Carboplatin.'}\n",
      "{'filename': 'patient20_report160_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 8, 'start': 47, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 8, 'start': 9, 'end': 14}, 'context': 'Presents today for cycle # 3 of Paclitaxel and Carboplatin.'}\n",
      "{'filename': 'patient20_report160_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 24, 'start': 684, 'end': 696}, 'arg2': {'mention': 'today', 'nth_sent': 24, 'start': 749, 'end': 754}, 'context': 'Normal appearance, no discharge, lesions, cystocele or rectocele,  Cervix: Absent  Uterus: Absent  Adnexae: Absent, no mass  Parametrium: Not Involved   Outpatient Prescriptions Marked as Taking for the 9/5/12 encounter (Office Visit) with Fly Person5, PA-C  Medication Sig Dispense Refill   dexamethasone (DECADRON) 4 mg Oral tablet 5 tablets at bedtime the night before and 5 tablets the morning of chemotherapy 60 Tab 1   Venlafaxine (EFFEXOR XR) 75 mg Oral Capsule, Ext Release 24 hr daily     Amlodipine (NORVASC) 10 mg Oral Tablet daily     Metformin (GLUCOPHAGE) 1,000 mg Oral Tablet twice daily     Aspirin (ASPIR-81) 81 mg Oral Tablet, Delayed Release (E.C.) twice daily     Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient20_report194_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 18, 'start': 11, 'end': 21}, 'arg2': {'mention': '9/24', 'nth_sent': 18, 'start': 30, 'end': 34}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25.  '}\n",
      "{'filename': 'patient20_report180_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 58, 'start': 29, 'end': 40}, 'arg2': {'mention': 'September 24', 'nth_sent': 58, 'start': 69, 'end': 81}, 'context': 'She had received 3 cycles of carboplatin and Taxol; most recently on September 24 with her most recent dose of Neulasta on September 25.  '}\n",
      "{'filename': 'patient20_report180_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 58, 'start': 45, 'end': 50}, 'arg2': {'mention': 'September 24', 'nth_sent': 58, 'start': 69, 'end': 81}, 'context': 'She had received 3 cycles of carboplatin and Taxol; most recently on September 24 with her most recent dose of Neulasta on September 25.  '}\n",
      "{'filename': 'patient20_report180_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 59, 'start': 167, 'end': 179}, 'arg2': {'mention': 'October 15, 2012', 'nth_sent': 59, 'start': 123, 'end': 139}, 'context': 'DISPOSITION:  The patient was discharged home on hospital day 3 with instructions to follow up with the Oncology office on October 15, 2012, for discussion of further chemotherapy.'}\n",
      "{'filename': 'patient20_report180_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 45, 'start': 39, 'end': 51}, 'arg2': {'mention': 'recent', 'nth_sent': 45, 'start': 32, 'end': 38}, 'context': 'Her platelets in the setting of recent chemotherapy remained low but stable.'}\n",
      "{'filename': 'patient20_report173_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 32, 'end': 44}, 'arg2': {'mention': 'July 19, 2012', 'nth_sent': 4, 'start': 58, 'end': 71}, 'context': 'She received her first cycle of chemotherapy inpatient on July 19, 2012.'}\n",
      "{'filename': 'patient20_report173_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 6, 'start': 31, 'end': 36}, 'arg2': {'mention': 'September 5, 2012', 'nth_sent': 6, 'start': 62, 'end': 79}, 'context': 'She received her last cycle of Taxol carboplatin, her 3rd, on September 5, 2012.  '}\n",
      "{'filename': 'patient20_report173_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 37, 'end': 48}, 'arg2': {'mention': 'September 5, 2012', 'nth_sent': 6, 'start': 62, 'end': 79}, 'context': 'She received her last cycle of Taxol carboplatin, her 3rd, on September 5, 2012.  '}\n",
      "{'filename': 'patient20_report173_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 24, 'start': 35, 'end': 40}, 'arg2': {'mention': 'today', 'nth_sent': 24, 'start': 41, 'end': 46}, 'context': 'We will proceed with her 4th cycle chemo today and support with neulasta.     '}\n",
      "{'filename': 'patient20_report176_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 21, 'start': 466, 'end': 476}, 'arg2': {'mention': '9/24', 'nth_sent': 21, 'start': 488, 'end': 492}, 'context': 'Inpatient Medications  Scheduled Medications PRN Medications haloperidol (Haldol) 0.5mg IVP Q6H hydromorphone (Dilaudid) 0.2mg IVP Q4H ondansetron (Zofran) 4mg IVP Q6H  Continuous Infusions Sodium Chloride 0.9% 1,000 mL Initial Rate= 125mL/hr IV  Allergies  NKA  Assessment and Plan 68yo HD2 w/ history of stage IIIC high grade papillary serous adenocarcinoma admitted for deconditioning, symptomatic control of n/v, and fluid resuscitation in the context of recent carbotaxol cycle 4 on 9/24.  '}\n",
      "{'filename': 'patient20_report176_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 2, 'start': 148, 'end': 153}, 'arg2': {'mention': '9/24', 'nth_sent': 2, 'start': 165, 'end': 169}, 'context': 'None Author: Person128  Basic Information 68 yo HD2 w/ high grade serous OvCA p/w N/V/decreased PO in take/abdominal pain in the context of cycle 4 carbo / taxol on 9/24 and s/p debulking/XL/supracervical hys/BSO/omx/rectosigmoid resection/ileocolonic rsxn w/ side to side reanastomosis/creation of loop ileostomy and cystotomy repair with stents in 6/2012 and s/p 7/5 illeostomy repair and venting G-tube complicated by a protracted hospital stay including ICU admission 2/2 intraop blood loss.'}\n",
      "{'filename': 'patient20_report176_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 156, 'end': 161}, 'arg2': {'mention': '9/24', 'nth_sent': 2, 'start': 165, 'end': 169}, 'context': 'None Author: Person128  Basic Information 68 yo HD2 w/ high grade serous OvCA p/w N/V/decreased PO in take/abdominal pain in the context of cycle 4 carbo / taxol on 9/24 and s/p debulking/XL/supracervical hys/BSO/omx/rectosigmoid resection/ileocolonic rsxn w/ side to side reanastomosis/creation of loop ileostomy and cystotomy repair with stents in 6/2012 and s/p 7/5 illeostomy repair and venting G-tube complicated by a protracted hospital stay including ICU admission 2/2 intraop blood loss.'}\n",
      "{'filename': 'patient20_report156_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 86, 'start': 13, 'end': 18}, 'arg2': {'mention': 'July 19, 2012', 'nth_sent': 86, 'start': 39, 'end': 52}, 'context': 'She received Carbo-Tax chemotherapy on July 19, 2012 with a subsequent neutropenia with an ANC nadir of 345.'}\n",
      "{'filename': 'patient20_report156_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Tax', 'nth_sent': 86, 'start': 19, 'end': 22}, 'arg2': {'mention': 'July 19, 2012', 'nth_sent': 86, 'start': 39, 'end': 52}, 'context': 'She received Carbo-Tax chemotherapy on July 19, 2012 with a subsequent neutropenia with an ANC nadir of 345.'}\n",
      "{'filename': 'patient20_report156_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 120, 'start': 91, 'end': 103}, 'arg2': {'mention': 'July 13, 2012', 'nth_sent': 120, 'start': 63, 'end': 76}, 'context': 'The patient was instructed to follow up with Person40 _____ on July 13, 2012 at 8 a.m. for chemotherapy.'}\n",
      "{'filename': 'patient20_report156_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'CARBOTAXOL', 'nth_sent': 8, 'start': 15, 'end': 25}, 'arg2': {'mention': 'JULY 19, 2012', 'nth_sent': 8, 'start': 39, 'end': 52}, 'context': '4. STATUS POST CARBOTAXOL TREATMENT ON JULY 19, 2012.'}\n",
      "{'filename': 'patient20_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 65, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 65, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 65, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 65, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report174_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 17, 'start': 11, 'end': 21}, 'arg2': {'mention': '9/24', 'nth_sent': 17, 'start': 30, 'end': 34}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Review of Systems  Constitutional:  Negative.  '}\n",
      "{'filename': 'patient20_report174_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 17, 'start': 59, 'end': 64}, 'arg2': {'mention': '9/5', 'nth_sent': 17, 'start': 98, 'end': 101}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Review of Systems  Constitutional:  Negative.  '}\n",
      "{'filename': 'patient20_report174_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 17, 'start': 65, 'end': 76}, 'arg2': {'mention': '9/5', 'nth_sent': 17, 'start': 98, 'end': 101}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Review of Systems  Constitutional:  Negative.  '}\n",
      "{'filename': 'patient20_report174_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 46, 'start': 200, 'end': 210}, 'arg2': {'mention': '9/24', 'nth_sent': 46, 'start': 222, 'end': 226}, 'context': 'Impression and Plan  68yo w/ history of stage IIIC high grade papillary serous adenocarcinoma admitted for deconditioning, symptomatic control of n/v, and fluid resuscitation in the context of recent carbotaxol cycle 4 on 9/24.  '}\n",
      "{'filename': 'patient20_report236_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 34, 'start': 73, 'end': 84}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 34, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.  '}\n",
      "{'filename': 'patient20_report236_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 34, 'start': 89, 'end': 94}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 34, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.  '}\n",
      "{'filename': 'patient20_report236_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 38, 'start': 47, 'end': 59}, 'arg2': {'mention': 'recent', 'nth_sent': 38, 'start': 40, 'end': 46}, 'context': 'Her symptoms are likely a result of her recent chemotherapy.  '}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 49, 'start': 43, 'end': 48}, 'arg2': {'mention': '7/19', 'nth_sent': 49, 'start': 55, 'end': 59}, 'context': 'D15 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 49, 'start': 49, 'end': 54}, 'arg2': {'mention': '7/19', 'nth_sent': 49, 'start': 55, 'end': 59}, 'context': 'D15 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 67, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 67, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Plan for D/C today  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 67, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 67, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Plan for D/C today  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 64, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 64, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 13, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 13, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 13, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 13, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report259_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 28, 'start': 15, 'end': 27}, 'arg2': {'mention': 'today', 'nth_sent': 28, 'start': 28, 'end': 33}, 'context': 'She will start chemotherapy today.'}\n",
      "{'filename': 'patient20_report259_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 0, 'start': 328, 'end': 338}, 'arg2': {'mention': '9/24', 'nth_sent': 0, 'start': 340, 'end': 344}, 'context': 'SUBJECTIVE 68 year old with IIIC pap serous ovCA s/p suboptimal tumor debulking/XL/supra cervical hyst/ rsx/ileocolonic rsx and SSA/loop ileostomy/cystotomy repair and stent placement in June 2012 complicated by ileostomy repair/gtube placement, recent admission for gtube site infection requiring removal, now s/p fourth cycle carbotaxol (9/24), neulasta 9/25.   '}\n",
      "{'filename': 'patient20_report259_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 23, 'start': 340, 'end': 352}, 'arg2': {'mention': 'today', 'nth_sent': 23, 'start': 405, 'end': 410}, 'context': '30 mg Oral tablet extended release 2 bid 60 Tab    morphine (MS IR) 15 mg Oral tablet 1 to 1.5 tabs prn q4 270 Tab    Ondansetron (ZOFRAN ODT) 8 mg Oral tablet,disintegrating one po every 6 hours 30 Tab 2   dexamethasone (DECADRON) 4 mg Oral tablet 5 tablets at bedtime the night before and 5 tablets the morning of chemotherapy 60 Tab 1   Chemotherapy labs were reviewed and are acceptable for treatment today.   '}\n",
      "{'filename': 'patient20_report244_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 8, 'start': 73, 'end': 84}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 8, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report244_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 89, 'end': 94}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 8, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report159_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 24, 'end': 36}, 'arg2': {'mention': '7/19/12', 'nth_sent': 5, 'start': 51, 'end': 58}, 'context': 'Received first cycle of chemotherapy in patient on 7/19/12.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 43, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 43, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 43, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 43, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 10, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 10, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 10, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 10, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 57, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 57, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 57, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 57, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 60, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 60, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 60, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 60, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report257_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 28, 'start': 86, 'end': 97}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 28, 'start': 155, 'end': 173}, 'context': 'After she recovered postoperatively, the patient had started on adjuvant therapy with carboplatin and Taxol and had received 4 cycles with the last one on September 24, 2012.'}\n",
      "{'filename': 'patient20_report257_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 28, 'start': 102, 'end': 107}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 28, 'start': 155, 'end': 173}, 'context': 'After she recovered postoperatively, the patient had started on adjuvant therapy with carboplatin and Taxol and had received 4 cycles with the last one on September 24, 2012.'}\n",
      "{'filename': 'patient20_report257_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 64, 'start': 137, 'end': 149}, 'arg2': {'mention': 'November 26, 2012', 'nth_sent': 64, 'start': 62, 'end': 79}, 'context': 'The *U*P*M*C* Patient20#: patient does have an appointment on November 26, 2012, at 8:30 a.m. with Dr. Person29 prior to proceeding with chemotherapy.'}\n",
      "{'filename': 'patient20_report257_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 65, 'start': 219, 'end': 231}, 'arg2': {'mention': 'today', 'nth_sent': 65, 'start': 242, 'end': 247}, 'context': 'As the patient is being discharged on this same date from the hospital, she was premedicated 20 mg of Decadron the evening of November 25, 2012, and again 20 mg this morning prior to discharge from the hospital for her chemotherapy treatment today.  '}\n",
      "{'filename': 'patient20_report179_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 60, 'start': 29, 'end': 40}, 'arg2': {'mention': 'September 24', 'nth_sent': 60, 'start': 69, 'end': 81}, 'context': 'She had received 3 cycles of carboplatin and Taxol; most recently on September 24 with her most recent dose of Neulasta on September 25.  '}\n",
      "{'filename': 'patient20_report179_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 60, 'start': 45, 'end': 50}, 'arg2': {'mention': 'September 24', 'nth_sent': 60, 'start': 69, 'end': 81}, 'context': 'She had received 3 cycles of carboplatin and Taxol; most recently on September 24 with her most recent dose of Neulasta on September 25.  '}\n",
      "{'filename': 'patient20_report179_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 61, 'start': 167, 'end': 179}, 'arg2': {'mention': 'October 15, 2012', 'nth_sent': 61, 'start': 123, 'end': 139}, 'context': 'DISPOSITION:  The patient was discharged home on hospital day 3 with instructions to follow up with the Oncology office on October 15, 2012, for discussion of further chemotherapy.'}\n",
      "{'filename': 'patient20_report179_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 48, 'start': 39, 'end': 51}, 'arg2': {'mention': 'recent', 'nth_sent': 48, 'start': 32, 'end': 38}, 'context': 'Her platelets in the setting of recent chemotherapy remained low but stable.'}\n",
      "{'filename': 'patient20_report133_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 64, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person341 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report133_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 64, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person341 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 12, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 12, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 12, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 12, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 56, 'start': 8, 'end': 13}, 'arg2': {'mention': '7/19', 'nth_sent': 56, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 56, 'start': 14, 'end': 19}, 'arg2': {'mention': '7/19', 'nth_sent': 56, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 73, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 73, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 73, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 73, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 76, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 76, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 76, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 76, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report262_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 0, 'start': 328, 'end': 338}, 'arg2': {'mention': '9/24', 'nth_sent': 0, 'start': 340, 'end': 344}, 'context': 'SUBJECTIVE 68 year old with IIIC pap serous ovCA s/p suboptimal tumor debulking/XL/supra cervical hyst/ rsx/ileocolonic rsx and SSA/loop ileostomy/cystotomy repair and stent placement in June 2012 complicated by ileostomy repair/gtube placement, recent admission for gtube site infection requiring removal, now s/p fourth cycle carbotaxol (9/24), neulasta 9/25.  October 19, 2012, the patient underwent exploratory laparotomy/ileostomy revision/small bowel resection with reanastomosis/colonic anastomosis.  '}\n",
      "{'filename': 'patient20_report186_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbotaxol', 'nth_sent': 0, 'start': 342, 'end': 352}, 'arg2': {'mention': '9/24', 'nth_sent': 0, 'start': 354, 'end': 358}, 'context': 'SUBJECTIVE:  68 year old with IIIC pap serous ovCA a/f deconditioning, s/p suboptimal tumor debulking/XL/supracv hys/ rsx/ileocolonic rsx and SSA/loop ileostomy/cystotomy repair and stent placement in June 2012 complicated by ileostomy repair/gtube placement, recent admission for gtube site infection requiring removal, now s/p fourth cycle carbotaxol (9/24), neulasta 9/25.   '}\n",
      "{'filename': 'patient20_report177_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 57, 'start': 167, 'end': 179}, 'arg2': {'mention': 'October 15, 2012', 'nth_sent': 57, 'start': 123, 'end': 139}, 'context': 'DISPOSITION:  The patient was discharged home on hospital day 3 with instructions to follow up with the Oncology office on October 15, 2012, for discussion of further chemotherapy.  '}\n",
      "{'filename': 'patient20_report177_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 56, 'start': 29, 'end': 40}, 'arg2': {'mention': 'September 24', 'nth_sent': 56, 'start': 69, 'end': 81}, 'context': 'She had received 3 cycles of carboplatin and Taxol; most recently on September 24 with her most recent dose of Neulasta on September 25.'}\n",
      "{'filename': 'patient20_report177_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 56, 'start': 45, 'end': 50}, 'arg2': {'mention': 'September 24', 'nth_sent': 56, 'start': 69, 'end': 81}, 'context': 'She had received 3 cycles of carboplatin and Taxol; most recently on September 24 with her most recent dose of Neulasta on September 25.'}\n",
      "{'filename': 'patient20_report177_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 44, 'start': 39, 'end': 51}, 'arg2': {'mention': 'recent', 'nth_sent': 44, 'start': 32, 'end': 38}, 'context': 'Her platelets in the setting of recent chemotherapy remained low but stable.  '}\n",
      "{'filename': 'patient20_report245_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 9, 'start': 73, 'end': 84}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 9, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012 with a a fairly good response to her chemotherapy.  '}\n",
      "{'filename': 'patient20_report245_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 9, 'start': 89, 'end': 94}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 9, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012 with a a fairly good response to her chemotherapy.  '}\n",
      "{'filename': 'patient20_report126_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 54, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 54, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person66: MD.'}\n",
      "{'filename': 'patient20_report126_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 54, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 54, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person66: MD.'}\n",
      "{'filename': 'patient20_report126_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 48, 'start': 200, 'end': 205}, 'arg2': {'mention': 'last week', 'nth_sent': 48, 'start': 206, 'end': 215}, 'context': 'Ostomy putting out 375 over last 24hrs -- Will stop TPN now given fever --Cont antiemetics GU: foley out, +spont void, adequate UOP yesterday, Cr wnl ID: Febril e 38.4, WBC 2.3 - nadir too soon after chemo last week.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 9, 'start': 42, 'end': 47}, 'arg2': {'mention': '7/19', 'nth_sent': 9, 'start': 54, 'end': 58}, 'context': 'D9 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 9, 'start': 48, 'end': 53}, 'arg2': {'mention': '7/19', 'nth_sent': 9, 'start': 54, 'end': 58}, 'context': 'D9 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 49, 'start': 42, 'end': 47}, 'arg2': {'mention': '7/19', 'nth_sent': 49, 'start': 54, 'end': 58}, 'context': 'D9 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 49, 'start': 48, 'end': 53}, 'arg2': {'mention': '7/19', 'nth_sent': 49, 'start': 54, 'end': 58}, 'context': 'D9 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 62, 'start': 18, 'end': 23}, 'arg2': {'mention': '7/19', 'nth_sent': 62, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 62, 'start': 24, 'end': 29}, 'arg2': {'mention': '7/19', 'nth_sent': 62, 'start': 30, 'end': 34}, 'context': 'Following ANC s/p carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 64, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 64, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 64, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person70: MD.'}\n",
      "{'filename': 'patient20_report138_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 57, 'start': 37, 'end': 42}, 'arg2': {'mention': '7/19', 'nth_sent': 57, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report138_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 57, 'start': 31, 'end': 36}, 'arg2': {'mention': '7/19', 'nth_sent': 57, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report256_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 27, 'start': 86, 'end': 97}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 27, 'start': 155, 'end': 173}, 'context': 'After she recovered postoperatively, the patient had started on adjuvant therapy with carboplatin and Taxol and had received 4 cycles with the last one on September 24, 2012.  '}\n",
      "{'filename': 'patient20_report256_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 27, 'start': 102, 'end': 107}, 'arg2': {'mention': 'September 24, 2012', 'nth_sent': 27, 'start': 155, 'end': 173}, 'context': 'After she recovered postoperatively, the patient had started on adjuvant therapy with carboplatin and Taxol and had received 4 cycles with the last one on September 24, 2012.  '}\n",
      "{'filename': 'patient20_report256_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 61, 'start': 135, 'end': 147}, 'arg2': {'mention': 'November 26, 2012', 'nth_sent': 61, 'start': 60, 'end': 77}, 'context': 'The *U*P*M*C* Person6#: patient does have an appointment on November 26, 2012, at 8:30 a.m. with Dr. Person27 prior to proceeding with chemotherapy.  '}\n",
      "{'filename': 'patient20_report256_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 62, 'start': 219, 'end': 231}, 'arg2': {'mention': 'today', 'nth_sent': 62, 'start': 242, 'end': 247}, 'context': 'As the patient is being discharged on this same date from the hospital, she was premedicated 20 mg of Decadron the evening of November 25, 2012, and again 20 mg this morning prior to discharge from the hospital for her chemotherapy treatment today.'}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 10, 'start': 125, 'end': 130}, 'arg2': {'mention': 'September 22, 2010', 'nth_sent': 10, 'start': 169, 'end': 187}, 'context': 'The patient then was started on the GOG 252 trial receiving IV IP chemotherapy completing six cycles of chemotherapy with IV Taxol, IP carboplatin, and IV Avastin as of September 22, 2010.'}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 10, 'start': 135, 'end': 146}, 'arg2': {'mention': 'September 22, 2010', 'nth_sent': 10, 'start': 169, 'end': 187}, 'context': 'The patient then was started on the GOG 252 trial receiving IV IP chemotherapy completing six cycles of chemotherapy with IV Taxol, IP carboplatin, and IV Avastin as of September 22, 2010.'}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 10, 'start': 155, 'end': 162}, 'arg2': {'mention': 'September 22, 2010', 'nth_sent': 10, 'start': 169, 'end': 187}, 'context': 'The patient then was started on the GOG 252 trial receiving IV IP chemotherapy completing six cycles of chemotherapy with IV Taxol, IP carboplatin, and IV Avastin as of September 22, 2010.'}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 18, 'start': 25, 'end': 32}, 'arg2': {'mention': 'September 22', 'nth_sent': 18, 'start': 39, 'end': 51}, 'context': 'The patient has been off Avastin since September 22 and now desires to have her IP port removed.'}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 20, 'start': 32, 'end': 44}, 'arg2': {'mention': 'September\\n22', 'nth_sent': 20, 'start': 48, 'end': 60}, 'context': 'Her CA-125 at the conclusion of chemotherapy on September 22 was 6 and as of November 04, it was 13.    '}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 98, 'start': 90, 'end': 97}, 'arg2': {'mention': 'September 22', 'nth_sent': 98, 'start': 104, 'end': 116}, 'context': 'The patient has completed the first part of this trial and has been off chemotherapy with Avastin since September 22 and now desires to have her IP port removed.'}\n",
      "{'filename': 'patient30_report024_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 59, 'start': 108, 'end': 120}, 'arg2': {'mention': '08/09/2010', 'nth_sent': 59, 'start': 65, 'end': 75}, 'context': 'The patient is to follow up in the Gynecology/Oncology Office on 08/09/2010 at 8:20 a.m. with Person127 for chemotherapy visit.  '}\n",
      "{'filename': 'patient30_report024_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 19, 'end': 24}, 'arg2': {'mention': '07/12/2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.  '}\n",
      "{'filename': 'patient30_report024_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 7, 'start': 38, 'end': 43}, 'arg2': {'mention': '07/12/2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.  '}\n",
      "{'filename': 'patient30_report024_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 19, 'end': 24}, 'arg2': {'mention': '07/12/2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.  '}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 16, 'start': 39, 'end': 51}, 'arg2': {'mention': 'June 15, 2010', 'nth_sent': 16, 'start': 55, 'end': 68}, 'context': 'The patient received her last cycle of chemotherapy on June 15, 2010.  '}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 20, 'start': 31, 'end': 43}, 'arg2': {'mention': 'June 26, 2010', 'nth_sent': 20, 'start': 72, 'end': 85}, 'context': 'The patient had follow-up post chemotherapy laboratories in Location on June 26, 2010, that reportedly showed an ANC level of 200.  '}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 43, 'start': 42, 'end': 54}, 'arg2': {'mention': 'July 06, 2010', 'nth_sent': 43, 'start': 59, 'end': 72}, 'context': 'The patient was due for her next cycle of chemotherapy for July 06, 2010; however, given this recent admission with neutropenic fever, the plan is to hold her chemotherapy for an additional week.'}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 54, 'start': 14, 'end': 26}, 'arg2': {'mention': 'July\\n06, 2010', 'nth_sent': 54, 'start': 43, 'end': 56}, 'context': \"The patient's chemotherapy appointment for July 06, 2010, will be on hold for one week secondary to recent hospital admission for neutropenic fever.\"}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 55, 'start': 55, 'end': 67}, 'arg2': {'mention': 'July 12, 2010', 'nth_sent': 55, 'start': 27, 'end': 40}, 'context': 'The patient will follow up July 12, 2010, for her next chemotherapy appointment.'}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 53, 'start': 35, 'end': 47}, 'arg2': {'mention': 'July 09, 2010', 'nth_sent': 53, 'start': 64, 'end': 77}, 'context': 'In addition, the patient will have chemotherapy laboratories on July 09, 2010.'}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 14, 'start': 39, 'end': 51}, 'arg2': {'mention': 'June 15, 2010', 'nth_sent': 14, 'start': 55, 'end': 68}, 'context': 'The patient received her last cycle of chemotherapy on June 15, 2010.'}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 19, 'start': 31, 'end': 43}, 'arg2': {'mention': 'June 26, 2010', 'nth_sent': 19, 'start': 72, 'end': 85}, 'context': 'The patient had follow-up post chemotherapy laboratories in Location on June 26, 2010, that reportedly showed an ANC level of 200.    '}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 46, 'start': 42, 'end': 54}, 'arg2': {'mention': 'July 06, 2010', 'nth_sent': 46, 'start': 59, 'end': 72}, 'context': 'The patient was due for her next cycle of chemotherapy for July 06, 2010; however, given this recent admission with neutropenic fever, the plan is to hold her chemotherapy for an additional week.'}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 59, 'start': 55, 'end': 67}, 'arg2': {'mention': 'July 12, 2010', 'nth_sent': 59, 'start': 27, 'end': 40}, 'context': 'The patient will follow up July 12, 2010, for her next chemotherapy appointment.'}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 56, 'start': 35, 'end': 47}, 'arg2': {'mention': 'July 09, 2010', 'nth_sent': 56, 'start': 64, 'end': 77}, 'context': 'In addition, the patient will have chemotherapy laboratories on July 09, 2010.'}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 57, 'start': 14, 'end': 26}, 'arg2': {'mention': 'July', 'nth_sent': 57, 'start': 43, 'end': 47}, 'context': \"The patient's chemotherapy appointment for July *U*P*M*C*\"}\n",
      "{'filename': 'patient30_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 58, 'start': 118, 'end': 130}, 'arg2': {'mention': '08/09/2010', 'nth_sent': 58, 'start': 76, 'end': 86}, 'context': 'FOLLOWUP:  The patient is to follow up in the Gynecology/Oncology Office on 08/09/2010 at 8:20 a.m. with Person41 for chemotherapy visit.'}\n",
      "{'filename': 'patient30_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 19, 'end': 24}, 'arg2': {'mention': '07/12/2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.    '}\n",
      "{'filename': 'patient30_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 7, 'start': 38, 'end': 43}, 'arg2': {'mention': '07/12/2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.    '}\n",
      "{'filename': 'patient30_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 19, 'end': 24}, 'arg2': {'mention': '07/12/2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.    '}\n",
      "{'filename': 'patient38_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 13, 'end': 24}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 74, 'end': 84}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013.'}\n",
      "{'filename': 'patient38_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 26, 'end': 31}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 74, 'end': 84}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013.'}\n",
      "{'filename': 'patient38_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 36, 'end': 43}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 74, 'end': 84}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013.'}\n",
      "{'filename': 'patient38_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 5, 'start': 34, 'end': 41}, 'arg2': {'mention': '19th', 'nth_sent': 5, 'start': 177, 'end': 181}, 'context': 'She underwent continued plans for Avastin maintenance therapy, of which the first 2 were generally uncomplicated, but she reports that the most recent dose, administered on the 19th, last Thursday, left her somewhat weakened and more nauseated.'}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 17, 'end': 28}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 65, 'end': 75}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.  '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 30, 'end': 40}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 65, 'end': 75}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.  '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 4, 'start': 45, 'end': 56}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 65, 'end': 75}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.  '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 30, 'end': 41}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 57, 'end': 70}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel July 25, 2013 through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 46, 'end': 56}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 57, 'end': 70}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel July 25, 2013 through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 5, 2013', 'nth_sent': 7, 'start': 79, 'end': 96}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel July 25, 2013 through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 46, 'end': 56}, 'arg2': {'mention': 'September 5, 2013', 'nth_sent': 7, 'start': 79, 'end': 96}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel July 25, 2013 through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 8, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 26, 2013', 'nth_sent': 9, 'start': 77, 'end': 95}, 'context': 'CURRENT THERAPY:  Maintenance bevacizumab 7.5 mg/kg every 21 days, initiated September 26, 2013.'}\n",
      "{'filename': 'patient38_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 60, 'start': 9, 'end': 14}, 'arg2': {'mention': 'today', 'nth_sent': 60, 'start': 63, 'end': 68}, 'context': 'Plan for chemo as outpatient, plan for chemo teaching in house today Prophylaxis: SCDs in place, amulation, PP Lovenox, Continue PT/OT  Dispo: Continue postop management, NPO as above.'}\n",
      "{'filename': 'patient38_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 77, 'start': 70, 'end': 82}, 'arg2': {'mention': 'December\\n26', 'nth_sent': 77, 'start': 35, 'end': 46}, 'context': 'She has a follow up appointment on December 26 at which point further chemotherapy plans will be discussed.'}\n",
      "{'filename': 'patient38_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 91, 'start': 110, 'end': 122}, 'arg2': {'mention': 'December 26, 2012', 'nth_sent': 91, 'start': 43, 'end': 60}, 'context': 'The patient has a follow up appointment on December 26, 2012, at 2:40 p.m. for staple removal and for further chemotherapy education.'}\n",
      "{'filename': 'patient38_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 56, 'start': 34, 'end': 46}, 'arg2': {'mention': 'next week', 'nth_sent': 56, 'start': 56, 'end': 65}, 'context': 'We will make arrangements for her chemotherapy to begin next week.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 77, 'start': 47, 'end': 58}, 'arg2': {'mention': 'today', 'nth_sent': 77, 'start': 69, 'end': 74}, 'context': 'She will receive her second of three cycles of carboplatin and Taxol today.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 77, 'start': 63, 'end': 68}, 'arg2': {'mention': 'today', 'nth_sent': 77, 'start': 69, 'end': 74}, 'context': 'She will receive her second of three cycles of carboplatin and Taxol today.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 4, 'start': 3, 'end': 14}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 61, 'end': 71}, 'context': '2. Carboplatin, paclitaxel, and Avastin for 6 cycles through April 2013.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 16, 'end': 26}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 61, 'end': 71}, 'context': '2. Carboplatin, paclitaxel, and Avastin for 6 cycles through April 2013.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 32, 'end': 39}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 61, 'end': 71}, 'context': '2. Carboplatin, paclitaxel, and Avastin for 6 cycles through April 2013.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 9, 'start': 18, 'end': 28}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 10, 'start': 77, 'end': 90}, 'context': 'CURRENT THERAPY:  Paclitaxel and carboplatin. She received postop cycle 1 on July 25, 2013.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 9, 'start': 33, 'end': 44}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 10, 'start': 77, 'end': 90}, 'context': 'CURRENT THERAPY:  Paclitaxel and carboplatin. She received postop cycle 1 on July 25, 2013.'}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 5, 'start': 17, 'end': 28}, 'arg2': {'mention': 'April 2013', 'nth_sent': 5, 'start': 61, 'end': 71}, 'context': '2. Six cycles of carboplatin, paclitaxel and Avastin through April 2013.  '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 5, 'start': 30, 'end': 40}, 'arg2': {'mention': 'April 2013', 'nth_sent': 5, 'start': 61, 'end': 71}, 'context': '2. Six cycles of carboplatin, paclitaxel and Avastin through April 2013.  '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 5, 'start': 45, 'end': 52}, 'arg2': {'mention': 'April 2013', 'nth_sent': 5, 'start': 61, 'end': 71}, 'context': '2. Six cycles of carboplatin, paclitaxel and Avastin through April 2013.  '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 8, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 5, 2013', 'nth_sent': 8, 'start': 83, 'end': 100}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel on July 25, 2013, through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 8, 'start': 46, 'end': 56}, 'arg2': {'mention': 'September 5, 2013', 'nth_sent': 8, 'start': 83, 'end': 100}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel on July 25, 2013, through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 83, 'start': 111, 'end': 118}, 'arg2': {'mention': 'today', 'nth_sent': 83, 'start': 84, 'end': 89}, 'context': 'Postoperatively, she has completed 3 cycles of carboplatin, paclitaxel and presents today to start maintenance Avastin.'}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 8, 'start': 30, 'end': 41}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 8, 'start': 60, 'end': 73}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel on July 25, 2013, through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 8, 'start': 46, 'end': 56}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 8, 'start': 60, 'end': 73}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel on July 25, 2013, through September 5, 2013.    '}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 84, 'start': 125, 'end': 132}, 'arg2': {'mention': 'today', 'nth_sent': 84, 'start': 174, 'end': 179}, 'context': 'She has no evidence of disease on CT scans and her CA-125 remains normal; therefore, she will receive cycle 1 of maintenance Avastin 7.5 mg/kg IV once every 21 days starting today.'}\n",
      "{'filename': 'patient38_report102_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 1, 'start': 6, 'end': 17}, 'arg2': {'mention': '12/19/13', 'nth_sent': 1, 'start': 86, 'end': 94}, 'context': 'note: bevacizumab associated hyponatremia grade 3-4 incidence = 4%; last administered 12/19/13 2) Stage 4 High grade Mullerian Serous Cancer of ovary and abdominal cavity in remission Plan: renal has been consulted     Perform - Completed by Person2 (on 12/22/2013 08:54)  '}\n",
      "{'filename': 'patient38_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 46, 'start': 9, 'end': 14}, 'arg2': {'mention': 'today', 'nth_sent': 46, 'start': 63, 'end': 68}, 'context': 'Plan for chemo as outpatient, plan for chemo teaching in house today Prophylaxis: SCDs in place, amulation, PP Lovenox, Continue PT/OT  Dispo:'}\n",
      "{'filename': 'patient38_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 49, 'start': 9, 'end': 14}, 'arg2': {'mention': 'today', 'nth_sent': 49, 'start': 63, 'end': 68}, 'context': 'Plan for chemo as outpatient, plan for chemo teaching in house today Prophylaxis: SCDs in place, amulation, PP Lovenox, Continue PT/OT  Dispo:'}\n",
      "{'filename': 'patient38_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 75, 'start': 81, 'end': 88}, 'arg2': {'mention': 'one year', 'nth_sent': 75, 'start': 114, 'end': 122}, 'context': 'Dr. Person29 is recommending 3-4 cycles postoperative carboplatin and Taxol with Avastin and continue Avastin for one year.    '}\n",
      "{'filename': 'patient38_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 51, 'start': 77, 'end': 89}, 'arg2': {'mention': 'April', 'nth_sent': 51, 'start': 93, 'end': 98}, 'context': 'She describes peripheral neuropathy, has numbness and tingling since cycle 5 chemotherapy in April.'}\n",
      "{'filename': 'patient38_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 13, 'end': 24}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 74, 'end': 84}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013.'}\n",
      "{'filename': 'patient38_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 26, 'end': 31}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 74, 'end': 84}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013.'}\n",
      "{'filename': 'patient38_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 36, 'end': 43}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 74, 'end': 84}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013.'}\n",
      "{'filename': 'patient38_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 5, 'start': 34, 'end': 41}, 'arg2': {'mention': '19th', 'nth_sent': 5, 'start': 177, 'end': 181}, 'context': 'She underwent continued plans for Avastin maintenance therapy, of which the first 2 were generally uncomplicated, but she reports that the most recent dose, administered on the 19th, last Thursday, left her somewhat weakened and more nauseated.'}\n",
      "{'filename': 'patient38_report041_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 72, 'start': 70, 'end': 82}, 'arg2': {'mention': 'December\\n26', 'nth_sent': 72, 'start': 35, 'end': 46}, 'context': 'She has a follow up appointment on December 26 at which point further chemotherapy plans will be discussed.  '}\n",
      "{'filename': 'patient38_report041_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 86, 'start': 110, 'end': 122}, 'arg2': {'mention': 'December 26, 2012', 'nth_sent': 86, 'start': 43, 'end': 60}, 'context': 'The patient has a follow up appointment on December 26, 2012, at 2:40 p.m. for staple removal and for further chemotherapy education.  '}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 27, 'end': 38}, 'arg2': {'mention': 'April 2013', 'nth_sent': 6, 'start': 76, 'end': 86}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 6, 'start': 40, 'end': 50}, 'arg2': {'mention': 'April 2013', 'nth_sent': 6, 'start': 76, 'end': 86}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 6, 'start': 56, 'end': 67}, 'arg2': {'mention': 'April 2013', 'nth_sent': 6, 'start': 76, 'end': 86}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 47, 'end': 57}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 79, 'end': 92}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 79, 'end': 92}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 47, 'end': 57}, 'arg2': {'mention': 'September 5,\\n2013', 'nth_sent': 7, 'start': 101, 'end': 118}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': 'September 5,\\n2013', 'nth_sent': 7, 'start': 101, 'end': 118}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 8, 'start': 28, 'end': 39}, 'arg2': {'mention': 'September 26, 2013', 'nth_sent': 9, 'start': 78, 'end': 96}, 'context': 'She has been on maintenance bevacizumab 7.5 mg/kg every 21 days instituted on September 26, 2013, last administered on December 19, 2013.  '}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 8, 'start': 28, 'end': 39}, 'arg2': {'mention': 'December 19, 2013', 'nth_sent': 9, 'start': 119, 'end': 136}, 'context': 'She has been on maintenance bevacizumab 7.5 mg/kg every 21 days instituted on September 26, 2013, last administered on December 19, 2013.  '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 17, 'end': 28}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 65, 'end': 75}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.  '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 30, 'end': 40}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 65, 'end': 75}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.  '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 4, 'start': 45, 'end': 56}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 65, 'end': 75}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.  '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 30, 'end': 41}, 'arg2': {'mention': 'July 25th, 2013', 'nth_sent': 6, 'start': 58, 'end': 73}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel, July 25th, 2013 through September 5th, 2013.    '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 6, 'start': 46, 'end': 56}, 'arg2': {'mention': 'July 25th, 2013', 'nth_sent': 6, 'start': 58, 'end': 73}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel, July 25th, 2013 through September 5th, 2013.    '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 5th, 2013', 'nth_sent': 6, 'start': 82, 'end': 101}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel, July 25th, 2013 through September 5th, 2013.    '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 6, 'start': 46, 'end': 56}, 'arg2': {'mention': 'September 5th, 2013', 'nth_sent': 6, 'start': 82, 'end': 101}, 'context': '4. Three cycles postoperative carboplatin and paclitaxel, July 25th, 2013 through September 5th, 2013.    '}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 7, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 26th, 2013', 'nth_sent': 8, 'start': 77, 'end': 97}, 'context': 'CURRENT THERAPY:  Maintenance bevacizumab 7.5 mg/kg every 21 days, initiated September 26th, 2013.'}\n",
      "{'filename': 'patient38_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 104, 'end': 116}, 'arg2': {'mention': 'recently', 'nth_sent': 2, 'start': 91, 'end': 99}, 'context': 'HISTORY OF PRESENT ILLNESS:  This 70-year-old white female patient has ovarian cancer, has recently had chemotherapy.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 27, 'end': 38}, 'arg2': {'mention': 'April 2013', 'nth_sent': 6, 'start': 76, 'end': 86}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 6, 'start': 40, 'end': 50}, 'arg2': {'mention': 'April 2013', 'nth_sent': 6, 'start': 76, 'end': 86}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 6, 'start': 56, 'end': 67}, 'arg2': {'mention': 'April 2013', 'nth_sent': 6, 'start': 76, 'end': 86}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 79, 'end': 92}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': 'September 5,\\n2013', 'nth_sent': 7, 'start': 101, 'end': 118}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 47, 'end': 57}, 'arg2': {'mention': 'September 5,\\n2013', 'nth_sent': 7, 'start': 101, 'end': 118}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 47, 'end': 57}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 79, 'end': 92}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 47, 'end': 57}, 'arg2': {'mention': 'September 5,\\n2013', 'nth_sent': 7, 'start': 101, 'end': 118}, 'context': 'Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 8, 'start': 28, 'end': 39}, 'arg2': {'mention': 'September 26, 2013', 'nth_sent': 9, 'start': 78, 'end': 96}, 'context': 'She has been on maintenance bevacizumab 7.5 mg/kg every 21 days instituted on September 26, 2013, last administered on December 19, 2013.  '}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 8, 'start': 28, 'end': 39}, 'arg2': {'mention': 'December 19, 2013', 'nth_sent': 9, 'start': 119, 'end': 136}, 'context': 'She has been on maintenance bevacizumab 7.5 mg/kg every 21 days instituted on September 26, 2013, last administered on December 19, 2013.  '}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 5, 'start': 3, 'end': 14}, 'arg2': {'mention': 'April 2013', 'nth_sent': 5, 'start': 58, 'end': 68}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.  '}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 5, 'start': 16, 'end': 26}, 'arg2': {'mention': 'April 2013', 'nth_sent': 5, 'start': 58, 'end': 68}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.  '}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 5, 'start': 32, 'end': 39}, 'arg2': {'mention': 'April 2013', 'nth_sent': 5, 'start': 58, 'end': 68}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.  '}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 73, 'start': 63, 'end': 74}, 'arg2': {'mention': 'July 25th', 'nth_sent': 73, 'start': 93, 'end': 102}, 'context': 'Ms. Patient38 will be scheduled to start cycle 1 postoperative carboplatin and paclitaxel on July 25th.'}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 73, 'start': 79, 'end': 89}, 'arg2': {'mention': 'July 25th', 'nth_sent': 73, 'start': 93, 'end': 102}, 'context': 'Ms. Patient38 will be scheduled to start cycle 1 postoperative carboplatin and paclitaxel on July 25th.'}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 72, 'start': 147, 'end': 154}, 'arg2': {'mention': 'one year', 'nth_sent': 72, 'start': 126, 'end': 134}, 'context': 'The consensus recommendation for postoperative chemotherapy is three to four cycles of carboplatin and paclitaxel followed by one year maintenance Avastin.'}\n",
      "{'filename': 'patient38_report101_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 104, 'end': 116}, 'arg2': {'mention': 'recently', 'nth_sent': 1, 'start': 91, 'end': 99}, 'context': 'HISTORY OF PRESENT ILLNESS:  This 70-year-old white female patient has ovarian cancer, has recently had chemotherapy.'}\n",
      "{'filename': 'patient38_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 72, 'start': 70, 'end': 82}, 'arg2': {'mention': 'December\\n26', 'nth_sent': 72, 'start': 35, 'end': 46}, 'context': 'She has a follow up appointment on December 26 at which point further chemotherapy plans will be discussed.'}\n",
      "{'filename': 'patient38_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 86, 'start': 110, 'end': 122}, 'arg2': {'mention': 'December 26, 2012', 'nth_sent': 86, 'start': 43, 'end': 60}, 'context': 'The patient has a follow up appointment on December 26, 2012, at 2:40 p.m. for staple removal and for further chemotherapy education.'}\n",
      "{'filename': 'patient38_report025_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 55, 'start': 30, 'end': 35}, 'arg2': {'mention': 'today', 'nth_sent': 55, 'start': 36, 'end': 41}, 'context': 'Discussing option of possible chemo today.'}\n",
      "{'filename': 'patient38_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 93, 'end': 103}, 'arg2': {'mention': '7/25/13', 'nth_sent': 4, 'start': 116, 'end': 123}, 'context': 'History of Present Illness  70 y/o female with ovarian cancer, s/p post - op carboplatin and paclitaxel chemo given 7/25/13 without Neulasta.'}\n",
      "{'filename': 'patient38_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 77, 'end': 88}, 'arg2': {'mention': '7/25/13', 'nth_sent': 4, 'start': 116, 'end': 123}, 'context': 'History of Present Illness  70 y/o female with ovarian cancer, s/p post - op carboplatin and paclitaxel chemo given 7/25/13 without Neulasta.'}\n",
      "{'filename': 'patient38_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 14, 'start': 3, 'end': 14}, 'arg2': {'mention': 'April 2013', 'nth_sent': 14, 'start': 58, 'end': 68}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.  '}\n",
      "{'filename': 'patient38_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 14, 'start': 16, 'end': 26}, 'arg2': {'mention': 'April 2013', 'nth_sent': 14, 'start': 58, 'end': 68}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.  '}\n",
      "{'filename': 'patient38_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 14, 'start': 32, 'end': 39}, 'arg2': {'mention': 'April 2013', 'nth_sent': 14, 'start': 58, 'end': 68}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.  '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 17, 'end': 28}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 62, 'end': 72}, 'context': '2. Six cycles of carboplatin, paclitaxel, and Avastin through April 2013.  '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 30, 'end': 40}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 62, 'end': 72}, 'context': '2. Six cycles of carboplatin, paclitaxel, and Avastin through April 2013.  '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 46, 'end': 53}, 'arg2': {'mention': 'April 2013', 'nth_sent': 4, 'start': 62, 'end': 72}, 'context': '2. Six cycles of carboplatin, paclitaxel, and Avastin through April 2013.  '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 45, 'end': 55}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 81, 'end': 94}, 'context': 'CURRENT THERAPY:  Three cycles postoperative paclitaxel and carboplatin starting July 25, 2013, presenting for cycle #3 followed by maintenance Avastin.    '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 60, 'end': 71}, 'arg2': {'mention': 'July 25, 2013', 'nth_sent': 7, 'start': 81, 'end': 94}, 'context': 'CURRENT THERAPY:  Three cycles postoperative paclitaxel and carboplatin starting July 25, 2013, presenting for cycle #3 followed by maintenance Avastin.    '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 82, 'start': 40, 'end': 50}, 'arg2': {'mention': 'today', 'nth_sent': 82, 'start': 91, 'end': 96}, 'context': 'She presents for cycle #3 postoperative paclitaxel and carboplatin, which she will receive today.'}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 82, 'start': 55, 'end': 66}, 'arg2': {'mention': 'today', 'nth_sent': 82, 'start': 91, 'end': 96}, 'context': 'She presents for cycle #3 postoperative paclitaxel and carboplatin, which she will receive today.'}\n",
      "{'filename': 'patient48_report078_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report017_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 10, 'start': 40, 'end': 45}, 'arg2': {'mention': '4 weeks ago', 'nth_sent': 10, 'start': 52, 'end': 63}, 'context': 'Patient has h/o ovarian Ca treated with chemo (last 4 weeks ago) at West Person27 hospital.'}\n",
      "{'filename': 'patient48_report083_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 31, 'end': 43}, 'arg2': {'mention': 'presently', 'nth_sent': 4, 'start': 45, 'end': 54}, 'context': 'She was not felt to be fit for chemotherapy, presently.'}\n",
      "{'filename': 'patient48_report094_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report131_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report046_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 52, 'start': 0, 'end': 12}, 'arg2': {'mention': 'currently', 'nth_sent': 52, 'start': 30, 'end': 39}, 'context': 'Chemotherapy is not an option currently.'}\n",
      "{'filename': 'patient48_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 41, 'start': 33, 'end': 42}, 'arg2': {'mention': '4/13', 'nth_sent': 41, 'start': 51, 'end': 55}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR.'}\n",
      "{'filename': 'patient48_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 41, 'start': 25, 'end': 30}, 'arg2': {'mention': '4/13', 'nth_sent': 41, 'start': 51, 'end': 55}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR.'}\n",
      "{'filename': 'patient48_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 47, 'start': 29, 'end': 41}, 'arg2': {'mention': 'currently', 'nth_sent': 47, 'start': 42, 'end': 51}, 'context': 'Not a candidate for systemic chemotherapy currently due to poor performance status.  '}\n",
      "{'filename': 'patient48_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 64, 'start': 0, 'end': 12}, 'arg2': {'mention': 'currently', 'nth_sent': 64, 'start': 30, 'end': 39}, 'context': 'Chemotherapy is not an option currently.'}\n",
      "{'filename': 'patient48_report135_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 8, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report015_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 49, 'start': 61, 'end': 73}, 'arg2': {'mention': 'April', 'nth_sent': 49, 'start': 46, 'end': 51}, 'context': 'My suspicion is that from the time since late April when the chemotherapy was last administered until now, she has had disease progression.'}\n",
      "{'filename': 'patient48_report105_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report028_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 60, 'start': 0, 'end': 12}, 'arg2': {'mention': 'currently', 'nth_sent': 60, 'start': 30, 'end': 39}, 'context': 'Chemotherapy is not an option currently.'}\n",
      "{'filename': 'patient48_report023_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 40, 'start': 3, 'end': 15}, 'arg2': {'mention': 'currently', 'nth_sent': 40, 'start': 24, 'end': 33}, 'context': 'No chemotherapy options currently given open wounds and poor performance status.'}\n",
      "{'filename': 'patient48_report158_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 6, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 49, 'start': 61, 'end': 73}, 'arg2': {'mention': 'April', 'nth_sent': 49, 'start': 46, 'end': 51}, 'context': 'My suspicion is that from the time since late April when the chemotherapy was last administered until now, she has had disease progression.'}\n",
      "{'filename': 'patient48_report100_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 31, 'end': 43}, 'arg2': {'mention': 'presently', 'nth_sent': 4, 'start': 45, 'end': 54}, 'context': 'She was not felt to be fit for chemotherapy, presently.'}\n",
      "{'filename': 'patient48_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 10, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report065_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 12, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 12, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report110_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 49, 'start': 25, 'end': 30}, 'arg2': {'mention': '4/13', 'nth_sent': 49, 'start': 51, 'end': 55}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR.'}\n",
      "{'filename': 'patient48_report110_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 49, 'start': 33, 'end': 42}, 'arg2': {'mention': '4/13', 'nth_sent': 49, 'start': 51, 'end': 55}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR.'}\n",
      "{'filename': 'patient48_report053_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 2, 'start': 25, 'end': 34}, 'arg2': {'mention': '4/2013', 'nth_sent': 2, 'start': 47, 'end': 53}, 'context': 'CTX - 3 cycles - Carbo + Docetaxel - last dose 4/2013 Abdoinal paracentesis x2 for recurrent ascites Several weeks of worsening fatigue, B/L LE, Dehydration, Abdominal discomfort.'}\n",
      "{'filename': 'patient48_report053_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 2, 'start': 17, 'end': 22}, 'arg2': {'mention': '4/2013', 'nth_sent': 2, 'start': 47, 'end': 53}, 'context': 'CTX - 3 cycles - Carbo + Docetaxel - last dose 4/2013 Abdoinal paracentesis x2 for recurrent ascites Several weeks of worsening fatigue, B/L LE, Dehydration, Abdominal discomfort.'}\n",
      "{'filename': 'patient48_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 8, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient48_report016_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 32, 'end': 44}, 'arg2': {'mention': '4 weeks ago', 'nth_sent': 6, 'start': 106, 'end': 117}, 'context': 'Since that time she has been on chemotherapy and has completed three rounds, with the last one being over 4 weeks ago.'}\n",
      "{'filename': 'patient48_report101_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'docetaxel', 'nth_sent': 46, 'start': 33, 'end': 42}, 'arg2': {'mention': '4/13', 'nth_sent': 46, 'start': 51, 'end': 55}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR.'}\n",
      "{'filename': 'patient48_report101_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 46, 'start': 25, 'end': 30}, 'arg2': {'mention': '4/13', 'nth_sent': 46, 'start': 51, 'end': 55}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR.'}\n",
      "{'filename': 'patient48_report024_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 53, 'start': 0, 'end': 12}, 'arg2': {'mention': 'currently', 'nth_sent': 53, 'start': 30, 'end': 39}, 'context': 'Chemotherapy is not an option currently.'}\n",
      "{'filename': 'patient48_report150_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 58, 'end': 70}, 'arg2': {'mention': 'April', 'nth_sent': 6, 'start': 83, 'end': 88}, 'context': 'According to the oncology notes, she has not received any chemotherapy since about April.'}\n",
      "{'filename': 'patient12_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 16, 'end': 28}, 'arg2': {'mention': 'this morning', 'nth_sent': 5, 'start': 54, 'end': 66}, 'context': \"She was due for chemotherapy at Dr. Person27's office this morning, and she had another episode of right arm paresis and was therefore admitted to the hospital for further management.  \"}\n",
      "{'filename': 'patient46_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 11, 'start': 24, 'end': 29}, 'arg2': {'mention': '5 wks ago', 'nth_sent': 11, 'start': 67, 'end': 76}, 'context': 'Onc:  debulking 10/2011 carbo/taxol -> rxn single agent carbo last 5 wks ago.'}\n",
      "{'filename': 'patient46_report078_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 86, 'end': 98}, 'arg2': {'mention': 'October 2011', 'nth_sent': 8, 'start': 9, 'end': 21}, 'context': 'In early October 2011, Patient46 had returned back to the hospital after a session of chemotherapy where she was dehydrated.'}\n",
      "{'filename': 'patient46_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 200, 'end': 211}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 144, 'end': 153}, 'context': \"History of Present Illness  HTN Ovarian cancer S/P debulking surgery 9/2011 (had new postop atrial fibrillation-Rx w/ short term amiodarone and currently on Toprol and pradaxa), currently on chemo Rx carboplatin and taxol complicated by anemia/ thrombocytopenia requiring PRBC's 2 weeks ago - now neutropenic  Paroxysmal atrial fibrillation  HLD GERD anxiety/depression Spinal stneosis  Presented with several weeks of RLQ pain with radiatin to the low back.\"}\n",
      "{'filename': 'patient46_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 216, 'end': 221}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 144, 'end': 153}, 'context': \"History of Present Illness  HTN Ovarian cancer S/P debulking surgery 9/2011 (had new postop atrial fibrillation-Rx w/ short term amiodarone and currently on Toprol and pradaxa), currently on chemo Rx carboplatin and taxol complicated by anemia/ thrombocytopenia requiring PRBC's 2 weeks ago - now neutropenic  Paroxysmal atrial fibrillation  HLD GERD anxiety/depression Spinal stneosis  Presented with several weeks of RLQ pain with radiatin to the low back.\"}\n",
      "{'filename': 'patient46_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 7, 'start': 21, 'end': 26}, 'arg2': {'mention': '10/31', 'nth_sent': 7, 'start': 47, 'end': 52}, 'context': 'Had her first chemo (taxol and carboplatin) on 10/31.'}\n",
      "{'filename': 'patient46_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': '10/31', 'nth_sent': 7, 'start': 47, 'end': 52}, 'context': 'Had her first chemo (taxol and carboplatin) on 10/31.'}\n",
      "{'filename': 'patient46_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 54, 'start': 67, 'end': 79}, 'arg2': {'mention': 'December 19', 'nth_sent': 54, 'start': 43, 'end': 54}, 'context': 'The patient will followup in the office on December 19 for further chemotherapy planning.'}\n",
      "{'filename': 'patient46_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 9, 'start': 102, 'end': 107}, 'arg2': {'mention': 'October 31', 'nth_sent': 9, 'start': 123, 'end': 133}, 'context': 'Her postoperative course is complicated by wound suppuration and atrial fibrillation and she received Taxol Carboplatin on October 31 with subsequent syncope and atrial fibrillation.'}\n",
      "{'filename': 'patient46_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 9, 'start': 108, 'end': 119}, 'arg2': {'mention': 'October 31', 'nth_sent': 9, 'start': 123, 'end': 133}, 'context': 'Her postoperative course is complicated by wound suppuration and atrial fibrillation and she received Taxol Carboplatin on October 31 with subsequent syncope and atrial fibrillation.'}\n",
      "{'filename': 'patient46_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 10, 'start': 33, 'end': 44}, 'arg2': {'mention': 'November 28', 'nth_sent': 10, 'start': 69, 'end': 80}, 'context': 'She was switched to single agent carboplatin and received 1 cycle on November 28 and her next cycle is scheduled for December 19.    '}\n",
      "{'filename': 'patient46_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 10, 'start': 33, 'end': 44}, 'arg2': {'mention': 'December\\n19', 'nth_sent': 10, 'start': 117, 'end': 128}, 'context': 'She was switched to single agent carboplatin and received 1 cycle on November 28 and her next cycle is scheduled for December 19.    '}\n",
      "{'filename': 'patient46_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 47, 'start': 67, 'end': 79}, 'arg2': {'mention': 'December 19', 'nth_sent': 47, 'start': 43, 'end': 54}, 'context': 'The patient will followup in the office on December 19 for further chemotherapy planning.  '}\n",
      "{'filename': 'patient46_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 33, 'end': 44}, 'arg2': {'mention': 'December 19', 'nth_sent': 6, 'start': 117, 'end': 128}, 'context': 'She was switched to single agent carboplatin and received 1 cycle on November 28 and her next cycle is scheduled for December 19.  '}\n",
      "{'filename': 'patient46_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 33, 'end': 44}, 'arg2': {'mention': 'November 28', 'nth_sent': 6, 'start': 69, 'end': 80}, 'context': 'She was switched to single agent carboplatin and received 1 cycle on November 28 and her next cycle is scheduled for December 19.  '}\n",
      "{'filename': 'patient46_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 5, 'start': 108, 'end': 119}, 'arg2': {'mention': 'October 31', 'nth_sent': 5, 'start': 123, 'end': 133}, 'context': 'Her postoperative course is complicated by wound suppuration and atrial fibrillation and she received Taxol Carboplatin on October 31 with subsequent syncope and atrial fibrillation.  '}\n",
      "{'filename': 'patient46_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 5, 'start': 102, 'end': 107}, 'arg2': {'mention': 'October 31', 'nth_sent': 5, 'start': 123, 'end': 133}, 'context': 'Her postoperative course is complicated by wound suppuration and atrial fibrillation and she received Taxol Carboplatin on October 31 with subsequent syncope and atrial fibrillation.  '}\n",
      "{'filename': 'patient46_report072_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 3, 'start': 12, 'end': 17}, 'arg2': {'mention': 'Monday', 'nth_sent': 3, 'start': 21, 'end': 27}, 'context': 'Pt received chemo on Monday then for the next 2 days could only take in clear liquids.'}\n",
      "{'filename': 'patient46_report072_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 385, 'end': 390}, 'arg2': {'mention': '10/31/2011', 'nth_sent': 2, 'start': 408, 'end': 418}, 'context': 'None Author:   Person24  Basic Information Visit Information:  Patient seen on 11/4/2011.  History of Present Illness *HTN *Ovarian cancer  S/P debulking surgery 9/2011 post op complicated by anemia requiring multiple transfusions and atrial fibrillation w/ trop leak to 0.4- suply demand mismatch;  treated w/ amio/beta blocker/asa:  now undergoing chemo therpay with carboplatin and taxol received dose on 10/31/2011 *Atrial fibrillation  Presented to the ER after a near syncopal event.  '}\n",
      "{'filename': 'patient46_report072_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 2, 'start': 369, 'end': 380}, 'arg2': {'mention': '10/31/2011', 'nth_sent': 2, 'start': 408, 'end': 418}, 'context': 'None Author:   Person24  Basic Information Visit Information:  Patient seen on 11/4/2011.  History of Present Illness *HTN *Ovarian cancer  S/P debulking surgery 9/2011 post op complicated by anemia requiring multiple transfusions and atrial fibrillation w/ trop leak to 0.4- suply demand mismatch;  treated w/ amio/beta blocker/asa:  now undergoing chemo therpay with carboplatin and taxol received dose on 10/31/2011 *Atrial fibrillation  Presented to the ER after a near syncopal event.  '}\n",
      "{'filename': 'patient46_report063_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 279, 'end': 290}, 'arg2': {'mention': '10/31/2011', 'nth_sent': 6, 'start': 318, 'end': 328}, 'context': 'History of Present Illness  77yo F w/ PMHX:  HTN Ovarian cancer S/P debulking surgery 9/2011 post op complicated by anemia requiring multiple transfusions and atrial fibrillation w/ trop leak to 0.4- suply demand mismatch; treated w/ amio/asa:  now undergoign chemo therpay with carboplatin and taxol received dose on 10/31/2011 Atrial fibrillation  Presented to the ER after a near syncopal event.'}\n",
      "{'filename': 'patient46_report063_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 295, 'end': 300}, 'arg2': {'mention': '10/31/2011', 'nth_sent': 6, 'start': 318, 'end': 328}, 'context': 'History of Present Illness  77yo F w/ PMHX:  HTN Ovarian cancer S/P debulking surgery 9/2011 post op complicated by anemia requiring multiple transfusions and atrial fibrillation w/ trop leak to 0.4- suply demand mismatch; treated w/ amio/asa:  now undergoign chemo therpay with carboplatin and taxol received dose on 10/31/2011 Atrial fibrillation  Presented to the ER after a near syncopal event.'}\n",
      "{'filename': 'patient46_report063_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 7, 'start': 12, 'end': 17}, 'arg2': {'mention': 'Monday', 'nth_sent': 7, 'start': 21, 'end': 27}, 'context': 'Pt received chemo on Monday then for the next 2 days could only take in clear liquids; This am she felt lightheaded but was up to brush her teeth and then slid to the floor she states that if she had a LOC it was very brief.'}\n",
      "{'filename': 'patient46_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 7, 'start': 109, 'end': 114}, 'arg2': {'mention': '6wks ago', 'nth_sent': 7, 'start': 115, 'end': 123}, 'context': 'Chief Complaint  constipation   History of Present Illness  77yo F with IIIC ovarian cancer s/p debulk, last chemo 6wks ago, admitted with hydronephrosis from tumor-related ureteral obstruction & bacteremia from UTI, palliative care consulted re: goals & symptoms  '}\n",
      "{'filename': 'patient46_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 10, 'start': 9, 'end': 14}, 'arg2': {'mention': '6wks ago', 'nth_sent': 10, 'start': 25, 'end': 33}, 'context': 'Her last chemo was about 6wks ago, c/b anemia requiring blood transfusion and thrombocytopenia nadir 13.'}\n",
      "{'filename': 'patient46_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 5, 'end': 17}, 'arg2': {'mention': '3 weeks earlier', 'nth_sent': 6, 'start': 32, 'end': 47}, 'context': 'Last chemotherapy approximately 3 weeks earlier.'}\n",
      "{'filename': 'patient46_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 16, 'start': 35, 'end': 40}, 'arg2': {'mention': 'Monday', 'nth_sent': 16, 'start': 24, 'end': 30}, 'context': 'Check CT A/P. Return on Monday for chemo, notify if worsening pain.     '}\n",
      "{'filename': 'patient46_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 17, 'start': 10, 'end': 15}, 'arg2': {'mention': 'one week', 'nth_sent': 17, 'start': 65, 'end': 73}, 'context': \"Will hold chemo and give IVF's/antiemetic today, delay chemo for one week.\"}\n",
      "{'filename': 'patient46_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 3, 'start': 66, 'end': 71}, 'arg2': {'mention': 'last week', 'nth_sent': 3, 'start': 115, 'end': 124}, 'context': 'Additionally, she was hospitalized after her first cycle of taxol/carbo with a syncopal episode and Afib   Delayed last week for cycle 5 of carbo due to pain and UTI.'}\n",
      "{'filename': 'patient46_report073_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 7, 'start': 21, 'end': 26}, 'arg2': {'mention': '10/31', 'nth_sent': 7, 'start': 47, 'end': 52}, 'context': 'Had her first chemo (taxol and carboplatin) on 10/31.'}\n",
      "{'filename': 'patient46_report073_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': '10/31', 'nth_sent': 7, 'start': 47, 'end': 52}, 'context': 'Had her first chemo (taxol and carboplatin) on 10/31.'}\n",
      "{'filename': 'patient46_report073_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 63, 'start': 35, 'end': 40}, 'arg2': {'mention': '10/31', 'nth_sent': 63, 'start': 41, 'end': 46}, 'context': 'Plan Follows with Dr Person31, s/p chemo 10/31.'}\n",
      "{'filename': 'patient31_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 1, 'start': 267, 'end': 272}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 341, 'end': 346}, 'context': 'HISTORY OF PRESENT ILLNESS:  Ms. Patient31 is a 65-year-old woman who is a nonsmoker with a past medical history significant for hypertension, hyperlipidemia, cardiac dysrhythmia, and recent diagnosis of early stage ovarian CA, status post chemo with carboplatin and Taxol x6. Last chemo was on January 24, 2012, who presents to Urgent Care today with a complaint of right ear pain, sore throat, and cough.'}\n",
      "{'filename': 'patient31_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 25, 'start': 102, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 25, 'start': 167, 'end': 172}, 'context': '300 mg Oral Tablet 1 po bid 180 Tab 3   CALTRATE-600 PLUS TABLET 600-200 PO 1 tablet, PO, q day  0    Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient31_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 26, 'start': 185, 'end': 197}, 'arg2': {'mention': 'the morning', 'nth_sent': 26, 'start': 170, 'end': 181}, 'context': '50 mg Oral Tablet take 2 tablet (50 mg) by oral route once daily 90 Tab 1   Dexamethasone (DECADRON) 4 mg Oral Tablet 5 tablets at bedtime the night before and 5 tablets the morning of chemotherapy 60 Tab 2   Prochlorperazine Maleate (COMPAZINE)'}\n",
      "{'filename': 'patient31_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 6, 'start': 32, 'end': 37}, 'arg2': {'mention': 'taxol   carbo last month', 'nth_sent': 6, 'start': 26, 'end': 48}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)'}\n",
      "{'filename': 'patient31_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 29, 'start': 77, 'end': 89}, 'arg2': {'mention': 'today', 'nth_sent': 29, 'start': 142, 'end': 147}, 'context': '5 mg Oral Tablet Take 1 tablet by mouth daily for 2 weeks total 14 Tab 3     Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient31_report036_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 28, 'start': 262, 'end': 274}, 'arg2': {'mention': 'the morning', 'nth_sent': 28, 'start': 247, 'end': 258}, 'context': 'mg Oral Capsule Take 1 by mouth twice a day 14 Cap 0   Triamterene-Hydrochlorothiazide (DYAZIDE) 37.5-25 mg Oral Capsule 1 capsule, PO, Q day 90 Cap 1   Dexamethasone (DECADRON) 4 mg Oral Tablet 5 tablets at bedtime the night before and 5 tablets the morning of chemotherapy 60 Tab 2   Prochlorperazine Maleate (COMPAZINE)'}\n",
      "{'filename': 'patient31_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 6, 'start': 32, 'end': 37}, 'arg2': {'mention': '3   26   2012', 'nth_sent': 7, 'start': 121, 'end': 130}, 'context': 'She completed 6 cycles of taxol/carbo last month and CT shows Person29 (stable pulmonary nodules)    PET CT completed on 3/26/2012 No evidence of FDG avid recurrent or metastatic ovarian cancer.'}\n",
      "{'filename': 'patient16_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 366, 'end': 378}, 'arg2': {'mention': 'recent', 'nth_sent': 3, 'start': 132, 'end': 138}, 'context': 'Hx of paroxysmal atrial fibrillation not on anticoagulation, cirrhosis of unk etiology with ascites s/p paracentesis on 12/11 and a recent admission to Institution (2/4 to 2/12) for urosepsis that triggered atrial fibrillation discharged home on Diltiazem, whom presents with shortness of breath. Pt states that she always becomes SOB and has palpitations after her chemotherapy sessions.'}\n",
      "{'filename': 'patient16_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 3, 'start': 40, 'end': 45}, 'arg2': {'mention': '12   15   2011', 'nth_sent': 3, 'start': 53, 'end': 63}, 'context': 'Her first and only dose of carboplatin/ taxol was on 12/15/2011 by Dr Person5.  '}\n",
      "{'filename': 'patient16_report078_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 57, 'start': 24, 'end': 36}, 'arg2': {'mention': 'Her last several weeks', 'nth_sent': 58, 'start': 38, 'end': 60}, 'context': 'She has been started on chemotherapy. Her last several weeks have been complicated by the development of ascites and atrial fibrillation as well as hydronephrosis.'}\n",
      "{'filename': 'patient16_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 131, 'start': 28, 'end': 39}, 'arg2': {'mention': 'May', 'nth_sent': 132, 'start': 43, 'end': 46}, 'context': 'She recently had ataxol and carboplatin.   May be cause of thrombocytopenia.'}\n",
      "{'filename': 'patient16_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 100, 'start': 28, 'end': 39}, 'arg2': {'mention': 'May', 'nth_sent': 101, 'start': 43, 'end': 46}, 'context': 'She recently had ataxol and carboplatin.   May be cause of thrombocytopenia.'}\n",
      "{'filename': 'patient16_report089_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 86, 'end': 98}, 'arg2': {'mention': 'early this morning', 'nth_sent': 10, 'start': 275, 'end': 293}, 'context': 'Apparently, the  patient presented to Institution on February 2, 2012, for scheduled  chemotherapy, but her blood sugars were found to be in the 600s, and she was  admitted to the hospital for further monitoring and therapy.    Since then, she has been doing fairly well but early this morning she was  found to be quite hypotensive with the blood pressures in the low 80s.'}\n",
      "{'filename': 'patient16_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 103, 'start': 28, 'end': 39}, 'arg2': {'mention': 'May', 'nth_sent': 104, 'start': 43, 'end': 46}, 'context': 'She recently had ataxol and carboplatin.   May be cause of thrombocytopenia.'}\n",
      "{'filename': 'patient16_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 106, 'start': 30, 'end': 41}, 'arg2': {'mention': '12   15   2001', 'nth_sent': 106, 'start': 55, 'end': 65}, 'context': 'She received her 1st cycle of Carboplatin and Taxol on 12/15/2001 with resultant neutropenia but without fever or signs/symptoms of infection.'}\n",
      "{'filename': 'patient16_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 7, 'start': 205, 'end': 216}, 'arg2': {'mention': '2   20   12', 'nth_sent': 7, 'start': 218, 'end': 225}, 'context': 'Hospital Course   64 yo female with Hx of Metastatic Ovarian cancer (poorly differentiated mucinous CA of R ovary with solitary mets to lung s/p resection in 11/11) currently s/p third cycle of Paclitaxel/Carboplatin (2/20/12), Hx of Breast cancer (s/p masectomy, Ductal carcinoma in situ),'}\n",
      "{'filename': 'patient16_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 55, 'end': 67}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 75, 'end': 84}, 'context': 'The pt has a h/o paroxysmal Afibb following cycle 1 of chemotherapy who is currently rate controlled and not on anticoagulation.'}\n",
      "{'filename': 'patient16_report028_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 83, 'start': 28, 'end': 39}, 'arg2': {'mention': 'May', 'nth_sent': 84, 'start': 43, 'end': 46}, 'context': 'She recently had ataxol and carboplatin.   May be cause of thrombocytopenia.'}\n",
      "{'filename': 'patient16_report114_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 13, 'start': 55, 'end': 65}, 'arg2': {'mention': '6   13   12', 'nth_sent': 13, 'start': 29, 'end': 36}, 'context': 'She had a chemo treatment on 6/13/12- cistoplatin; and paclitaxel.'}\n",
      "{'filename': 'patient17_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 27, 'start': 38, 'end': 49}, 'arg2': {'mention': 'November 5   2012', 'nth_sent': 28, 'start': 140, 'end': 156}, 'context': 'Dr. Person4 is recommending Paxil and carboplatin to start in the next 2-3 weeks. The patient has a followup appointment with our office on November 5, 2012.'}\n",
      "{'filename': 'patient17_report131_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'TC', 'nth_sent': 4, 'start': 30, 'end': 32}, 'arg2': {'mention': '2   21   13', 'nth_sent': 4, 'start': 39, 'end': 46}, 'context': 'She has completed 5 cycles of TC as of 2/21/13 with Moon Twp Cancer center.'}\n",
      "{'filename': 'patient17_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 9, 'start': 129, 'end': 134}, 'arg2': {'mention': 'about 3 weeks', 'nth_sent': 9, 'start': 32, 'end': 45}, 'context': 'She was last seen in the clinic about 3 weeks ago at which time she received her first dose of chemotherapy with Carboplatin and Taxol.'}\n",
      "{'filename': 'patient17_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 186, 'end': 198}, 'arg2': {'mention': 'today  ', 'nth_sent': 1, 'start': 146, 'end': 151}, 'context': 'Patient17  PATIENT ID#:  DATE OF BIRTH: 03/06/1932 DATE OF VISIT: 11/12/2012   Office Note  CHIEF COMPLAINT:  Ms. Patient17 returns to the office today for consideration to initiate her chemotherapy of Taxol and carboplatin for an ovarian carcinoma.  '}\n",
      "{'filename': 'patient17_report132_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 16, 'start': 232, 'end': 237}, 'arg2': {'mention': 'end of April  ', 'nth_sent': 15, 'start': 168, 'end': 180}, 'context': 'She has visited with Dr. Person4 on the 27th and currently is planned for CT scan on April 10th and follow-up with Dr. Person4 on April 13th, likely for surgery by the end of April. She has for 6th and final dose of Carboplatin and Taxol today.  '}\n",
      "{'filename': 'patient17_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 13, 'start': 543, 'end': 548}, 'arg2': {'mention': 'currently', 'nth_sent': 14, 'start': 657, 'end': 666}, 'context': 'Past medical history: Stage IV ovarian cancer status post omentectomy and debulking to relieve large bowel obstruction with colostomy, hypertension, hyperlipidemia, history of pulmonary embolism in October 2012, history of heparin-induced Darvocet p.m., insomnia, osteoarthritis, history of C. difficile diarrhea Past surgical:  Exploratory laparotomy on 9/22/12 with omentectomy and debulking of tumor, colostomy, D. and C., TCH, right hip replacement Medications: Ativan, Protonix, metoprolol, lisinopril, simvastatin, Arixtra, carboplatin, Taxol, Neulasta Allergies: Heparin Social history: Denies smoking cigarettes use alcohol or illicit drug use. She currently lives alone and is able to complete her activities of daily living and care for herself Family history:'}\n",
      "{'filename': 'patient17_report102_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Avastin', 'nth_sent': 22, 'start': 64, 'end': 71}, 'arg2': {'mention': 'for one year', 'nth_sent': 22, 'start': 72, 'end': 84}, 'context': 'After reversal of her colostomy, we would recommend maintenance Avastin for one year.  '}\n",
      "{'filename': 'patient17_report137_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 39, 'end': 50}, 'arg2': {'mention': 'March 14', 'nth_sent': 7, 'start': 64, 'end': 72}, 'context': 'She has finished 6 cycles of Taxol and carboplatin completed on March 14.   '}\n",
      "{'filename': 'patient07_report071_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 5, 'start': 13, 'end': 24}, 'arg2': {'mention': 'daily', 'nth_sent': 5, 'start': 99, 'end': 104}, 'context': '1. Taxol and carboplatin at a dose of 70 mg/m2 with carboplatin at AUC of 2. 2. Lovenox 40 mg subQ daily.'}\n",
      "{'filename': 'patient07_report075_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 13, 'end': 24}, 'arg2': {'mention': 'daily', 'nth_sent': 5, 'start': 166, 'end': 171}, 'context': '1. Taxol and carboplatin weekly, Taxol has a dose of 70 mg/m2 weekly, three weeks on and one week off and carboplatin at an AUC of 2. 2. Lovenox 40 mg subcutaneously daily.'}\n",
      "{'filename': 'patient07_report072_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 174, 'end': 185}, 'arg2': {'mention': '  1 week', 'nth_sent': 3, 'start': 198, 'end': 204}, 'context': 'HISTORY OF PRESENT ILLNESS:  This is a very pleasant 65-year-old female who is known to our office with a history of stage IV ovarian cancer who has been receiving Taxol and carboplatin 3 weeks on, 1 week off who reports today for routine exam and evaluation.'}\n",
      "{'filename': 'patient07_report074_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 13, 'end': 24}, 'arg2': {'mention': '  3 weeks', 'nth_sent': 5, 'start': 62, 'end': 69}, 'context': '1. Taxol and carboplatin weekly. Taxol at a dose of 70 mg/m2, 3 weeks on and 1 week off and carboplatin at an AUC of 2. 2.'}\n",
      "{'filename': 'patient42_report008_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 22, 'start': 83, 'end': 95}, 'arg2': {'mention': 'currently', 'nth_sent': 22, 'start': 97, 'end': 106}, 'context': 'DIAGNOSIS:  Stage IA malignant Brenner tumor of the ovary, status post staging and chemotherapy, currently without evidence of disease.  '}\n",
      "{'filename': 'patient42_report006_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 21, 'end': 33}, 'arg2': {'mention': '12   10   2010', 'nth_sent': 3, 'start': 158, 'end': 168}, 'context': 'Patient is receiving chemotherapy, with the most recent treatment dated 04/04/2011. The patient underwent hysterectomy and bilateral salpingo-oophorectomy on 12/10/2010.  '}\n",
      "{'filename': 'patient08_report109_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 22, 'start': 23, 'end': 34}, 'arg2': {'mention': '04   24   14 5   09', 'nth_sent': 22, 'start': 6, 'end': 19}, 'context': '40 mg 04/24/14 5:09 pm gemcitabine'}\n",
      "{'filename': 'patient08_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 0, 'start': 77, 'end': 88}, 'arg2': {'mention': 'day', 'nth_sent': 0, 'start': 20, 'end': 23}, 'context': 'Patient08 came in today as scheduled for day 15 of Cycle #5 dose dense Taxol/Carboplatin.'}\n",
      "{'filename': 'patient08_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cisplatin', 'nth_sent': 2, 'start': 194, 'end': 203}, 'arg2': {'mention': 'february   2014', 'nth_sent': 2, 'start': 137, 'end': 151}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 166, 'end': 177}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 200, 'end': 205}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin. The patient presents today for cycle 2 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 79, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 7, 'end': 16}, 'context': 'She is currently undergoing neoadjuvant chemotherapy with dose dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cisplatin', 'nth_sent': 2, 'start': 194, 'end': 203}, 'arg2': {'mention': 'february   2014', 'nth_sent': 2, 'start': 137, 'end': 151}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor..  '}\n",
      "{'filename': 'patient08_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 166, 'end': 177}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 200, 'end': 205}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin. The patient presents today for cycle 3 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 0, 'start': 154, 'end': 159}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 201, 'end': 206}, 'context': 'SUBJECTIVE Patient08 is a 66 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin.    The patient presents today for cycle 5 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report121_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'cisplatin', 'nth_sent': 2, 'start': 194, 'end': 203}, 'arg2': {'mention': 'february   2014', 'nth_sent': 2, 'start': 137, 'end': 151}, 'context': 'Summary Statement : The patient is a 66 y/o female with progressing ovarian carcinoma despite debulking with neoadjuvant chemotherapy in february, 2014 and one of three planned cycles of gemzar/cisplatin starting 4/23 presenting with nausea, vomiting, and pain due to malignant bowel obstruction, found to have progressive disease and gastric outlet obstruction due to compressing tumor, now s/p GJ placement by IR and plans to go home on hospice..  '}\n",
      "{'filename': 'patient08_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 1, 'start': 79, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 7, 'end': 16}, 'context': 'She is currently undergoing neoadjuvant chemotherapy with dose dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 166, 'end': 177}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 200, 'end': 205}, 'context': 'SUBJECTIVE:  Patient08 is a 65 year old female with a history of likely stage IIIC ovarian ca currently undergoing neoadjuvant chemotherapy with dose-dense Taxol and carboplatin. The patient presents today for cycle 4 of dose-dense Taxol and carboplatin.'}\n",
      "{'filename': 'patient08_report122_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 18, 'start': 159, 'end': 171}, 'arg2': {'mention': 'the time', 'nth_sent': 18, 'start': 101, 'end': 109}, 'context': 'Of note, this patient has had a prolonged oncologic course and was receiving cisplatin and Gemzar at the time of her admission and had progressed despite this chemotherapy.  '}\n",
      "{'filename': 'patient20_report140_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 59, 'start': 37, 'end': 42}, 'arg2': {'mention': '7   19', 'nth_sent': 59, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person283 PhD. Title: Resident.'}\n",
      "{'filename': 'patient20_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 45, 'start': 13, 'end': 24}, 'arg2': {'mention': 'over 14 hours', 'nth_sent': 45, 'start': 181, 'end': 194}, 'context': '[7/19 20:33] carboplatin 565mg IV ONCE [7/20 10:15] ketorolac (Toradol) 15mg IVP ONCE Recently Discontinued Medications AMINO ACID/DEXTROSE/LIPID TPN (ADULT) 1,800 mL 1,800mL Cycle over 14 hours IV haloperidol (Haldol) 1mg IVP Q4H hydromorphone 30 mL (Hydromorphone 1 mg/mL'}\n",
      "{'filename': 'patient20_report155_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 10, 'start': 49, 'end': 54}, 'arg2': {'mention': '7   19', 'nth_sent': 10, 'start': 55, 'end': 59}, 'context': 'D13 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report161_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 8, 'start': 37, 'end': 48}, 'arg2': {'mention': '3   day', 'nth_sent': 9, 'start': 112, 'end': 117}, 'context': 'She received her last cycle of Taxol carboplatin, her 3rd, on September 5, 2012.    Acutely she presents with a 3-day history of fever up to 100.8 at home.'}\n",
      "{'filename': 'patient20_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 59, 'start': 13, 'end': 24}, 'arg2': {'mention': '7   19 20   33', 'nth_sent': 59, 'start': 1, 'end': 11}, 'context': '[7/19 20:33] carboplatin 565mg IV ONCE [7/19 14:55] dexamethasone 20mg IV ONCE'}\n",
      "{'filename': 'patient20_report239_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 34, 'start': 31, 'end': 43}, 'arg2': {'mention': 'September 24   2012', 'nth_sent': 34, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report238_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 32, 'start': 31, 'end': 43}, 'arg2': {'mention': 'September 24   2012', 'nth_sent': 32, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report123_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 41, 'start': 13, 'end': 24}, 'arg2': {'mention': '7   19 20   33', 'nth_sent': 41, 'start': 1, 'end': 11}, 'context': '[7/19 20:33] carboplatin 565mg IV ONCE [7/19 14:55] dexamethasone 20mg IV ONCE'}\n",
      "{'filename': 'patient20_report263_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 21, 'start': 271, 'end': 283}, 'arg2': {'mention': '2   11   13', 'nth_sent': 21, 'start': 217, 'end': 224}, 'context': 'Normal appearance, no discharge, lesions, cystocele or rectocele,  Cervix: Absent  Uterus: Absent  Adnexae: Absent, no mass  Parametrium: Not Involved    No outpatient prescriptions have been marked as taking for the 2/11/13 encounter (Appointment) with Person2, PA-C.   Chemotherapy labs were reviewed and are acceptable for treatment today.   '}\n",
      "{'filename': 'patient20_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 11, 'start': 14, 'end': 19}, 'arg2': {'mention': '7   19', 'nth_sent': 11, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report181_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 154, 'end': 159}, 'arg2': {'mention': '9   24', 'nth_sent': 2, 'start': 163, 'end': 167}, 'context': 'None Author: Person128  Basic Information 68 yo HD3 w/ high grade serous OvCA p/w N/V/decreased PO in take/abdominal pain in the context of cycle 4 carbo/taxol on 9/24 and s/p debulking/XL/supracervical hys/BSO/omx/rectosigmoid resection/ileocolonic rsxn w/ side to side reanastomosis/creation of loop ileostomy and cystotomy repair with stents in 6/2012 and s/p 7/5 illeostomy repair and venting G-tube complicated by a protracted hospital stay including ICU admission 2/2 intraop blood loss.'}\n",
      "{'filename': 'patient20_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 82, 'start': 184, 'end': 196}, 'arg2': {'mention': 'August 03   2012 6   55', 'nth_sent': 82, 'start': 24, 'end': 44}, 'context': 'Addendum by Person22 on August 03, 2012 6:55 AM: Pt doing betterp still has a venting g-tube and is slowly improving po intake - will continue to follow her an dplan is for additional chemotherapy and then ostomy reversal.'}\n",
      "{'filename': 'patient20_report258_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 28, 'start': 116, 'end': 128}, 'arg2': {'mention': 'the next couple of weeks', 'nth_sent': 28, 'start': 136, 'end': 160}, 'context': 'The patient had been discharged home postoperatively with the plan to present to see Dr. Person29 to again start on chemotherapy within the next couple of weeks once she had been medically stable from a postoperative standpoint.  '}\n",
      "{'filename': 'patient20_report249_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 12, 'start': 6, 'end': 11}, 'arg2': {'mention': '9   24   12', 'nth_sent': 12, 'start': 20, 'end': 27}, 'context': 'Carbo/taxol x4 last 9/24/12.  '}\n",
      "{'filename': 'patient20_report160_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 24, 'start': 684, 'end': 696}, 'arg2': {'mention': '  twice daily', 'nth_sent': 24, 'start': 591, 'end': 602}, 'context': 'Normal appearance, no discharge, lesions, cystocele or rectocele,  Cervix: Absent  Uterus: Absent  Adnexae: Absent, no mass  Parametrium: Not Involved   Outpatient Prescriptions Marked as Taking for the 9/5/12 encounter (Office Visit) with Fly Person5, PA-C  Medication Sig Dispense Refill   dexamethasone (DECADRON) 4 mg Oral tablet 5 tablets at bedtime the night before and 5 tablets the morning of chemotherapy 60 Tab 1   Venlafaxine (EFFEXOR XR) 75 mg Oral Capsule, Ext Release 24 hr daily     Amlodipine (NORVASC) 10 mg Oral Tablet daily     Metformin (GLUCOPHAGE) 1,000 mg Oral Tablet twice daily     Aspirin (ASPIR-81) 81 mg Oral Tablet, Delayed Release (E.C.) twice daily     Chemotherapy labs were reviewed and are acceptable for treatment today.'}\n",
      "{'filename': 'patient20_report180_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 44, 'start': 37, 'end': 49}, 'arg2': {'mention': 'recent', 'nth_sent': 45, 'start': 162, 'end': 168}, 'context': 'In the setting of actively receiving chemotherapy, she was transfused 2 units of packed red blood cells which she tolerated well. Her platelets in the setting of recent chemotherapy remained low but stable.'}\n",
      "{'filename': 'patient20_report173_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 37, 'end': 48}, 'arg2': {'mention': '9   17   12', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She received her last cycle of Taxol carboplatin, her 3rd, on September 5, 2012.   She then developed fever was admitted 9/17/12.'}\n",
      "{'filename': 'patient20_report176_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 156, 'end': 161}, 'arg2': {'mention': '9   24', 'nth_sent': 2, 'start': 165, 'end': 169}, 'context': 'None Author: Person128  Basic Information 68 yo HD2 w/ high grade serous OvCA p/w N/V/decreased PO in take/abdominal pain in the context of cycle 4 carbo / taxol on 9/24 and s/p debulking/XL/supracervical hys/BSO/omx/rectosigmoid resection/ileocolonic rsxn w/ side to side reanastomosis/creation of loop ileostomy and cystotomy repair with stents in 6/2012 and s/p 7/5 illeostomy repair and venting G-tube complicated by a protracted hospital stay including ICU admission 2/2 intraop blood loss.'}\n",
      "{'filename': 'patient20_report156_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 86, 'start': 23, 'end': 35}, 'arg2': {'mention': 'July 19   2012', 'nth_sent': 86, 'start': 39, 'end': 52}, 'context': 'She received Carbo-Tax chemotherapy on July 19, 2012 with a subsequent neutropenia with an ANC nadir of 345.'}\n",
      "{'filename': 'patient20_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 65, 'start': 37, 'end': 42}, 'arg2': {'mention': '7   19', 'nth_sent': 65, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report174_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 17, 'start': 65, 'end': 76}, 'arg2': {'mention': '9   5', 'nth_sent': 17, 'start': 98, 'end': 101}, 'context': 'Chemo: s/p carbotaxol cycle 4 9/24 with neulasta 9/25; s/p Taxol carboplatin x3 cycles, last dose 9/5     Review of Systems  Constitutional:  Negative.  '}\n",
      "{'filename': 'patient20_report236_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 34, 'start': 31, 'end': 43}, 'arg2': {'mention': 'September 24   2012', 'nth_sent': 34, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.  '}\n",
      "{'filename': 'patient20_report157_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 13, 'start': 14, 'end': 19}, 'arg2': {'mention': '7   19', 'nth_sent': 13, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report259_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 29, 'start': 40, 'end': 51}, 'arg2': {'mention': 'for at least 2 weeks', 'nth_sent': 30, 'start': 149, 'end': 169}, 'context': 'Taxol dose of 135 mg per meter squared, carboplatin an AUC of 4. Augmentin 875 twice a day x14 days. Patient will receive IV hydration at home daily for at least 2 weeks and then we will reassess.'}\n",
      "{'filename': 'patient20_report244_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 31, 'end': 43}, 'arg2': {'mention': 'September 24   2012', 'nth_sent': 8, 'start': 130, 'end': 148}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012.'}\n",
      "{'filename': 'patient20_report159_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 64, 'end': 74}, 'arg2': {'mention': '8   5   12', 'nth_sent': 6, 'start': 11, 'end': 17}, 'context': 'Discharged 8/5/12   She presents for cycle 2 of carboplatin and paclitaxel.'}\n",
      "{'filename': 'patient20_report145_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 10, 'start': 14, 'end': 19}, 'arg2': {'mention': '7   19', 'nth_sent': 10, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report257_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 30, 'start': 103, 'end': 115}, 'arg2': {'mention': 'the next couple of weeks', 'nth_sent': 30, 'start': 123, 'end': 148}, 'context': 'The patient had been discharged home postoperatively with the plan to f/u with Dr. Person29 restart on chemotherapy within the next  couple of weeks once she had been medically stable from a postoperative  standpoint.  '}\n",
      "{'filename': 'patient20_report179_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 47, 'start': 37, 'end': 49}, 'arg2': {'mention': 'recent', 'nth_sent': 48, 'start': 162, 'end': 168}, 'context': 'In the setting of actively receiving chemotherapy, she was transfused 2 units of packed red blood cells which she tolerated well. Her platelets in the setting of recent chemotherapy remained low but stable.'}\n",
      "{'filename': 'patient20_report148_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 12, 'start': 14, 'end': 19}, 'arg2': {'mention': '7   19', 'nth_sent': 12, 'start': 20, 'end': 24}, 'context': 'Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report262_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 14, 'start': 371, 'end': 383}, 'arg2': {'mention': 'today', 'nth_sent': 14, 'start': 442, 'end': 447}, 'context': 'ORAL twice daily     Venlafaxine (EFFEXOR XR) 150 mg Oral capsule,extended release 24hr one tablet daily 30 Cap 5   morphine (MS IR) 15 mg Oral tablet 1 po daily 270 Tab    Ondansetron (ZOFRAN ODT) 8 mg Oral tablet,disintegrating one po every 6 hours 30 Tab 2   dexamethasone (DECADRON) 4 mg Oral tablet 5 tablets at bedtime the night before and 5 tablets the morning of chemotherapy 60 Tab 1   Ultrasound of the abdomen/liver were evaluated today because of elevated LFTs.'}\n",
      "{'filename': 'patient20_report186_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 16, 'start': 215, 'end': 226}, 'arg2': {'mention': 'today  ', 'nth_sent': 17, 'start': 357, 'end': 362}, 'context': 'Rectal: Deferred Extremities: No clubbing, cyanosis, or edema, full range of motion x4 Pelvic Examination:  ASSESSMENT Advanced ovarian cancer, status post suboptimal debulking and now status post 4 cycles of Taxol/carboplatin. Nausea and vomiting, although she does not appear to have an acute obstruction.  PLAN:  Dr. Person4 was not available the clinic today.'}\n",
      "{'filename': 'patient20_report177_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 43, 'start': 37, 'end': 49}, 'arg2': {'mention': 'recent', 'nth_sent': 44, 'start': 164, 'end': 170}, 'context': 'In the setting of actively receiving chemotherapy, she was transfused 2 units of packed red blood cells which she tolerated well.   Her platelets in the setting of recent chemotherapy remained low but stable.  '}\n",
      "{'filename': 'patient20_report245_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 31, 'end': 43}, 'arg2': {'mention': 'October 2   2012', 'nth_sent': 10, 'start': 239, 'end': 254}, 'context': 'The patient has been receiving chemotherapy and has received 4 cycles of carboplatin and Taxol with the fourth cycle completed on September 24, 2012 with a a fairly good response to her chemotherapy.   She required a hospital admission on October 2, 2012, due to nausea, vomiting, deconditioning and poor p.o. intake for which time during that hospital course, she received symptom control with IV antiemetics, electrolyte repletion and IV fluid hydration.  '}\n",
      "{'filename': 'patient20_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 9, 'start': 48, 'end': 53}, 'arg2': {'mention': '7   19', 'nth_sent': 9, 'start': 54, 'end': 58}, 'context': 'D9 Zosyn following E Coli sepsis. Started carbo/taxol 7/19.'}\n",
      "{'filename': 'patient20_report138_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 57, 'start': 37, 'end': 42}, 'arg2': {'mention': '7   19', 'nth_sent': 57, 'start': 43, 'end': 47}, 'context': 'ambulation encouraged Onc: s/p carbo/taxol 7/19 Dispo: Continue post-operative care, PT/OT  Professional Services Credentials Title and Author Person65: MD.'}\n",
      "{'filename': 'patient20_report256_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 29, 'start': 103, 'end': 115}, 'arg2': {'mention': 'the next couple of weeks', 'nth_sent': 29, 'start': 123, 'end': 147}, 'context': 'The patient had been discharged home postoperatively with the plan to f/u with Dr. Person27 restart on chemotherapy within the next couple of weeks once she had been medically stable from a postoperative standpoint.'}\n",
      "{'filename': 'patient30_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 10, 'start': 66, 'end': 78}, 'arg2': {'mention': 'September 22', 'nth_sent': 10, 'start': 169, 'end': 181}, 'context': 'The patient then was started on the GOG 252 trial receiving IV IP chemotherapy completing six cycles of chemotherapy with IV Taxol, IP carboplatin, and IV Avastin as of September 22, 2010.'}\n",
      "{'filename': 'patient30_report024_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 19, 'end': 24}, 'arg2': {'mention': '07   12   2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.  '}\n",
      "{'filename': 'patient30_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 16, 'start': 39, 'end': 51}, 'arg2': {'mention': 'June 27   2010', 'nth_sent': 17, 'start': 75, 'end': 88}, 'context': 'The patient received her last cycle of chemotherapy on June 15, 2010.   On June 27, 2010, the patient was a direct admission from home with the complaint of a fever of 102 degrees Fahrenheit.  '}\n",
      "{'filename': 'patient30_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 14, 'start': 39, 'end': 51}, 'arg2': {'mention': 'June 15   2010', 'nth_sent': 14, 'start': 55, 'end': 68}, 'context': 'The patient received her last cycle of chemotherapy on June 15, 2010.'}\n",
      "{'filename': 'patient30_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 19, 'end': 24}, 'arg2': {'mention': '07   12   2010', 'nth_sent': 8, 'start': 138, 'end': 148}, 'context': 'She is status post Taxol, __________, Carbo-Taxol IV and IP along with the GOG 252 trial. She got 3 cycles of that with her last cycle on 07/12/2010.    '}\n",
      "{'filename': 'patient38_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 36, 'end': 43}, 'arg2': {'mention': 'recent', 'nth_sent': 5, 'start': 230, 'end': 236}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013. She underwent continued plans for Avastin maintenance therapy, of which the first 2 were generally uncomplicated, but she reports that the most recent dose, administered on the 19th, last Thursday, left her somewhat weakened and more nauseated.'}\n",
      "{'filename': 'patient38_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 4, 'start': 45, 'end': 56}, 'arg2': {'mention': 'June 5   2013', 'nth_sent': 5, 'start': 122, 'end': 134}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.   3. Optimal cytoreductive debulking surgery June 5, 2013.'}\n",
      "{'filename': 'patient38_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 77, 'start': 70, 'end': 82}, 'arg2': {'mention': 'December 26', 'nth_sent': 77, 'start': 35, 'end': 46}, 'context': 'She has a follow up appointment on December 26 at which point further chemotherapy plans will be discussed.'}\n",
      "{'filename': 'patient38_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 32, 'end': 39}, 'arg2': {'mention': 'June 5   2013', 'nth_sent': 5, 'start': 119, 'end': 131}, 'context': '2. Carboplatin, paclitaxel, and Avastin for 6 cycles through April 2013. 3. Optimal cytoreductive debulking surgery on June 5, 2013.'}\n",
      "{'filename': 'patient38_report096_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 82, 'start': 211, 'end': 223}, 'arg2': {'mention': 'today', 'nth_sent': 83, 'start': 351, 'end': 356}, 'context': 'IMPRESSION AND PLAN:  Mrs. Patient38 is a 70-year-old female with history of stage IV high-grade Mullerian serous carcinoma of the ovary and abdominal cavity diagnosed in December 2012, status post preoperative chemotherapy followed by optimal cytoreductive surgery. Postoperatively, she has completed 3 cycles of carboplatin, paclitaxel and presents today to start maintenance Avastin.'}\n",
      "{'filename': 'patient38_report102_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 1, 'start': 6, 'end': 17}, 'arg2': {'mention': '12   22   2013', 'nth_sent': 1, 'start': 254, 'end': 264}, 'context': 'note: bevacizumab associated hyponatremia grade 3-4 incidence = 4%; last administered 12/19/13 2) Stage 4 High grade Mullerian Serous Cancer of ovary and abdominal cavity in remission Plan: renal has been consulted     Perform - Completed by Person2 (on 12/22/2013 08:54)  '}\n",
      "{'filename': 'patient38_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 55, 'start': 115, 'end': 127}, 'arg2': {'mention': 'December 20   2012 8   54', 'nth_sent': 54, 'start': 24, 'end': 46}, 'context': 'Addendum by Person22 on December 20, 2012 8:54 AM: Doing well- pt seen and exmained. Awaiting placement- will need chemotherapy teachin.'}\n",
      "{'filename': 'patient38_report107_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 36, 'end': 43}, 'arg2': {'mention': 'recent', 'nth_sent': 5, 'start': 230, 'end': 236}, 'context': 'She received carboplatin, Taxol and Avastin therapy through approximately April 2013. She underwent continued plans for Avastin maintenance therapy, of which the first 2 were generally uncomplicated, but she reports that the most recent dose, administered on the 19th, last Thursday, left her somewhat weakened and more nauseated.'}\n",
      "{'filename': 'patient38_report041_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 72, 'start': 70, 'end': 82}, 'arg2': {'mention': 'December 26', 'nth_sent': 72, 'start': 35, 'end': 46}, 'context': 'She has a follow up appointment on December 26 at which point further chemotherapy plans will be discussed.  '}\n",
      "{'filename': 'patient38_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 6, 'start': 56, 'end': 67}, 'arg2': {'mention': 'September 5   2013', 'nth_sent': 7, 'start': 370, 'end': 387}, 'context': 'She received six cycles of carboplatin, paclitaxel, and bevacizumab through April 2013, then underwent cytoreductive debulking surgery on June 5, 2013 with pathology being positive for adenocarcinoma in the right ovary, the fallopian tube and scattered in the omentum. Three postoperative courses of carboplatin and paclitaxel were administered on July 25, 2013 through September 5, 2013.'}\n",
      "{'filename': 'patient38_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'bevacizumab', 'nth_sent': 4, 'start': 45, 'end': 56}, 'arg2': {'mention': 'June 5th   2013', 'nth_sent': 5, 'start': 122, 'end': 136}, 'context': '2. Six cycles of carboplatin, paclitaxel and bevacizumab through April 2013.   3. Optimal cytoreductive debulking surgery June 5th, 2013, pathology revealing adenocarcinoma clusters within the right ovary, fallopian tube and scattered throughout the omentum.  '}\n",
      "{'filename': 'patient38_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 104, 'end': 116}, 'arg2': {'mention': 'the week', 'nth_sent': 3, 'start': 168, 'end': 176}, 'context': 'HISTORY OF PRESENT ILLNESS:  This 70-year-old white female patient has ovarian cancer, has recently had chemotherapy. She developed marked weakness and fatigue through the week prior to admission, prompting her to come to the ER.'}\n",
      "{'filename': 'patient38_report106_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'TC', 'nth_sent': 73, 'start': 50, 'end': 52}, 'arg2': {'mention': '12   26   2013', 'nth_sent': 74, 'start': 148, 'end': 158}, 'context': 'Dictated by: Person9, MD  D:  12/22/2013 08:51AM, TC T:  12/22/2013 09:45AM, cn R:  Confirmation # / Document ID:  Authenticated by Person10, MD On 12/26/2013 07:34:01 AM     '}\n",
      "{'filename': 'patient38_report082_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 70, 'start': 178, 'end': 189}, 'arg2': {'mention': 'June 5th   2013', 'nth_sent': 70, 'start': 270, 'end': 284}, 'context': 'Ms. Patient38 is a 70-year-old female with stage IV high-grade mullerian serous carcinoma of the ovary and abdominal cavity diagnosed in December 2012, status post six cycles of carboplatin, paclitaxel, and Avastin followed by optimal cytoreductive debulking surgery on June 5th, 2013.'}\n",
      "{'filename': 'patient38_report101_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 104, 'end': 116}, 'arg2': {'mention': 'the week', 'nth_sent': 2, 'start': 168, 'end': 176}, 'context': 'HISTORY OF PRESENT ILLNESS:  This 70-year-old white female patient has ovarian cancer, has recently had chemotherapy. She developed marked weakness and fatigue through the week prior to admission, prompting her to come to the ER.'}\n",
      "{'filename': 'patient38_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 72, 'start': 70, 'end': 82}, 'arg2': {'mention': 'December 26', 'nth_sent': 72, 'start': 35, 'end': 46}, 'context': 'She has a follow up appointment on December 26 at which point further chemotherapy plans will be discussed.'}\n",
      "{'filename': 'patient38_report025_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 60, 'start': 79, 'end': 84}, 'arg2': {'mention': '12   14   2012', 'nth_sent': 61, 'start': 152, 'end': 162}, 'context': 'Addendum by Person22 on December 14, 2012 6:53 AM: Consider IV carboplatin and taxol in-house prior to discharge.   Perform - Completed by Person24 (on 12/14/2012 06:35)'}\n",
      "{'filename': 'patient38_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Avastin', 'nth_sent': 14, 'start': 32, 'end': 39}, 'arg2': {'mention': 'June 5   2013', 'nth_sent': 15, 'start': 115, 'end': 127}, 'context': '2. Carboplatin, paclitaxel, and Avastin x6 cycles through April 2013.   3. Optimal cytoreductive debulking surgery June 5, 2013.   '}\n",
      "{'filename': 'patient38_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Avastin', 'nth_sent': 4, 'start': 46, 'end': 53}, 'arg2': {'mention': 'June 5   2013', 'nth_sent': 5, 'start': 119, 'end': 131}, 'context': '2. Six cycles of carboplatin, paclitaxel, and Avastin through April 2013.   3. Optimal cytoreductive debulking surgery June 5, 2013.'}\n",
      "{'filename': 'patient48_report078_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 31, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 32, 'start': 442, 'end': 454}, 'context': 'Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report083_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 31, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 32, 'start': 442, 'end': 454}, 'context': 'Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 31, 'end': 43}, 'arg2': {'mention': 'early next week', 'nth_sent': 5, 'start': 120, 'end': 135}, 'context': 'She was not felt to be fit for chemotherapy, presently. Consideration is being given to surgical debulking of her tumor early next week for palliation.'}\n",
      "{'filename': 'patient48_report094_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 30, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 31, 'start': 442, 'end': 454}, 'context': 'Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report131_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 30, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 31, 'start': 442, 'end': 454}, 'context': 'Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report141_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 41, 'start': 25, 'end': 30}, 'arg2': {'mention': 'now', 'nth_sent': 42, 'start': 160, 'end': 163}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR. She presented progressive disease now with a large mucinous tumor in the pelvis extending into the lower abdomen.'}\n",
      "{'filename': 'patient48_report135_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 28, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 29, 'start': 442, 'end': 454}, 'context': 'Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Social History : Life and Living Situation: lifetime non-smoker, no alcohol lives with her Husband and has several children and grandchildren. .'}\n",
      "{'filename': 'patient48_report015_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 49, 'start': 61, 'end': 73}, 'arg2': {'mention': 'now', 'nth_sent': 49, 'start': 102, 'end': 105}, 'context': 'My suspicion is that from the time since late April when the chemotherapy was last administered until now, she has had disease progression.'}\n",
      "{'filename': 'patient48_report105_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 29, 'start': 437, 'end': 448}, 'arg2': {'mention': '20 years ago', 'nth_sent': 30, 'start': 686, 'end': 698}, 'context': 'She also had an episode of near syncope with bradycardia that seemed to be secondary to a mucus plug 7/10 - Patient had a second episode of near syncope with bradycardia, which appeared to be a vasovagal episode while trying to cough up mucus  Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report158_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 55, 'end': 67}, 'arg2': {'mention': 'March of this year', 'nth_sent': 5, 'start': 210, 'end': 228}, 'context': 'Apparently, the patient has received several rounds of chemotherapy, and, according to the oncology notes, she responded well with decrease in CA-125 and size of tumor. She was scheduled for tumor debulking in March of this year, but she was found to be in afib with RVR and determined to be medically unstable for the OR.'}\n",
      "{'filename': 'patient48_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 49, 'start': 61, 'end': 73}, 'arg2': {'mention': 'now', 'nth_sent': 49, 'start': 102, 'end': 105}, 'context': 'My suspicion is that from the time since late April when the chemotherapy was last administered until now, she has had disease progression.'}\n",
      "{'filename': 'patient48_report100_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 29, 'start': 295, 'end': 306}, 'arg2': {'mention': '20 years ago', 'nth_sent': 30, 'start': 544, 'end': 556}, 'context': 'She also had an episode of near syncope with bradycardia that seemed to be secondary to a mucus plug  Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 31, 'end': 43}, 'arg2': {'mention': 'early next week', 'nth_sent': 5, 'start': 120, 'end': 135}, 'context': 'She was not felt to be fit for chemotherapy, presently. Consideration is being given to surgical debulking of her tumor early next week for palliation.'}\n",
      "{'filename': 'patient48_report116_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 29, 'start': 563, 'end': 574}, 'arg2': {'mention': '20 years ago', 'nth_sent': 30, 'start': 812, 'end': 824}, 'context': 'She also had an episode of near syncope with bradycardia that seemed to be secondary to a mucus plug 7/10 - Patient had a second episode of near syncope with bradycardia, which appeared to be a vasovagal episode while trying to cough up mucus 7/11 - No events overnight, but patient had 2 more episodes of bradycardia, this time with asystole and loss of consciousness  Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Family History : Unable to obtain due to: patient is intubated and sedated.'}\n",
      "{'filename': 'patient48_report065_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 27, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 28, 'start': 478, 'end': 490}, 'context': 'Histories  Past Medical History: Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis, Additional Past Medical History: hyperlipidemia h/o fall with SDH - managed conservatively (May 2012).   Past Surgical History: appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient.  '}\n",
      "{'filename': 'patient48_report110_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 49, 'start': 25, 'end': 30}, 'arg2': {'mention': 'now', 'nth_sent': 50, 'start': 160, 'end': 163}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR. She presented progressive disease now with a large mucinous tumor in the pelvis extending into the lower abdomen.'}\n",
      "{'filename': 'patient48_report053_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Carbo', 'nth_sent': 2, 'start': 17, 'end': 22}, 'arg2': {'mention': 'ascites Several weeks', 'nth_sent': 2, 'start': 93, 'end': 114}, 'context': 'CTX - 3 cycles - Carbo + Docetaxel - last dose 4/2013 Abdoinal paracentesis x2 for recurrent ascites Several weeks of worsening fatigue, B/L LE, Dehydration, Abdominal discomfort.'}\n",
      "{'filename': 'patient48_report142_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 26, 'start': 193, 'end': 204}, 'arg2': {'mention': '20 years ago', 'nth_sent': 27, 'start': 442, 'end': 454}, 'context': 'Histories Past Medical History : Hypertension, Afib: with RVR on 2 separate occasions as noted above in HPI, DM, Cancer: ovarian cancer as noted above - she responded well to chemotherapy with carboplatin and docetaxel s/p several therapeutic paracentesis hyperlipidemia h/o fall with SDH - managed conservatively (May 2012) Past Surgical History : appendectomy in the past CCY power port placement left oopherectomy for unknown ovarian mass 20 years ago - not malignant according to the patient Social History : Life and Living Situation: lifetime non-smoker, no alcohol lives with her Husband and has several children and grandchildren.  '}\n",
      "{'filename': 'patient48_report016_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 32, 'end': 44}, 'arg2': {'mention': 'every 2 weeks', 'nth_sent': 7, 'start': 196, 'end': 209}, 'context': 'Since that time she has been on chemotherapy and has completed three rounds, with the last one being over 4 weeks ago. She does not know what chemo she was on but stated that she was receiving it every 2 weeks.'}\n",
      "{'filename': 'patient48_report101_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 46, 'start': 25, 'end': 30}, 'arg2': {'mention': 'now', 'nth_sent': 47, 'start': 160, 'end': 163}, 'context': 'She received 3 cycles of carbo - docetaxel (last on4/13) since surgical intervention was deffered secondary to Afib with RVR. She presented progressive disease now with a large mucinous tumor in the pelvis extending into the lower abdomen.'}\n",
      "{'filename': 'patient48_report150_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 55, 'end': 67}, 'arg2': {'mention': 'March of this year', 'nth_sent': 5, 'start': 210, 'end': 228}, 'context': 'Apparently, the patient has received several rounds of chemotherapy, and, according to the oncology notes, she responded well with decrease in CA-125 and size of tumor. She was scheduled for tumor debulking in March of this year, but she was found to be in afib with RVR and determined to be medically unstable for the OR.'}\n",
      "{'filename': 'patient12_report017_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 16, 'end': 28}, 'arg2': {'mention': 'office this morning', 'nth_sent': 5, 'start': 47, 'end': 66}, 'context': \"She was due for chemotherapy at Dr. Person27's office this morning, and she had another episode of right arm paresis and was therefore admitted to the hospital for further management.  \"}\n",
      "{'filename': 'patient46_report097_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Carbo', 'nth_sent': 13, 'start': 31, 'end': 36}, 'arg2': {'mention': '4   2   12', 'nth_sent': 13, 'start': 43, 'end': 49}, 'context': 'Thrombocytopenia w/ nadir 13K. Carbo sched 4/2/12 held.  '}\n",
      "{'filename': 'patient46_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 216, 'end': 221}, 'arg2': {'mention': 'several weeks', 'nth_sent': 6, 'start': 402, 'end': 415}, 'context': \"History of Present Illness  HTN Ovarian cancer S/P debulking surgery 9/2011 (had new postop atrial fibrillation-Rx w/ short term amiodarone and currently on Toprol and pradaxa), currently on chemo Rx carboplatin and taxol complicated by anemia/ thrombocytopenia requiring PRBC's 2 weeks ago - now neutropenic  Paroxysmal atrial fibrillation  HLD GERD anxiety/depression Spinal stneosis  Presented with several weeks of RLQ pain with radiatin to the low back.\"}\n",
      "{'filename': 'patient46_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 31, 'end': 42}, 'arg2': {'mention': '10   31', 'nth_sent': 7, 'start': 47, 'end': 52}, 'context': 'Had her first chemo (taxol and carboplatin) on 10/31.'}\n",
      "{'filename': 'patient46_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 10, 'start': 33, 'end': 44}, 'arg2': {'mention': 'December 19', 'nth_sent': 10, 'start': 117, 'end': 128}, 'context': 'She was switched to single agent carboplatin and received 1 cycle on November 28 and her next cycle is scheduled for December 19.    '}\n",
      "{'filename': 'patient46_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carboplatin', 'nth_sent': 6, 'start': 33, 'end': 44}, 'arg2': {'mention': 'December 19', 'nth_sent': 6, 'start': 117, 'end': 128}, 'context': 'She was switched to single agent carboplatin and received 1 cycle on November 28 and her next cycle is scheduled for December 19.  '}\n",
      "{'filename': 'patient46_report072_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 385, 'end': 390}, 'arg2': {'mention': 'the next 2 days', 'nth_sent': 3, 'start': 529, 'end': 544}, 'context': 'None Author:   Person24  Basic Information Visit Information:  Patient seen on 11/4/2011.  History of Present Illness *HTN *Ovarian cancer  S/P debulking surgery 9/2011 post op complicated by anemia requiring multiple transfusions and atrial fibrillation w/ trop leak to 0.4- suply demand mismatch;  treated w/ amio/beta blocker/asa:  now undergoing chemo therpay with carboplatin and taxol received dose on 10/31/2011 *Atrial fibrillation  Presented to the ER after a near syncopal event.   Pt received chemo on Monday then for the next 2 days could only take in clear liquids.'}\n",
      "{'filename': 'patient46_report063_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 295, 'end': 300}, 'arg2': {'mention': 'the next 2 days', 'nth_sent': 7, 'start': 436, 'end': 451}, 'context': 'History of Present Illness  77yo F w/ PMHX:  HTN Ovarian cancer S/P debulking surgery 9/2011 post op complicated by anemia requiring multiple transfusions and atrial fibrillation w/ trop leak to 0.4- suply demand mismatch; treated w/ amio/asa:  now undergoign chemo therpay with carboplatin and taxol received dose on 10/31/2011 Atrial fibrillation  Presented to the ER after a near syncopal event. Pt received chemo on Monday then for the next 2 days could only take in clear liquids; This am she felt lightheaded but was up to brush her teeth and then slid to the floor she states that if she had a LOC it was very brief.'}\n",
      "{'filename': 'patient46_report104_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 18, 'start': 29, 'end': 41}, 'arg2': {'mention': '11 years ago', 'nth_sent': 19, 'start': 188, 'end': 200}, 'context': 'They feel that at this point chemotherapy is causing more burden than benefit and they would like to focus on comfort. They had hospice involved when her husband passed away from lymphoma 11 years ago and they had a positive experience with that.'}\n",
      "{'filename': 'patient46_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 63, 'end': 75}, 'arg2': {'mention': 'approximately 3 weeks', 'nth_sent': 6, 'start': 112, 'end': 133}, 'context': 'History of ovarian cancer diagnosed November 2011, status post chemotherapy with carboplatin. Last chemotherapy approximately 3 weeks earlier.'}\n",
      "{'filename': 'patient46_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 3, 'start': 66, 'end': 71}, 'arg2': {'mention': 'Today', 'nth_sent': 3, 'start': 105, 'end': 110}, 'context': \"Additionally, she was hospitalized after her first cycle of taxol/carbo with a syncopal episode and Afib Today she reports that she doesn't feel well.\"}\n",
      "{'filename': 'patient46_report091_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'carbo', 'nth_sent': 3, 'start': 66, 'end': 71}, 'arg2': {'mention': 'now', 'nth_sent': 4, 'start': 225, 'end': 228}, 'context': 'Additionally, she was hospitalized after her first cycle of taxol/carbo with a syncopal episode and Afib   Delayed last week for cycle 5 of carbo due to pain and UTI. Today presented to ER with acute abdominal pain which has now resolved.'}\n",
      "{'filename': 'patient46_report073_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 't/c', 'nth_sent': 7, 'start': 12, 'end': 15}, 'arg2': {'mention': '10   31', 'nth_sent': 7, 'start': 47, 'end': 52}, 'context': 'Had her first chemo (taxol and carboplatin) on 10/31.'}\n",
      "{'filename': 'patient06_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 15, 'start': 43, 'end': 53}, 'arg2': {'mention': 'September 28, 2010', 'nth_sent': 15, 'start': 107, 'end': 125}, 'context': 'He was then also treated with off-protocol paclitaxel at the 70 mg/m sq, 3 weeks on, 1 week off, initiated September 28, 2010, completed 2 cycles on November 9, 2010, and unfortunately had progression of disease at that time.'}\n",
      "{'filename': 'patient06_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 15, 'start': 43, 'end': 53}, 'arg2': {'mention': 'November 9, 2010', 'nth_sent': 15, 'start': 149, 'end': 165}, 'context': 'He was then also treated with off-protocol paclitaxel at the 70 mg/m sq, 3 weeks on, 1 week off, initiated September 28, 2010, completed 2 cycles on November 9, 2010, and unfortunately had progression of disease at that time.'}\n",
      "{'filename': 'patient06_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Vaccinia virus', 'nth_sent': 17, 'start': 21, 'end': 35}, 'arg2': {'mention': 'December, 2010', 'nth_sent': 17, 'start': 55, 'end': 69}, 'context': 'He was placed on the Vaccinia virus protocol beginning December, 2010, and had such an amazing response he was given a compassionate access for a second dosing.'}\n",
      "{'filename': 'patient06_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'temozolomide', 'nth_sent': 11, 'start': 25, 'end': 37}, 'arg2': {'mention': 'several months', 'nth_sent': 11, 'start': 76, 'end': 90}, 'context': 'He was then treated with temozolomide therapy at 75 mg/kg dosing schema for several months with unfortunate progression of disease.'}\n",
      "{'filename': 'patient06_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'temozolomide', 'nth_sent': 13, 'start': 25, 'end': 37}, 'arg2': {'mention': 'several months', 'nth_sent': 13, 'start': 77, 'end': 91}, 'context': 'He was then treated with temozolomide therapy at 75 mg/kg dosing schema for  several months with unfortunate progression of disease.'}\n",
      "{'filename': 'patient06_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 17, 'start': 43, 'end': 53}, 'arg2': {'mention': 'September 28, 2010', 'nth_sent': 17, 'start': 107, 'end': 125}, 'context': 'He was then also treated with off-protocol paclitaxel at the 70 mg/m sq, 3 weeks on, 1 week off, initiated September 28, 2010, completed 2 cycles on November 9, 2010, and unfortunately had progression of disease at that time.'}\n",
      "{'filename': 'patient06_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 17, 'start': 43, 'end': 53}, 'arg2': {'mention': 'November 9, 2010', 'nth_sent': 17, 'start': 149, 'end': 165}, 'context': 'He was then also treated with off-protocol paclitaxel at the 70 mg/m sq, 3 weeks on, 1 week off, initiated September 28, 2010, completed 2 cycles on November 9, 2010, and unfortunately had progression of disease at that time.'}\n",
      "{'filename': 'patient06_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Vaccinia virus', 'nth_sent': 19, 'start': 21, 'end': 35}, 'arg2': {'mention': 'December, 2010', 'nth_sent': 19, 'start': 55, 'end': 69}, 'context': 'He was placed on the Vaccinia virus protocol beginning December, 2010, and had such an amazing response he was given a compassionate access for a second dosing.'}\n",
      "{'filename': 'patient06_report018_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 8, 'start': 47, 'end': 57}, 'arg2': {'mention': '9/28/10', 'nth_sent': 9, 'start': 121, 'end': 128}, 'context': 'CURRENT THERAPY Off protocol administration of paclitaxel at 70 mg/msq, 3 weeks on, 1 week off. Therapy was initiated on 9/28/10, and he has completed 2 cycles, last one was on  11/9/10.  '}\n",
      "{'filename': 'patient06_report018_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 8, 'start': 47, 'end': 57}, 'arg2': {'mention': '11/9/10', 'nth_sent': 9, 'start': 178, 'end': 185}, 'context': 'CURRENT THERAPY Off protocol administration of paclitaxel at 70 mg/msq, 3 weeks on, 1 week off. Therapy was initiated on 9/28/10, and he has completed 2 cycles, last one was on  11/9/10.  '}\n",
      "{'filename': 'patient06_report027_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'vaccinia', 'nth_sent': 21, 'start': 70, 'end': 78}, 'arg2': {'mention': 'Today', 'nth_sent': 21, 'start': 0, 'end': 5}, 'context': 'Today, the patient was seen by Dr. Person209 for consideration of the vaccinia trial, and it looks like we will be proposing this, although he is previously not been used for melanoma.  '}\n",
      "{'filename': 'patient06_report027_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'methotrexate', 'nth_sent': 42, 'start': 40, 'end': 52}, 'arg2': {'mention': 'last Tuesday', 'nth_sent': 42, 'start': 53, 'end': 65}, 'context': 'He last had prednisone this morning and methotrexate last Tuesday and Wednesday.  '}\n",
      "{'filename': 'patient06_report027_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'methotrexate', 'nth_sent': 42, 'start': 40, 'end': 52}, 'arg2': {'mention': 'Wednesday', 'nth_sent': 42, 'start': 70, 'end': 79}, 'context': 'He last had prednisone this morning and methotrexate last Tuesday and Wednesday.  '}\n",
      "{'filename': 'patient06_report010_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'temozolomide', 'nth_sent': 13, 'start': 18, 'end': 30}, 'arg2': {'mention': 'June 2010', 'nth_sent': 13, 'start': 34, 'end': 43}, 'context': 'He was placed  on temozolomide in June 2010 and presents today after 2 months of therapy with  the 75 mg/m sq dosing, 21 days on then 7 days off.'}\n",
      "{'filename': 'patient06_report010_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'temozolomide', 'nth_sent': 13, 'start': 18, 'end': 30}, 'arg2': {'mention': '2 months', 'nth_sent': 13, 'start': 69, 'end': 77}, 'context': 'He was placed  on temozolomide in June 2010 and presents today after 2 months of therapy with  the 75 mg/m sq dosing, 21 days on then 7 days off.'}\n",
      "{'filename': 'patient06_report010_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'temozolomide', 'nth_sent': 62, 'start': 126, 'end': 138}, 'arg2': {'mention': 'recently', 'nth_sent': 62, 'start': 100, 'end': 108}, 'context': 'ASSESSMENT AND PLAN Mr. Person4 is a 76-year-old gentleman with a diagnosis of metastatic melanoma, recently being treated on temozolomide as his first line of therapy with unfortunate progression of disease today.'}\n",
      "{'filename': 'patient18_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 4, 'start': 94, 'end': 113}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date for the continuation of the induction of high-dose alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 55, 'start': 86, 'end': 105}, 'arg2': {'mention': 'today', 'nth_sent': 55, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date for the initiation of week 3 of high- dose alpha-2b interferon as per the standard FDA approved regimen.\"}\n",
      "{'filename': 'patient18_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 6, 'start': 19, 'end': 29}, 'arg2': {'mention': 'January', 'nth_sent': 6, 'start': 41, 'end': 48}, 'context': 'She was started on interferon therapy in January, but was unable to tolerate even with reduce dosage.'}\n",
      "{'filename': 'patient18_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 6, 'start': 19, 'end': 29}, 'arg2': {'mention': 'April', 'nth_sent': 7, 'start': 124, 'end': 129}, 'context': 'She was started on interferon therapy in January, but was unable to tolerate even with reduce dosage. This was completed in April.'}\n",
      "{'filename': 'patient18_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 4, 'start': 36, 'end': 46}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 7, 'end': 16}, 'context': 'She is currently receiving adjuvant interferon therapy and doing well.'}\n",
      "{'filename': 'patient18_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 12, 'start': 36, 'end': 46}, 'arg2': {'mention': 'currently', 'nth_sent': 12, 'start': 7, 'end': 16}, 'context': 'She is currently receiving adjuvant interferon therapy and is followed by medical oncology.'}\n",
      "{'filename': 'patient18_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 4, 'start': 94, 'end': 113}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date for the continuation of her induction of high-dose alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 64, 'start': 94, 'end': 104}, 'arg2': {'mention': 'today', 'nth_sent': 64, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date for week 4 of the induction phase of her high-dose interferon therapy.\"}\n",
      "{'filename': 'patient18_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 6, 'start': 113, 'end': 132}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date for the initiation of the maintenance phase of subcutaneous high-dose alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 5, 'start': 75, 'end': 94}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date for the initiation of week 2 of alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 3, 'start': 187, 'end': 206}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 129, 'end': 134}, 'context': \"NOTE     PRINCIPAL DIAGNOSIS Ms. Patient18 is currently followed for history of a stage III melanoma,  presents to the office on today's date for continuation of her induction high- dose alpha-2b interferon as per standard FDA-approved regimen.   \"}\n",
      "{'filename': 'patient18_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 4, 'start': 110, 'end': 129}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 75, 'end': 80}, 'context': \"[BBB CCC] is a 26-year-old, Caucasian female, presenting to the office on  today's date for the initiation of alpha-2b interferon as per the standard FDA  approved regimen for stage IIIA melanoma.   \"}\n",
      "{'filename': 'patient18_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 62, 'start': 167, 'end': 186}, 'arg2': {'mention': 'today', 'nth_sent': 62, 'start': 30, 'end': 35}, 'context': \"She presents to the office on today's date and engaged in conversation with Dr. Person6 regarding the relative toxicities, theoretical benefits, and general schema of alpha-2b interferon as per the standard FDA approved dosing regimen.\"}\n",
      "{'filename': 'patient18_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 3, 'start': 193, 'end': 212}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 131, 'end': 136}, 'context': \"NOTE     PRINCIPAL DIAGNOSIS Ms. Patient18 is currently followed for history of a stage III melanoma,  presenting to the office on today's date for continuation of management of her  high-dose alpha-2b interferon per standard FDA-approved regimen.   \"}\n",
      "{'filename': 'patient18_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 33, 'start': 25, 'end': 35}, 'arg2': {'mention': 'for the last week', 'nth_sent': 33, 'start': 36, 'end': 53}, 'context': 'She has been holding her interferon for the last week approximately secondary to nausea and vomiting which are so severe that she is unable to go to work.'}\n",
      "{'filename': 'patient42_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 2, 'start': 39, 'end': 49}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 58, 'end': 67}, 'context': 'CURRENT TREATMENT:  Adjuvant high-dose interferon alfa-2B currently being administered at Institution in Location.  '}\n",
      "{'filename': 'patient42_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 46, 'start': 44, 'end': 54}, 'arg2': {'mention': 'December 30, 2013', 'nth_sent': 46, 'start': 109, 'end': 126}, 'context': 'PLAN:  Mr. Patient42 will continue with the interferon injections at the Location facility until the week of December 30, 2013.'}\n",
      "{'filename': 'patient42_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 35, 'start': 42, 'end': 52}, 'arg2': {'mention': 'today', 'nth_sent': 35, 'start': 12, 'end': 17}, 'context': 'He presents today with plans to start the interferon at this facility; however, he is very lethargic today and questions whether he will be able to tolerate continued interferon.  '}\n",
      "{'filename': 'patient42_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 35, 'start': 42, 'end': 52}, 'arg2': {'mention': 'today', 'nth_sent': 35, 'start': 12, 'end': 17}, 'context': 'He presents today with plans to start the interferon at this facility; however, he is very lethargic today and questions whether he will be able to tolerate continued interferon.  '}\n",
      "{'filename': 'patient42_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alfa-2b interferon', 'nth_sent': 6, 'start': 188, 'end': 206}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 29, 'end': 34}, 'context': \"He presents to the office on today's date for discussion with regard to the relative toxicities, theoretical benefits, and general schema of UPCI protocol 1609, randomization to high-dose alfa-2b interferon versus high-dose ipilimumab or low-dose ipilimumab.  \"}\n",
      "{'filename': 'patient42_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 6, 'start': 224, 'end': 234}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 29, 'end': 34}, 'context': \"He presents to the office on today's date for discussion with regard to the relative toxicities, theoretical benefits, and general schema of UPCI protocol 1609, randomization to high-dose alfa-2b interferon versus high-dose ipilimumab or low-dose ipilimumab.  \"}\n",
      "{'filename': 'patient42_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 6, 'start': 224, 'end': 234}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 29, 'end': 34}, 'context': \"He presents to the office on today's date for discussion with regard to the relative toxicities, theoretical benefits, and general schema of UPCI protocol 1609, randomization to high-dose alfa-2b interferon versus high-dose ipilimumab or low-dose ipilimumab.  \"}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 6, 'start': 59, 'end': 69}, 'arg2': {'mention': 'last week', 'nth_sent': 6, 'start': 30, 'end': 39}, 'context': 'The patient had a colonoscopy last week and therefore held interferon last week.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 5, 'start': 35, 'end': 45}, 'arg2': {'mention': 'January 2014', 'nth_sent': 5, 'start': 67, 'end': 79}, 'context': 'He has been receiving subcutaneous interferon at Institution since January 2014.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 8, 'start': 106, 'end': 116}, 'arg2': {'mention': '4/30/14', 'nth_sent': 8, 'start': 46, 'end': 53}, 'context': 'The patient presented to the cancer center on 4/30/14 stating that he did not feel well enough to receive interferon.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 73, 'start': 44, 'end': 54}, 'arg2': {'mention': 'January\\n2014', 'nth_sent': 73, 'start': 76, 'end': 88}, 'context': 'He has been receiving adjuvant subcutaneous interferon at Institution since January 2014.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 77, 'start': 28, 'end': 38}, 'arg2': {'mention': 'today', 'nth_sent': 77, 'start': 39, 'end': 44}, 'context': 'He was scheduled to receive interferon today, but presented to the cancer center today stating that he did not feel well enough to receive the interferon.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 77, 'start': 28, 'end': 38}, 'arg2': {'mention': 'today', 'nth_sent': 77, 'start': 39, 'end': 44}, 'context': 'He was scheduled to receive interferon today, but presented to the cancer center today stating that he did not feel well enough to receive the interferon.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 82, 'start': 80, 'end': 90}, 'arg2': {'mention': '4/30/14', 'nth_sent': 82, 'start': 94, 'end': 101}, 'context': 'Fever has not been a complaint of this patient and also, he did not receive the interferon on 4/30/14.'}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 10, 'start': 22, 'end': 32}, 'arg2': {'mention': 'November 11, 2013', 'nth_sent': 10, 'start': 56, 'end': 73}, 'context': 'He is to proceed with interferon therapy next Monday on November 11, 2013.  '}\n",
      "{'filename': 'patient42_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alfa-2b interferon', 'nth_sent': 93, 'start': 59, 'end': 77}, 'arg2': {'mention': 'November 11, 2013', 'nth_sent': 94, 'start': 186, 'end': 203}, 'context': 'He has already discussed and planned on starting high-dose alfa-2b interferon per standard FDA-approved regimen with Dr. Person6 in Location, Pennsylvania. He is slated to start this on November 11, 2013.'}\n",
      "{'filename': 'patient42_report094_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interferon', 'nth_sent': 4, 'start': 45, 'end': 55}, 'arg2': {'mention': 'at this time', 'nth_sent': 4, 'start': 56, 'end': 68}, 'context': 'Pt has decided that he does not want further interferon at this time.'}\n",
      "{'filename': 'patient06_report031_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Methotrexate', 'nth_sent': 30, 'start': 3, 'end': 15}, 'arg2': {'mention': 'weekly', 'nth_sent': 30, 'start': 22, 'end': 28}, 'context': '2.\\tMethotrexate 25 mg weekly.'}\n",
      "{'filename': 'patient06_report032_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'Methotrexate', 'nth_sent': 34, 'start': 3, 'end': 15}, 'arg2': {'mention': '1 mg 6 times a week', 'nth_sent': 35, 'start': 44, 'end': 63}, 'context': '2.\\tMethotrexate 25 mg weekly. 3.\\tFolic acid 1 mg 6 times a week.'}\n",
      "{'filename': 'patient06_report018_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 8, 'start': 47, 'end': 57}, 'arg2': {'mention': '11   9   10', 'nth_sent': 9, 'start': 178, 'end': 185}, 'context': 'CURRENT THERAPY Off protocol administration of paclitaxel at 70 mg/msq, 3 weeks on, 1 week off. Therapy was initiated on 9/28/10, and he has completed 2 cycles, last one was on  11/9/10.  '}\n",
      "{'filename': 'patient06_report027_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'methotrexate', 'nth_sent': 4, 'start': 148, 'end': 160}, 'arg2': {'mention': 'June 2009', 'nth_sent': 5, 'start': 288, 'end': 297}, 'context': 'SUMMARY OF STAY:  Mr. Person14 is a 77-year-old Caucasian male with a past history of heart disease, rheumatoid arthritis for which he has received methotrexate and prednisone, DVT, TIA, and in-transit melanoma of the left upper extremity.   He was initially diagnosed with a melanoma in June 2009 when he presented with a small mass in his left forearm.  '}\n",
      "{'filename': 'patient06_report010_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'methotrexate', 'nth_sent': 23, 'start': 61, 'end': 73}, 'arg2': {'mention': 'last 2 months  ', 'nth_sent': 24, 'start': 207, 'end': 220}, 'context': 'Still continues to be well controlled on his  prednisone and methotrexate. He is concerned that the area on the left arm is  getting worse and his wife is quite convinced that it has gotten worse since the  last 2 months.  '}\n",
      "{'filename': 'patient18_report018_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 4, 'start': 199, 'end': 218}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 42, 'end': 51}, 'context': \"NOTE     PRINCIPAL DIAGNOSIS [BBB AAA] is currently being followed for a history of stage IIIA melanoma. She presents to the office on today's date for the continuation of the induction of high-dose alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 6, 'start': 19, 'end': 29}, 'arg2': {'mention': 'April  ', 'nth_sent': 7, 'start': 124, 'end': 129}, 'context': 'She was started on interferon therapy in January, but was unable to tolerate even with reduce dosage. This was completed in April.'}\n",
      "{'filename': 'patient18_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 4, 'start': 208, 'end': 218}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 42, 'end': 51}, 'context': \"NOTE     PRINCIPLE DIAGNOSIS [BBB AAA] is currently being followed for a history of stage IIIA melanoma. She presents to the office on today's date for the continuation of her induction of high-dose alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 6, 'start': 227, 'end': 237}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 42, 'end': 51}, 'context': \"NOTE     PRINCIPAL DIAGNOSIS [BBB AAA] is currently being followed for a history of stage IIIA melanoma. She presents to the office on today's date for the initiation of the maintenance phase of subcutaneous high-dose alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 5, 'start': 160, 'end': 170}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 13, 'end': 22}, 'context': \"[BBB CCC] is currently being followed for a history of stage IIIA melanoma. She presents to the office on today's date for the initiation of week 2 of alpha-2b interferon as per the standard FDA approved regimen.   \"}\n",
      "{'filename': 'patient18_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'alpha-2b interferon', 'nth_sent': 3, 'start': 187, 'end': 206}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 46, 'end': 55}, 'context': \"NOTE     PRINCIPAL DIAGNOSIS Ms. Patient18 is currently followed for history of a stage III melanoma,  presents to the office on today's date for continuation of her induction high- dose alpha-2b interferon as per standard FDA-approved regimen.   \"}\n",
      "{'filename': 'patient18_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 411, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 3, 'start': 202, 'end': 212}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 46, 'end': 55}, 'context': \"NOTE     PRINCIPAL DIAGNOSIS Ms. Patient18 is currently followed for history of a stage III melanoma,  presenting to the office on today's date for continuation of management of her  high-dose alpha-2b interferon per standard FDA-approved regimen.   \"}\n",
      "{'filename': 'patient42_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 2, 'start': 39, 'end': 49}, 'arg2': {'mention': 'late 2012', 'nth_sent': 3, 'start': 235, 'end': 244}, 'context': 'CURRENT TREATMENT:  Adjuvant high-dose interferon alfa-2B currently being administered at Institution in Location.   HISTORY OF PRESENT ILLNESS:  Mr. Patient42 is a 68-year-old gentleman who noted a lesion on his left temporal area in late 2012.'}\n",
      "{'filename': 'patient42_report081_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 4, 'start': 41, 'end': 51}, 'arg2': {'mention': 'December 19   2013', 'nth_sent': 5, 'start': 170, 'end': 187}, 'context': 'He has been receiving adjuvant high-dose interferon under the direction of Dr. Person6 at the Institution. He presented as a new patient to Institution at Institution on December 19, 2013, stating that he wanted to transfer his care here because he lives closer to this facility.'}\n",
      "{'filename': 'patient42_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': {}, 'label': 'negative', 'arg1': {'mention': 'interferon', 'nth_sent': 4, 'start': 31, 'end': 41}, 'arg2': {'mention': 'January 2014', 'nth_sent': 5, 'start': 296, 'end': 308}, 'context': 'He received adjuvant high-dose interferon under the direction of Dr. Person28 at [WWW VVV] Institution and then transferred oncologic care to Institution at Institution in December 2013, because he lives closer to this facility. He has been receiving subcutaneous interferon at Institution since January 2014.'}\n"
     ]
    }
   ],
   "source": [
    "mode = \"train\"\n",
    "\n",
    "\n",
    "final_lst = []\n",
    "for cancer in [\"breast\", \"ovarian\", \"melanoma\"]:\n",
    "    file = f\"/users/the/NER_MTB/timeset/my_code_result/notebooks1/{cancer}_{mode}_non_empty_rel.json\"\n",
    "    with open(file, \"r\") as infile: \n",
    "        dct = json.load(infile)\n",
    "    for pair in dct:\n",
    "        print(pair)\n",
    "        # if dct[\"args1\"][\"start\"] is None or dct[\"args2\"][\"start\"] is None:\n",
    "        #     print(cancer, mode)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'filename': 'patient36_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 6, 'start': 69, 'end': 79}, 'arg2': {'mention': '6/27/11', 'nth_sent': 6, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 6, 'start': 84, 'end': 91}, 'arg2': {'mention': '6/27/11', 'nth_sent': 6, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report022_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 38, 'end': 43}, 'arg2': {'mention': 'Today', 'nth_sent': 7, 'start': 0, 'end': 5}, 'context': 'Today she had her first dose of 12 of Taxol.'}, {'filename': 'patient36_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 5, 'start': 62, 'end': 67}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 68, 'end': 73}, 'context': 'She has a history of breast CA and received the first dose of Taxol today along with a dose of IV Decadron.'}, {'filename': 'patient36_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 0, 'start': 132, 'end': 144}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 110, 'end': 119}, 'context': 'PRINCIPAL DIAGNOSIS:  Ms. Patient36 is a 57-year-old with stage I, T1c, N0, M0 triple negative breast cancer, currently on adjuvant chemotherapy.  '}, {'filename': 'patient36_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 1, 'start': 57, 'end': 59}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 60, 'end': 65}, 'context': 'CURRENT THERAPY:  The patient is here for her cycle 4 of AC today.'}, {'filename': 'patient36_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 66, 'end': 71}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 59, 'end': 65}, 'context': 'We plan to give her 4 cycles of AC followed by 12 weeks of weekly Taxol.  '}, {'filename': 'patient36_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 39, 'start': 33, 'end': 35}, 'arg2': {'mention': 'today', 'nth_sent': 39, 'start': 36, 'end': 41}, 'context': 'We will continue with cycle 4 of AC today  2.'}, {'filename': 'patient36_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 40, 'start': 72, 'end': 77}, 'arg2': {'mention': 'weekly', 'nth_sent': 40, 'start': 65, 'end': 71}, 'context': 'The patient will return back to us in about 3 weeks to start her weekly Taxol therapy  3.'}, {'filename': 'patient36_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 40, 'start': 72, 'end': 77}, 'arg2': {'mention': 'about 3 weeks', 'nth_sent': 40, 'start': 38, 'end': 51}, 'context': 'The patient will return back to us in about 3 weeks to start her weekly Taxol therapy  3.'}, {'filename': 'patient36_report024_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 7, 'start': 69, 'end': 79}, 'arg2': {'mention': '6/27/11', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report024_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 7, 'start': 84, 'end': 91}, 'arg2': {'mention': '6/27/11', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report024_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 38, 'end': 43}, 'arg2': {'mention': 'Today', 'nth_sent': 8, 'start': 0, 'end': 5}, 'context': 'Today she had her first dose of 12 of Taxol.'}, {'filename': 'patient36_report024_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 24, 'start': 21, 'end': 33}, 'arg2': {'mention': '6/27/11', 'nth_sent': 24, 'start': 34, 'end': 41}, 'context': 'Immunologic:  recent chemotherapy 6/27/11.'}, {'filename': 'patient36_report025_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 7, 'start': 69, 'end': 79}, 'arg2': {'mention': '6/27/11', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report025_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 7, 'start': 84, 'end': 91}, 'arg2': {'mention': '6/27/11', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report025_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 38, 'end': 43}, 'arg2': {'mention': 'Today', 'nth_sent': 8, 'start': 0, 'end': 5}, 'context': 'Today she had her first dose of 12 of Taxol.'}, {'filename': 'patient36_report025_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 24, 'start': 21, 'end': 33}, 'arg2': {'mention': '6/27/11', 'nth_sent': 24, 'start': 34, 'end': 41}, 'context': 'Immunologic:  recent chemotherapy 6/27/11.'}, {'filename': 'patient36_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 5, 'start': 68, 'end': 78}, 'arg2': {'mention': 'June 27, 2011', 'nth_sent': 5, 'start': 115, 'end': 128}, 'context': 'She underwent a left segmental mastectomy and completed 4 cycles of Adriamycin and Cytoxan, the last dose being on June 27, 2011.'}, {'filename': 'patient36_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 5, 'start': 83, 'end': 90}, 'arg2': {'mention': 'June 27, 2011', 'nth_sent': 5, 'start': 115, 'end': 128}, 'context': 'She underwent a left segmental mastectomy and completed 4 cycles of Adriamycin and Cytoxan, the last dose being on June 27, 2011.'}, {'filename': 'patient36_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 6, 'start': 53, 'end': 58}, 'arg2': {'mention': 'day of admission', 'nth_sent': 6, 'start': 3, 'end': 19}, 'context': 'On day of admission, she had her first dose of 12 of Taxol.'}, {'filename': 'patient36_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 65, 'end': 70}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 58, 'end': 64}, 'context': 'The patient has completed 4 cycles of AC and 11 cycles of weekly Taxol therapy.'}, {'filename': 'patient36_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 0, 'start': 180, 'end': 192}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 158, 'end': 167}, 'context': 'PRINCIPAL DIAGNOSIS:  Ms. Patient36 is a pleasant 57-year-old, African American postmenopausal female with stage I, T1c N0 M0, triple negative breast cancer, currently on adjuvant chemotherapy.  '}, {'filename': 'patient36_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 43, 'start': 28, 'end': 33}, 'arg2': {'mention': 'today', 'nth_sent': 43, 'start': 34, 'end': 39}, 'context': '1. Continue with cycle 8 of Taxol today.  '}, {'filename': 'patient36_report028_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 6, 'start': 68, 'end': 78}, 'arg2': {'mention': 'June 27, 2011', 'nth_sent': 6, 'start': 115, 'end': 128}, 'context': 'She underwent a left segmental mastectomy and completed 4 cycles of Adriamycin and Cytoxan, the last dose being on June 27, 2011.'}, {'filename': 'patient36_report028_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 6, 'start': 83, 'end': 90}, 'arg2': {'mention': 'June 27, 2011', 'nth_sent': 6, 'start': 115, 'end': 128}, 'context': 'She underwent a left segmental mastectomy and completed 4 cycles of Adriamycin and Cytoxan, the last dose being on June 27, 2011.'}, {'filename': 'patient36_report028_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 53, 'end': 58}, 'arg2': {'mention': 'day of admission', 'nth_sent': 7, 'start': 3, 'end': 19}, 'context': 'On day of admission, she had her first dose of 12 of Taxol.'}, {'filename': 'patient36_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 0, 'start': 137, 'end': 149}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 115, 'end': 124}, 'context': 'PRINCIPAL DIAGNOSIS:  A 57-year-old female with a history of stage I, T1c N0, triple-negative breast cancer who is currently on adjuvant chemotherapy program.  '}, {'filename': 'patient36_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 1, 'start': 27, 'end': 29}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 38, 'end': 43}, 'context': 'CURRENT THERAPY:  Here for AC cycle 3 today.'}, {'filename': 'patient36_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 59, 'end': 64}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 52, 'end': 58}, 'context': 'Plan to give 4 cycles of AC followed by 12 weeks of weekly Taxol.  '}, {'filename': 'patient36_report020_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'AC', 'nth_sent': 40, 'start': 17, 'end': 19}, 'arg2': {'mention': 'today', 'nth_sent': 40, 'start': 35, 'end': 40}, 'context': '1. Continue with AC cycle number 3 today.  '}, {'filename': 'patient36_report026_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 7, 'start': 69, 'end': 79}, 'arg2': {'mention': '6/27/11', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report026_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 7, 'start': 84, 'end': 91}, 'arg2': {'mention': '6/27/11', 'nth_sent': 7, 'start': 121, 'end': 128}, 'context': 'She underwent a L-Segmental Mastectomy and has completed 4 cycles of Adriamycin and Cytoxan, with the last dose being on 6/27/11.'}, {'filename': 'patient36_report026_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 8, 'start': 38, 'end': 43}, 'arg2': {'mention': 'Today', 'nth_sent': 8, 'start': 0, 'end': 5}, 'context': 'Today she had her first dose of 12 of Taxol.'}, {'filename': 'patient36_report026_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 23, 'start': 21, 'end': 33}, 'arg2': {'mention': '6/27/11', 'nth_sent': 23, 'start': 34, 'end': 41}, 'context': 'Immunologic:  recent chemotherapy 6/27/11.'}, {'filename': 'patient36_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 0, 'start': 138, 'end': 150}, 'arg2': {'mention': 'currently', 'nth_sent': 0, 'start': 116, 'end': 125}, 'context': 'PRINCIPAL DIAGNOSIS:  A 57-year-old female with a history of stage I, T1c, N0, triple-negative breast cancer who is currently on adjuvant chemotherapy program.  '}, {'filename': 'patient36_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 83, 'end': 88}, 'arg2': {'mention': 'weekly', 'nth_sent': 2, 'start': 76, 'end': 82}, 'context': 'For AC cycle number 2, plan to give 4 cycles of AC followed by 12 cycles of weekly Taxol.  '}, {'filename': 'patient36_report019_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 32, 'start': 13, 'end': 23}, 'arg2': {'mention': 'today', 'nth_sent': 32, 'start': 32, 'end': 37}, 'context': 'We will give Adriamycin cycle 2 today.'}, {'filename': 'patient45_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 51, 'start': 31, 'end': 43}, 'arg2': {'mention': 'At this point', 'nth_sent': 51, 'start': 0, 'end': 13}, 'context': 'At this point, the caution for chemotherapy is certainly debatable in her case.'}, {'filename': 'patient45_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'anastrozole', 'nth_sent': 4, 'start': 158, 'end': 169}, 'arg2': {'mention': '5 years', 'nth_sent': 4, 'start': 183, 'end': 190}, 'context': 'REVIEW OF SYSTEMS:  She had breast cancer diagnosed this summer with positive lymph nodes, had a mastectomy on the right side and is going to be treated with anastrozole for the next 5 years because of her estrogen positivity on the cancer.   '}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 4, 'start': 71, 'end': 81}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 neoadjuvant Adriamycin and Cytoxan.'}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 4, 'start': 86, 'end': 93}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 neoadjuvant Adriamycin and Cytoxan.'}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 95, 'start': 71, 'end': 81}, 'arg2': {'mention': 'today', 'nth_sent': 95, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 neoadjuvant Adriamycin and Cytoxan.  '}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 95, 'start': 86, 'end': 93}, 'arg2': {'mention': 'today', 'nth_sent': 95, 'start': 38, 'end': 43}, 'context': 'She presents to our outpatient clinic today for cycle #2/4 neoadjuvant Adriamycin and Cytoxan.  '}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Adriamycin', 'nth_sent': 97, 'start': 81, 'end': 91}, 'arg2': {'mention': '3 weeks', 'nth_sent': 97, 'start': 46, 'end': 53}, 'context': 'URI-->Z pak 5 day course  Return to clinic in 3 weeks for cycle #3/4 neoadjuvant Adriamycin and Cytoxan.  '}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Cytoxan', 'nth_sent': 97, 'start': 96, 'end': 103}, 'arg2': {'mention': '3 weeks', 'nth_sent': 97, 'start': 46, 'end': 53}, 'context': 'URI-->Z pak 5 day course  Return to clinic in 3 weeks for cycle #3/4 neoadjuvant Adriamycin and Cytoxan.  '}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Docetaxel', 'nth_sent': 16, 'start': 85, 'end': 94}, 'arg2': {'mention': '10/22/2013', 'nth_sent': 16, 'start': 123, 'end': 133}, 'context': 'Drug Name Person17 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person63 4 10/22/2013     Paclitaxel Person63 12  Radiation Oncology Therapies:  '}, {'filename': 'patient16_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 16, 'start': 95, 'end': 111}, 'arg2': {'mention': '10/22/2013', 'nth_sent': 16, 'start': 123, 'end': 133}, 'context': 'Drug Name Person17 Cycles Date Started Date Completed Reason Discontinued  Comments  Docetaxel/Cyclophosphamide Person63 4 10/22/2013     Paclitaxel Person63 12  Radiation Oncology Therapies:  '}, {'filename': 'patient16_report008_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 122, 'start': 127, 'end': 139}, 'arg2': {'mention': 'today', 'nth_sent': 122, 'start': 96, 'end': 101}, 'context': 'I have personally performed the medical decision making and would like to add: Person94 is here today to start her neoadjuvant chemotherapy.'}, {'filename': 'patient16_report008_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 109, 'start': 109, 'end': 114}, 'arg2': {'mention': '12 weeks', 'nth_sent': 109, 'start': 97, 'end': 105}, 'context': 'If the recurrence score is high, we would recommend Adriamycin and Cytoxan x4 cycles followed by 12 weeks of Taxol.  '}, {'filename': 'patient17_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 11, 'start': 23, 'end': 31}, 'arg2': {'mention': 'May 2013', 'nth_sent': 11, 'start': 35, 'end': 43}, 'context': '4. The patient started Arimidex in May 2013.  '}, {'filename': 'patient17_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 48, 'start': 12, 'end': 20}, 'arg2': {'mention': 'weekly', 'nth_sent': 48, 'start': 33, 'end': 39}, 'context': '2. Continue Arimidex and Fosamax weekly.  '}, {'filename': 'patient17_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 10, 'start': 96, 'end': 105}, 'arg2': {'mention': 'five years', 'nth_sent': 10, 'start': 82, 'end': 92}, 'context': '3. Oncotype DX score equaled 11 correlating to 7% risk of distant recurrence with five years of tamoxifen.  '}, {'filename': 'patient17_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 45, 'start': 57, 'end': 65}, 'arg2': {'mention': 'currently', 'nth_sent': 45, 'start': 44, 'end': 53}, 'context': 'She had a low risk Oncotype DX score and is currently on Arimidex and doing well with this.    '}, {'filename': 'patient17_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 221, 'end': 233}, 'arg2': {'mention': 'May 16, 2013', 'nth_sent': 5, 'start': 167, 'end': 179}, 'context': 'She, of note, is scheduled to see Dr. Person2 tomorrow in regards to discussion for right adjuvant radiation therapy ____ back to see her oncologist, Dr. Person14, on May 16, 2013, in regards to discussion for additional chemotherapy.   '}, {'filename': 'patient17_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 11, 'start': 23, 'end': 31}, 'arg2': {'mention': 'May 2013', 'nth_sent': 11, 'start': 41, 'end': 49}, 'context': '4. The patient started Arimidex in early May 2013.    '}, {'filename': 'patient17_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 10, 'start': 110, 'end': 119}, 'arg2': {'mention': '5 years', 'nth_sent': 10, 'start': 99, 'end': 106}, 'context': '3. Oncotype score equals 11 correlated to a 7% risk of distant recurrence in patients treated with 5 years of tamoxifen.  '}, {'filename': 'patient17_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Arimidex', 'nth_sent': 47, 'start': 20, 'end': 28}, 'arg2': {'mention': 'currently', 'nth_sent': 47, 'start': 7, 'end': 16}, 'context': 'She is currently on Arimidex therapy over the past couple of weeks and is doing well with this so far.'}, {'filename': 'patient01_report058_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 11, 'start': 9, 'end': 21}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 11, 'start': 29, 'end': 38}, 'context': 'Her last chemotherapy was on 4/10/2012.'}, {'filename': 'patient01_report058_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 14, 'start': 39, 'end': 48}, 'arg2': {'mention': '6/11/2012', 'nth_sent': 14, 'start': 71, 'end': 80}, 'context': 'The patient will continue single agent Herceptin, which is due next on 6/11/2012.'}, {'filename': 'patient01_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TRASTUZUMAB', 'nth_sent': 18, 'start': 280, 'end': 291}, 'arg2': {'mention': '2/17/12', 'nth_sent': 16, 'start': 80, 'end': 87}, 'context': 'Reactions    Morphine Rash    Outpatient prescriptions marked as taking for the 2/17/12 encounter (Office Visit) with Person213 (ATIVAN) 0.5 mg Oral Tabletprn Prochlorperazine Maleate (COMPAZINE) 10 mg Oral TabletNone Entered Dexamethasone (DECADRON) 4 mg Oral TabletNone Entered TRASTUZUMAB (HERCEPTIN IV)None Entered Valsartan (DIOVAN)'}, {'filename': 'patient01_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'HERCEPTIN', 'nth_sent': 18, 'start': 293, 'end': 302}, 'arg2': {'mention': '2/17/12', 'nth_sent': 16, 'start': 80, 'end': 87}, 'context': 'Reactions    Morphine Rash    Outpatient prescriptions marked as taking for the 2/17/12 encounter (Office Visit) with Person213 (ATIVAN) 0.5 mg Oral Tabletprn Prochlorperazine Maleate (COMPAZINE) 10 mg Oral TabletNone Entered Dexamethasone (DECADRON) 4 mg Oral TabletNone Entered TRASTUZUMAB (HERCEPTIN IV)None Entered Valsartan (DIOVAN)'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 8, 'start': 0, 'end': 9}, 'arg2': {'mention': '5/1/2012', 'nth_sent': 8, 'start': 61, 'end': 69}, 'context': 'Herceptin single agent every 21 days for 11 cycles initiated 5/1/2012.  '}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 4, 'start': 27, 'end': 35}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 103, 'end': 120}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 4, 'start': 37, 'end': 48}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 103, 'end': 120}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 4, 'start': 53, 'end': 62}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 103, 'end': 120}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 4, 'start': 64, 'end': 67}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 103, 'end': 120}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 4, 'start': 27, 'end': 35}, 'arg2': {'mention': 'April 10,\\n2012', 'nth_sent': 4, 'start': 135, 'end': 149}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 4, 'start': 37, 'end': 48}, 'arg2': {'mention': 'April 10,\\n2012', 'nth_sent': 4, 'start': 135, 'end': 149}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 4, 'start': 53, 'end': 62}, 'arg2': {'mention': 'April 10,\\n2012', 'nth_sent': 4, 'start': 135, 'end': 149}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 4, 'start': 64, 'end': 67}, 'arg2': {'mention': 'April 10,\\n2012', 'nth_sent': 4, 'start': 135, 'end': 149}, 'context': 'PRIOR THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011 and completed April 10, 2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 85, 'start': 37, 'end': 40}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 85, 'start': 67, 'end': 76}, 'context': 'She received 6 cycles of neoadjuvant TCH chemotherapy completed on 4/10/2012.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 91, 'start': 31, 'end': 40}, 'arg2': {'mention': 'today', 'nth_sent': 91, 'start': 41, 'end': 46}, 'context': 'She will initiate single agent Herceptin today.'}, {'filename': 'patient01_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 8, 'start': 0, 'end': 9}, 'arg2': {'mention': 'every 21 days', 'nth_sent': 8, 'start': 23, 'end': 36}, 'context': 'Herceptin single agent every 21 days for 11 cycles initiated 5/1/2012.  '}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 8, 'start': 0, 'end': 9}, 'arg2': {'mention': 'May 1, 2012', 'nth_sent': 8, 'start': 50, 'end': 61}, 'context': 'Herceptin #1 is tentatively scheduled to begin on May 1, 2012.  '}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 4, 'start': 29, 'end': 37}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 105, 'end': 122}, 'context': 'CURRENT THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011.   '}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 4, 'start': 39, 'end': 50}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 105, 'end': 122}, 'context': 'CURRENT THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011.   '}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 4, 'start': 55, 'end': 64}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 105, 'end': 122}, 'context': 'CURRENT THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011.   '}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 94, 'start': 168, 'end': 171}, 'arg2': {'mention': 'today', 'nth_sent': 95, 'start': 199, 'end': 204}, 'context': 'Mrs. Person6 is a 54 year old female with clinical stage T1N1 invasive right breast cancer, which is ER positive, PR positive, HER2/neu positive, receiving neoadjuvant TCH. She presents for cycle #6 today.'}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 106, 'start': 41, 'end': 50}, 'arg2': {'mention': 'May 1,\\n2012', 'nth_sent': 106, 'start': 54, 'end': 65}, 'context': 'She is tentatively scheduled to initiate Herceptin on May 1, 2012.    '}, {'filename': 'patient01_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 4, 'start': 66, 'end': 69}, 'arg2': {'mention': 'December 27, 2011', 'nth_sent': 4, 'start': 105, 'end': 122}, 'context': 'CURRENT THERAPY: Neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) chemotherapy x 6 cycles initiated December 27, 2011.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 5, 'start': 26, 'end': 34}, 'arg2': {'mention': '12/27/2011', 'nth_sent': 5, 'start': 73, 'end': 83}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 5, 'start': 36, 'end': 47}, 'arg2': {'mention': '12/27/2011', 'nth_sent': 5, 'start': 73, 'end': 83}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 5, 'start': 52, 'end': 61}, 'arg2': {'mention': '12/27/2011', 'nth_sent': 5, 'start': 73, 'end': 83}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 5, 'start': 63, 'end': 66}, 'arg2': {'mention': '12/27/2011', 'nth_sent': 5, 'start': 73, 'end': 83}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxotere', 'nth_sent': 5, 'start': 26, 'end': 34}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 5, 'start': 92, 'end': 101}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 5, 'start': 36, 'end': 47}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 5, 'start': 92, 'end': 101}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 5, 'start': 52, 'end': 61}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 5, 'start': 92, 'end': 101}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 5, 'start': 63, 'end': 66}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 5, 'start': 92, 'end': 101}, 'context': 'Six cycles of neoadjuvant Taxotere, Carboplatin and Herceptin (TCH) from 12/27/2011 through 4/10/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 7, 'start': 0, 'end': 9}, 'arg2': {'mention': '6/5/2012', 'nth_sent': 7, 'start': 84, 'end': 92}, 'context': 'Herceptin alone x 11 cycles, cycle #1 given on 5/1/2012, and cycle #2 scheduled for 6/5/2012 as she has breast surgery scheduled for 5/21/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 7, 'start': 0, 'end': 9}, 'arg2': {'mention': '5/1/2012', 'nth_sent': 7, 'start': 47, 'end': 55}, 'context': 'Herceptin alone x 11 cycles, cycle #1 given on 5/1/2012, and cycle #2 scheduled for 6/5/2012 as she has breast surgery scheduled for 5/21/2012.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 10, 'start': 132, 'end': 141}, 'arg2': {'mention': '5/1/2012', 'nth_sent': 10, 'start': 153, 'end': 161}, 'context': 'She reports a two week history of soreness and pain affecting the muscles of her legs, back, buttocks and arms ever since receiving Herceptin therapy on 5/1/2012.'}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TCH', 'nth_sent': 90, 'start': 159, 'end': 162}, 'arg2': {'mention': '4/10/2012', 'nth_sent': 90, 'start': 186, 'end': 195}, 'context': 'Mrs. Person6 is a 54 year old female with clinical stage T1N1 invasive ductal carcinoma of the right breast, ER and HER2/neu positive, status post neoadjuvant TCH chemotherapy completed 4/10/2012.'}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 91, 'start': 33, 'end': 42}, 'arg2': {'mention': '5/1/2012', 'nth_sent': 91, 'start': 57, 'end': 65}, 'context': 'She received her first out of 11 Herceptin treatments on 5/1/2012.'}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 92, 'start': 78, 'end': 87}, 'arg2': {'mention': 'June 5th', 'nth_sent': 92, 'start': 116, 'end': 124}, 'context': 'She is scheduled for breast surgery on Monday, 5/21/2012 and due for her next Herceptin which will be delayed until June 5th.   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 100, 'start': 14, 'end': 26}, 'arg2': {'mention': '5 weeks ago', 'nth_sent': 100, 'start': 27, 'end': 38}, 'context': 'She completed chemotherapy 5 weeks ago.'}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 107, 'start': 49, 'end': 58}, 'arg2': {'mention': 'June 5th', 'nth_sent': 107, 'start': 96, 'end': 104}, 'context': 'but she is having breast surgery on May 21st, so Herceptin will be delayed for two weeks, until June 5th).   '}, {'filename': 'patient01_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 106, 'start': 65, 'end': 74}, 'arg2': {'mention': 'May 22nd', 'nth_sent': 106, 'start': 108, 'end': 116}, 'context': 'It will be interesting to see if she feels any better off of the Herceptin (her next Herceptin would be due May 22nd'}, {'filename': 'patient01_report018_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 1, 'start': 30, 'end': 42}, 'arg2': {'mention': '2011', 'nth_sent': 1, 'start': 70, 'end': 74}, 'context': 'Lumpectomy with radiation and chemotherapy for right breast cancer in 2011.'}, {'filename': 'patient02_report025_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 14, 'start': 9, 'end': 21}, 'arg2': {'mention': '02/29/2012', 'nth_sent': 14, 'start': 29, 'end': 39}, 'context': 'Her last chemotherapy was on 02/29/2012.  COMPARISON: MRI of the breast on 11/11/2011.  '}, {'filename': 'patient02_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Herceptin', 'nth_sent': 5, 'start': 58, 'end': 67}, 'arg2': {'mention': '1 year', 'nth_sent': 5, 'start': 70, 'end': 76}, 'context': 'Her medical oncologist, Dr. Person3 plans to start her on Herceptin x 1 year.'}, {'filename': 'patient02_report079_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'tamoxifen', 'nth_sent': 6, 'start': 28, 'end': 37}, 'arg2': {'mention': '5 years', 'nth_sent': 6, 'start': 40, 'end': 47}, 'context': 'She will then continue with tamoxifen x 5 years.'}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Abraxane', 'nth_sent': 4, 'start': 28, 'end': 36}, 'arg2': {'mention': '2 weeks', 'nth_sent': 4, 'start': 50, 'end': 57}, 'context': 'The patient states that her Abraxane was held for 2 weeks with neuropathy feeling better but has worsened with subsequent therapy.'}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Abraxane', 'nth_sent': 74, 'start': 74, 'end': 82}, 'arg2': {'mention': 'today', 'nth_sent': 74, 'start': 113, 'end': 118}, 'context': 'She is s/p neoadjuvant AC x 4 and bilateral total mastectomy, followed by Abraxane x 9 that will be discontinued today secondary to neuropathy.   '}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 88, 'start': 241, 'end': 252}, 'arg2': {'mention': '12/23/2011', 'nth_sent': 88, 'start': 282, 'end': 292}, 'context': 'Right 12/6/2011   Total Mastectomy  Right 4/2/2012   Other   11/18/2011 MRI guided core biopsy                     Comments:  Medical Oncology Therapies:  Drug Name Person130 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person148 4 12/23/2011 2/29/2012  Completed 4 cycles  Paclitaxel Person148 9'}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 88, 'start': 241, 'end': 252}, 'arg2': {'mention': '2/29/2012', 'nth_sent': 88, 'start': 293, 'end': 302}, 'context': 'Right 12/6/2011   Total Mastectomy  Right 4/2/2012   Other   11/18/2011 MRI guided core biopsy                     Comments:  Medical Oncology Therapies:  Drug Name Person130 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person148 4 12/23/2011 2/29/2012  Completed 4 cycles  Paclitaxel Person148 9'}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 88, 'start': 324, 'end': 334}, 'arg2': {'mention': '5/9/2012', 'nth_sent': 89, 'start': 347, 'end': 355}, 'context': 'Right 12/6/2011   Total Mastectomy  Right 4/2/2012   Other   11/18/2011 MRI guided core biopsy                     Comments:  Medical Oncology Therapies:  Drug Name Person130 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person148 4 12/23/2011 2/29/2012  Completed 4 cycles  Paclitaxel Person148 9 5/9/2012 7/18/2012 Toxicity Neuropathy             '}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 88, 'start': 324, 'end': 334}, 'arg2': {'mention': '7/18/2012', 'nth_sent': 89, 'start': 356, 'end': 365}, 'context': 'Right 12/6/2011   Total Mastectomy  Right 4/2/2012   Other   11/18/2011 MRI guided core biopsy                     Comments:  Medical Oncology Therapies:  Drug Name Person130 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person148 4 12/23/2011 2/29/2012  Completed 4 cycles  Paclitaxel Person148 9 5/9/2012 7/18/2012 Toxicity Neuropathy             '}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 88, 'start': 253, 'end': 269}, 'arg2': {'mention': '12/23/2011', 'nth_sent': 88, 'start': 282, 'end': 292}, 'context': 'Right 12/6/2011   Total Mastectomy  Right 4/2/2012   Other   11/18/2011 MRI guided core biopsy                     Comments:  Medical Oncology Therapies:  Drug Name Person130 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person148 4 12/23/2011 2/29/2012  Completed 4 cycles  Paclitaxel Person148 9'}, {'filename': 'patient02_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Cyclophosphamide', 'nth_sent': 88, 'start': 253, 'end': 269}, 'arg2': {'mention': '2/29/2012', 'nth_sent': 88, 'start': 293, 'end': 302}, 'context': 'Right 12/6/2011   Total Mastectomy  Right 4/2/2012   Other   11/18/2011 MRI guided core biopsy                     Comments:  Medical Oncology Therapies:  Drug Name Person130 Cycles Date Started Date Completed Reason Discontinued  Comments  Doxorubicin/Cyclophosphamide Person148 4 12/23/2011 2/29/2012  Completed 4 cycles  Paclitaxel Person148 9'}, {'filename': 'patient02_report067_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 21, 'start': 9, 'end': 21}, 'arg2': {'mention': 'one month ago', 'nth_sent': 21, 'start': 32, 'end': 45}, 'context': 'The last chemotherapy was about one month ago.'}, {'filename': 'patient24_report011_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'CHEMOTHERAPY', 'nth_sent': 1, 'start': 88, 'end': 100}, 'arg2': {'mention': 'OCTOBER 3, 2001', 'nth_sent': 1, 'start': 107, 'end': 122}, 'context': 'THE PATIENT HAS A HISTORY OF BREAST CARCINOMA AND HAS BEEN EXPERIENCING HEADACHES SINCE CHEMOTHERAPY BEGAN OCTOBER 3, 2001.  '}, {'filename': 'patient24_report008_RAD', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CHEMOTHERAPY', 'nth_sent': 2, 'start': 0, 'end': 12}, 'arg2': {'mention': '2 WEEKS AGO', 'nth_sent': 2, 'start': 23, 'end': 34}, 'context': 'CHEMOTHERAPY COMPLETED 2 WEEKS AGO.  '}]\n",
      "113\n",
      "[{'filename': 'patient29_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 2, 'start': 23, 'end': 28}, 'arg2': {'mention': '5/2012', 'nth_sent': 2, 'start': 55, 'end': 61}, 'context': 'She is s/p 3 cycles of taxol and carboplatin completed 5/2012.'}, {'filename': 'patient29_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 2, 'start': 33, 'end': 44}, 'arg2': {'mention': '5/2012', 'nth_sent': 2, 'start': 55, 'end': 61}, 'context': 'She is s/p 3 cycles of taxol and carboplatin completed 5/2012.'}, {'filename': 'patient29_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 2, 'start': 34, 'end': 36}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 12, 'end': 17}, 'context': 'She is here today for cycle #2 of TC.'}, {'filename': 'patient29_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 12, 'start': 326, 'end': 338}, 'arg2': {'mention': 'today', 'nth_sent': 12, 'start': 391, 'end': 396}, 'context': 'Normal appearance, no discharge, lesions, cystocele or rectocele,  Cervix: Absent  Uterus: Absent  Adnexae: Absent, no mass  Parametrium: Not Involved  Rectal: No mass, no lesions, no rectovaginal fullness   No outpatient prescriptions have been marked as taking for the 4/24/12 encounter (Office Visit) with Person6, PA-C.   Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient29_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 3, 'start': 21, 'end': 26}, 'arg2': {'mention': '4/3/12', 'nth_sent': 3, 'start': 30, 'end': 36}, 'context': 'Pt has 1st scheduled chemo on 4/3/12.'}, {'filename': 'patient29_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 21, 'start': 0, 'end': 12}, 'arg2': {'mention': 'today', 'nth_sent': 21, 'start': 65, 'end': 70}, 'context': 'Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient29_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'TC', 'nth_sent': 2, 'start': 34, 'end': 36}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 12, 'end': 17}, 'context': 'She is here today for cycle #3 of TC.'}, {'filename': 'patient47_report050_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'cisplatin', 'nth_sent': 38, 'start': 42, 'end': 51}, 'arg2': {'mention': '04/20', 'nth_sent': 38, 'start': 3, 'end': 8}, 'context': 'On 04/20 she received chemo, single agent cisplatin, as well as 20 mg IV Lasix and over the next several days her pulmonary status began to improve.'}, {'filename': 'patient47_report050_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 38, 'start': 22, 'end': 27}, 'arg2': {'mention': '04/20', 'nth_sent': 38, 'start': 3, 'end': 8}, 'context': 'On 04/20 she received chemo, single agent cisplatin, as well as 20 mg IV Lasix and over the next several days her pulmonary status began to improve.'}, {'filename': 'patient47_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 75, 'end': 86}, 'arg2': {'mention': 'last week', 'nth_sent': 4, 'start': 150, 'end': 159}, 'context': 'She is status post cisplatin x2 cycles at Institution, and now 2 cycles of carboplatin and Taxol with Dr. Person4 in Location. Her last treatment was last week.'}, {'filename': 'patient47_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 91, 'end': 96}, 'arg2': {'mention': 'last week', 'nth_sent': 4, 'start': 150, 'end': 159}, 'context': 'She is status post cisplatin x2 cycles at Institution, and now 2 cycles of carboplatin and Taxol with Dr. Person4 in Location. Her last treatment was last week.'}, {'filename': 'patient35_report138_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report138_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 31, 'start': 130, 'end': 142}, 'arg2': {'mention': 'today', 'nth_sent': 31, 'start': 195, 'end': 200}, 'context': 'mg Oral tablet 1 po daily     No Facility-Administered Medications for the 11/5/13 encounter (Office Visit) with Person6, PA-C.   Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report138_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 14, 'start': 29, 'end': 34}, 'arg2': {'mention': '10/8/13', 'nth_sent': 15, 'start': 82, 'end': 89}, 'context': 'She was started on GOG 3003 (Doxil and VTX versus placebo). She received cycle #1 10/8/13.'}, {'filename': 'patient35_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 29, 'start': 25, 'end': 37}, 'arg2': {'mention': 'today', 'nth_sent': 29, 'start': 90, 'end': 95}, 'context': 'Once Person145, MD       Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report140_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 14, 'start': 29, 'end': 34}, 'arg2': {'mention': '10/8/13', 'nth_sent': 15, 'start': 82, 'end': 89}, 'context': 'She was started on GOG 3003 (Doxil and VTX versus placebo). She received cycle #1 10/8/13.'}, {'filename': 'patient35_report140_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CARBOPLATIN', 'nth_sent': 1, 'start': 110, 'end': 121}, 'arg2': {'mention': 'JANUARY 9,\\n2013', 'nth_sent': 1, 'start': 138, 'end': 153}, 'context': '1. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 2013.'}, {'filename': 'patient35_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TAXOL', 'nth_sent': 1, 'start': 122, 'end': 127}, 'arg2': {'mention': 'JANUARY 9,\\n2013', 'nth_sent': 1, 'start': 138, 'end': 153}, 'context': '1. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 2013.'}, {'filename': 'patient35_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CARBOPLATIN', 'nth_sent': 8, 'start': 110, 'end': 121}, 'arg2': {'mention': 'JANUARY 9,\\n20123', 'nth_sent': 8, 'start': 138, 'end': 154}, 'context': '2. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 20123.'}, {'filename': 'patient35_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TAXOL', 'nth_sent': 8, 'start': 122, 'end': 127}, 'arg2': {'mention': 'JANUARY 9,\\n20123', 'nth_sent': 8, 'start': 138, 'end': 154}, 'context': '2. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 20123.'}, {'filename': 'patient35_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 19, 'start': 39, 'end': 50}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 19, 'start': 87, 'end': 102}, 'context': 'The patient then underwent 4 cycles of carboplatin/Taxol with the last cycle ending on January 9, 2013.'}, {'filename': 'patient35_report038_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 19, 'start': 51, 'end': 56}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 19, 'start': 87, 'end': 102}, 'context': 'The patient then underwent 4 cycles of carboplatin/Taxol with the last cycle ending on January 9, 2013.'}, {'filename': 'patient35_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 6, 'start': 35, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #3 of Paclitaxel and Carboplatin.'}, {'filename': 'patient35_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 30, 'start': 0, 'end': 12}, 'arg2': {'mention': 'today', 'nth_sent': 30, 'start': 65, 'end': 70}, 'context': 'Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report013_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 6, 'start': 50, 'end': 61}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #3 of Paclitaxel and Carboplatin.'}, {'filename': 'patient35_report152_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 39, 'start': 26, 'end': 31}, 'arg2': {'mention': 'today', 'nth_sent': 39, 'start': 58, 'end': 63}, 'context': 'Will discuss plan of care/chemo regimen with Dr. Person46 today  Professional Services Credentials Title and Author Person45: MD.'}, {'filename': 'patient35_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 14, 'end': 26}, 'arg2': {'mention': '4/17/13', 'nth_sent': 8, 'start': 34, 'end': 41}, 'context': 'Last cycle of chemotherapy was on 4/17/13.'}, {'filename': 'patient35_report157_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 17, 'start': 46, 'end': 58}, 'arg2': {'mention': 'July 11, 2013', 'nth_sent': 17, 'start': 99, 'end': 112}, 'context': 'The patient was treated with 6 cycles of IVIP chemotherapy, the last dose of which was admitted on July 11, 2013.'}, {'filename': 'patient35_report157_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 23, 'start': 41, 'end': 46}, 'arg2': {'mention': 'October 8th', 'nth_sent': 24, 'start': 82, 'end': 93}, 'context': 'The patient was started on GOG 3003 with Taxol. The plan is to begin treatment on October 8th.  '}, {'filename': 'patient35_report074_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 30, 'start': 140, 'end': 145}, 'arg2': {'mention': '10/8', 'nth_sent': 30, 'start': 146, 'end': 150}, 'context': 'GU: - UOP adaquate - Creatinine normal ID: - Afebrile, no signs/symptoms of infection Onc: Recurrent ovarian cancer, was scheduled to begin Doxil 10/8.'}, {'filename': 'patient35_report052_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': 'today', 'nth_sent': 7, 'start': 53, 'end': 58}, 'context': 'She was restarted on IV/IP chemotherapy and presents today for cycle #5.'}, {'filename': 'patient35_report052_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 39, 'start': 25, 'end': 37}, 'arg2': {'mention': 'today', 'nth_sent': 39, 'start': 90, 'end': 95}, 'context': 'Once Person145, MD       Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report063_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report077_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 27, 'start': 62, 'end': 67}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 28, 'start': 90, 'end': 105}, 'context': 'On September 26 in the office, the plan was to begin 303 with Doxil. Plan was to start on October 8, 2013.  '}, {'filename': 'patient35_report077_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 58, 'start': 26, 'end': 31}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 58, 'start': 35, 'end': 50}, 'context': 'She is scheduled to begin Doxil on October 8, 2013.'}, {'filename': 'patient35_report077_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 65, 'start': 32, 'end': 44}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 65, 'start': 60, 'end': 75}, 'context': 'The patient is to follow up for chemotherapy appointment on October 8, 2013.'}, {'filename': 'patient35_report077_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 20, 'start': 27, 'end': 39}, 'arg2': {'mention': 'July 11, 2013', 'nth_sent': 20, 'start': 89, 'end': 102}, 'context': 'She was treated with IV/IP chemotherapy and has now completed 6 cycles, last dose was on July 11, 2013.'}, {'filename': 'patient35_report146_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 7, 'start': 52, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 7, 'start': 15, 'end': 24}, 'context': 'The patient is currently in a chemo study involving Doxil +/-'}, {'filename': 'patient35_report156_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 8, 'start': 52, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 8, 'start': 15, 'end': 24}, 'context': 'The patient is currently in a chemo study involving Doxil +/-'}, {'filename': 'patient35_report064_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 8, 'start': 29, 'end': 34}, 'arg2': {'mention': '7/2013', 'nth_sent': 8, 'start': 41, 'end': 47}, 'context': 'She received systemic and IP chemo until 7/2013.'}, {'filename': 'patient35_report090_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'doxorubicin', 'nth_sent': 14, 'start': 42, 'end': 53}, 'arg2': {'mention': '10/8/13', 'nth_sent': 14, 'start': 57, 'end': 64}, 'context': 'She started second line chemotherapy with doxorubicin on 10/8/13.'}, {'filename': 'patient35_report127_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 53, 'start': 63, 'end': 68}, 'arg2': {'mention': '10/24', 'nth_sent': 53, 'start': 86, 'end': 91}, 'context': 'ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 .'}, {'filename': 'patient35_report127_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 9, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 8, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion.'}, {'filename': 'patient35_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 45, 'start': 97, 'end': 102}, 'arg2': {'mention': '10/24', 'nth_sent': 45, 'start': 120, 'end': 125}, 'context': ': UOP adequate, will decrease IVF ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 Prophylaxis: SCDs, encourage ambulation, holding lovenox today for procedure tomorrow.'}, {'filename': 'patient35_report093_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 9, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 8, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/27 03:53\\t 37.0\\t 142/76\\t 71\\t 16\\t 95 10/26 23:40\\t\\t 160/87\\t 69\\t 16\\t 96 10/26 23:39\\t 36.7 10/26 19:45\\t\\t\\t 68\\t 16\\t 95 10/26 19:44\\t 36.5\\t 144/81 10/26 16:12\\t 36.6\\t 144/82\\t 70\\t 18\\t 97 10/26 12:23\\t 36.5\\t 147/85\\t 71\\t\\t 95  24 Hr Max Temp: 37.0 at 10/27 03:53\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.0 at 10/27 03:53\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report095_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 51, 'start': 76, 'end': 81}, 'arg2': {'mention': '10/24', 'nth_sent': 51, 'start': 99, 'end': 104}, 'context': 'UOP adequate ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 Prophylaxis: SCDs, encourage ambulation, Lovenox held in anticipation procedure today Dispo: continued inpatient management  Professional Services Credentials Title and Author Person26: MD.'}, {'filename': 'patient35_report095_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 9, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 8, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/28 03:35\\t 36.4\\t 153/89\\t 73\\t 18\\t 96 10/27 23:33\\t\\t 159/87\\t 67\\t 16\\t 95 10/27 23:32\\t 36.9 10/27 19:27\\t 37.0\\t 155/83\\t 72\\t 16\\t 95 10/27 16:32\\t\\t 158/88\\t 71\\t 16\\t 93 10/27 16:31\\t 36.7 10/27 11:25\\t\\t\\t 71\\t 18\\t 98  24 Hr Max Temp: 37.0 at 10/27 19:27\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.0 at 10/27 19:27\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report102_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 8, 'start': 96, 'end': 101}, 'arg2': {'mention': 'currently', 'nth_sent': 7, 'start': 75, 'end': 84}, 'context': 'No F/C/CP/N/V.  History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/29 17:01\\t\\t\\t 75\\t 15\\t 92 10/29 16:58\\t\\t 163/76 10/29 16:57\\t 36.5 10/29 16:45\\t 36.4\\t 144/65\\t 72\\t 20\\t 97 10/29 16:30\\t\\t 144/65\\t 70\\t 18\\t 94 10/29 16:15\\t\\t 137/65\\t 73\\t 20\\t 95 10/29 16:00\\t\\t 126/59\\t 68\\t 15\\t 94  24 Hr Max Temp: 37.0 at 10/29 11:46\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.0 at 10/29 11:46\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 60, 'end': 71}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 72, 'end': 77}, 'context': '71 yo female dx w/ ovarian cancer Receiving 1st cycle taxol/carboplatin today PMH: HTN, HLD, GERD  Pt reports good appetite, states she has been eating \"light\" and has reviewed nutrition information provided in patient resource book.'}, {'filename': 'patient35_report010_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 0, 'start': 54, 'end': 59}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 72, 'end': 77}, 'context': '71 yo female dx w/ ovarian cancer Receiving 1st cycle taxol/carboplatin today PMH: HTN, HLD, GERD  Pt reports good appetite, states she has been eating \"light\" and has reviewed nutrition information provided in patient resource book.'}, {'filename': 'patient35_report139_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 14, 'start': 29, 'end': 34}, 'arg2': {'mention': '10/8/13', 'nth_sent': 15, 'start': 82, 'end': 89}, 'context': 'She was started on GOG 3003 (Doxil and VTX versus placebo). She received cycle #1 10/8/13.'}, {'filename': 'patient35_report139_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CARBOPLATIN', 'nth_sent': 4, 'start': 110, 'end': 121}, 'arg2': {'mention': 'JANUARY 9,\\n2013', 'nth_sent': 4, 'start': 138, 'end': 153}, 'context': '1. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 2013.'}, {'filename': 'patient35_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TAXOL', 'nth_sent': 4, 'start': 122, 'end': 127}, 'arg2': {'mention': 'JANUARY 9,\\n2013', 'nth_sent': 4, 'start': 138, 'end': 153}, 'context': '1. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 2013.'}, {'filename': 'patient35_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CARBOPLATIN', 'nth_sent': 11, 'start': 110, 'end': 121}, 'arg2': {'mention': 'JANUARY 9,\\n20123', 'nth_sent': 11, 'start': 138, 'end': 154}, 'context': '2. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 20123.'}, {'filename': 'patient35_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TAXOL', 'nth_sent': 11, 'start': 122, 'end': 127}, 'arg2': {'mention': 'JANUARY 9,\\n20123', 'nth_sent': 11, 'start': 138, 'end': 154}, 'context': '2. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 20123.'}, {'filename': 'patient35_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 22, 'start': 39, 'end': 50}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 22, 'start': 87, 'end': 102}, 'context': 'The patient then underwent 4 cycles of carboplatin/Taxol with the last cycle ending on January 9, 2013.'}, {'filename': 'patient35_report037_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 22, 'start': 51, 'end': 56}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 22, 'start': 87, 'end': 102}, 'context': 'The patient then underwent 4 cycles of carboplatin/Taxol with the last cycle ending on January 9, 2013.'}, {'filename': 'patient35_report011_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 5, 'start': 35, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #2 of Paclitaxel and Carboplatin.'}, {'filename': 'patient35_report011_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 5, 'start': 50, 'end': 61}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #2 of Paclitaxel and Carboplatin.'}, {'filename': 'patient35_report011_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 21, 'start': 17, 'end': 29}, 'arg2': {'mention': 'today', 'nth_sent': 21, 'start': 82, 'end': 87}, 'context': 'None Entered     Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report062_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxorubicin', 'nth_sent': 7, 'start': 19, 'end': 30}, 'arg2': {'mention': '10/8/13', 'nth_sent': 7, 'start': 39, 'end': 46}, 'context': 'She was started on Doxorubicin cycle 1 10/8/13 and completed this cycle several days ago.'}, {'filename': 'patient35_report105_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 36, 'end': 48}, 'arg2': {'mention': '7/11/2013', 'nth_sent': 5, 'start': 49, 'end': 58}, 'context': 'She then completed 6 doses of IV/IP chemotherapy 7/11/2013.'}, {'filename': 'patient35_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 45, 'start': 63, 'end': 68}, 'arg2': {'mention': '10/24', 'nth_sent': 45, 'start': 86, 'end': 91}, 'context': 'ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 .'}, {'filename': 'patient35_report122_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 6, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion.'}, {'filename': 'patient35_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 21, 'start': 93, 'end': 105}, 'arg2': {'mention': 'today', 'nth_sent': 21, 'start': 158, 'end': 163}, 'context': 'mg Oral tablet 1 po daily     MULTIVITAMIN W-MINERALS/LUTEIN (CENTRUM SILVER ORAL) daily     Chemotherapy labs were reviewed and are acceptable for treatment today.  '}, {'filename': 'patient35_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Caboplatin', 'nth_sent': 4, 'start': 33, 'end': 43}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 4, 'start': 78, 'end': 93}, 'context': 'She was treated with neoadjuvant Caboplatin/Taxol for 4 cycles, last dose was January 9, 2013.'}, {'filename': 'patient35_report017_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 44, 'end': 49}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 4, 'start': 78, 'end': 93}, 'context': 'She was treated with neoadjuvant Caboplatin/Taxol for 4 cycles, last dose was January 9, 2013.'}, {'filename': 'patient35_report081_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 41, 'start': 200, 'end': 205}, 'arg2': {'mention': '10/8', 'nth_sent': 41, 'start': 206, 'end': 210}, 'context': '- Continue home Simvastatin GU: - UOP adaquate when being recorded fully - Creatinine stable @ 1.1 ID: - Afebrile, no signs/symptoms of infection Onc: Recurrent ovarian cancer, was scheduled to begin Doxil 10/8.'}, {'filename': 'patient35_report085_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 10, 'start': 13, 'end': 18}, 'arg2': {'mention': 'today', 'nth_sent': 10, 'start': 37, 'end': 42}, 'context': 'She received Doxil Cycle #1, Day #17 today, she tolerated it well.   '}, {'filename': 'patient35_report085_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 60, 'start': 162, 'end': 167}, 'arg2': {'mention': 'today', 'nth_sent': 60, 'start': 185, 'end': 190}, 'context': '-Monitor O2 sats, supplemental O2 as indicated :  -Regular  -NPO at MN -zofran PRN GU: Monitor UOP ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 today.'}, {'filename': 'patient35_report085_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 18, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 18, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 22, 'start': 173, 'end': 185}, 'arg2': {'mention': 'today', 'nth_sent': 22, 'start': 238, 'end': 243}, 'context': '40 mg Oral tablet 1 po daily     MULTIVITAMIN W-MINERALS/LUTEIN (CENTRUM SILVER ORAL) daily     DISCONTD: hydrochlorothiazide (MICROZIDE) 25 mg Oral tablet 1 po daily       Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report087_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 36, 'start': 79, 'end': 84}, 'arg2': {'mention': '10/24', 'nth_sent': 36, 'start': 102, 'end': 107}, 'context': 'GU: Monitor UOP ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 Prophylaxis: SCDs, encourage ambulation, will likely start pLovneox after procedure Dispo: inpatient observation overnight likely after procedure  Professional Services Credentials Title and Author Person26: MD.'}, {'filename': 'patient35_report087_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 5, 'start': 171, 'end': 176}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 150, 'end': 159}, 'context': 'No f/c/CP/N/V. Tol small amount of oral intake yeseterday, but reports decreased appetite  History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/25 03:43\\t 37.2\\t 128/80\\t 91\\t 16\\t 97 10/24 23:00\\t\\t\\t\\t\\t\\t 2% 10/24 22:13\\t 37.1\\t 146/82\\t 90\\t 18\\t 94 10/24 17:07\\t 36.7\\t 143/86\\t 81\\t 18\\t 95 10/24 16:21\\t\\t 132/69\\t 78\\t 16\\t 94 10/24 16:04\\t\\t 134/67\\t 80\\t 18\\t 94 10/24 15:42\\t 36.3\\t 139/79\\t 82\\t 18\\t 95  24 Hr Max Temp: 37.2 at 10/25 03:43\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.2 at 10/25 03:43\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report158_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 17, 'start': 46, 'end': 58}, 'arg2': {'mention': 'July 11, 2013', 'nth_sent': 17, 'start': 99, 'end': 112}, 'context': 'The patient was treated with 6 cycles of IVIP chemotherapy, the last dose of which was admitted on July 11, 2013.'}, {'filename': 'patient35_report158_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 23, 'start': 41, 'end': 46}, 'arg2': {'mention': 'October 8th', 'nth_sent': 24, 'start': 82, 'end': 93}, 'context': 'The patient was started on GOG 3003 with Taxol. The plan is to begin treatment on October 8th.  '}, {'filename': 'patient35_report069_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 25, 'start': 51, 'end': 56}, 'arg2': {'mention': '10/8', 'nth_sent': 26, 'start': 76, 'end': 80}, 'context': '9/26 office visit with plan to begin GOG 3003 with Doxil. Plan was to start 10/8.     '}, {'filename': 'patient35_report069_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 77, 'start': 78, 'end': 83}, 'arg2': {'mention': '10/8', 'nth_sent': 77, 'start': 84, 'end': 88}, 'context': 'AF, no s/s of infection Onc: recurrent ovarian cancer, was scheduled to begin Doxil 10/8.  '}, {'filename': 'patient35_report069_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 18, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 18, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 30, 'start': 62, 'end': 67}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 31, 'start': 90, 'end': 105}, 'context': 'On September 26 in the office, the plan was to begin 303 with Doxil. Plan was to start on October 8, 2013.  '}, {'filename': 'patient35_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 61, 'start': 26, 'end': 31}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 61, 'start': 35, 'end': 50}, 'context': 'She is scheduled to begin Doxil on October 8, 2013.'}, {'filename': 'patient35_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 68, 'start': 32, 'end': 44}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 68, 'start': 60, 'end': 75}, 'context': 'The patient is to follow up for chemotherapy appointment on October 8, 2013.'}, {'filename': 'patient35_report080_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 23, 'start': 27, 'end': 39}, 'arg2': {'mention': 'July 11, 2013', 'nth_sent': 23, 'start': 89, 'end': 102}, 'context': 'She was treated with IV/IP chemotherapy and has now completed 6 cycles, last dose was on July 11, 2013.'}, {'filename': 'patient35_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 14, 'start': 28, 'end': 40}, 'arg2': {'mention': 'today', 'nth_sent': 14, 'start': 18, 'end': 23}, 'context': 'She was consented today for chemotherapy by Person5.     '}, {'filename': 'patient35_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 6, 'start': 384, 'end': 396}, 'arg2': {'mention': '3 weeks', 'nth_sent': 6, 'start': 354, 'end': 361}, 'context': 'Rectal: Deferred Extremities: No clubbing, cyanosis, or edema, full range of motion x4   ASSESSMENT:  71 year old s/p interval debulking and IP port placement for high grade serous carcinoma of the ovary  PLAN:  Post-operative instruction given:  No heavy lifting more than 5-10 pounds No strenuous activity until 4 weeks postop Driving is acceptable at 3 weeks Return in 3 weeks for chemotherapy will commence with IV/IP PGH Nothing in vagina for 8 weeks postop Pathology report printed a copy given to patient and her husband.  '}, {'filename': 'patient35_report099_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 51, 'start': 76, 'end': 81}, 'arg2': {'mention': '10/24', 'nth_sent': 51, 'start': 99, 'end': 104}, 'context': 'UOP adequate ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 Prophylaxis: SCDs, encourage ambulation, Lovenox held in anticipation procedure today Dispo: continued inpatient management  Professional Services Credentials Title and Author Person26: MD.'}, {'filename': 'patient35_report099_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 8, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 7, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/29 03:59\\t 36.8\\t 150/76\\t 70\\t 18\\t 96 10/29 00:52\\t\\t 158/82 10/29 00:46\\t\\t 170/96\\t 74\\t\\t 95 10/29 00:45\\t 36.9\\t\\t\\t 16 10/28 20:40\\t 37.0\\t 147/80\\t 75\\t 16\\t 93 10/28 15:33\\t 37.0\\t 125/76\\t 80\\t 16\\t 94 10/28 11:31\\t\\t 158/80  24 Hr Max Temp: 37.0 at 10/28 20:40\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.0 at 10/28 20:40\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report092_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 49, 'start': 253, 'end': 258}, 'arg2': {'mention': '10/24', 'nth_sent': 49, 'start': 276, 'end': 281}, 'context': '-Monitor O2 sats, wean O2 as tolerated GI: -Tolerating regular diet, antiemetics PRN -Paracentesis not performed yesterday, will monitor ascites clinically : UOP adequate, will decrease IVF ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 Prophylaxis: SCDs, encourage ambulation, t/c pLovenox today Dispo: continued inpatient management  Professional Services Credentials Title and Author Person26: MD.'}, {'filename': 'patient35_report092_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 8, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 7, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/26 02:57\\t\\t 147/92\\t 76\\t\\t 99 10/26 02:53\\t 36.7\\t 162/92\\t 78\\t 18\\t 99 10/25 23:22\\t 36.8\\t 126/75\\t 71\\t 16\\t 97 10/25 19:49\\t 37.0\\t 136/74\\t 78\\t 16\\t 95 10/25 19:44\\t 37.0\\t 136/74\\t 78\\t 16\\t 95 10/25 15:48\\t 36.7\\t 139/84\\t 78\\t\\t 96 10/25 15:42\\t\\t\\t\\t 16  24 Hr Max Temp: 37.0 at 10/25 19:49\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.2 at 10/25 03:43\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report078_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 63, 'start': 32, 'end': 44}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 63, 'start': 60, 'end': 75}, 'context': 'The patient is to follow up for chemotherapy appointment on October 8, 2013.  '}, {'filename': 'patient35_report078_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 30, 'start': 62, 'end': 67}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 31, 'start': 92, 'end': 107}, 'context': 'On September 26 in the office, the plan was to begin 303 with Doxil.   Plan was to start on October 8, 2013.'}, {'filename': 'patient35_report078_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 57, 'start': 26, 'end': 31}, 'arg2': {'mention': 'October 8, 2013', 'nth_sent': 57, 'start': 35, 'end': 50}, 'context': 'She is scheduled to begin Doxil on October 8, 2013.  '}, {'filename': 'patient35_report078_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 23, 'start': 27, 'end': 39}, 'arg2': {'mention': 'July 11, 2013', 'nth_sent': 23, 'start': 89, 'end': 102}, 'context': 'She was treated with IV/IP chemotherapy and has now completed 6 cycles, last dose was on July 11, 2013.  '}, {'filename': 'patient35_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 28, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 28, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report111_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 56, 'start': 63, 'end': 68}, 'arg2': {'mention': '10/24', 'nth_sent': 56, 'start': 86, 'end': 91}, 'context': 'ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 Prophylaxis: SCDs, encourage ambulation, pLovenox Dispo: continued inpatient management  Professional Services Credentials Title and Author Person26: MD.'}, {'filename': 'patient35_report111_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 7, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 6, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion  Physical Examination  Vital Signs (Last 7 in past 36 hours)  Vitals\\t TempC\\t BP\\t Pulse\\t RR\\t SaO2\\t FiO2 10/30 04:56\\t\\t\\t 75\\t\\t 96 10/30 04:55\\t 36.7\\t 155/82\\t\\t 16 10/30 01:17\\t\\t\\t 76\\t\\t 93 10/30 01:16\\t 36.7\\t 127/76\\t\\t 16 10/29 20:55\\t 36.8\\t 134/78\\t 79\\t 18\\t 95 10/29 18:26\\t\\t\\t 78\\t\\t 95 10/29 18:25\\t\\t\\t\\t 16  24 Hr Max Temp: 37.0 at 10/29 11:46\\t Dosing Wt: 61.2 kg (As of 10:24:13 17:09) 36 Hr Max Temp: 37.0 at 10/29 11:46\\t BMI: 23 (As of 10:24:13 17:09)  '}, {'filename': 'patient35_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': 'today', 'nth_sent': 7, 'start': 53, 'end': 58}, 'context': 'She was restarted on IV/IP chemotherapy and presents today for cycle #6.'}, {'filename': 'patient35_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 22, 'start': 207, 'end': 219}, 'arg2': {'mention': 'today', 'nth_sent': 22, 'start': 272, 'end': 277}, 'context': 'Normal appearance, no discharge, lesions, cystocele or rectocele,  Cervix: Absent  Uterus: Absent  Adnexae: Absent, no mass  Parametrium: Not Involved  Rectal: No mass, no lesions, no rectovaginal fullness  Chemotherapy labs were reviewed and are acceptable for treatment today.  '}, {'filename': 'patient35_report165_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 64, 'start': 16, 'end': 28}, 'arg2': {'mention': '11/7', 'nth_sent': 64, 'start': 136, 'end': 140}, 'context': 'Her most recent chemotherapy has been GOG 3003 - ( PLD 40 mg/m2 plus VTX-2337 or placebo) - and has received 2 cycles, most recently on 11/7.'}, {'filename': 'patient35_report162_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'doxorubicin', 'nth_sent': 4, 'start': 181, 'end': 192}, 'arg2': {'mention': '10/8/13', 'nth_sent': 4, 'start': 205, 'end': 212}, 'context': 'Following surgery she completed 6 additional cycles if IV/IP therpay, but unfortunately she was found to have extensive metastatic disease in 9/13 and then underwent treatment with doxorubicin starting on 10/8/13.'}, {'filename': 'patient35_report135_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 43, 'start': 63, 'end': 68}, 'arg2': {'mention': '10/24', 'nth_sent': 43, 'start': 86, 'end': 91}, 'context': 'ID: AF, no s/s of infection Onc: recurrent ovarian cancer, had Doxil cycle #1 day #17 10/24 .'}, {'filename': 'patient35_report135_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 417, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Doxil', 'nth_sent': 9, 'start': 80, 'end': 85}, 'arg2': {'mention': 'currently', 'nth_sent': 8, 'start': 59, 'end': 68}, 'context': 'History of Present Illness  72yo with recurrent ovarian ca currently on cycle 1 Doxil p/f chemo but c/o SOB, found to have recurrent L pleural effusion.'}, {'filename': 'patient35_report036_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CARBOPLATIN', 'nth_sent': 3, 'start': 107, 'end': 118}, 'arg2': {'mention': 'JANUARY 9,\\n2013', 'nth_sent': 3, 'start': 135, 'end': 150}, 'context': 'A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 2013.'}, {'filename': 'patient35_report036_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TAXOL', 'nth_sent': 3, 'start': 119, 'end': 124}, 'arg2': {'mention': 'JANUARY 9,\\n2013', 'nth_sent': 3, 'start': 135, 'end': 150}, 'context': 'A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 2013.'}, {'filename': 'patient35_report036_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'CARBOPLATIN', 'nth_sent': 9, 'start': 110, 'end': 121}, 'arg2': {'mention': 'JANUARY 9,\\n20123', 'nth_sent': 9, 'start': 138, 'end': 154}, 'context': '2. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 20123.'}, {'filename': 'patient35_report036_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'TAXOL', 'nth_sent': 9, 'start': 122, 'end': 127}, 'arg2': {'mention': 'JANUARY 9,\\n20123', 'nth_sent': 9, 'start': 138, 'end': 154}, 'context': '2. A 3 CENTIMETER ADNEXAL MASS WITH BIOPSY SHOWING INVASIVE CARCINOMA OF MALARIAN ORIGIN STATUS POST 4 CYCLES CARBOPLATIN/TAXOL ENDING ON JANUARY 9, 20123.'}, {'filename': 'patient35_report036_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 20, 'start': 39, 'end': 50}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 20, 'start': 87, 'end': 102}, 'context': 'The patient then underwent 4 cycles of carboplatin/Taxol with the last cycle ending on January 9, 2013.  '}, {'filename': 'patient35_report036_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 20, 'start': 51, 'end': 56}, 'arg2': {'mention': 'January 9, 2013', 'nth_sent': 20, 'start': 87, 'end': 102}, 'context': 'The patient then underwent 4 cycles of carboplatin/Taxol with the last cycle ending on January 9, 2013.  '}, {'filename': 'patient35_report048_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 14, 'end': 26}, 'arg2': {'mention': '4/17/13', 'nth_sent': 8, 'start': 34, 'end': 41}, 'context': 'Last cycle of chemotherapy was on 4/17/13.'}, {'filename': 'patient35_report110_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 20, 'start': 6, 'end': 11}, 'arg2': {'mention': '7/11/13', 'nth_sent': 20, 'start': 34, 'end': 41}, 'context': 'IV/IP chemo x 6 cycles, last dose 7/11/13.'}, {'filename': 'patient35_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 44, 'start': 25, 'end': 37}, 'arg2': {'mention': 'today', 'nth_sent': 44, 'start': 90, 'end': 95}, 'context': 'Once PRN Person5, MD     Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient35_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Paclitaxel', 'nth_sent': 6, 'start': 35, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #4 of Paclitaxel and Carboplatin.'}, {'filename': 'patient35_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 6, 'start': 50, 'end': 61}, 'arg2': {'mention': 'today', 'nth_sent': 6, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #4 of Paclitaxel and Carboplatin.'}, {'filename': 'patient35_report067_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 7, 'start': 27, 'end': 39}, 'arg2': {'mention': '7/11/13', 'nth_sent': 7, 'start': 82, 'end': 89}, 'context': 'She was restarted on IV/IP chemotherapy and has now completed 6 cycles, last dose 7/11/13.'}, {'filename': 'patient11_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 102, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 8, 'start': 13, 'end': 18}, 'context': 'She presents today for a followup postop check, as well as to discuss the need for continued adjuvant chemotherapy.  '}, {'filename': 'patient11_report051_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 4, 'end': 16}, 'arg2': {'mention': 'May 30th', 'nth_sent': 8, 'start': 34, 'end': 42}, 'context': 'Her chemotherapy was completed on May 30th.'}, {'filename': 'patient11_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 4, 'start': 36, 'end': 41}, 'arg2': {'mention': 'May 30th', 'nth_sent': 4, 'start': 78, 'end': 86}, 'context': 'She then had three cycles of postop Taxol and carbo, the last of which was on May 30th.   '}, {'filename': 'patient11_report054_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 4, 'start': 46, 'end': 51}, 'arg2': {'mention': 'May 30th', 'nth_sent': 4, 'start': 78, 'end': 86}, 'context': 'She then had three cycles of postop Taxol and carbo, the last of which was on May 30th.   '}, {'filename': 'patient11_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 102, 'end': 114}, 'arg2': {'mention': 'today', 'nth_sent': 8, 'start': 13, 'end': 18}, 'context': 'She presents today for a followup postop check, as well as to discuss the need for continued adjuvant chemotherapy.  '}, {'filename': 'patient11_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 66, 'start': 57, 'end': 69}, 'arg2': {'mention': 'February 2nd', 'nth_sent': 66, 'start': 76, 'end': 88}, 'context': 'She probably would have to hold off on the next cycle of chemotherapy dated February 2nd until recuperation.'}, {'filename': 'patient11_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 19, 'start': 60, 'end': 72}, 'arg2': {'mention': 'currently', 'nth_sent': 19, 'start': 42, 'end': 51}, 'context': 'Again, significant for ovarian carcinoma, currently getting chemotherapy.'}, {'filename': 'patient39_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 56, 'end': 61}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 49, 'end': 55}, 'context': 'The patient presents for chemo cycle 2, day 1 of weekly Taxol and carboplatin.'}, {'filename': 'patient39_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 66, 'end': 77}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 49, 'end': 55}, 'context': 'The patient presents for chemo cycle 2, day 1 of weekly Taxol and carboplatin.'}, {'filename': 'patient39_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 19, 'start': 134, 'end': 139}, 'arg2': {'mention': 'weekly', 'nth_sent': 19, 'start': 127, 'end': 133}, 'context': 'ASSESSMENT: 80 year old woman who has a history of Stage II B high grade serous adenocarcinoma now ready for cycle 2, day 1 of weekly Taxol and carboplatin.  '}, {'filename': 'patient39_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 19, 'start': 144, 'end': 155}, 'arg2': {'mention': 'weekly', 'nth_sent': 19, 'start': 127, 'end': 133}, 'context': 'ASSESSMENT: 80 year old woman who has a history of Stage II B high grade serous adenocarcinoma now ready for cycle 2, day 1 of weekly Taxol and carboplatin.  '}, {'filename': 'patient39_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 6, 'start': 45, 'end': 50}, 'arg2': {'mention': 'next week', 'nth_sent': 6, 'start': 15, 'end': 24}, 'context': 'Plan for chemo next week, will do dose dense carbo/taxol.'}, {'filename': 'patient39_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 6, 'start': 51, 'end': 56}, 'arg2': {'mention': 'next week', 'nth_sent': 6, 'start': 15, 'end': 24}, 'context': 'Plan for chemo next week, will do dose dense carbo/taxol.'}, {'filename': 'patient39_report025_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemo', 'nth_sent': 6, 'start': 9, 'end': 14}, 'arg2': {'mention': 'next week', 'nth_sent': 6, 'start': 15, 'end': 24}, 'context': 'Plan for chemo next week, will do dose dense carbo/taxol.'}, {'filename': 'patient39_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 33, 'start': 108, 'end': 113}, 'arg2': {'mention': 'monthly', 'nth_sent': 33, 'start': 100, 'end': 107}, 'context': \"Patient has very little neuropathy and has tolerated chemotherapy very well and given the fact that monthly Taxol hasn't improved progression free survival over Avastin I think that would be the optimal maintenance chemotherapy for the patient this time we'll proceed ahead with maintenance Taxol at 135 mg per meter squared I've explained all this to the patient consents for chemotherapy was signed today we'll plan for 6 cycles and then have her colostomy reversed and that we can continue with 6 more cycles at this time.  \"}, {'filename': 'patient39_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 3, 'start': 25, 'end': 30}, 'arg2': {'mention': 'July 25, 2012', 'nth_sent': 4, 'start': 60, 'end': 73}, 'context': 'She received 6 cycles of carbo Taxol. Last treatment was in July 25, 2012.'}, {'filename': 'patient39_report034_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 31, 'end': 36}, 'arg2': {'mention': 'July 25, 2012', 'nth_sent': 4, 'start': 60, 'end': 73}, 'context': 'She received 6 cycles of carbo Taxol. Last treatment was in July 25, 2012.'}, {'filename': 'patient39_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 29, 'end': 34}, 'arg2': {'mention': 'Today', 'nth_sent': 3, 'start': 0, 'end': 5}, 'context': 'Today she present for weekly Taxol/Carbo Q 21 days.'}, {'filename': 'patient39_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carbo', 'nth_sent': 3, 'start': 35, 'end': 40}, 'arg2': {'mention': 'Today', 'nth_sent': 3, 'start': 0, 'end': 5}, 'context': 'Today she present for weekly Taxol/Carbo Q 21 days.'}, {'filename': 'patient39_report029_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 24, 'start': 331, 'end': 343}, 'arg2': {'mention': 'today', 'nth_sent': 24, 'start': 396, 'end': 401}, 'context': 'mg Oral Tablet daily     Aspirin (ASPIR-LOW) 81 mg Oral Tablet, Delayed Release (E.C.) daily     Fish Oil-DHA-EPA (FISH OIL) 1, mg Oral Capsule daily     ASCORBATE CALCIUM/BIOFLAV (ESTER-C ORAL) daily     CALCIUM CARBONATE/VITAMIN D3 (CALTRATE 600 + D ORAL) daily     MULTIVITAMIN W-MINERALS/LUTEIN (CENTRUM SILVER ORAL) daily     Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient39_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 3, 'start': 34, 'end': 39}, 'arg2': {'mention': 'Today', 'nth_sent': 3, 'start': 0, 'end': 5}, 'context': 'Today presents for cycle 4 weekly taxol/carbo Q 21 days.  '}, {'filename': 'patient39_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carbo', 'nth_sent': 3, 'start': 40, 'end': 45}, 'arg2': {'mention': 'Today', 'nth_sent': 3, 'start': 0, 'end': 5}, 'context': 'Today presents for cycle 4 weekly taxol/carbo Q 21 days.  '}, {'filename': 'patient39_report028_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Chemotherapy', 'nth_sent': 21, 'start': 331, 'end': 343}, 'arg2': {'mention': 'today', 'nth_sent': 21, 'start': 396, 'end': 401}, 'context': 'mg Oral Tablet daily     Aspirin (ASPIR-LOW) 81 mg Oral Tablet, Delayed Release (E.C.) daily     Fish Oil-DHA-EPA (FISH OIL) 1, mg Oral Capsule daily     ASCORBATE CALCIUM/BIOFLAV (ESTER-C ORAL) daily     CALCIUM CARBONATE/VITAMIN D3 (CALTRATE 600 + D ORAL) daily     MULTIVITAMIN W-MINERALS/LUTEIN (CENTRUM SILVER ORAL) daily     Chemotherapy labs were reviewed and are acceptable for treatment today.'}, {'filename': 'patient39_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 56, 'end': 61}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 49, 'end': 55}, 'context': 'The patient presents for chemo cycle 3, day 1 of weekly Taxol and carboplatin.'}, {'filename': 'patient39_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 66, 'end': 77}, 'arg2': {'mention': 'weekly', 'nth_sent': 3, 'start': 49, 'end': 55}, 'context': 'The patient presents for chemo cycle 3, day 1 of weekly Taxol and carboplatin.'}, {'filename': 'patient39_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 24, 'start': 134, 'end': 139}, 'arg2': {'mention': 'weekly', 'nth_sent': 24, 'start': 127, 'end': 133}, 'context': 'ASSESSMENT: 80 year old woman who has a history of Stage II B high grade serous adenocarcinoma now ready for cycle 3, day 1 of weekly Taxol and carboplatin.  '}, {'filename': 'patient39_report027_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 24, 'start': 144, 'end': 155}, 'arg2': {'mention': 'weekly', 'nth_sent': 24, 'start': 127, 'end': 133}, 'context': 'ASSESSMENT: 80 year old woman who has a history of Stage II B high grade serous adenocarcinoma now ready for cycle 3, day 1 of weekly Taxol and carboplatin.  '}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 38, 'end': 50}, 'arg2': {'mention': 'early October 2013', 'nth_sent': 9, 'start': 54, 'end': 72}, 'context': 'The patient was scheduled for cycle 4 chemotherapy in early October 2013; however, she reported that she wanted to take some time off from the chemotherapy and presents today for followup.   '}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 46, 'start': 42, 'end': 53}, 'arg2': {'mention': 'early October 2013', 'nth_sent': 46, 'start': 73, 'end': 91}, 'context': 'The patient was scheduled for cycle #4 of carboplatin and gemcitabine in early October 2013, but she contacted my office stating that she wanted a break from the chemotherapy and she presents today for followup stating that she is ready to receive chemotherapy today.  '}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 46, 'start': 58, 'end': 69}, 'arg2': {'mention': 'early October 2013', 'nth_sent': 46, 'start': 73, 'end': 91}, 'context': 'The patient was scheduled for cycle #4 of carboplatin and gemcitabine in early October 2013, but she contacted my office stating that she wanted a break from the chemotherapy and she presents today for followup stating that she is ready to receive chemotherapy today.  '}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 46, 'start': 162, 'end': 174}, 'arg2': {'mention': 'today', 'nth_sent': 46, 'start': 192, 'end': 197}, 'context': 'The patient was scheduled for cycle #4 of carboplatin and gemcitabine in early October 2013, but she contacted my office stating that she wanted a break from the chemotherapy and she presents today for followup stating that she is ready to receive chemotherapy today.  '}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 47, 'start': 50, 'end': 61}, 'arg2': {'mention': 'today', 'nth_sent': 47, 'start': 78, 'end': 83}, 'context': 'PLAN:  Mrs. Patient19 did proceed with cycle 4 of carboplatin and gemcitabine today.'}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 47, 'start': 66, 'end': 77}, 'arg2': {'mention': 'today', 'nth_sent': 47, 'start': 78, 'end': 83}, 'context': 'PLAN:  Mrs. Patient19 did proceed with cycle 4 of carboplatin and gemcitabine today.'}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 49, 'start': 93, 'end': 104}, 'arg2': {'mention': 'November 14, 2013', 'nth_sent': 49, 'start': 108, 'end': 125}, 'context': 'She will have weekly blood work and if her blood counts are adequate, she will receive day 8 gemcitabine on November 14, 2013.'}, {'filename': 'patient19_report050_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 32, 'end': 44}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 5, 'start': 48, 'end': 60}, 'context': 'Mrs. Patient19 received cycle 1 chemotherapy on May 30, 2013 and it was well tolerated, but she then had a reaction to the paclitaxel and the chemotherapy regimen was changed to carboplatin and gemcitabine.'}, {'filename': 'patient19_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 83, 'start': 35, 'end': 47}, 'arg2': {'mention': 'May\\n30', 'nth_sent': 83, 'start': 51, 'end': 57}, 'context': 'This patient had her first dose of chemotherapy on May 30.'}, {'filename': 'patient19_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 48, 'end': 53}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 7, 'start': 73, 'end': 85}, 'context': 'The patient had her first cycle of reduced dose Taxol and carboplatin on May 30, 2013.'}, {'filename': 'patient19_report023_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 58, 'end': 69}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 7, 'start': 73, 'end': 85}, 'context': 'The patient had her first cycle of reduced dose Taxol and carboplatin on May 30, 2013.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 31, 'start': 105, 'end': 116}, 'arg2': {'mention': 'today', 'nth_sent': 31, 'start': 81, 'end': 86}, 'context': 'She tolerated day 1 cycle 1 chemotherapy well; however, blood counts are too low today for day 8 cycle 1 gemcitabine.  '}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 32, 'start': 35, 'end': 47}, 'arg2': {'mention': 'today', 'nth_sent': 32, 'start': 48, 'end': 53}, 'context': 'PLAN:  The patient did not receive chemotherapy today.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 34, 'start': 25, 'end': 37}, 'arg2': {'mention': 'next week', 'nth_sent': 34, 'start': 38, 'end': 47}, 'context': 'She will not receive the chemotherapy next week, but blood counts will be obtained.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 35, 'start': 85, 'end': 97}, 'arg2': {'mention': 'at that time', 'nth_sent': 35, 'start': 98, 'end': 110}, 'context': 'It is anticipated that she will follow up in 2 weeks and will receive cycle 2, day 1 chemotherapy at that time.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 27, 'end': 39}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 7, 'end': 16}, 'context': 'She is currently receiving chemotherapy for a poorly differentiated peritoneal cancer, which is probably of gynecologic origin.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 28, 'end': 39}, 'arg2': {'mention': 'July 16, 2013', 'nth_sent': 4, 'start': 120, 'end': 133}, 'context': 'She received cycle 1, day 1 carboplatin and gemcitabine consisting of gemcitabine 800 mg/m2 and carboplatin AUC of 5 on July 16, 2013.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 4, 'start': 44, 'end': 55}, 'arg2': {'mention': 'July 16, 2013', 'nth_sent': 4, 'start': 120, 'end': 133}, 'context': 'She received cycle 1, day 1 carboplatin and gemcitabine consisting of gemcitabine 800 mg/m2 and carboplatin AUC of 5 on July 16, 2013.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 4, 'start': 44, 'end': 55}, 'arg2': {'mention': 'July 16, 2013', 'nth_sent': 4, 'start': 120, 'end': 133}, 'context': 'She received cycle 1, day 1 carboplatin and gemcitabine consisting of gemcitabine 800 mg/m2 and carboplatin AUC of 5 on July 16, 2013.'}, {'filename': 'patient19_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 28, 'end': 39}, 'arg2': {'mention': 'July 16, 2013', 'nth_sent': 4, 'start': 120, 'end': 133}, 'context': 'She received cycle 1, day 1 carboplatin and gemcitabine consisting of gemcitabine 800 mg/m2 and carboplatin AUC of 5 on July 16, 2013.'}, {'filename': 'patient19_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 7, 'start': 95, 'end': 105}, 'arg2': {'mention': 'June 20, 2013', 'nth_sent': 7, 'start': 26, 'end': 39}, 'context': 'Cycle #2 was initiated on June 20, 2013; however, the patient had a severe reaction during the paclitaxel infusion.'}, {'filename': 'patient19_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 12, 'start': 64, 'end': 76}, 'arg2': {'mention': 'today', 'nth_sent': 12, 'start': 15, 'end': 20}, 'context': 'She does state today that she wants to continue with additional chemotherapy.  '}, {'filename': 'patient19_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 41, 'start': 54, 'end': 65}, 'arg2': {'mention': 'next week', 'nth_sent': 41, 'start': 31, 'end': 40}, 'context': 'PLAN:  The patient will return next week for cycle #1 carboplatin and gemcitabine.'}, {'filename': 'patient19_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 41, 'start': 70, 'end': 81}, 'arg2': {'mention': 'next week', 'nth_sent': 41, 'start': 31, 'end': 40}, 'context': 'PLAN:  The patient will return next week for cycle #1 carboplatin and gemcitabine.'}, {'filename': 'patient19_report043_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 33, 'end': 45}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 5, 'start': 49, 'end': 61}, 'context': 'Mrs. Patient19 received cycle #1 chemotherapy on May 30, 2013.'}, {'filename': 'patient19_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 45, 'start': 22, 'end': 34}, 'arg2': {'mention': 'On the day', 'nth_sent': 45, 'start': 0, 'end': 10}, 'context': 'On the day of cycle 1 chemotherapy, she did see blood in her stool and presented for evaluation and was briefly hospitalized.'}, {'filename': 'patient19_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 50, 'start': 71, 'end': 83}, 'arg2': {'mention': 'June 20, 2013', 'nth_sent': 50, 'start': 37, 'end': 50}, 'context': 'She will return for reexamination on June 20, 2013 and will be due for chemotherapy at that time.      '}, {'filename': 'patient19_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 3, 'start': 244, 'end': 249}, 'arg2': {'mention': '3 month', 'nth_sent': 3, 'start': 269, 'end': 276}, 'context': 'I indicated to the patient and her daughter that in light of her advanced age and medical comorbidities as well as findings on CT scan which revealed heavy small bowel mesenteric involvement that I would recommend neoadjuvant chemotherapy with Taxol and carboplatin at 3 month intervals followed by consideration of an interval debulking.'}, {'filename': 'patient19_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 254, 'end': 265}, 'arg2': {'mention': '3 month', 'nth_sent': 3, 'start': 269, 'end': 276}, 'context': 'I indicated to the patient and her daughter that in light of her advanced age and medical comorbidities as well as findings on CT scan which revealed heavy small bowel mesenteric involvement that I would recommend neoadjuvant chemotherapy with Taxol and carboplatin at 3 month intervals followed by consideration of an interval debulking.'}, {'filename': 'patient19_report014_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 112, 'end': 124}, 'arg2': {'mention': 'within the next 2 weeks', 'nth_sent': 9, 'start': 141, 'end': 164}, 'context': \"I've asked her to contact her general surgeon to determine if an IV port can be placed within the next week for chemotherapy to be initiated within the next 2 weeks.     \"}, {'filename': 'patient19_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 38, 'end': 50}, 'arg2': {'mention': 'early October 2013', 'nth_sent': 9, 'start': 54, 'end': 72}, 'context': 'The patient was scheduled for cycle 4 chemotherapy in early October 2013; however, at her request she had interruption of the chemotherapy and resumed treatment in November 2013.  '}, {'filename': 'patient19_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 38, 'end': 50}, 'arg2': {'mention': 'November 2013', 'nth_sent': 9, 'start': 164, 'end': 177}, 'context': 'The patient was scheduled for cycle 4 chemotherapy in early October 2013; however, at her request she had interruption of the chemotherapy and resumed treatment in November 2013.  '}, {'filename': 'patient19_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 44, 'start': 45, 'end': 56}, 'arg2': {'mention': 'tomorrow', 'nth_sent': 44, 'start': 17, 'end': 25}, 'context': 'She is scheduled tomorrow for cycle 4/ day 8 gemcitabine; however, her neutrophil count today is 700 and her total white blood cell count of 1100.'}, {'filename': 'patient19_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 46, 'start': 4, 'end': 16}, 'arg2': {'mention': 'tomorrow', 'nth_sent': 46, 'start': 42, 'end': 50}, 'context': 'The chemotherapy will not be administered tomorrow.'}, {'filename': 'patient19_report059_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 32, 'end': 44}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 5, 'start': 48, 'end': 60}, 'context': 'Mrs. Patient19 received cycle 1 chemotherapy on May 30, 2013 and it was well tolerated, but she then had a reaction to the paclitaxel and the chemotherapy regimen was changed to carboplatin and gemcitabine.'}, {'filename': 'patient19_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 27, 'end': 39}, 'arg2': {'mention': 'August 13, 2013', 'nth_sent': 5, 'start': 48, 'end': 63}, 'context': 'The patient did have day 8 chemotherapy held on August 13, 2013 and on July 23, 2013 due to low blood counts.  '}, {'filename': 'patient19_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 27, 'end': 39}, 'arg2': {'mention': 'July 23, 2013', 'nth_sent': 5, 'start': 71, 'end': 84}, 'context': 'The patient did have day 8 chemotherapy held on August 13, 2013 and on July 23, 2013 due to low blood counts.  '}, {'filename': 'patient19_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 38, 'start': 49, 'end': 60}, 'arg2': {'mention': 'September 3, 2013', 'nth_sent': 38, 'start': 80, 'end': 97}, 'context': 'PLAN:  Mrs. Patient19 will continue with cycle 3 carboplatin and gemcitabine on September 3, 2013.'}, {'filename': 'patient19_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 38, 'start': 65, 'end': 76}, 'arg2': {'mention': 'September 3, 2013', 'nth_sent': 38, 'start': 80, 'end': 97}, 'context': 'PLAN:  Mrs. Patient19 will continue with cycle 3 carboplatin and gemcitabine on September 3, 2013.'}, {'filename': 'patient19_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 27, 'end': 39}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 4, 'end': 13}, 'context': 'She currently is receiving chemotherapy for poorly differentiated peritoneal cancer, which is most likely of gynecologic origin.'}, {'filename': 'patient19_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 9, 'start': 61, 'end': 73}, 'arg2': {'mention': 'today', 'nth_sent': 9, 'start': 13, 'end': 18}, 'context': 'She presents today for evaluation prior to receiving cycle 2 chemotherapy.'}, {'filename': 'patient19_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 5, 'start': 32, 'end': 44}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 5, 'start': 48, 'end': 60}, 'context': 'Mrs. Patient19 received cycle 1 chemotherapy on May 30, 2013.'}, {'filename': 'patient19_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 7, 'start': 58, 'end': 69}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 7, 'start': 73, 'end': 85}, 'context': 'The patient had her first cycle of reduced dose Taxol and carboplatin on May 30, 2013.'}, {'filename': 'patient19_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 7, 'start': 48, 'end': 53}, 'arg2': {'mention': 'May 30, 2013', 'nth_sent': 7, 'start': 73, 'end': 85}, 'context': 'The patient had her first cycle of reduced dose Taxol and carboplatin on May 30, 2013.'}, {'filename': 'patient19_report026_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 84, 'start': 35, 'end': 47}, 'arg2': {'mention': 'May\\n30', 'nth_sent': 84, 'start': 51, 'end': 57}, 'context': 'This patient had her first dose of chemotherapy on May 30.'}, {'filename': 'patient19_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'gemcitabine', 'nth_sent': 26, 'start': 57, 'end': 68}, 'arg2': {'mention': 'today', 'nth_sent': 26, 'start': 13, 'end': 18}, 'context': 'She presents today for evaluation prior to cycle 2 day 1 gemcitabine and carboplatin.'}, {'filename': 'patient19_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 26, 'start': 73, 'end': 84}, 'arg2': {'mention': 'today', 'nth_sent': 26, 'start': 13, 'end': 18}, 'context': 'She presents today for evaluation prior to cycle 2 day 1 gemcitabine and carboplatin.'}, {'filename': 'patient19_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 2, 'start': 27, 'end': 39}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 7, 'end': 16}, 'context': 'She is currently receiving chemotherapy for poorly differentiated peritoneal cancer, which is probably of gynecologic origin.'}, {'filename': 'patient19_report045_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 25, 'start': 72, 'end': 84}, 'arg2': {'mention': 'currently', 'nth_sent': 25, 'start': 51, 'end': 60}, 'context': 'IMPRESSION:  Mrs. Patient19 is an 80-year-old lady currently undergoing chemotherapy for a poorly differentiated peritoneal cancer, which is probably of gynecological origin.'}, {'filename': 'patient19_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 55, 'start': 58, 'end': 68}, 'arg2': {'mention': 'today', 'nth_sent': 55, 'start': 42, 'end': 47}, 'context': 'PLAN:  The patient initiated chemotherapy today utilizing paclitaxel 150 mg/m2 for total dose of 269 mg and carboplatin AUC of 5 for final dose of 254 mg.'}, {'filename': 'patient19_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 55, 'start': 108, 'end': 119}, 'arg2': {'mention': 'today', 'nth_sent': 55, 'start': 42, 'end': 47}, 'context': 'PLAN:  The patient initiated chemotherapy today utilizing paclitaxel 150 mg/m2 for total dose of 269 mg and carboplatin AUC of 5 for final dose of 254 mg.'}, {'filename': 'patient19_report021_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 413, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 59, 'start': 21, 'end': 33}, 'arg2': {'mention': '21 days', 'nth_sent': 59, 'start': 102, 'end': 109}, 'context': 'If she tolerates the chemotherapy adequately, she will proceed with a second cycle of chemotherapy in 21 days and followup CAT scan after that.'}, {'filename': 'patient28_report035_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 8, 'start': 60, 'end': 72}, 'arg2': {'mention': 'today', 'nth_sent': 8, 'start': 44, 'end': 49}, 'context': 'Patient and husband have multiple questions today regarding chemotherapy, side effects, hair loss, and work restrictions.'}, {'filename': 'patient28_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 32, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #4 Carboplatin/Taxol.'}, {'filename': 'patient28_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 44, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #4 Carboplatin/Taxol.'}, {'filename': 'patient28_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 32, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #3 Carboplatin/Taxol.'}, {'filename': 'patient28_report041_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 44, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #3 Carboplatin/Taxol.'}, {'filename': 'patient28_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 32, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #3 Carboplatin/Taxol.'}, {'filename': 'patient28_report040_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 44, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #3 Carboplatin/Taxol.'}, {'filename': 'patient28_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 32, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #5 Carboplatin/Taxol.'}, {'filename': 'patient28_report044_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 44, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #5 Carboplatin/Taxol.'}, {'filename': 'patient28_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 32, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #2 Carboplatin/Taxol.'}, {'filename': 'patient28_report039_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 44, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #2 Carboplatin/Taxol.'}, {'filename': 'patient28_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Carboplatin', 'nth_sent': 2, 'start': 32, 'end': 43}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #6 Carboplatin/Taxol.   '}, {'filename': 'patient28_report046_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Taxol', 'nth_sent': 2, 'start': 44, 'end': 49}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle #6 Carboplatin/Taxol.   '}, {'filename': 'patient09_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 5, 'start': 43, 'end': 54}, 'arg2': {'mention': 'March 15,\\n2013', 'nth_sent': 6, 'start': 93, 'end': 107}, 'context': 'The patient went on to receive 6 cycles of carboplatin and paclitaxel. This was completed on March 15, 2013.'}, {'filename': 'patient09_report053_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 5, 'start': 59, 'end': 69}, 'arg2': {'mention': 'March 15,\\n2013', 'nth_sent': 6, 'start': 93, 'end': 107}, 'context': 'The patient went on to receive 6 cycles of carboplatin and paclitaxel. This was completed on March 15, 2013.'}, {'filename': 'patient09_report055_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 43, 'end': 54}, 'arg2': {'mention': 'March 15,\\n2013', 'nth_sent': 4, 'start': 93, 'end': 107}, 'context': 'The patient went on to receive 6 cycles of carboplatin and paclitaxel. This was completed on March 15, 2013.'}, {'filename': 'patient09_report055_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 3, 'start': 59, 'end': 69}, 'arg2': {'mention': 'March 15,\\n2013', 'nth_sent': 4, 'start': 93, 'end': 107}, 'context': 'The patient went on to receive 6 cycles of carboplatin and paclitaxel. This was completed on March 15, 2013.'}, {'filename': 'patient09_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 0, 'start': 28, 'end': 39}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 46, 'end': 51}, 'context': 'Patient receiving cycle 5/6 carboplatin/taxol today.'}, {'filename': 'patient09_report047_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 0, 'start': 40, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 0, 'start': 46, 'end': 51}, 'context': 'Patient receiving cycle 5/6 carboplatin/taxol today.'}, {'filename': 'patient09_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'taxol', 'nth_sent': 3, 'start': 391, 'end': 396}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 409, 'end': 414}, 'context': 'Usual Wt: 163 lb (73.936 kg) Ideal/Desirable Wt: 143 lb (64.864 kg) - maintain current weight  Pertinent Medical/Surgical History:  Stage IIIC ovarian Cancer S/P XL/TAH/BSO/OMX/RSR-RA/diverting ileostomy Post-op wound breakdown --> wound vac placement Vaginal cancer  Pertinent Biochemical Data/Tests:  No abnormal pertinent labs  Pertinent Medications/Treatments:  Reviewed above 1st cycle taxol/carboplatin today  '}, {'filename': 'patient09_report033_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 3, 'start': 397, 'end': 408}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 409, 'end': 414}, 'context': 'Usual Wt: 163 lb (73.936 kg) Ideal/Desirable Wt: 143 lb (64.864 kg) - maintain current weight  Pertinent Medical/Surgical History:  Stage IIIC ovarian Cancer S/P XL/TAH/BSO/OMX/RSR-RA/diverting ileostomy Post-op wound breakdown --> wound vac placement Vaginal cancer  Pertinent Biochemical Data/Tests:  No abnormal pertinent labs  Pertinent Medications/Treatments:  Reviewed above 1st cycle taxol/carboplatin today  '}, {'filename': 'patient09_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 34, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle 6 of carboplatin and paclitaxel.'}, {'filename': 'patient09_report049_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 50, 'end': 60}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 13, 'end': 18}, 'context': 'She presents today for cycle 6 of carboplatin and paclitaxel.'}, {'filename': 'patient09_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 4, 'start': 14, 'end': 26}, 'arg2': {'mention': 'March 15, 2013', 'nth_sent': 4, 'start': 30, 'end': 44}, 'context': 'She completed chemotherapy on March 15, 2013, and of note is the fact that many years before she had vaginal cancer and was treated with pelvic radiation.'}, {'filename': 'patient09_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 13, 'start': 163, 'end': 175}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 49, 'end': 54}, 'context': 'DISCUSSION:  We have had an extensive discussion today and I have explained to her that the choices of further therapy of this detected cancer tissue include one, chemotherapy, the alternative is surgery and at this time, chemotherapy may represent a better option based on the fact that this cancer tissue is being noted within 3 months of completing primary chemotherapy and also the fact that she had previous pelvic radiation and therefore this is occurring in a pre-radiated field, which will make the area even more difficult to dissect in view of previous surgery and also radiation.'}, {'filename': 'patient09_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 13, 'start': 163, 'end': 175}, 'arg2': {'mention': 'today', 'nth_sent': 13, 'start': 49, 'end': 54}, 'context': 'DISCUSSION:  We have had an extensive discussion today and I have explained to her that the choices of further therapy of this detected cancer tissue include one, chemotherapy, the alternative is surgery and at this time, chemotherapy may represent a better option based on the fact that this cancer tissue is being noted within 3 months of completing primary chemotherapy and also the fact that she had previous pelvic radiation and therefore this is occurring in a pre-radiated field, which will make the area even more difficult to dissect in view of previous surgery and also radiation.'}, {'filename': 'patient09_report084_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'chemotherapy', 'nth_sent': 3, 'start': 14, 'end': 26}, 'arg2': {'mention': 'March 15, 2013', 'nth_sent': 3, 'start': 30, 'end': 44}, 'context': 'She completed chemotherapy on March 15, 2013, and of note is the fact that many years before she had vaginal cancer and was treated with pelvic radiation.  '}, {'filename': 'patient09_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'carboplatin', 'nth_sent': 4, 'start': 19, 'end': 30}, 'arg2': {'mention': 'last week', 'nth_sent': 4, 'start': 46, 'end': 55}, 'context': 'She had cycle 3 of carboplatin and paclitaxel last week.'}, {'filename': 'patient09_report042_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'paclitaxel', 'nth_sent': 4, 'start': 35, 'end': 45}, 'arg2': {'mention': 'last week', 'nth_sent': 4, 'start': 46, 'end': 55}, 'context': 'She had cycle 3 of carboplatin and paclitaxel last week.'}]\n",
      "226\n",
      "[{'filename': 'patient32_report024_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 4, 'start': 21, 'end': 31}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 66, 'end': 71}, 'context': \"He was randomized to ipilimumab arm and presents to the office on today's  date for concurrent followup.  \"}, {'filename': 'patient32_report020_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 4, 'start': 25, 'end': 35}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 83, 'end': 88}, 'context': \"He was randomized to the ipilimumab arm, and is here to commence with treatment on today's date.  \"}, {'filename': 'patient32_report022_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 4, 'start': 25, 'end': 35}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 70, 'end': 75}, 'context': \"He was randomized to the ipilimumab arm and presents to the office on today's date for clearance for potential treatment with dose #3.  \"}, {'filename': 'patient32_report026_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 2, 'start': 148, 'end': 158}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 110, 'end': 119}, 'context': 'PRINCIPAL DIAGNOSES Mr. Person4 is a 59-year-old gentleman with history of locally recurrent melanoma, who is currently being treated with adjuvant ipilimumab at 10 mg/kg on  the E1609 trial.  '}, {'filename': 'patient32_report026_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 46, 'start': 143, 'end': 153}, 'arg2': {'mention': 'currently', 'nth_sent': 46, 'start': 114, 'end': 123}, 'context': 'IMPRESSION AND PLAN Mr. Person4 is a 59-year-old gentleman with history of high-risk, locally recurrent melanoma, currently being treated with ipilimumab at 10 mg/kg on the E1609 trial, status post 3 doses total, complicated by hepatitis, for which he is on immunosuppression with prednisone at 80 mg p.o. twice a day and CellCept 1  g p.o.'}, {'filename': 'patient32_report028_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 2, 'start': 107, 'end': 117}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 29, 'end': 34}, 'context': \"He presents to the office on today's date in followup of ECOG 1609, adjuvant trial being randomized to the ipilimumab dosing at 10 mg/kg.  \"}, {'filename': 'patient32_report021_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'ipilimumab', 'nth_sent': 5, 'start': 35, 'end': 45}, 'arg2': {'mention': 'today', 'nth_sent': 5, 'start': 80, 'end': 85}, 'context': \"He was  randomized to the 10 mg/kg ipilimumab arm and presents to the office on today's  date for dose number 2 of this treatment regimen.  \"}, {'filename': 'patient43_report047_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/25/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report047_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/25/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report047_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 59, 'start': 145, 'end': 156}, 'arg2': {'mention': '9/4', 'nth_sent': 59, 'start': 11, 'end': 13}, 'context': '03:35\\t 100 94 09/24 16:45\\t 70  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report047_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 59, 'start': 145, 'end': 156}, 'arg2': {'mention': '09/18', 'nth_sent': 59, 'start': 177, 'end': 182}, 'context': '03:35\\t 100 94 09/24 16:45\\t 70  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report077_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 9, 'start': 110, 'end': 121}, 'arg2': {'mention': '09/18', 'nth_sent': 9, 'start': 142, 'end': 147}, 'context': 'Hospital Course  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admittted for high dose IL2 (first cycle).'}, {'filename': 'patient43_report077_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 9, 'start': 110, 'end': 121}, 'arg2': {'mention': '9/4', 'nth_sent': 9, 'start': 122, 'end': 125}, 'context': 'Hospital Course  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admittted for high dose IL2 (first cycle).'}, {'filename': 'patient43_report135_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 78, 'start': 48, 'end': 59}, 'arg2': {'mention': 'today', 'nth_sent': 78, 'start': 68, 'end': 73}, 'context': 'Therefore, we plan to withhold the patient from aflibercept therapy today.'}, {'filename': 'patient43_report133_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 68, 'start': 107, 'end': 118}, 'arg2': {'mention': 'next week', 'nth_sent': 68, 'start': 119, 'end': 128}, 'context': 'If it is determined that these are not areas of splenic infarcts, then we will proceed with treatment with aflibercept next week pending a negative hypercoagulable profile.'}, {'filename': 'patient43_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 17, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 17, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.  '}, {'filename': 'patient43_report144_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 19, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 19, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.  '}, {'filename': 'patient43_report124_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 7, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 7, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.  '}, {'filename': 'patient43_report044_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/24/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report044_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/24/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report044_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 64, 'start': 269, 'end': 280}, 'arg2': {'mention': '9/4', 'nth_sent': 64, 'start': 151, 'end': 153}, 'context': 'Date and Time \\t FiO 2 SpO 2 ______________________________________________________________________________ ___________________________ 09/23 23:40\\t 40 94  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report044_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 64, 'start': 269, 'end': 280}, 'arg2': {'mention': '09/18', 'nth_sent': 64, 'start': 301, 'end': 306}, 'context': 'Date and Time \\t FiO 2 SpO 2 ______________________________________________________________________________ ___________________________ 09/23 23:40\\t 40 94  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report167_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 97, 'end': 110}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report167_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 125, 'end': 136}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 3, 'start': 127, 'end': 140}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, randomized to arm A, which is high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 155, 'end': 166}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, randomized to arm A, which is high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report098_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 55, 'start': 43, 'end': 56}, 'arg2': {'mention': 'two weeks ago', 'nth_sent': 55, 'start': 57, 'end': 70}, 'context': 'He tolerated his second cycle of high-dose interleukin-2 two weeks ago very well.'}, {'filename': 'patient43_report153_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 20, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 20, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.'}, {'filename': 'patient43_report153_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 30, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/4', 'nth_sent': 30, 'start': 77, 'end': 80}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report153_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 30, 'start': 115, 'end': 118}, 'arg2': {'mention': '9/18', 'nth_sent': 30, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report153_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 30, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/18', 'nth_sent': 30, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report169_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 97, 'end': 110}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with Aflibercept, a VEGF trap molecule.    '}, {'filename': 'patient43_report169_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 2, 'start': 125, 'end': 136}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with Aflibercept, a VEGF trap molecule.    '}, {'filename': 'patient43_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 11, 'start': 67, 'end': 78}, 'arg2': {'mention': '9/4', 'nth_sent': 11, 'start': 79, 'end': 82}, 'context': 'Patient enrolled in UPCI protocol 10-095  He had his first dose of aflibercept 9/4 and second dose 9/18 prior to admission for his first cycle of high dose IL2.'}, {'filename': 'patient43_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 11, 'start': 67, 'end': 78}, 'arg2': {'mention': '9/18', 'nth_sent': 11, 'start': 99, 'end': 103}, 'context': 'Patient enrolled in UPCI protocol 10-095  He had his first dose of aflibercept 9/4 and second dose 9/18 prior to admission for his first cycle of high dose IL2.'}, {'filename': 'patient43_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 14, 'start': 38, 'end': 41}, 'arg2': {'mention': '9/22', 'nth_sent': 14, 'start': 48, 'end': 52}, 'context': 'He received his 9th and final dose of IL2 at MN 9/22.'}, {'filename': 'patient43_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 42, 'start': 9152, 'end': 9163}, 'arg2': {'mention': '9/4', 'nth_sent': 42, 'start': 322, 'end': 325}, 'context': '9/18/2012 8:00:00 AM\\t 13 mEq/L\\t\\t 7-15 Common Chem\\t BUN\\t 9/18/2012 8:00:00 AM\\t 12 mg/dL\\t\\t 8-26 Common Chem\\t Cr\\t 9/18/2012 8:00:00 AM\\t 1.0 mg/dL\\t\\t 0.5-1.4 Common Chem\\t GFR (estimated)\\t 9/18/2012 8:00:00 AM\\t eGFR>60 \\t\\t\\t Y Common Chem\\t Glucose\\t 9/18/2012 8:00:00 AM\\t 85 mg/dL\\t\\t 70-99\\t Y Common Chem\\t Ca\\t 9/18/2012 8:00:00 AM\\t 9.4 mg/dL\\t\\t 8.4-10.2 Common Chem\\t Phos\\t 9/18/2012 8:00:00 AM\\t 4.0 mg/dL\\t\\t 2.5-4.6 Common Chem\\t Albumin\\t 9/18/2012 8:00:00 AM\\t 3.7 gm/dL\\t\\t 3.4-5.0 Common Chem\\t Total Protein\\t 9/18/2012 8:00:00 AM\\t 7.1 gm/dL\\t\\t 6.3-7.7 Common Chem\\t Bili, Total\\t 9/18/2012 8:00:00 AM\\t 0.5 mg/dL\\t\\t 0.3-1.5 Common Chem\\t ALT/SGPT\\t 9/18/2012 8:00:00 AM\\t 19 IU/L\\t\\t 17-63 Common Chem\\t AST/SGOT\\t 9/18/2012 8:00:00 AM\\t 26 IU/L\\t\\t 15-41 Common Chem\\t Alk Phos\\t 9/18/2012 8:00:00 AM\\t 51 IU/L\\t\\t 38-126 Common Chem\\t LDH\\t 9/18/2012 8:00:00 AM\\t 164 IU/L  Group\\t Detail\\t Date\\t Value w/Units\\t Flags\\t Normal Range\\t Comment Ind Hematology\\t WBC\\t 9/23/2012 4:05:00 AM\\t 9.1 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/23/2012 4:05:00 AM\\t 4.14 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/23/2012 4:05:00 AM\\t 12.7 gm/dL\\t Low\\t 12.9-16.9 Hematology\\t Hct\\t 9/23/2012 4:05:00 AM\\t 36.0 %\\t Low\\t 38.0-48.8 Hematology\\t MCV\\t 9/23/2012 4:05:00 AM\\t 86.9 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/23/2012 4:05:00 AM\\t 30.7 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/23/2012 4:05:00 AM\\t 35.4 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/23/2012 4:05:00 AM\\t 14.2 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/23/2012 4:05:00 AM\\t 8.7 fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/23/2012 4:05:00 AM\\t 32 X10E+09/L\\t Low\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/23/2012 4:05:00 AM\\t 70.7 %\\t\\t 44.3-77.1 Hematology\\t Lymphs-Manual\\t 9/23/2012 4:05:00 AM\\t 18.7 %\\t\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/23/2012 4:05:00 AM\\t 9.4 %\\t\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.8 %\\t\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.4 %\\t\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/23/2012 4:05:00 AM\\t 6.4 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/23/2012 4:05:00 AM\\t 1.7 X1OE+09/L\\t\\t 0.80-3.65  Hematology\\t ABS Monocytes-Manual\\t 9/23/2012 4:05:00 AM\\t 0.9 X1OE+09/L 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.1 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/23/2012 4:05:00 AM\\t Auto diff performed  Hematology\\t WBC\\t 9/22/2012 4:55:00 AM\\t 3.6 X10E+09/L\\t Low\\t 3.8-10.6 Hematology\\t RBC\\t 9/22/2012 4:55:00 AM\\t 4.25 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/22/2012 4:55:00 AM\\t 12.9 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/22/2012 4:55:00 AM\\t 36.8 %\\t Low\\t 38.0-48.8 Hematology\\t MCV\\t 9/22/2012 4:55:00 AM\\t 86.6 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/22/2012 4:55:00 AM\\t 30.3 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/22/2012 4:55:00 AM\\t 35.0 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/22/2012 4:55:00 AM\\t 13.8 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/22/2012 4:55:00 AM\\t 7.2 fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/22/2012 4:55:00 AM\\t 42 X10E+09/L\\t Low\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/22/2012 4:55:00 AM\\t 35.6 %\\t Low\\t 44.3-77.1 Hematology\\t Bands-Manual\\t 9/22/2012 4:55:00 AM\\t 50.0 %\\t High\\t 2-8 Hematology\\t Monocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 1.9 %\\t Low\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/22/2012 4:55:00 AM\\t 3.8 %\\t\\t 0.2-6.0 Hematology\\t Myelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 1.9 %\\t High Hematology\\t Metamyelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 6.7 %\\t High Hematology\\t Nucleated rbc\\t 9/22/2012 4:55:00 AM\\t 1.0 Hematology\\t ABS Neutrophils-Manual\\t 9/22/2012 4:55:00 AM\\t 3.1 X10E+09/L 2.24-7.68 Hematology\\t ABS Monocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 0.1 X1OE+09/L\\t Low 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/22/2012 4:55:00 AM\\t 0.1 X1OE+09/L 0.0-0.4 Hematology\\t ABS Myelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 0.1 X1OE+09/L\\t High  Hematology\\t ABS Metamyelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 0.2 X1OE+09/L High Hematology\\t Type of Differential\\t 9/22/2012 4:55:00 AM\\t Image Differential Performed Hematology\\t RBC Fragments\\t 9/22/2012 4:55:00 AM\\t 1+ Hematology\\t Burr Cells\\t 9/22/2012 4:55:00 AM\\t 1+ Hematology\\t WBC\\t 9/21/2012 4:05:00 AM\\t 4.5 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/21/2012 4:05:00 AM\\t 4.34 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/21/2012 4:05:00 AM\\t 13.4 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/21/2012 4:05:00 AM\\t 38.2 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/21/2012 4:05:00 AM\\t 87.9 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/21/2012 4:05:00 AM\\t 31.0 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/21/2012 4:05:00 AM\\t 35.3 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/21/2012 4:05:00 AM\\t 13.9 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/21/2012 4:05:00 AM\\t Unavailable fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/21/2012 4:05:00 AM\\t 111 X10E+09/L\\t Low\\t 156-369\\t Y Hematology\\t Neutrophils-Manual\\t 9/21/2012 4:05:00 AM\\t 78.8 %\\t High\\t 44.3-77.1  Hematology\\t Lymphs-Manual\\t 9/21/2012 4:05:00 AM\\t 5.6 %\\t Low\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/21/2012 4:05:00 AM\\t 8.9 %\\t\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/21/2012 4:05:00 AM\\t 6.4 %\\t High\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/21/2012 4:05:00 AM\\t 0.3 %\\t\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/21/2012 4:05:00 AM\\t 3.5 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/21/2012 4:05:00 AM\\t 0.3 X1OE+09/L\\t Low 0.80-3.65 Hematology\\t ABS Monocytes-Manual\\t 9/21/2012 4:05:00 AM\\t 0.4 X1OE+09/L 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/21/2012 4:05:00 AM\\t 0.3 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/21/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/21/2012 4:05:00 AM\\t Auto diff performed  Hematology\\t WBC\\t 9/20/2012 8:39:00 AM\\t 5.9 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/20/2012 8:39:00 AM\\t 4.59 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/20/2012 8:39:00 AM\\t 14.0 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/20/2012 8:39:00 AM\\t 40.5 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/20/2012 8:39:00 AM\\t 88.3 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/20/2012 8:39:00 AM\\t 30.6 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/20/2012 8:39:00 AM\\t 34.7 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/20/2012 8:39:00 AM\\t 13.6 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/20/2012 8:39:00 AM\\t 6.4 fL\\t Low\\t 6.8-10.4 Hematology\\t Platelets\\t 9/20/2012 8:39:00 AM\\t 190 X10E+09/L\\t\\t 156-369 Hematology\\t WBC\\t 9/19/2012 4:05:00 AM\\t 6.2 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/19/2012 4:05:00 AM\\t 4.74 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/19/2012 4:05:00 AM\\t 14.5 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/19/2012 4:05:00 AM\\t 41.9 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/19/2012 4:05:00 AM\\t 88.3 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/19/2012 4:05:00 AM\\t 30.5 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/19/2012 4:05:00 AM\\t 34.6 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/19/2012 4:05:00 AM\\t 13.4 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/19/2012 4:05:00 AM\\t 6.8 fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/19/2012 4:05:00 AM\\t 271 X10E+09/L\\t\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/19/2012 4:05:00 AM\\t 96.4 %\\t High\\t 44.3-77.1  Hematology\\t Lymphs-Manual\\t 9/19/2012 4:05:00 AM\\t 1.8 %\\t Low\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/19/2012 4:05:00 AM\\t 1.5 %\\t Low\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.3 %\\t\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.0 %\\t Low\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/19/2012 4:05:00 AM\\t 6.0 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/19/2012 4:05:00 AM\\t 0.1 X1OE+09/L\\t Low 0.80-3.65 Hematology\\t ABS Monocytes-Manual\\t 9/19/2012 4:05:00 AM\\t 0.1 X1OE+09/L\\t Low 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/19/2012 4:05:00 AM\\t Auto diff performed  Hematology\\t WBC\\t 9/18/2012 8:00:00 AM\\t 4.4 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/18/2012 8:00:00 AM\\t 4.90 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/18/2012 8:00:00 AM\\t 15.0 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/18/2012 8:00:00 AM\\t 44.0 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/18/2012 8:00:00 AM\\t 89.7 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/18/2012 8:00:00 AM\\t 30.5 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/18/2012 8:00:00 AM\\t 34.0 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/18/2012 8:00:00 AM\\t 13.7 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/18/2012 8:00:00 AM\\t 6.3 fL\\t Low\\t 6.8-10.4 Hematology\\t Platelets\\t 9/18/2012 8:00:00 AM\\t 402 X10E+09/L\\t High\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/18/2012 8:00:00 AM\\t 55.0 %\\t\\t 44.3-77.1 Hematology\\t Lymphs-Manual\\t 9/18/2012 8:00:00 AM\\t 27.3 %\\t\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/18/2012 8:00:00 AM\\t 14.8 %\\t High\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/18/2012 8:00:00 AM\\t 2.2 %\\t\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/18/2012 8:00:00 AM\\t 0.7 %\\t\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/18/2012 8:00:00 AM\\t 2.4 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/18/2012 8:00:00 AM\\t 1.2 X1OE+09/L\\t\\t 0.80-3.65  Hematology\\t ABS Monocytes-Manual\\t 9/18/2012 8:00:00 AM\\t 0.7 X1OE+09/L 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/18/2012 8:00:00 AM\\t 0.1 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/18/2012 8:00:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/18/2012 8:00:00 AM\\t Auto diff performed   Plan Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 42, 'start': 9152, 'end': 9163}, 'arg2': {'mention': '09/18', 'nth_sent': 42, 'start': 9184, 'end': 9189}, 'context': '9/18/2012 8:00:00 AM\\t 13 mEq/L\\t\\t 7-15 Common Chem\\t BUN\\t 9/18/2012 8:00:00 AM\\t 12 mg/dL\\t\\t 8-26 Common Chem\\t Cr\\t 9/18/2012 8:00:00 AM\\t 1.0 mg/dL\\t\\t 0.5-1.4 Common Chem\\t GFR (estimated)\\t 9/18/2012 8:00:00 AM\\t eGFR>60 \\t\\t\\t Y Common Chem\\t Glucose\\t 9/18/2012 8:00:00 AM\\t 85 mg/dL\\t\\t 70-99\\t Y Common Chem\\t Ca\\t 9/18/2012 8:00:00 AM\\t 9.4 mg/dL\\t\\t 8.4-10.2 Common Chem\\t Phos\\t 9/18/2012 8:00:00 AM\\t 4.0 mg/dL\\t\\t 2.5-4.6 Common Chem\\t Albumin\\t 9/18/2012 8:00:00 AM\\t 3.7 gm/dL\\t\\t 3.4-5.0 Common Chem\\t Total Protein\\t 9/18/2012 8:00:00 AM\\t 7.1 gm/dL\\t\\t 6.3-7.7 Common Chem\\t Bili, Total\\t 9/18/2012 8:00:00 AM\\t 0.5 mg/dL\\t\\t 0.3-1.5 Common Chem\\t ALT/SGPT\\t 9/18/2012 8:00:00 AM\\t 19 IU/L\\t\\t 17-63 Common Chem\\t AST/SGOT\\t 9/18/2012 8:00:00 AM\\t 26 IU/L\\t\\t 15-41 Common Chem\\t Alk Phos\\t 9/18/2012 8:00:00 AM\\t 51 IU/L\\t\\t 38-126 Common Chem\\t LDH\\t 9/18/2012 8:00:00 AM\\t 164 IU/L  Group\\t Detail\\t Date\\t Value w/Units\\t Flags\\t Normal Range\\t Comment Ind Hematology\\t WBC\\t 9/23/2012 4:05:00 AM\\t 9.1 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/23/2012 4:05:00 AM\\t 4.14 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/23/2012 4:05:00 AM\\t 12.7 gm/dL\\t Low\\t 12.9-16.9 Hematology\\t Hct\\t 9/23/2012 4:05:00 AM\\t 36.0 %\\t Low\\t 38.0-48.8 Hematology\\t MCV\\t 9/23/2012 4:05:00 AM\\t 86.9 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/23/2012 4:05:00 AM\\t 30.7 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/23/2012 4:05:00 AM\\t 35.4 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/23/2012 4:05:00 AM\\t 14.2 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/23/2012 4:05:00 AM\\t 8.7 fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/23/2012 4:05:00 AM\\t 32 X10E+09/L\\t Low\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/23/2012 4:05:00 AM\\t 70.7 %\\t\\t 44.3-77.1 Hematology\\t Lymphs-Manual\\t 9/23/2012 4:05:00 AM\\t 18.7 %\\t\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/23/2012 4:05:00 AM\\t 9.4 %\\t\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.8 %\\t\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.4 %\\t\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/23/2012 4:05:00 AM\\t 6.4 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/23/2012 4:05:00 AM\\t 1.7 X1OE+09/L\\t\\t 0.80-3.65  Hematology\\t ABS Monocytes-Manual\\t 9/23/2012 4:05:00 AM\\t 0.9 X1OE+09/L 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.1 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/23/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/23/2012 4:05:00 AM\\t Auto diff performed  Hematology\\t WBC\\t 9/22/2012 4:55:00 AM\\t 3.6 X10E+09/L\\t Low\\t 3.8-10.6 Hematology\\t RBC\\t 9/22/2012 4:55:00 AM\\t 4.25 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/22/2012 4:55:00 AM\\t 12.9 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/22/2012 4:55:00 AM\\t 36.8 %\\t Low\\t 38.0-48.8 Hematology\\t MCV\\t 9/22/2012 4:55:00 AM\\t 86.6 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/22/2012 4:55:00 AM\\t 30.3 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/22/2012 4:55:00 AM\\t 35.0 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/22/2012 4:55:00 AM\\t 13.8 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/22/2012 4:55:00 AM\\t 7.2 fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/22/2012 4:55:00 AM\\t 42 X10E+09/L\\t Low\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/22/2012 4:55:00 AM\\t 35.6 %\\t Low\\t 44.3-77.1 Hematology\\t Bands-Manual\\t 9/22/2012 4:55:00 AM\\t 50.0 %\\t High\\t 2-8 Hematology\\t Monocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 1.9 %\\t Low\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/22/2012 4:55:00 AM\\t 3.8 %\\t\\t 0.2-6.0 Hematology\\t Myelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 1.9 %\\t High Hematology\\t Metamyelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 6.7 %\\t High Hematology\\t Nucleated rbc\\t 9/22/2012 4:55:00 AM\\t 1.0 Hematology\\t ABS Neutrophils-Manual\\t 9/22/2012 4:55:00 AM\\t 3.1 X10E+09/L 2.24-7.68 Hematology\\t ABS Monocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 0.1 X1OE+09/L\\t Low 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/22/2012 4:55:00 AM\\t 0.1 X1OE+09/L 0.0-0.4 Hematology\\t ABS Myelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 0.1 X1OE+09/L\\t High  Hematology\\t ABS Metamyelocytes-Manual\\t 9/22/2012 4:55:00 AM\\t 0.2 X1OE+09/L High Hematology\\t Type of Differential\\t 9/22/2012 4:55:00 AM\\t Image Differential Performed Hematology\\t RBC Fragments\\t 9/22/2012 4:55:00 AM\\t 1+ Hematology\\t Burr Cells\\t 9/22/2012 4:55:00 AM\\t 1+ Hematology\\t WBC\\t 9/21/2012 4:05:00 AM\\t 4.5 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/21/2012 4:05:00 AM\\t 4.34 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/21/2012 4:05:00 AM\\t 13.4 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/21/2012 4:05:00 AM\\t 38.2 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/21/2012 4:05:00 AM\\t 87.9 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/21/2012 4:05:00 AM\\t 31.0 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/21/2012 4:05:00 AM\\t 35.3 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/21/2012 4:05:00 AM\\t 13.9 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/21/2012 4:05:00 AM\\t Unavailable fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/21/2012 4:05:00 AM\\t 111 X10E+09/L\\t Low\\t 156-369\\t Y Hematology\\t Neutrophils-Manual\\t 9/21/2012 4:05:00 AM\\t 78.8 %\\t High\\t 44.3-77.1  Hematology\\t Lymphs-Manual\\t 9/21/2012 4:05:00 AM\\t 5.6 %\\t Low\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/21/2012 4:05:00 AM\\t 8.9 %\\t\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/21/2012 4:05:00 AM\\t 6.4 %\\t High\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/21/2012 4:05:00 AM\\t 0.3 %\\t\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/21/2012 4:05:00 AM\\t 3.5 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/21/2012 4:05:00 AM\\t 0.3 X1OE+09/L\\t Low 0.80-3.65 Hematology\\t ABS Monocytes-Manual\\t 9/21/2012 4:05:00 AM\\t 0.4 X1OE+09/L 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/21/2012 4:05:00 AM\\t 0.3 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/21/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/21/2012 4:05:00 AM\\t Auto diff performed  Hematology\\t WBC\\t 9/20/2012 8:39:00 AM\\t 5.9 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/20/2012 8:39:00 AM\\t 4.59 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/20/2012 8:39:00 AM\\t 14.0 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/20/2012 8:39:00 AM\\t 40.5 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/20/2012 8:39:00 AM\\t 88.3 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/20/2012 8:39:00 AM\\t 30.6 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/20/2012 8:39:00 AM\\t 34.7 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/20/2012 8:39:00 AM\\t 13.6 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/20/2012 8:39:00 AM\\t 6.4 fL\\t Low\\t 6.8-10.4 Hematology\\t Platelets\\t 9/20/2012 8:39:00 AM\\t 190 X10E+09/L\\t\\t 156-369 Hematology\\t WBC\\t 9/19/2012 4:05:00 AM\\t 6.2 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/19/2012 4:05:00 AM\\t 4.74 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/19/2012 4:05:00 AM\\t 14.5 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/19/2012 4:05:00 AM\\t 41.9 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/19/2012 4:05:00 AM\\t 88.3 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/19/2012 4:05:00 AM\\t 30.5 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/19/2012 4:05:00 AM\\t 34.6 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/19/2012 4:05:00 AM\\t 13.4 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/19/2012 4:05:00 AM\\t 6.8 fL\\t\\t 6.8-10.4 Hematology\\t Platelets\\t 9/19/2012 4:05:00 AM\\t 271 X10E+09/L\\t\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/19/2012 4:05:00 AM\\t 96.4 %\\t High\\t 44.3-77.1  Hematology\\t Lymphs-Manual\\t 9/19/2012 4:05:00 AM\\t 1.8 %\\t Low\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/19/2012 4:05:00 AM\\t 1.5 %\\t Low\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.3 %\\t\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.0 %\\t Low\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/19/2012 4:05:00 AM\\t 6.0 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/19/2012 4:05:00 AM\\t 0.1 X1OE+09/L\\t Low 0.80-3.65 Hematology\\t ABS Monocytes-Manual\\t 9/19/2012 4:05:00 AM\\t 0.1 X1OE+09/L\\t Low 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/19/2012 4:05:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/19/2012 4:05:00 AM\\t Auto diff performed  Hematology\\t WBC\\t 9/18/2012 8:00:00 AM\\t 4.4 X10E+09/L\\t\\t 3.8-10.6 Hematology\\t RBC\\t 9/18/2012 8:00:00 AM\\t 4.90 X10E+12/L\\t\\t 4.13-5.57 Hematology\\t Hgb\\t 9/18/2012 8:00:00 AM\\t 15.0 gm/dL\\t\\t 12.9-16.9 Hematology\\t Hct\\t 9/18/2012 8:00:00 AM\\t 44.0 %\\t\\t 38.0-48.8 Hematology\\t MCV\\t 9/18/2012 8:00:00 AM\\t 89.7 fL\\t\\t 82.6-97.4 Hematology\\t MCH\\t 9/18/2012 8:00:00 AM\\t 30.5 pg\\t\\t 27.8-33.4 Hematology\\t MCHC\\t 9/18/2012 8:00:00 AM\\t 34.0 gm/dL\\t\\t 32.7-35.5 Hematology\\t RDW\\t 9/18/2012 8:00:00 AM\\t 13.7 %\\t\\t 11.8-15.2 Hematology\\t MPV\\t 9/18/2012 8:00:00 AM\\t 6.3 fL\\t Low\\t 6.8-10.4 Hematology\\t Platelets\\t 9/18/2012 8:00:00 AM\\t 402 X10E+09/L\\t High\\t 156-369 Hematology\\t Neutrophils-Manual\\t 9/18/2012 8:00:00 AM\\t 55.0 %\\t\\t 44.3-77.1 Hematology\\t Lymphs-Manual\\t 9/18/2012 8:00:00 AM\\t 27.3 %\\t\\t 13.0-43.8 Hematology\\t Monocytes-Manual\\t 9/18/2012 8:00:00 AM\\t 14.8 %\\t High\\t 3.7-12.5 Hematology\\t Eosinophils-Manual\\t 9/18/2012 8:00:00 AM\\t 2.2 %\\t\\t 0.2-6.0 Hematology\\t Basophils-Manual\\t 9/18/2012 8:00:00 AM\\t 0.7 %\\t\\t 0.1-1.2 Hematology\\t ABS Neutrophils-Manual\\t 9/18/2012 8:00:00 AM\\t 2.4 X10E+09/L 2.24-7.68 Hematology\\t ABS Lymphs-Manual\\t 9/18/2012 8:00:00 AM\\t 1.2 X1OE+09/L\\t\\t 0.80-3.65  Hematology\\t ABS Monocytes-Manual\\t 9/18/2012 8:00:00 AM\\t 0.7 X1OE+09/L 0.3-0.9 Hematology\\t ABS Eosinophils-Manual\\t 9/18/2012 8:00:00 AM\\t 0.1 X1OE+09/L 0.0-0.4 Hematology\\t ABS Basophils-Manual\\t 9/18/2012 8:00:00 AM\\t 0.0 X1OE+09/L 0.0-0.06 Hematology\\t Type of Differential\\t 9/18/2012 8:00:00 AM\\t Auto diff performed   Plan Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report041_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'ENDS-ON', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 44, 'start': 54, 'end': 57}, 'arg2': {'mention': 'yesterdat', 'nth_sent': 44, 'start': 10, 'end': 19}, 'context': 'Condition yesterdat appeared improved with lasix, and IL2 cycle discontinued.'}, {'filename': 'patient43_report168_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 97, 'end': 110}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.    '}, {'filename': 'patient43_report168_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 125, 'end': 136}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.    '}, {'filename': 'patient43_report085_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 20, 'start': 115, 'end': 118}, 'arg2': {'mention': '9/18', 'nth_sent': 20, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report085_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 20, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/18', 'nth_sent': 20, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report085_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 20, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/4', 'nth_sent': 20, 'start': 77, 'end': 80}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report170_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 97, 'end': 110}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with Aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report170_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 2, 'start': 125, 'end': 136}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, high-dose interleukin-2 combined with Aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report079_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 10/2/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report079_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 10/2/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report079_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 61, 'start': 114, 'end': 125}, 'arg2': {'mention': '9/4', 'nth_sent': 61, 'start': 126, 'end': 129}, 'context': 'Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report079_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 61, 'start': 114, 'end': 125}, 'arg2': {'mention': '09/18', 'nth_sent': 61, 'start': 146, 'end': 151}, 'context': 'Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report143_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 18, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 18, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.'}, {'filename': 'patient43_report143_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 28, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/4', 'nth_sent': 28, 'start': 77, 'end': 80}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report143_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 28, 'start': 115, 'end': 118}, 'arg2': {'mention': '9/18', 'nth_sent': 28, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report143_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 28, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/18', 'nth_sent': 28, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 179, 'end': 190}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 191, 'end': 194}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/20/2012.  History of Present Illness Patient enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)Thus far has received 7/7 planned doses.'}, {'filename': 'patient43_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 41, 'start': 54, 'end': 65}, 'arg2': {'mention': '9/4', 'nth_sent': 41, 'start': 66, 'end': 69}, 'context': 'Impression and Plan Met melanoma: received first dose aflibercept 9/4 second dose this admission to start IL2 as first cycle today as per protocol.'}, {'filename': 'patient43_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 179, 'end': 190}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 211, 'end': 216}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/20/2012.  History of Present Illness Patient enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)Thus far has received 7/7 planned doses.'}, {'filename': 'patient43_report035_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 41, 'start': 106, 'end': 109}, 'arg2': {'mention': 'today', 'nth_sent': 41, 'start': 125, 'end': 130}, 'context': 'Impression and Plan Met melanoma: received first dose aflibercept 9/4 second dose this admission to start IL2 as first cycle today as per protocol.'}, {'filename': 'patient43_report051_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/26/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report051_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/26/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report051_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 59, 'start': 287, 'end': 298}, 'arg2': {'mention': '9/4', 'nth_sent': 59, 'start': 299, 'end': 302}, 'context': 'Date and Time \\t FiO 2 SpO 2 ______________________________________________________________________________ ___________________________ 09/26 03:35\\t 100 98 09/25 13:45\\t 100  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report051_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 59, 'start': 358, 'end': 361}, 'arg2': {'mention': '09/18', 'nth_sent': 59, 'start': 319, 'end': 324}, 'context': 'Date and Time \\t FiO 2 SpO 2 ______________________________________________________________________________ ___________________________ 09/26 03:35\\t 100 98 09/25 13:45\\t 100  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report136_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 61, 'start': 51, 'end': 62}, 'arg2': {'mention': 'today', 'nth_sent': 61, 'start': 71, 'end': 76}, 'context': 'At this time, We plan to withhold the patient from aflibercept therapy today.'}, {'filename': 'patient43_report201_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 207, 'end': 220}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 46, 'end': 55}, 'context': 'Mr. Patient43 is a pleasant 27-year-old male, currently being followed for a history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095, high-dose bolus interleukin-2 with aflibercept.    '}, {'filename': 'patient43_report201_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 226, 'end': 237}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 46, 'end': 55}, 'context': 'Mr. Patient43 is a pleasant 27-year-old male, currently being followed for a history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095, high-dose bolus interleukin-2 with aflibercept.    '}, {'filename': 'patient43_report201_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 31, 'end': 42}, 'arg2': {'mention': 'Currently', 'nth_sent': 3, 'start': 18, 'end': 27}, 'context': 'CURRENT THERAPY:  Currently on aflibercept maintenance.    '}, {'filename': 'patient43_report201_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 66, 'start': 136, 'end': 147}, 'arg2': {'mention': 'currently', 'nth_sent': 66, 'start': 116, 'end': 125}, 'context': 'ASSESSMENT AND PLAN:  Mr. Patient43 is a pleasant 27-year-old Caucasian male with a history of metastatic melanoma, currently receiving aflibercept maintenance on UPCI protocol 10-095, high-dose bolus IL-2 with or without aflibercept for which he was randomized to the combination arm.'}, {'filename': 'patient43_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 2, 'start': 73, 'end': 77}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his first admission for IL-2, on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.   '}, {'filename': 'patient43_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 64, 'start': 38, 'end': 42}, 'arg2': {'mention': 'Today', 'nth_sent': 64, 'start': 0, 'end': 5}, 'context': 'Today will be his first admission for IL-2.'}, {'filename': 'patient43_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 134, 'end': 147}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his first admission for IL-2, on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.   '}, {'filename': 'patient43_report032_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 168, 'end': 179}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his first admission for IL-2, on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.   '}, {'filename': 'patient43_report197_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 46, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 33, 'end': 42}, 'context': 'CURRENT THERAPY:  The patient is currently on aflibercept maintenance.  '}, {'filename': 'patient43_report197_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 204, 'end': 217}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 46, 'end': 55}, 'context': 'Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report197_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 223, 'end': 234}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 46, 'end': 55}, 'context': 'Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report197_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 57, 'start': 149, 'end': 160}, 'arg2': {'mention': 'currently', 'nth_sent': 57, 'start': 68, 'end': 77}, 'context': 'ASSESSMENT AND PLAN:  Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma, currently receiving aflibercept maintenance under UPCI protocol 10-095 high-dose bolus interleukin-2 with or without aflibercept for which he was randomized to the combination arm.'}, {'filename': 'patient43_report166_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 10, 'start': 60, 'end': 71}, 'arg2': {'mention': 'currently', 'nth_sent': 10, 'start': 6, 'end': 15}, 'context': 'He is currently participating on clinical trial 10-095 with aflibercept.'}, {'filename': 'patient43_report125_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 7, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 7, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.  '}, {'filename': 'patient43_report192_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 54, 'start': 114, 'end': 125}, 'arg2': {'mention': 'currently', 'nth_sent': 54, 'start': 39, 'end': 48}, 'context': 'ASSESSMENT AND PLAN:  Mr. Patient43 is currently followed for history of metastatic melanoma, currently receiving aflibercept maintenance under UPCI protocol 10-095 high-dose bolus interleukin-2 with or without aflibercept for which he was randomized to the combination arm.'}, {'filename': 'patient43_report192_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 46, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 33, 'end': 42}, 'context': 'CURRENT THERAPY:  The patient is currently on aflibercept maintenance.  '}, {'filename': 'patient43_report192_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 1, 'start': 283, 'end': 296}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 131, 'end': 140}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 08/09/2013   Office Note  PRINCIPAL DIAGNOSIS:  Mr. Patient43 is currently followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report192_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 302, 'end': 313}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 131, 'end': 140}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 08/09/2013   Office Note  PRINCIPAL DIAGNOSIS:  Mr. Patient43 is currently followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report198_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 1, 'start': 318, 'end': 331}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 160, 'end': 169}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 09/06/2013   Office Note  PRINCIPAL DIAGNOSIS:  Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.    '}, {'filename': 'patient43_report198_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 337, 'end': 348}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 160, 'end': 169}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 09/06/2013   Office Note  PRINCIPAL DIAGNOSIS:  Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.    '}, {'filename': 'patient43_report198_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 46, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 33, 'end': 42}, 'context': 'CURRENT THERAPY:  The patient is currently on aflibercept maintenance.    '}, {'filename': 'patient43_report198_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 52, 'start': 149, 'end': 160}, 'arg2': {'mention': 'currently', 'nth_sent': 52, 'start': 68, 'end': 77}, 'context': 'ASSESSMENT AND PLAN:  Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma, currently receiving aflibercept maintenance under UPCI protocol 10-095, high-dose bolus interleukin-2 with or without aflibercept for which he was randomized to the combination arm.'}, {'filename': 'patient43_report186_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 61, 'start': 74, 'end': 85}, 'arg2': {'mention': 'today', 'nth_sent': 61, 'start': 120, 'end': 125}, 'context': 'He continues as a participant on UPCI protocol 10-095, interleukin-2 plus aflibercept, a VEGF Trap molecule, presenting today for aflibercept maintenance portion of the regimen.'}, {'filename': 'patient43_report152_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 63, 'start': 56, 'end': 69}, 'arg2': {'mention': 'today', 'nth_sent': 63, 'start': 12, 'end': 17}, 'context': 'He presents today for his sixth and final admission for interleukin-2.'}, {'filename': 'patient43_report152_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 73, 'end': 86}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his sixth admission for interleukin-2 on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.    '}, {'filename': 'patient43_report152_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 150, 'end': 161}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his sixth admission for interleukin-2 on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.    '}, {'filename': 'patient43_report126_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 7, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 7, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.  '}, {'filename': 'patient43_report113_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 7, 'start': 105, 'end': 116}, 'arg2': {'mention': 'currently', 'nth_sent': 7, 'start': 77, 'end': 86}, 'context': 'Hospital Course  Patient43, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.  '}, {'filename': 'patient43_report113_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 7, 'start': 131, 'end': 144}, 'arg2': {'mention': 'currently', 'nth_sent': 7, 'start': 77, 'end': 86}, 'context': 'Hospital Course  Patient43, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.  '}, {'filename': 'patient43_report117_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 10, 'start': 17, 'end': 28}, 'arg2': {'mention': 'today', 'nth_sent': 10, 'start': 29, 'end': 34}, 'context': 'Patient received Aflibercept today.'}, {'filename': 'patient43_report117_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 20, 'start': 115, 'end': 118}, 'arg2': {'mention': '9/18', 'nth_sent': 20, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report117_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 20, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/4', 'nth_sent': 20, 'start': 77, 'end': 80}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report117_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 20, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/18', 'nth_sent': 20, 'start': 95, 'end': 99}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4  #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report134_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 87, 'start': 107, 'end': 118}, 'arg2': {'mention': 'next week', 'nth_sent': 87, 'start': 119, 'end': 128}, 'context': 'If it is determined that these are not areas of splenic infarcts, then we will proceed with treatment with aflibercept next week pending a negative hypercoagulable profile.'}, {'filename': 'patient43_report191_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 46, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 33, 'end': 42}, 'context': 'CURRENT THERAPY:  The patient is currently on aflibercept maintenance portion of the regimen.  '}, {'filename': 'patient43_report191_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 1, 'start': 292, 'end': 305}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 132, 'end': 141}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 07/26/2013   Office Note   PRINCIPAL DIAGNOSIS:  Mr. Patient43 is currently being followed for a history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report191_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 311, 'end': 322}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 132, 'end': 141}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 07/26/2013   Office Note   PRINCIPAL DIAGNOSIS:  Mr. Patient43 is currently being followed for a history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095 high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 66, 'start': 109, 'end': 120}, 'arg2': {'mention': '9/4', 'nth_sent': 66, 'start': 121, 'end': 124}, 'context': 'Almost no symtoms currently on extended release mesalamine..   Diagnosis   met melanoma: received first dose aflibercept 9/4 second dose today to start IL2 as per protocol.'}, {'filename': 'patient43_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 11, 'start': 68, 'end': 78}, 'arg2': {'mention': '9/4', 'nth_sent': 11, 'start': 79, 'end': 82}, 'context': 'Patient enrolled in UPCI protocol 10-095 and received first dose of alibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)  '}, {'filename': 'patient43_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 11, 'start': 68, 'end': 78}, 'arg2': {'mention': 'today', 'nth_sent': 11, 'start': 99, 'end': 104}, 'context': 'Patient enrolled in UPCI protocol 10-095 and received first dose of alibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)  '}, {'filename': 'patient43_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 66, 'start': 109, 'end': 120}, 'arg2': {'mention': 'today', 'nth_sent': 66, 'start': 137, 'end': 142}, 'context': 'Almost no symtoms currently on extended release mesalamine..   Diagnosis   met melanoma: received first dose aflibercept 9/4 second dose today to start IL2 as per protocol.'}, {'filename': 'patient43_report031_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 11, 'start': 138, 'end': 141}, 'arg2': {'mention': 'today', 'nth_sent': 11, 'start': 99, 'end': 104}, 'context': 'Patient enrolled in UPCI protocol 10-095 and received first dose of alibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)  '}, {'filename': 'patient43_report187_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 11, 'start': 47, 'end': 58}, 'arg2': {'mention': 'currently', 'nth_sent': 11, 'start': 72, 'end': 81}, 'context': 'The patient proceeded with further maintenance aflibercept, which he is currently receiving.  '}, {'filename': 'patient43_report189_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 45, 'start': 113, 'end': 124}, 'arg2': {'mention': 'currently', 'nth_sent': 45, 'start': 197, 'end': 206}, 'context': 'ASSESSMENT AND PLAN:  A 27-year-old Caucasian male with metastatic melanoma on UPCI protocol 10-095 with IL-2 in aflibercept status post surgical resection of right lower lobe metastases in April, currently on aflibercept maintenance with PET/CT showing no evident disease and MRI showing periventricular signaling in the T2 phase of unclear significance.'}, {'filename': 'patient43_report116_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 5, 'start': 102, 'end': 113}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 74, 'end': 83}, 'context': 'Hospital Course Person4, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.'}, {'filename': 'patient43_report116_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 5, 'start': 128, 'end': 141}, 'arg2': {'mention': 'currently', 'nth_sent': 5, 'start': 74, 'end': 83}, 'context': 'Hospital Course Person4, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.'}, {'filename': 'patient43_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 3, 'start': 95, 'end': 105}, 'arg2': {'mention': '9/4', 'nth_sent': 3, 'start': 106, 'end': 109}, 'context': 'History of Present Illness Patient enrolled in UPCI protocol 10-095 and received first dose of alibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)  '}, {'filename': 'patient43_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 45, 'start': 54, 'end': 65}, 'arg2': {'mention': '9/4', 'nth_sent': 45, 'start': 66, 'end': 69}, 'context': 'Impression and Plan Met melanoma: received first dose aflibercept 9/4 second dose this admission to start IL2 as first cycle today as per protocol.'}, {'filename': 'patient43_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 3, 'start': 95, 'end': 105}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 126, 'end': 131}, 'context': 'History of Present Illness Patient enrolled in UPCI protocol 10-095 and received first dose of alibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)  '}, {'filename': 'patient43_report034_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 45, 'start': 106, 'end': 109}, 'arg2': {'mention': 'today', 'nth_sent': 45, 'start': 125, 'end': 130}, 'context': 'Impression and Plan Met melanoma: received first dose aflibercept 9/4 second dose this admission to start IL2 as first cycle today as per protocol.'}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 15, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 4th', 'nth_sent': 15, 'start': 45, 'end': 58}, 'context': 'He received his first dose of aflibercept on September 4th and second dose on September 18th prior to be admitted for the high-dose IL-2, which is his first cycle.'}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 15, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 18th', 'nth_sent': 15, 'start': 78, 'end': 92}, 'context': 'He received his first dose of aflibercept on September 4th and second dose on September 18th prior to be admitted for the high-dose IL-2, which is his first cycle.'}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 51, 'start': 53, 'end': 66}, 'arg2': {'mention': 'today', 'nth_sent': 51, 'start': 13, 'end': 18}, 'context': 'He presented today for the second cycle of high-dose interleukin-2 in combination with anti-VEGF antibody, aflibercept.'}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 3, 'start': 85, 'end': 89}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his second admission for cycle 2 of IL-2, on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept VEGF trap.  '}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 51, 'start': 107, 'end': 118}, 'arg2': {'mention': 'today', 'nth_sent': 51, 'start': 13, 'end': 18}, 'context': 'He presented today for the second cycle of high-dose interleukin-2 in combination with anti-VEGF antibody, aflibercept.'}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 3, 'start': 155, 'end': 168}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his second admission for cycle 2 of IL-2, on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept VEGF trap.  '}, {'filename': 'patient43_report083_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 183, 'end': 194}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his second admission for cycle 2 of IL-2, on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept VEGF trap.  '}, {'filename': 'patient43_report095_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 10, 'start': 120, 'end': 124}, 'arg2': {'mention': '10/19/2012', 'nth_sent': 10, 'start': 160, 'end': 170}, 'context': 'At this time, he was having issue with dropping platelet count (418 -> 235 -> 163 -> 60 -> 57K since admission) and his IL-2 doses were held since 3 PM dose on 10/19/2012.'}, {'filename': 'patient43_report065_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 205, 'end': 216}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 217, 'end': 220}, 'context': 'Author: Person101  Basic Information Visit Information : Patient seen on 9/29/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report065_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 205, 'end': 216}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 237, 'end': 242}, 'context': 'Author: Person101  Basic Information Visit Information : Patient seen on 9/29/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report065_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 56, 'start': 134, 'end': 145}, 'arg2': {'mention': '09/18', 'nth_sent': 56, 'start': 166, 'end': 171}, 'context': '09/28 22:50\\t 50 99  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report065_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 56, 'start': 134, 'end': 145}, 'arg2': {'mention': '9/4', 'nth_sent': 56, 'start': 146, 'end': 149}, 'context': '09/28 22:50\\t 50 99  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report140_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 3, 'start': 153, 'end': 157}, 'arg2': {'mention': \"today's\", 'nth_sent': 3, 'start': 49, 'end': 56}, 'context': \"CURRENT TREATMENT:  He presents to the office on today's date for continued participation on UPCI protocol 10-095 combination therapy of high-dose bolus IL-2 as per the standard FDA-approved regimen with or without the addition of aflibercept VEGF trap molecule.\"}, {'filename': 'patient43_report109_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'Aflibercept', 'nth_sent': 9, 'start': 0, 'end': 11}, 'arg2': {'mention': 'today', 'nth_sent': 9, 'start': 18, 'end': 23}, 'context': 'Aflibercept given today.'}, {'filename': 'patient43_report103_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 3, 'start': 32, 'end': 36}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 12, 'end': 17}, 'context': 'He presents today for high-dose IL-2.  '}, {'filename': 'patient43_report036_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 179, 'end': 190}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 191, 'end': 194}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/21/2012.  History of Present Illness Patient enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)Thus far has received 8/9 planned doses.'}, {'filename': 'patient43_report036_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 45, 'start': 54, 'end': 65}, 'arg2': {'mention': '9/4', 'nth_sent': 45, 'start': 66, 'end': 69}, 'context': 'Impression and Plan Met melanoma: received first dose aflibercept 9/4 second dose this admission to start IL2 as first cycle today as per protocol.'}, {'filename': 'patient43_report036_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 179, 'end': 190}, 'arg2': {'mention': 'today', 'nth_sent': 1, 'start': 211, 'end': 216}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/21/2012.  History of Present Illness Patient enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose today prior to admission for high dose IL2 (first cycle)Thus far has received 8/9 planned doses.'}, {'filename': 'patient43_report036_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 45, 'start': 106, 'end': 109}, 'arg2': {'mention': 'today', 'nth_sent': 45, 'start': 125, 'end': 130}, 'context': 'Impression and Plan Met melanoma: received first dose aflibercept 9/4 second dose this admission to start IL2 as first cycle today as per protocol.'}, {'filename': 'patient43_report199_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 1, 'start': 319, 'end': 332}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 160, 'end': 169}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 09/20/2013   Office Note  PRINCIPAL DIAGNOSIS:  Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095, high-dose bolus interleukin-2 with aflibercept.    '}, {'filename': 'patient43_report199_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 338, 'end': 349}, 'arg2': {'mention': 'currently', 'nth_sent': 1, 'start': 160, 'end': 169}, 'context': 'Patient43  PATIENT ID#:  DATE OF BIRTH: 04/13/1986 DATE OF VISIT: 09/20/2013   Office Note  PRINCIPAL DIAGNOSIS:  Mr. Patient43 is a pleasant 27-year-old male, currently being followed for history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095, high-dose bolus interleukin-2 with aflibercept.    '}, {'filename': 'patient43_report199_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 57, 'start': 126, 'end': 137}, 'arg2': {'mention': 'currently', 'nth_sent': 57, 'start': 106, 'end': 115}, 'context': 'ASSESSMENT AND PLAN:  Mr. Patient43 is a pleasant 27-year-old male with a history of metastatic melanoma, currently receiving aflibercept maintenance on UPCI protocol 10-095, high-dose bolus interleukin-2 with or without aflibercept, for which he was randomized to the combination arm.'}, {'filename': 'patient43_report199_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 46, 'end': 57}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 33, 'end': 42}, 'context': 'CURRENT THERAPY:  The patient is currently on aflibercept maintenance.    '}, {'filename': 'patient43_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 126, 'end': 139}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept, a VEGF Trap molecule.  '}, {'filename': 'patient43_report100_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 154, 'end': 165}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept, a VEGF Trap molecule.  '}, {'filename': 'patient43_report097_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 8, 'start': 121, 'end': 125}, 'arg2': {'mention': '10/19/2012', 'nth_sent': 8, 'start': 161, 'end': 171}, 'context': 'At this time, he was having issue with dropping platelet count ( 418 -> 235 -> 163 -> 60 -> 57K since admission) and his IL-2 doses were held since 3 PM dose on 10/19/2012.'}, {'filename': 'patient43_report071_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/30/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report071_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/30/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report071_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 61, 'start': 114, 'end': 125}, 'arg2': {'mention': '9/4', 'nth_sent': 61, 'start': 126, 'end': 129}, 'context': 'Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report071_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 61, 'start': 114, 'end': 125}, 'arg2': {'mention': '09/18', 'nth_sent': 61, 'start': 146, 'end': 151}, 'context': 'Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report194_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 11, 'start': 23, 'end': 34}, 'arg2': {'mention': 'currently', 'nth_sent': 11, 'start': 6, 'end': 15}, 'context': 'He is currently on the aflibercept maintenance.    '}, {'filename': 'patient43_report194_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 84, 'start': 23, 'end': 34}, 'arg2': {'mention': 'currently', 'nth_sent': 84, 'start': 6, 'end': 15}, 'context': 'He is currently on the aflibercept maintenance portion of the regimen.'}, {'filename': 'patient43_report194_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 83, 'start': 77, 'end': 90}, 'arg2': {'mention': 'currently', 'nth_sent': 83, 'start': 6, 'end': 15}, 'context': 'He is currently treated under UPCI protocol 10-095, which is high-dose bolus interleukin-2 with aflibercept.'}, {'filename': 'patient43_report194_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 83, 'start': 96, 'end': 107}, 'arg2': {'mention': 'currently', 'nth_sent': 83, 'start': 6, 'end': 15}, 'context': 'He is currently treated under UPCI protocol 10-095, which is high-dose bolus interleukin-2 with aflibercept.'}, {'filename': 'patient43_report204_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 66, 'start': 136, 'end': 147}, 'arg2': {'mention': 'currently', 'nth_sent': 66, 'start': 116, 'end': 125}, 'context': 'ASSESSMENT AND PLAN:  Mr. Patient43 is a pleasant 27-year-old Caucasian male with a history of metastatic melanoma, currently receiving aflibercept maintenance on UPCI protocol 10-095, high-dose bolus IL-2 with or without aflibercept for which he was randomized to the combination arm.'}, {'filename': 'patient43_report204_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 207, 'end': 220}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 46, 'end': 55}, 'context': 'Mr. Patient43 is a pleasant 27-year-old male, currently being followed for a history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095, high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report204_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 226, 'end': 237}, 'arg2': {'mention': 'currently', 'nth_sent': 2, 'start': 46, 'end': 55}, 'context': 'Mr. Patient43 is a pleasant 27-year-old male, currently being followed for a history of metastatic melanoma with resection of pulmonary metastatic disease, currently on UPCI protocol 10-095, high-dose bolus interleukin-2 with aflibercept.  '}, {'filename': 'patient43_report204_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 31, 'end': 42}, 'arg2': {'mention': 'Currently', 'nth_sent': 3, 'start': 18, 'end': 27}, 'context': 'CURRENT THERAPY:  Currently on aflibercept maintenance.  '}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 21, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 18th', 'nth_sent': 21, 'start': 78, 'end': 92}, 'context': 'He received his first dose of aflibercept on September 4th and second dose on September 18th prior to be admitted for the high-dose IL-2, which was his first cycle.'}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 73, 'start': 53, 'end': 66}, 'arg2': {'mention': 'today', 'nth_sent': 73, 'start': 13, 'end': 18}, 'context': 'He presented today for the second cycle of high-dose interleukin-2 in combination with VEGF Trap, aflibercept.'}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 73, 'start': 98, 'end': 109}, 'arg2': {'mention': 'today', 'nth_sent': 73, 'start': 13, 'end': 18}, 'context': 'He presented today for the second cycle of high-dose interleukin-2 in combination with VEGF Trap, aflibercept.'}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 4, 'start': 87, 'end': 91}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 41, 'end': 46}, 'context': 'CURRENT THERAPY:  - The patient presents today for his second admission for cycle 2 of IL-2, on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept VEGF trap.'}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 4, 'start': 157, 'end': 170}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 41, 'end': 46}, 'context': 'CURRENT THERAPY:  - The patient presents today for his second admission for cycle 2 of IL-2, on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept VEGF trap.'}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 4, 'start': 185, 'end': 196}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 41, 'end': 46}, 'context': 'CURRENT THERAPY:  - The patient presents today for his second admission for cycle 2 of IL-2, on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept VEGF trap.'}, {'filename': 'patient43_report086_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 21, 'start': 30, 'end': 41}, 'arg2': {'mention': 'September 4th', 'nth_sent': 21, 'start': 45, 'end': 58}, 'context': 'He received his first dose of aflibercept on September 4th and second dose on September 18th prior to be admitted for the high-dose IL-2, which was his first cycle.'}, {'filename': 'patient43_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 60, 'start': 84, 'end': 97}, 'arg2': {'mention': 'today', 'nth_sent': 59, 'start': 12, 'end': 17}, 'context': 'He presents today for initiation on UPCI protocol 10-095, randomized ____ high-dose interleukin-2 in combination with anti-VEGF antibody, VEGF-Trap.'}, {'filename': 'patient43_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 125, 'end': 138}, 'arg2': {'mention': \"today's\", 'nth_sent': 2, 'start': 42, 'end': 49}, 'context': \"CURRENT THERAPY:  The patient presents on today's date for initiation on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.  \"}, {'filename': 'patient43_report024_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 159, 'end': 170}, 'arg2': {'mention': \"today's\", 'nth_sent': 2, 'start': 42, 'end': 49}, 'context': \"CURRENT THERAPY:  The patient presents on today's date for initiation on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.  \"}, {'filename': 'patient43_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 63, 'start': 38, 'end': 42}, 'arg2': {'mention': 'Today', 'nth_sent': 63, 'start': 0, 'end': 5}, 'context': 'Today will be his first admission for IL-2.'}, {'filename': 'patient43_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 2, 'start': 73, 'end': 77}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his first admission for IL-2, on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.  '}, {'filename': 'patient43_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 134, 'end': 147}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his first admission for IL-2, on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.  '}, {'filename': 'patient43_report030_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 168, 'end': 179}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his first admission for IL-2, on UPCI protocol 10-095, randomized to arm A high-dose interleukin-2 in combination with aflibercept VEGF trap.  '}, {'filename': 'patient43_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/22/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/22/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 46, 'start': 114, 'end': 125}, 'arg2': {'mention': '9/4', 'nth_sent': 46, 'start': 126, 'end': 129}, 'context': 'Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report038_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 46, 'start': 114, 'end': 125}, 'arg2': {'mention': '09/18', 'nth_sent': 46, 'start': 146, 'end': 151}, 'context': 'Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report155_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 73, 'end': 86}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his sixth admission for interleukin-2 on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report155_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 63, 'start': 56, 'end': 69}, 'arg2': {'mention': 'today', 'nth_sent': 63, 'start': 12, 'end': 17}, 'context': 'He presents today for his sixth and final admission for interleukin-2.'}, {'filename': 'patient43_report155_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 2, 'start': 73, 'end': 86}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his sixth admission for interleukin-2 on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report155_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 150, 'end': 161}, 'arg2': {'mention': 'today', 'nth_sent': 2, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today for his sixth admission for interleukin-2 on UPCI protocol 10-095, high-dose interleukin-2 combined with aflibercept, a VEGF trap molecule.  '}, {'filename': 'patient43_report101_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 3, 'start': 126, 'end': 139}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept, a VEGF Trap molecule.'}, {'filename': 'patient43_report101_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 154, 'end': 165}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 39, 'end': 44}, 'context': 'CURRENT THERAPY:  The patient presents today as a participant on UPCI protocol 10-095, randomized to arm A which is high-dose interleukin-2 combined with aflibercept, a VEGF Trap molecule.'}, {'filename': 'patient43_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 3, 'start': 34, 'end': 38}, 'arg2': {'mention': 'today', 'nth_sent': 3, 'start': 12, 'end': 17}, 'context': 'He presents today for cycle #4 of IL-2.  '}, {'filename': 'patient43_report122_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 49, 'start': 42, 'end': 55}, 'arg2': {'mention': 'today', 'nth_sent': 49, 'start': 20, 'end': 25}, 'context': 'He will be admitted today for cycle #4 of interleukin-2'}, {'filename': 'patient43_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 7, 'start': 109, 'end': 120}, 'arg2': {'mention': '9/4', 'nth_sent': 7, 'start': 121, 'end': 124}, 'context': 'Hospital Course Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admittted for high dose IL2 (first cycle).'}, {'filename': 'patient43_report082_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 7, 'start': 109, 'end': 120}, 'arg2': {'mention': '09/18', 'nth_sent': 7, 'start': 141, 'end': 146}, 'context': 'Hospital Course Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admittted for high dose IL2 (first cycle).'}, {'filename': 'patient43_report121_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL-2', 'nth_sent': 4, 'start': 34, 'end': 38}, 'arg2': {'mention': 'today', 'nth_sent': 4, 'start': 12, 'end': 17}, 'context': 'He presents today for cycle #4 of IL-2.       '}, {'filename': 'patient43_report121_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 70, 'start': 42, 'end': 55}, 'arg2': {'mention': 'today', 'nth_sent': 70, 'start': 20, 'end': 25}, 'context': 'He will be admitted today for cycle #4 of interleukin-2'}, {'filename': 'patient43_report061_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 64, 'start': 131, 'end': 142}, 'arg2': {'mention': '09/18', 'nth_sent': 64, 'start': 163, 'end': 168}, 'context': '09/28 07:40\\t 50  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report061_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/28/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report061_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 9/28/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report061_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 64, 'start': 131, 'end': 142}, 'arg2': {'mention': '9/4', 'nth_sent': 64, 'start': 143, 'end': 146}, 'context': '09/28 07:40\\t 50  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report130_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 4, 'start': 105, 'end': 116}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 77, 'end': 86}, 'context': 'Hospital Course  Patient43, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.  '}, {'filename': 'patient43_report130_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 4, 'start': 131, 'end': 144}, 'arg2': {'mention': 'currently', 'nth_sent': 4, 'start': 77, 'end': 86}, 'context': 'Hospital Course  Patient43, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.  '}, {'filename': 'patient43_report057_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 120, 'end': 131}, 'arg2': {'mention': '9/4', 'nth_sent': 2, 'start': 132, 'end': 135}, 'context': 'History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report057_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 2, 'start': 120, 'end': 131}, 'arg2': {'mention': '09/18', 'nth_sent': 2, 'start': 152, 'end': 157}, 'context': 'History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report057_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 68, 'start': 307, 'end': 318}, 'arg2': {'mention': '9/4', 'nth_sent': 68, 'start': 170, 'end': 172}, 'context': 'Date and Time \\t FiO 2 SpO 2 ______________________________________________________________________________ ___________________________ 09/27 00:10\\t 50 95 09/26 17:47\\t 50 94 09/26 11:20\\t 70 99  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report057_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 68, 'start': 307, 'end': 318}, 'arg2': {'mention': '09/18', 'nth_sent': 68, 'start': 339, 'end': 344}, 'context': 'Date and Time \\t FiO 2 SpO 2 ______________________________________________________________________________ ___________________________ 09/27 00:10\\t 50 95 09/26 17:47\\t 50 94 09/26 11:20\\t 70 99  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report106_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'IL2', 'nth_sent': 18, 'start': 114, 'end': 117}, 'arg2': {'mention': '9/18', 'nth_sent': 18, 'start': 94, 'end': 98}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4 #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report106_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 18, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/18', 'nth_sent': 18, 'start': 94, 'end': 98}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4 #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report106_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'alibercept', 'nth_sent': 18, 'start': 66, 'end': 76}, 'arg2': {'mention': '9/4', 'nth_sent': 18, 'start': 77, 'end': 80}, 'context': '#Patient enrolled in UPCI protocol 10-095, received first dose of alibercept 9/4 #Second dose 9/18 with high dose IL2 (first cycle)'}, {'filename': 'patient43_report164_NOTE', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 412, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 11, 'start': 60, 'end': 71}, 'arg2': {'mention': 'currently', 'nth_sent': 11, 'start': 6, 'end': 15}, 'context': 'He is currently participating on clinical trial 10-095 with aflibercept.'}, {'filename': 'patient43_report132_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 3, 'start': 102, 'end': 113}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 74, 'end': 83}, 'context': 'Hospital Course Person4, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.'}, {'filename': 'patient43_report132_DS', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 415, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'interleukin-2', 'nth_sent': 3, 'start': 128, 'end': 141}, 'arg2': {'mention': 'currently', 'nth_sent': 3, 'start': 74, 'end': 83}, 'context': 'Hospital Course Person4, a 26-year-old gentleman with metastatic melanoma currently on treatment with aflibercept and high-dose interleukin-2 per UPCI protocol 10-095 was admitted for his third cycle of high-dose IL2.'}, {'filename': 'patient43_report076_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '9/4', 'nth_sent': 1, 'start': 216, 'end': 219}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 10/1/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report076_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 1, 'start': 204, 'end': 215}, 'arg2': {'mention': '09/18', 'nth_sent': 1, 'start': 236, 'end': 241}, 'context': 'Author: Person88  Basic Information Visit Information : Patient seen on 10/1/2012.  History of Present Illness Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report076_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'CONTAINS', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 67, 'start': 125, 'end': 136}, 'arg2': {'mention': '09/18', 'nth_sent': 67, 'start': 157, 'end': 162}, 'context': '23:00\\t 50  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}, {'filename': 'patient43_report076_PGN', 'statement': 'Does the arg1 and arg2 has relationship?', 'num_pre9_tokens': 416, 'rel_type': 'BEGINS-ON', 'label': 'positive', 'arg1': {'mention': 'aflibercept', 'nth_sent': 67, 'start': 125, 'end': 136}, 'arg2': {'mention': '9/4', 'nth_sent': 67, 'start': 137, 'end': 140}, 'context': '23:00\\t 50  Impression and Plan  Patient with metastatic melanoma enrolled in UPCI protocol 10-095 and received first dose of aflibercept 9/4 and second dose 09/18 prior to admission for high dose IL2 (first cycle)Thus far has received 9/12 planned doses.'}]\n",
      "201\n"
     ]
    }
   ],
   "source": [
    "# whole \n",
    "mode = \"dev\"\n",
    "\n",
    "\n",
    "final_lst = []\n",
    "for cancer in [\"breast\", \"ovarian\", \"melanoma\"]:\n",
    "    file = f\"/users/the/NER_MTB/timeset/my_code_result/input_data/{cancer}_{mode}_pos_neg_for_nli.json\"\n",
    "    with open(file, \"r\") as infile: \n",
    "        dct = json.load(infile)\n",
    "\n",
    "    non_none_rel = [] # exclude the one dones't have relatioship\n",
    "    for pair in dct: \n",
    "        # print(pair.keys())\n",
    "        # if pair[\"rel_type\"]is None or pair[\"arg1\"][\"start\"] is None or pair[\"arg2\"][\"end\"] is None or pair[\"arg2\"][\"start\"] or None or pair[\"arg1\"][\"end\"] is None: \n",
    "        if pair[\"rel_type\"]is None or pair[\"rel_type\"] == \"none\": \n",
    "            continue\n",
    "        # print(pair) \n",
    "        non_none_rel.append(pair)\n",
    "    print(non_none_rel)\n",
    "\n",
    "    with open(f'./{cancer}_{mode}_non_none_rel.json', 'w') as f:\n",
    "        json.dump(non_none_rel, f, indent=4) \n",
    "    print(len(non_none_rel)) \n",
    "\n",
    "    # size = _get_size(cancer, mode)\n",
    "    # print(size)\n",
    "    # random_lst = np.random.randint(0, len(dct), size)\n",
    "    # print(len(dct), random_lst)\n",
    "\n",
    "    for ind, pair in enumerate(non_none_rel):\n",
    "        # if ind in random_lst:\n",
    "        chose_pair = defaultdict()\n",
    "        chose_pair[\"filename\"] = pair[\"filename\"]\n",
    "        chose_pair[\"context\"] = pair[\"context\"]\n",
    "        chose_pair[\"arg1\"] = {\"mention\": pair[\"arg1\"][\"mention\"],\n",
    "                                \"start\": pair[\"arg1\"][\"start\"],\n",
    "                                \"end\": pair[\"arg1\"][\"end\"]}\n",
    "        chose_pair[\"arg2\"] = {\"mention\": pair[\"arg2\"][\"mention\"],\n",
    "                        \"start\": pair[\"arg2\"][\"start\"],\n",
    "                        \"end\": pair[\"arg2\"][\"end\"]}\n",
    "        chose_pair[\"relation\"] = pair[\"rel_type\"]\n",
    "        # print(chose_pair)\n",
    "        final_lst.append(chose_pair)\n",
    "\n",
    "\n",
    "with open(f'/users/the/NER_MTB/timeset/my_code_result/input_data/rel_label_task/tddiscourse/{mode}.json', 'w') as f:\n",
    "        json.dump(final_lst, f, indent=4) "
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.17"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
